molleo
{'population_size': 120, 'offspring_size': 70, 'mutation_rate': 0.0}
seed 0
custom_c-met_no_summary_2
MolFilter is using the following filters:
Rule_Glaxo: True
Rule_PAINS: True
Rule_SureChEMBL: True
Model: /home/ubuntu/LLaMA-Factory/output/llama3_sft_ppo_1200
Loading checkpoint shards:   0%|          | 0/4 [00:00<?, ?it/s]Loading checkpoint shards:  25%|██▌       | 1/4 [01:02<03:07, 62.42s/it]Loading checkpoint shards:  50%|█████     | 2/4 [02:40<02:46, 83.17s/it]Loading checkpoint shards:  75%|███████▌  | 3/4 [04:02<01:22, 82.85s/it]Loading checkpoint shards: 100%|██████████| 4/4 [04:15<00:00, 55.20s/it]Loading checkpoint shards: 100%|██████████| 4/4 [04:15<00:00, 63.85s/it]
120
CNC(=S)c1ccc(-c2cnc3ncc(Cc4cc(Cl)c5ncccc5c4)n3n2)cc1F

Boltz running on GPU 2
11.22
Cn1cc(-c2ccc(=O)n(CC3CN(c4ncc(OCC5CCNCC5)cn4)CCO3)n2)cn1

Boltz running on GPU 2
9.79
Fc1cc(F)cc(-c2ccc3nnc(CNc4ccnc5cc(OCCn6cncn6)cnc45)n3n2)c1

Boltz running on GPU 2
10.94
COc1ccc2c(OCc3nnc4ncc(-c5ccccc5)nn34)ccnc2c1

Boltz running on GPU 2
10.4
CCN1Cc2c(ccc(F)c2C#N)O[C@@H](C)CNC(=O)c2c(N)nn3ccc1nc23

Boltz running on GPU 2
11.2
CC/C(=N\N(C(N)=O)c1ccc(Oc2ccnc3cc(OCCCN4CCCCC4)c(OC)cc23)c(F)c1)c1ccccc1

Boltz running on GPU 2
9.53
Cc1c(O)ccc2nc(-c3cc(-c4cnn(C5CCNCC5)c4)cnc3N)oc12

Boltz running on GPU 2
8.83
N=C(NNC(N)=O)c1cnc2nnn(Cc3ccc4ncccc4c3)c2n1

Boltz running on GPU 2
11.39
CC(=NNC(N)=O)c1cnc2nnn(Cc3cc4cccnc4cc3F)c2n1

Boltz running on GPU 2
11.67
CC(=NNC(N)=O)c1ccc2nnc([C@@H](C)c3ccc4ncccc4c3)n2n1

Boltz running on GPU 2
11.42
Found local copy...
10/1000 | avg_top1: 11.670 | avg_top10: 10.639 | avg_top100: 10.639 | avg_sa: 3.196 | div: 0.835
{'avg_top1': 11.67, 'avg_top10': 10.639, 'avg_top100': 10.639, 'auc_top1': 0.05835, 'auc_top10': 0.05319499999999999, 'auc_top100': 0.05319499999999999, 'avg_sa': 3.1963304505386185, 'diversity_top100': 0.8346533798907555, 'n_oracle': 10}
CCN1CCC(n2cc(-c3cnc4ccc5ccc(NS(=O)(=O)N(C)C)cc5c(=O)c4c3)cn2)CC1

Boltz running on GPU 2
11.1
Cc1c(C(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)cc2)c(=O)n(-c2ccccc2)n1C

Boltz running on GPU 2
9.94
Fc1ccc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cc1

Boltz running on GPU 2
10.61
OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1

Boltz running on GPU 2
10.74
CC(c1ccc2ncc(-c3cnn(C)c3)cc2c1)n1nnc2ncc(-c3ccncc3)nc21

Boltz running on GPU 2
10.95
CC(c1c(F)cc2ncc(-c3cnn(C)c3)cc2c1F)n1nnc2ncc(-c3ccc(C(N)=O)c(F)c3)nc21

Boltz running on GPU 2
11.86
COc1ccc2c(OCc3nnc4c(F)cc(-c5cc(C)cs5)cn34)ccnc2c1

Boltz running on GPU 2
11.52
NC(=O)NN=Cc1cnc2nnn(Cc3ccc4ncccc4c3)c2n1

Boltz running on GPU 2
11.05
C[C@@H](Oc1c[nH]c(=O)c(C(=O)NC2CCOCC2)c1)c1c(Cl)ccc(F)c1Cl

Boltz running on GPU 2
10.94
COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CCO)n(-c5ccccc5)c4=O)nc3)ccnc2c1

Boltz running on GPU 2
10.34
20/1000 | avg_top1: 11.860 | avg_top10: 11.338 | avg_top100: 10.772 | avg_sa: 3.061 | div: 0.824
{'avg_top1': 11.86, 'avg_top10': 11.338, 'avg_top100': 10.772, 'auc_top1': 0.176, 'auc_top10': 0.16307999999999997, 'auc_top100': 0.16025, 'avg_sa': 3.0612029815217627, 'diversity_top100': 0.8240934320134674, 'n_oracle': 20}
CC(=O)NN=C(C)c1cnc2nnn(Cc3cc4cccnc4cc3F)c2n1

Boltz running on GPU 2
11.07
CC(N=O)c1ccc2nnc(Cc3c(F)cc4ncccc4c3F)n2n1

Boltz running on GPU 2
11.79
CC(c1c(F)cc2ncc(-c3cnn(C)c3)cc2c1F)n1nnc2ncc(-c3cnn(CCO)c3)nc21

Boltz running on GPU 2
11.72
Cn1cc(-c2ccc(=O)n(CCOc3ccnc4cc(OCc5ccc(C(=O)Nc6ccccc6N)cc5)ccc34)n2)cn1

Boltz running on GPU 2
9.42
CC(=NOC(N)=O)c1ccc2nnc([C@H](C)c3c(F)cc4ncccc4c3F)n2n1

Boltz running on GPU 2
11.2
Cc1c(C(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)c(=O)n(-c2ccccc2)n1C

Boltz running on GPU 2
10.25
O=C(Cc1ccc2c(c1)CCO2)N/N=C1\CNc2cc(C(=O)NCCCCN3CCC[C@H]3CO)cc(Br)c21

Boltz running on GPU 2
9.59
Cn1cc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1

Boltz running on GPU 2
11.31
Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6cnn(C)c6)cn45)c3c2)cn1

Boltz running on GPU 2
10.61
Cc1nc([C@H](C)NC(=O)c2ccc(-c3cnc4ncc(Cc5ccc6ncccc6c5)n4n3)cc2Cl)no1

Boltz running on GPU 2
10.52
30/1000 | avg_top1: 11.860 | avg_top10: 11.510 | avg_top100: 10.764 | avg_sa: 3.126 | div: 0.816
{'avg_top1': 11.86, 'avg_top10': 11.510000000000002, 'avg_top100': 10.764, 'auc_top1': 0.29460000000000003, 'auc_top10': 0.27732, 'auc_top100': 0.26793, 'avg_sa': 3.12557242125954, 'diversity_top100': 0.8158881682548839, 'n_oracle': 30}
O=C(NCCN1CCOCC1)Nc1nc2ccc(Sc3nnc4ccc(OC5CCCCC5)nn34)cc2s1

Boltz running on GPU 2
10.8
COc1ccc(-n2c(=O)c(C(=O)Nc3ccc(Oc4ccnc(N)c4Cl)c(F)c3)cc3ccccc32)cc1

Boltz running on GPU 2
9.56
C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl

Boltz running on GPU 2
11.17
COc1cc2nccc(Oc3ccc(NC(=O)c4c(I)ccn(-c5ccc(F)cc5)c4=O)cc3F)c2cc1OC

Boltz running on GPU 2
11.4
Cn1cc(-c2cnc3ccc4ccc(N)cc4c(=O)c3c2)cn1

Boltz running on GPU 2
10.8
Cc1cc(C)cc(-n2c(=O)c(C(=O)Nc3ccc(Oc4ccnc(N)c4Cl)c(F)c3)cc3ccccc32)c1

Boltz running on GPU 2
9.88
Cc1csc(-c2ccc3nnc(Cc4ccc5ncccc5c4)n3n2)c1

Boltz running on GPU 2
11.2
CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21

Boltz running on GPU 2
10.8
O=C(NCC1CCCCN1)c1ccc(-c2cc(F)c3ncc(Cc4ccc5ncccc5c4)n3c2)cc1F

Boltz running on GPU 2
10.9
O=[N+]([O-])c1cccc(CNc2cc(C(F)(F)F)cc3ncc(N4CCOCC4)cc23)c1

Boltz running on GPU 2
10.28
40/1000 | avg_top1: 11.860 | avg_top10: 11.530 | avg_top100: 10.743 | avg_sa: 3.043 | div: 0.823
{'avg_top1': 11.86, 'avg_top10': 11.53, 'avg_top100': 10.742750000000001, 'auc_top1': 0.41320000000000007, 'auc_top10': 0.39252, 'auc_top100': 0.37546375, 'avg_sa': 3.0431176690414206, 'diversity_top100': 0.8233563130071617, 'n_oracle': 40}
Cc1cc(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(N[C@H](C)CO)c34)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1

Boltz running on GPU 2
11.32
O=[N+]([O-])c1cccc(CNc2cc(C(F)(F)F)cc3ncc(N4CCN(S(=O)(=O)C5CC5)CC4)cc23)c1

Boltz running on GPU 2
9.52
O=c1ccc(-n2ccc3ccc(F)cc32)nn1CCOc1ccnc2cc(OCCCN3CCOCC3)ccc12

Boltz running on GPU 2
11.57
C[C@@H](Oc1cc(-c2ccn(C3CCNCC3)n2)cnc1N)c1c(Cl)ccc(F)c1Cl

Boltz running on GPU 2
10.19
Cn1ccnc1-c1cc2c(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)ccnc2s1

Boltz running on GPU 2
9.43
Cn1cc(-c2ccc3nnc(Sc4ccc5ncc(NCCO)cc5c4)n3c2)cn1

Boltz running on GPU 2
11.09
C#Cc1c(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)ccnc1N

Boltz running on GPU 2
9.93
N#Cc1cc(-c2cnc3nnn(CC4CN(c5ncc(-c6cnn(CCO)c6)cn5)CCO4)c3n2)ccc1F

Boltz running on GPU 2
9.83
COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1

Boltz running on GPU 2
10.04
CN1CCC(Nc2cnc3ccc(Sc4nnc5c(F)cc(-c6cnn(C)c6)cn45)cc3c2)CC1

Boltz running on GPU 2
11.09
50/1000 | avg_top1: 11.860 | avg_top10: 11.566 | avg_top100: 10.674 | avg_sa: 3.041 | div: 0.826
{'avg_top1': 11.86, 'avg_top10': 11.565999999999999, 'avg_top100': 10.6744, 'auc_top1': 0.5318, 'auc_top10': 0.508, 'auc_top100': 0.48254949999999996, 'avg_sa': 3.041323386589125, 'diversity_top100': 0.8261393238175742, 'n_oracle': 50}
Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c12

Boltz running on GPU 2
10.5
Cn1cc(-c2ccc3c(OCCn4c(=O)oc5cc(-c6cnn(C)c6)ccc54)ccnc3c2)cn1

Boltz running on GPU 2
10.47
Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1

Boltz running on GPU 2
10.3
COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2N(C)S(C)(=O)=O)n1

Boltz running on GPU 2
10.95
Cc1csc(-c2ccc3nnc(Cc4ccc(O)cc4)n3n2)c1

Boltz running on GPU 2
9.47
CC(c1c(F)cc2ncccc2c1F)n1cnc2ncc(-c3cnn(C)c3)nc21

Boltz running on GPU 2
10.95
CC1=NC(C)=C(C#N)C(c2ccc3[nH]nc(OCCOC(C)C)c3c2)C1C#N

Boltz running on GPU 2
9.45
COc1cnc2ccc([C@H](C)c3nnc4c(F)cc(-c5cn(C)cn5)cn34)cc2c1

Boltz running on GPU 2
11.42
COCCOc1cnc2ccn([C@H](C)c3nnc4c(F)cc(-c5cc(C)no5)cn34)c(=O)c2c1

Boltz running on GPU 2
11.18
N#Cc1cccc(-c2ccc(=O)n(Cc3cccc(-c4ncc(OCCN5CCOCC5)cn4)c3)n2)c1

Boltz running on GPU 2
10.38
60/1000 | avg_top1: 11.860 | avg_top10: 11.576 | avg_top100: 10.646 | avg_sa: 3.039 | div: 0.833
{'avg_top1': 11.86, 'avg_top10': 11.576, 'avg_top100': 10.6465, 'auc_top1': 0.6504000000000001, 'auc_top10': 0.62371, 'auc_top100': 0.589154, 'avg_sa': 3.038787448506568, 'diversity_top100': 0.8325766679951144, 'n_oracle': 60}
[C-]#[N+]C1C(C)=NC2=C(C(=O)OC2)C1c1ccc2n[nH]c(C)c2c1

Boltz running on GPU 2
10.35
CC(c1c(F)cc2ncccc2c1F)n1cnc2ncc(-c3cnn(CCO)c3)nc21

Boltz running on GPU 2
11.12
CNC(=O)c1ccc(-c2ccc3nnc(Cc4ccc(O)cc4)n3n2)cc1Cl

Boltz running on GPU 2
10.6
[C-]#[N+]C1=C(C)Nc2oncc2C1c1ccc2[nH]nc(OC)c2c1

Boltz running on GPU 2
9.24
Cc1cc(=O)n(-c2ccc(F)cc2)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1

Boltz running on GPU 2
8.49
C[C@H](c1cccc(-c2ncc(OCC3CCN(C)CC3)cn2)c1)n1cc(-c2cc(C#N)ccn2)cc(F)c1=O

Boltz running on GPU 2
10.34
CCn1cc(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(N[C@@H](C)COC)c34)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O

Boltz running on GPU 2
10.63
COc1cc2c(Oc3ccc(N=Cc4c(O)n(-c5ccc(C)cc5)c(=O)[nH]c4=O)cc3F)ccnc2cc1OCCCN1CCCC1

Boltz running on GPU 2
10.35
C[C@@H](c1cc2cccnc2cc1F)n1cnc2ncc(-c3ccc(C(N)=O)c(F)c3)nc21

Boltz running on GPU 2
10.9
O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cccc(-c2ccccc2)[n+]1[O-]

Boltz running on GPU 2
10.33
70/1000 | avg_top1: 11.860 | avg_top10: 11.576 | avg_top100: 10.588 | avg_sa: 3.075 | div: 0.835
{'avg_top1': 11.86, 'avg_top10': 11.576, 'avg_top100': 10.587714285714286, 'auc_top1': 0.7690000000000001, 'auc_top10': 0.7394700000000001, 'auc_top100': 0.6953250714285714, 'avg_sa': 3.0749616173239893, 'diversity_top100': 0.8347962600705654, 'n_oracle': 70}
COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC

Boltz running on GPU 2
10.3
Cc1ccc(Cl)c2c1NC(=O)C2=NNC(=O)[C@@H](C)c1ccc(O)cc1

Boltz running on GPU 2
9.62
COc1cc2c(Oc3ccc(NC(=O)NN=Cc4ccc(F)cc4F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1

Boltz running on GPU 2
10.99
COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)NC5=CCC(F)C=C5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1

Boltz running on GPU 2
11.36
O=C(Nc1ccc(Oc2ccnc(NC(=O)N3CCC3)c2)c(F)c1)c1cn(CC2CC2)c(=O)n(-c2ccc(F)cc2)c1=O

Boltz running on GPU 2
11.71
NC1CCC(=Cc2ccn3ncnc(Oc4ccc(NC(=O)NC(=O)Cc5ccc(F)cc5)cc4F)c23)CC1

Boltz running on GPU 2
8.97
CCC(c1ccc2ncccc2c1F)n1cnc2ncc(-c3ccc(C(N)=O)c(F)c3)nc21

Boltz running on GPU 2
10.71
Nc1ncnc2[nH]cc(-c3cc(F)c(NC(=O)c4cn(CC5CCOCC5)cc(-c5ccc(F)cc5)c4=O)cc3F)c12

Boltz running on GPU 2
11.42
Nc1nccc(Oc2ccc(NC(=O)c3c[nH]cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl

Boltz running on GPU 2
9.52
O=C(Nc1ccc(Oc2ccc3nc(NC(=O)C4CC4)cn3c2)c(F)c1)c1cccn(-c2ccccc2)c1=O

Boltz running on GPU 2
10.18
80/1000 | avg_top1: 11.860 | avg_top10: 11.610 | avg_top100: 10.574 | avg_sa: 3.063 | div: 0.834
{'avg_top1': 11.86, 'avg_top10': 11.61, 'avg_top100': 10.574, 'auc_top1': 0.8876000000000002, 'auc_top10': 0.8554, 'auc_top100': 0.8011336428571428, 'avg_sa': 3.063418382809787, 'diversity_top100': 0.8336594325423045, 'n_oracle': 80}
CN1CCN(CCOc2cnc(-c3cccc(Cn4nc(-n5ccc6ccc(F)cc65)ccc4=O)c3)nc2)CC1

Boltz running on GPU 2
11.18
N#Cc1cccc(-c2cc(F)c3ncc(Cc4ccc5ncccc5c4)n3c2)c1

Boltz running on GPU 2
11.07
Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12

Boltz running on GPU 2
10.58
CO/N=C(\C)c1ccc2ncc(Cc3c(F)cc4ncccc4c3F)n2n1

Boltz running on GPU 2
10.95
CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C(C)=O)CC3)ncc1Cl

Boltz running on GPU 2
11.28
O=C(Nc1ccc(Oc2ccnc(NC(=O)C3CC3)c2)cc1)c1nc2ccccc2n(-c2ccc(F)cc2)c1=O

Boltz running on GPU 2
10.76
Cn1cc(-c2ccc3nnc(Cc4cccc5c(=O)[nH]ccc45)n3n2)cn1

Boltz running on GPU 2
10.34
COc1ccc2c(OCc3nnc4sc(-c5cnn(C)c5)nn34)ccnc2c1

Boltz running on GPU 2
10.23
O=C(Cc1ccc(F)cc1)NC(=O)Nc1ccc(Oc2ccnc3[nH]cc(-c4cccnc4)c23)c(F)c1

Boltz running on GPU 2
9.82
COc1cnc2ccc([C@H](C)c3nnc4c(F)cc(-c5cc(C)no5)cn34)cc2c1

Boltz running on GPU 2
11.12
90/1000 | avg_top1: 11.860 | avg_top10: 11.610 | avg_top100: 10.592 | avg_sa: 3.033 | div: 0.834
{'avg_top1': 11.86, 'avg_top10': 11.61, 'avg_top100': 10.591666666666667, 'auc_top1': 1.0062000000000002, 'auc_top10': 0.9715000000000001, 'auc_top100': 0.9069619761904762, 'avg_sa': 3.0334189944182386, 'diversity_top100': 0.833869937008448, 'n_oracle': 90}
COCCOc1cnc2ccc([C@H](C)n3nnc4ccn(-c5cc(C)ns5)c(=O)c43)cc2c1

Boltz running on GPU 2
11.39
Cn1cc(-c2cnc3nnn(CC4CCCN(c5ncc(-c6cnn(CCO)c6)cn5)C4)c3n2)cn1

Boltz running on GPU 2
10.76
c1cc2ncc(N3CCOCC3)cc2cc1Sc1nnc2ccc(-c3cn[nH]c3)cn12

Boltz running on GPU 2
11.09
[C-]#[N+]C1=C(c2ccc(F)cc2F)N=C2COC(=O)C2C1c1ccc2n[nH]c(C)c2c1

Boltz running on GPU 2
10.1
N#Cc1cc(-c2cnc3nnn(C[C@@H]4CN(c5ncc(C6=CCNCC6)cn5)CCO4)c3n2)ccc1F

Boltz running on GPU 2
10.56
COCCOc1cnc2ccc([C@H](C)n3nnc4ccn(-c5cccs5)c(=O)c43)cc2c1

Boltz running on GPU 2
10.93
CC(=NNC(N)=O)c1ccc2ncc(C(O)c3c(F)cc4ncccc4c3F)n2n1

Boltz running on GPU 2
11.5
CNc1snc(SCc2nnc3ncc(-c4ccc(F)cc4)nn23)c1C(N)=O

Boltz running on GPU 2
10.65
[C-]#[N+]C1=C2COCCN2C2=C(C(=O)OC2)C1c1ccc2[nH]nc(C)c2c1

Boltz running on GPU 2
10.9
CCN1CCC(COc2cnc(-c3cccc(Cn4c(=O)ccn5c6cc(C#N)ccc6nc45)c3)nc2)CC1

Boltz running on GPU 2
10.31
100/1000 | avg_top1: 11.860 | avg_top10: 11.618 | avg_top100: 10.614 | avg_sa: 3.082 | div: 0.838
{'avg_top1': 11.86, 'avg_top10': 11.618, 'avg_top100': 10.614399999999998, 'auc_top1': 1.1248000000000002, 'auc_top10': 1.0876400000000002, 'auc_top100': 1.0129923095238096, 'avg_sa': 3.082062843785506, 'diversity_top100': 0.838201655284592, 'n_oracle': 100}
Cc1c(OCC(O)CN2CCC(O)CC2)cn2ncnc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12

Boltz running on GPU 2
10.89
CNC(=O)c1ccc(-c2ccc3nnc(COc4ccnc5cc(OC)ccc45)n3c2)s1

Boltz running on GPU 2
11.21
O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cc2cccnc2n(-c2ccc(Cl)cc2)c1=O

Boltz running on GPU 2
9.44
COc1cc2nccc(Oc3ccc(NC(=O)C(OC(=O)c4ccc(F)cc4)C(C)(C)C)cc3F)c2cc1OC

Boltz running on GPU 2
10.46
Cc1cc2ccnc(Nc3ccc(Oc4ccnc(N)c4I)c(F)c3)c2c(=O)n1-c1ccc(F)cc1

Boltz running on GPU 2
10.92
C/C(=N\OCCCO)c1ccc2nnc(Cc3c(F)cc4ncccc4c3F)n2n1

Boltz running on GPU 2
11.55
COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)c(F)c5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1

Boltz running on GPU 2
9.72
CC(NC/N=C/c1cnn(C)c1)c1ccc2ncccc2c1

Boltz running on GPU 2
10.19
O=C(Nc1cccc(CC(=O)N2CCC(c3cc(Cl)ccc3Cl)=N2)c1)OCCCN1CCOCC1

Boltz running on GPU 2
9.06
Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1

Boltz running on GPU 2
10.42
110/1000 | avg_top1: 11.860 | avg_top10: 11.631 | avg_top100: 10.735 | avg_sa: 3.080 | div: 0.833
{'avg_top1': 11.86, 'avg_top10': 11.631, 'avg_top100': 10.734999999999998, 'auc_top1': 1.2434, 'auc_top10': 1.2038850000000003, 'auc_top100': 1.1197393095238097, 'avg_sa': 3.0795202990448725, 'diversity_top100': 0.8331934213459512, 'n_oracle': 110}
CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(F)cc4)c3=O)cc2)ccn1

Boltz running on GPU 2
9.45
COc1cnc2ccc([C@H](C)c3nnc4ccc(-c5ccccc5)nn34)cc2c1

Boltz running on GPU 2
10.63
CN(C)CCCOc1cnc(-c2cccc(Cn3nc(-c4cc(F)cc(F)c4)ccc3=O)c2)nc1

Boltz running on GPU 2
9.74
CN1CCN(c2cnc3cc(C(F)(F)F)cc(OCc4cccc([N+](=O)[O-])c4)c3c2)CC1

Boltz running on GPU 2
9.79
Cc1c(C(C)n2cnc3ncc(-c4cn[nH]c4)nc32)ccc2ncccc12

Boltz running on GPU 2
9.93
O=C(Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1)C1CC1

Boltz running on GPU 2
10.49
CNC(=O)c1ccc(-c2ccc(=O)n(CCc3ccc4ncc(-c5cnn(CCO)c5)cc4c3)n2)cc1C(F)(F)F

Boltz running on GPU 2
11.8
FC(F)(c1ccc2ncccc2c1)c1nnc2ncc(-c3ccccc3)nn12

Boltz running on GPU 2
10.21
C[C@@H](c1ccc2ncccc2c1)n1nnc2ncc(-c3cnn(CCO)c3)nc21

Boltz running on GPU 2
11.3
O=C1NCCCCn2cc(cn2)-c2cnc3ccc(cc3c2)CCn2nc(ccc2=O)-c2ccc1c(C(F)(F)F)c2

Boltz running on GPU 2
12.05
120/1000 | avg_top1: 12.050 | avg_top10: 11.724 | avg_top100: 10.828 | avg_sa: 3.110 | div: 0.831
{'avg_top1': 12.05, 'avg_top10': 11.724, 'avg_top100': 10.828499999999998, 'auc_top1': 1.36295, 'auc_top10': 1.3206600000000004, 'auc_top100': 1.2275568095238096, 'avg_sa': 3.110125665722502, 'diversity_top100': 0.8309237393984792, 'n_oracle': 120}
[(11.22, <rdkit.Chem.rdchem.Mol object at 0x761912392a50>), (9.79, <rdkit.Chem.rdchem.Mol object at 0x7619123929e0>), (10.94, <rdkit.Chem.rdchem.Mol object at 0x761912392890>), (10.4, <rdkit.Chem.rdchem.Mol object at 0x7619123926d0>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912392350>), (9.53, <rdkit.Chem.rdchem.Mol object at 0x761912392200>), (8.83, <rdkit.Chem.rdchem.Mol object at 0x761912392190>), (11.39, <rdkit.Chem.rdchem.Mol object at 0x761912392f90>), (11.67, <rdkit.Chem.rdchem.Mol object at 0x761912392f20>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912392eb0>), (11.1, <rdkit.Chem.rdchem.Mol object at 0x761912392e40>), (9.94, <rdkit.Chem.rdchem.Mol object at 0x761912392dd0>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x761912392c80>), (10.74, <rdkit.Chem.rdchem.Mol object at 0x761912392c10>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912392ba0>), (11.86, <rdkit.Chem.rdchem.Mol object at 0x761912392b30>), (11.52, <rdkit.Chem.rdchem.Mol object at 0x761912392ac0>), (11.05, <rdkit.Chem.rdchem.Mol object at 0x761912392970>), (10.94, <rdkit.Chem.rdchem.Mol object at 0x761912392900>), (10.34, <rdkit.Chem.rdchem.Mol object at 0x761912392820>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x7619123927b0>), (11.79, <rdkit.Chem.rdchem.Mol object at 0x761912392740>), (11.72, <rdkit.Chem.rdchem.Mol object at 0x761912392660>), (9.42, <rdkit.Chem.rdchem.Mol object at 0x761912392580>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912392510>), (10.25, <rdkit.Chem.rdchem.Mol object at 0x7619123924a0>), (9.59, <rdkit.Chem.rdchem.Mol object at 0x761912392430>), (11.31, <rdkit.Chem.rdchem.Mol object at 0x7619123923c0>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x7619123922e0>), (10.52, <rdkit.Chem.rdchem.Mol object at 0x761912392270>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912392120>), (9.56, <rdkit.Chem.rdchem.Mol object at 0x761912392040>), (11.17, <rdkit.Chem.rdchem.Mol object at 0x7619123d0970>), (11.4, <rdkit.Chem.rdchem.Mol object at 0x7619123d0510>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x7619123d09e0>), (9.88, <rdkit.Chem.rdchem.Mol object at 0x761912379f90>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912379eb0>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912379e40>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912379dd0>), (10.28, <rdkit.Chem.rdchem.Mol object at 0x761912379d60>), (11.32, <rdkit.Chem.rdchem.Mol object at 0x761912379cf0>), (9.52, <rdkit.Chem.rdchem.Mol object at 0x761912379270>), (11.57, <rdkit.Chem.rdchem.Mol object at 0x7619123790b0>), (10.19, <rdkit.Chem.rdchem.Mol object at 0x761912356740>), (9.43, <rdkit.Chem.rdchem.Mol object at 0x761912356ac0>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356b30>), (9.93, <rdkit.Chem.rdchem.Mol object at 0x761912356c10>), (9.83, <rdkit.Chem.rdchem.Mol object at 0x761912356ba0>), (10.04, <rdkit.Chem.rdchem.Mol object at 0x761912356c80>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356cf0>), (10.5, <rdkit.Chem.rdchem.Mol object at 0x761912356d60>), (10.47, <rdkit.Chem.rdchem.Mol object at 0x761912356dd0>), (10.3, <rdkit.Chem.rdchem.Mol object at 0x761912356e40>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356eb0>), (9.47, <rdkit.Chem.rdchem.Mol object at 0x761912356f20>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356f90>), (9.45, <rdkit.Chem.rdchem.Mol object at 0x761912356660>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x7619123566d0>), (11.18, <rdkit.Chem.rdchem.Mol object at 0x761912356820>), (10.38, <rdkit.Chem.rdchem.Mol object at 0x7619123567b0>), (10.35, <rdkit.Chem.rdchem.Mol object at 0x761912356890>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912356900>), (10.6, <rdkit.Chem.rdchem.Mol object at 0x761912356970>), (9.24, <rdkit.Chem.rdchem.Mol object at 0x7619123569e0>), (8.49, <rdkit.Chem.rdchem.Mol object at 0x761912356a50>), (10.34, <rdkit.Chem.rdchem.Mol object at 0x761912365040>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123650b0>), (10.35, <rdkit.Chem.rdchem.Mol object at 0x761912365120>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365190>), (10.33, <rdkit.Chem.rdchem.Mol object at 0x761912365200>), (10.3, <rdkit.Chem.rdchem.Mol object at 0x761912365270>), (9.62, <rdkit.Chem.rdchem.Mol object at 0x7619123652e0>), (10.99, <rdkit.Chem.rdchem.Mol object at 0x761912365350>), (11.36, <rdkit.Chem.rdchem.Mol object at 0x7619123653c0>), (11.71, <rdkit.Chem.rdchem.Mol object at 0x761912365430>), (8.97, <rdkit.Chem.rdchem.Mol object at 0x7619123654a0>), (10.71, <rdkit.Chem.rdchem.Mol object at 0x761912365510>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912365580>), (9.52, <rdkit.Chem.rdchem.Mol object at 0x7619123655f0>), (10.18, <rdkit.Chem.rdchem.Mol object at 0x761912365660>), (11.18, <rdkit.Chem.rdchem.Mol object at 0x7619123656d0>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x761912365740>), (10.58, <rdkit.Chem.rdchem.Mol object at 0x7619123657b0>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912365820>), (11.28, <rdkit.Chem.rdchem.Mol object at 0x761912365890>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365900>), (10.34, <rdkit.Chem.rdchem.Mol object at 0x761912365970>), (10.23, <rdkit.Chem.rdchem.Mol object at 0x7619123659e0>), (9.82, <rdkit.Chem.rdchem.Mol object at 0x761912365a50>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912365ac0>), (11.39, <rdkit.Chem.rdchem.Mol object at 0x761912365b30>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365ba0>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912365c10>), (10.1, <rdkit.Chem.rdchem.Mol object at 0x761912365c80>), (10.56, <rdkit.Chem.rdchem.Mol object at 0x761912365cf0>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761912365d60>), (11.5, <rdkit.Chem.rdchem.Mol object at 0x761912365dd0>), (10.65, <rdkit.Chem.rdchem.Mol object at 0x761912365e40>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365eb0>), (10.31, <rdkit.Chem.rdchem.Mol object at 0x761912365f20>), (10.89, <rdkit.Chem.rdchem.Mol object at 0x761912365f90>), (11.21, <rdkit.Chem.rdchem.Mol object at 0x761912363040>), (9.44, <rdkit.Chem.rdchem.Mol object at 0x7619123630b0>), (10.46, <rdkit.Chem.rdchem.Mol object at 0x761912363120>), (10.92, <rdkit.Chem.rdchem.Mol object at 0x761912363190>), (11.55, <rdkit.Chem.rdchem.Mol object at 0x761912363200>), (9.72, <rdkit.Chem.rdchem.Mol object at 0x761912363270>), (10.19, <rdkit.Chem.rdchem.Mol object at 0x7619123632e0>), (9.06, <rdkit.Chem.rdchem.Mol object at 0x761912363350>), (10.42, <rdkit.Chem.rdchem.Mol object at 0x7619123633c0>), (9.45, <rdkit.Chem.rdchem.Mol object at 0x761912363430>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123634a0>), (9.74, <rdkit.Chem.rdchem.Mol object at 0x761912363510>), (9.79, <rdkit.Chem.rdchem.Mol object at 0x761912363580>), (9.93, <rdkit.Chem.rdchem.Mol object at 0x7619123635f0>), (10.49, <rdkit.Chem.rdchem.Mol object at 0x761912363660>), (11.8, <rdkit.Chem.rdchem.Mol object at 0x7619123636d0>), (10.21, <rdkit.Chem.rdchem.Mol object at 0x761912363740>), (11.3, <rdkit.Chem.rdchem.Mol object at 0x7619123637b0>), (12.05, <rdkit.Chem.rdchem.Mol object at 0x761912363820>)]
[0.008829848350104308, 0.007704475521179474, 0.008609495628356787, 0.008184529664986572, 0.008814108869979484, 0.007499862279556777, 0.006948980475187979, 0.008963633931165301, 0.009183986652912821, 0.008987243151352535, 0.00873541146935537, 0.007822521622115646, 0.008349794206297211, 0.00845210082710856, 0.008617365368419198, 0.009333511714098637, 0.00906594055197665, 0.008696062769043314, 0.008609495628356787, 0.008137311224612103, 0.008711802249168137, 0.009278423533661758, 0.009223335353224879, 0.007413295138870252, 0.008814108869979484, 0.0080664835640504, 0.007547080719931246, 0.008900676010666011, 0.008349794206297211, 0.008278966545735508, 0.008499319267483029, 0.007523471499744013, 0.00879049964979225, 0.008971503671227713, 0.008499319267483029, 0.007775303181741178, 0.008814108869979484, 0.008499319267483029, 0.008578016668107142, 0.008090092784237633, 0.008908545750728422, 0.007491992539494366, 0.009105289252288708, 0.008019265123675932, 0.007421164878932664, 0.00872754172929296, 0.007814651882053235, 0.00773595448142912, 0.007901219022739759, 0.00872754172929296, 0.008263227065610685, 0.008239617845423451, 0.008105832264362458, 0.008617365368419198, 0.00745264383918231, 0.008617365368419198, 0.007436904359057486, 0.008987243151352535, 0.008798369389854661, 0.00816879018486175, 0.008145180964674514, 0.008751150949480193, 0.0083419244662348, 0.007271639817746847, 0.006681409313065991, 0.008137311224612103, 0.008365533686422035, 0.008145180964674514, 0.008578016668107142, 0.008129441484549691, 0.008105832264362458, 0.00757068994011848, 0.008648844328668845, 0.008940024710978068, 0.009215465613162468, 0.007059156836061739, 0.008428491606921325, 0.008987243151352535, 0.007491992539494366, 0.00801139538361352, 0.008798369389854661, 0.008711802249168137, 0.008326184986109977, 0.008617365368419198, 0.008877066790478776, 0.008467840307233382, 0.008137311224612103, 0.008050744083925577, 0.007728084741366709, 0.008751150949480193, 0.008963633931165301, 0.008467840307233382, 0.00872754172929296, 0.007948437463114228, 0.008310445505985154, 0.008601625888294375, 0.009050201071851827, 0.008381273166546858, 0.008578016668107142, 0.008113702004424869, 0.00857014692804473, 0.008821978610041897, 0.007429034618995075, 0.00823174810536104, 0.008593756148231964, 0.009089549772163886, 0.007649387340742595, 0.008019265123675932, 0.007129984496623442, 0.008200269145111395, 0.007436904359057486, 0.008365533686422035, 0.007665126820867418, 0.007704475521179474, 0.007814651882053235, 0.008255357325548274, 0.009286293273724171, 0.008035004603800754, 0.0088928062706036, 0.009483036775284455]
[(10.34, <rdkit.Chem.rdchem.Mol object at 0x761912365040>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365900>), (10.99, <rdkit.Chem.rdchem.Mol object at 0x761912365350>), (10.34, <rdkit.Chem.rdchem.Mol object at 0x761912365040>), (10.5, <rdkit.Chem.rdchem.Mol object at 0x761912356d60>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912365580>), (10.3, <rdkit.Chem.rdchem.Mol object at 0x761912356e40>), (9.72, <rdkit.Chem.rdchem.Mol object at 0x761912363270>), (10.49, <rdkit.Chem.rdchem.Mol object at 0x761912363660>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356b30>), (10.56, <rdkit.Chem.rdchem.Mol object at 0x761912365cf0>), (9.24, <rdkit.Chem.rdchem.Mol object at 0x7619123569e0>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365190>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123634a0>), (11.67, <rdkit.Chem.rdchem.Mol object at 0x761912392f20>), (11.1, <rdkit.Chem.rdchem.Mol object at 0x761912392e40>), (10.94, <rdkit.Chem.rdchem.Mol object at 0x761912392890>), (10.31, <rdkit.Chem.rdchem.Mol object at 0x761912365f20>), (10.1, <rdkit.Chem.rdchem.Mol object at 0x761912365c80>), (10.92, <rdkit.Chem.rdchem.Mol object at 0x761912363190>), (10.21, <rdkit.Chem.rdchem.Mol object at 0x761912363740>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761912365d60>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356f90>), (10.1, <rdkit.Chem.rdchem.Mol object at 0x761912365c80>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912392ba0>), (10.71, <rdkit.Chem.rdchem.Mol object at 0x761912365510>), (11.52, <rdkit.Chem.rdchem.Mol object at 0x761912392ac0>), (9.79, <rdkit.Chem.rdchem.Mol object at 0x761912363580>), (10.6, <rdkit.Chem.rdchem.Mol object at 0x761912356970>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356cf0>), (9.56, <rdkit.Chem.rdchem.Mol object at 0x761912392040>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912365c10>), (9.47, <rdkit.Chem.rdchem.Mol object at 0x761912356f20>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365190>), (10.94, <rdkit.Chem.rdchem.Mol object at 0x761912392890>), (11.71, <rdkit.Chem.rdchem.Mol object at 0x761912365430>), (11.36, <rdkit.Chem.rdchem.Mol object at 0x7619123653c0>), (11.71, <rdkit.Chem.rdchem.Mol object at 0x761912365430>), (9.79, <rdkit.Chem.rdchem.Mol object at 0x761912363580>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x761912365740>), (11.57, <rdkit.Chem.rdchem.Mol object at 0x7619123790b0>), (10.3, <rdkit.Chem.rdchem.Mol object at 0x761912356e40>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912365820>), (11.39, <rdkit.Chem.rdchem.Mol object at 0x761912392f90>), (11.18, <rdkit.Chem.rdchem.Mol object at 0x7619123656d0>), (11.18, <rdkit.Chem.rdchem.Mol object at 0x7619123656d0>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912392510>), (11.86, <rdkit.Chem.rdchem.Mol object at 0x761912392b30>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912379e40>), (10.19, <rdkit.Chem.rdchem.Mol object at 0x761912356740>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365190>), (10.3, <rdkit.Chem.rdchem.Mol object at 0x761912356e40>), (11.3, <rdkit.Chem.rdchem.Mol object at 0x7619123637b0>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x761912392c80>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912392510>), (10.94, <rdkit.Chem.rdchem.Mol object at 0x761912392900>), (9.52, <rdkit.Chem.rdchem.Mol object at 0x7619123655f0>), (10.52, <rdkit.Chem.rdchem.Mol object at 0x761912392270>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356f90>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x7619123922e0>), (10.94, <rdkit.Chem.rdchem.Mol object at 0x761912392900>), (10.74, <rdkit.Chem.rdchem.Mol object at 0x761912392c10>), (9.52, <rdkit.Chem.rdchem.Mol object at 0x7619123655f0>), (11.52, <rdkit.Chem.rdchem.Mol object at 0x761912392ac0>), (11.72, <rdkit.Chem.rdchem.Mol object at 0x761912392660>), (10.19, <rdkit.Chem.rdchem.Mol object at 0x761912356740>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365eb0>), (9.94, <rdkit.Chem.rdchem.Mol object at 0x761912392dd0>), (10.89, <rdkit.Chem.rdchem.Mol object at 0x761912365f90>), (9.94, <rdkit.Chem.rdchem.Mol object at 0x761912392dd0>), (10.21, <rdkit.Chem.rdchem.Mol object at 0x761912363740>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356f90>), (10.21, <rdkit.Chem.rdchem.Mol object at 0x761912363740>), (10.99, <rdkit.Chem.rdchem.Mol object at 0x761912365350>), (9.82, <rdkit.Chem.rdchem.Mol object at 0x761912365a50>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912392350>), (11.4, <rdkit.Chem.rdchem.Mol object at 0x7619123d0510>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912392ba0>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x7619123d09e0>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912392ba0>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912379e40>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356cf0>), (11.39, <rdkit.Chem.rdchem.Mol object at 0x761912392f90>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912365820>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365190>), (9.56, <rdkit.Chem.rdchem.Mol object at 0x761912392040>), (10.6, <rdkit.Chem.rdchem.Mol object at 0x761912356970>), (9.94, <rdkit.Chem.rdchem.Mol object at 0x761912392dd0>), (10.33, <rdkit.Chem.rdchem.Mol object at 0x761912365200>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123634a0>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912379e40>), (11.18, <rdkit.Chem.rdchem.Mol object at 0x7619123656d0>), (11.86, <rdkit.Chem.rdchem.Mol object at 0x761912392b30>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365900>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x7619123d09e0>), (11.79, <rdkit.Chem.rdchem.Mol object at 0x761912392740>), (10.3, <rdkit.Chem.rdchem.Mol object at 0x761912365270>), (10.94, <rdkit.Chem.rdchem.Mol object at 0x761912392890>), (10.31, <rdkit.Chem.rdchem.Mol object at 0x761912365f20>), (11.22, <rdkit.Chem.rdchem.Mol object at 0x761912392a50>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x761912365740>), (9.56, <rdkit.Chem.rdchem.Mol object at 0x761912392040>), (9.82, <rdkit.Chem.rdchem.Mol object at 0x761912365a50>), (10.49, <rdkit.Chem.rdchem.Mol object at 0x761912363660>), (10.52, <rdkit.Chem.rdchem.Mol object at 0x761912392270>), (10.33, <rdkit.Chem.rdchem.Mol object at 0x761912365200>), (9.62, <rdkit.Chem.rdchem.Mol object at 0x7619123652e0>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365190>), (9.59, <rdkit.Chem.rdchem.Mol object at 0x761912392430>), (9.93, <rdkit.Chem.rdchem.Mol object at 0x7619123635f0>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356eb0>), (11.21, <rdkit.Chem.rdchem.Mol object at 0x761912363040>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912365820>), (9.88, <rdkit.Chem.rdchem.Mol object at 0x761912379f90>), (10.65, <rdkit.Chem.rdchem.Mol object at 0x761912365e40>), (9.83, <rdkit.Chem.rdchem.Mol object at 0x761912356ba0>), (11.55, <rdkit.Chem.rdchem.Mol object at 0x761912363200>), (10.33, <rdkit.Chem.rdchem.Mol object at 0x761912365200>), (11.55, <rdkit.Chem.rdchem.Mol object at 0x761912363200>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912365820>)]
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(Cc1ccc2c(c1)CCO2)N/N=C1\CNc2cc(C(=O)NCCCCN3CCC[C@H]3CO)cc(Br)c21,-9.59]
[C[C@@H](Oc1cc(-c2ccn(C3CCNCC3)n2)cnc1N)c1c(Cl)ccc(F)c1Cl,-10.19]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity in favorable regions, and optimize aromatic interactions. The first molecule has promising amide and hydrazone linkages supporting hydrogen bonding, while the second molecule uses heterocycles and halogen substitutions for hydrophobic and electronic effects.

Comparing the two, the second molecule has potentially better aromatic stacking and halogen bonding, but its binding affinity is slightly lower. To close this gap, I would consider replacing the more flexible but possibly solvation-penalty-rich linker in the first molecule with a more rigid, heterocyclic scaffold that maintains or improves hydrogen bonding and electronic complementarity.

Specifically, I would propose a fused bicyclic core with an embedded lactam ring to increase rigidity and a hydrazone linkage attached to a piperazine-containing side chain to maintain hydrogen bonding and enhance solubility. This design combines the beneficial features from both molecules and adds a more defined conformational framework.

Therefore, the new molecule I generate is:

\box{CC1CN(C(=O)NN=Cc2cc(C(=O)NCCN3CCC[C@H]3CO)cc(Br)c21)C(=O)C(C)C1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 1
NON-LLM GENERATED: O=C(C=CCl)NCCCCN1CCCC1CO
O=C(C=CCl)NCCCCN1CCCC1CO

Boltz running on GPU 2
6.93
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COc1ccc(-n2c(=O)c(C(=O)Nc3ccc(Oc4ccnc(N)c4Cl)c(F)c3)cc3ccccc32)cc1,-9.56]
[CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21,-10.8]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase planarity for better stacking interactions, and introduce groups that interact well with the binding pocket without adding too much steric hindrance. Both initial molecules show that incorporating heterocycles and maintaining the amide linkage are beneficial. The second molecule's thiophene ring and methylated triazole improve affinity, suggesting that these groups provide favorable electronic or spatial complementarity.

To build on this, I would replace the methylated triazole with a more planar pyridine ring to potentially enhance π-stacking and stack multiple aromatic systems. I would also introduce a fluorine-substituted phenyl ring to increase hydrophobic interactions and improve metabolic stability. Maintaining the amide and heterocyclic core ensures key binding interactions are preserved.

Following these considerations, I propose this new molecule:

\box{O=C(Nc1ccc(Oc2ccnc3cc(-c4ccc(F)cc4)cc23)c(F)c1)c1cnc2ccnn2c1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 2
NON-LLM GENERATED: CN1C(=O)COC2=C1C=NC1=CC=C(SC3=CC=NC(N)=C3Cl)C=C12
CN1C(=O)COc2c1cnc1ccc(Sc3ccnc(N)c3Cl)cc21

Boltz running on GPU 2
9.62
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN3C(SC4=CC=C5N=CC6=C(OCC(=O)N6C)C5=C4)=NN=C3C(F)=C2)C=N1,-10.8]
[CNC(=O)c1ccc(-c2ccc3nnc(COc4ccnc5cc(OC)ccc45)n3c2)s1,-11.21]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity in favorable regions, and maintain or enhance aromatic interactions. The first molecule has a fluorine substituent which contributes to affinity, and the second molecule uses hydrogen bond donors/acceptors with amide and heterocyclic groups. 

To build on this, introducing an amide group on the aromatic ring could provide additional hydrogen bonding capability and polarity without disrupting the core scaffold. Also, maintaining the fluorine substitution seems beneficial, so keeping that in place would be advantageous.

Based on this, I propose adding a cystamine moiety (–NH–C(=O)–) to the aromatic ring bearing the fluorine substituent to enhance H-bonding and polarity.

\box{CNC(=O)c1ccc(-c2ccc3nnc(COc4ccnc5cc(OCC(=O)N6CC6)ccc45)n3c2)c(F)c1}
LLM-GENERATED: CNC(=O)c1ccc(-c2ccc3nnc(COc4ccnc5cc(OCC(=O)N6CC6)ccc45)n3c2)c(F)c1
CNC(=O)c1ccc(-c2ccc3nnc(COc4ccnc5cc(OCC(=O)N6CC6)ccc45)n3c2)c(F)c1

Boltz running on GPU 2
11.06
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1)C1CC1,-10.49]
[CC(c1ccc2ncc(-c3cnn(C)c3)cc2c1)n1nnc2ncc(-c3ccncc3)nc21,-10.95]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase planarity for better π-stacking, and optimize substituents to fit the hydrophobic pockets of c-MET. The first molecule has strong hydrogen bond donors and acceptors via amide linkages and fluorinated rings, but its binding affinity is moderate probably due to rigidity and limited aromatic interactions. The second molecule has a more fused heterocyclic system and multiple nitrogen atoms, suggesting potential for hydrogen bonding and π-stacking, but its binding affinity is only slightly better.

To build on this, I would introduce a hydroxyl group on the fused heterocycle to enhance hydrogen bonding and add a methoxy-substituted phenyl ring to increase hydrophobic and electronic interactions. Also, incorporating a flexible but aromatic substituent like a benzyloxyphenyl group could improve shape complementarity and binding affinity by engaging additional sub-pockets in the receptor.

Based on these considerations, I propose the molecule:

\box{O=C(Nc1cc(Oc2ccnc3[nH]ccc(Oc4ccc(-c5ccc(OCCc6ccccc6)cc5)cc4F)c23)c1)c1CC1,-10.49}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 3
NON-LLM GENERATED: O=C(NC1=CC=C(F)C=C1)C1(C(=O)NC2=CC(F)=C(OCCC3=CC=NC=C3)C=C2F)CC1
O=C(Nc1ccc(F)cc1)C1(C(=O)Nc2cc(F)c(OCCc3ccncc3)cc2F)CC1

Boltz running on GPU 2
8.0
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(C1=CC=C2N=CC(C3=CN(C)N=C3)=CC2=C1)N1N=NC2=NC=C(C3=CC=NC=C3)N=C21,-10.95]
[FC(F)(c1ccc2ncccc2c1)c1nnc2ncc(-c3ccccc3)nn12,-10.21]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, pi-stacking, and electrostatics. The existing molecules already have aromatic rings and heterocycles that contribute to these interactions, so adding groups that can increase polarity or introduce additional hydrogen bond donors/acceptors could be beneficial.

Molecule 1 has methyl groups on the pyrazole rings, while Molecule 2 introduces a fluorine-substituted phenyl ring and a pyridine-like moiety. Combining these ideas, introducing a polar hydroxyl group on one of the aromatic rings could provide extra hydrogen bonding opportunity, and replacing a methyl on the pyrazole with a larger, more flexible heterocycle like a morpholine ring might increase solubility and interaction possibilities.

Thus, I would propose a molecule that keeps the core fused pyrazole-pyrimidine system but replaces the methyl on one pyrazole with a morpholine substituent and adds a hydroxyl group on the phenyl ring to enhance binding affinity.

\box{C[C@@H]1=CC=C2N=CC(C3=CN(C)CCOCC3)=CC2=C1Nc1cccc(-c2ccc3nnc4ncc(-c5cccc(O)c5)nn34)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 4
NON-LLM GENERATED: FC(F)(C1=CC=C2N=CC=CC2=C1)C1=NN=C2N=CC(C=CC3=CC=NC=C3)=NN21
FC(F)(c1ccc2ncccc2c1)c1nnc2ncc(C=Cc3ccncc3)nn12

Boltz running on GPU 2
10.75
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(CC1=CC=C2OCCC2=C1)N/N=C1\CNC2=C1C(Br)=CC(C(=O)NCCCCN1CCC[C@H]1CO)=C2,-9.59]
[CN1CCN(c2cnc3cc(C(F)(F)F)cc(OCc4cccc([N+](=O)[O-])c4)c3c2)CC1,-9.79]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both incorporate aromatic rings and polar functional groups, likely contributing to hydrogen bonding and hydrophobic interactions within the binding pocket. The first molecule features a fused heterocycle with a trifluoromethyl group and a piperazine moiety, while the second molecule contains a trifluoromethyl-substituted phenyl ring and an N-ethylated piperazine.

To improve binding affinity, I would consider enhancing hydrogen bonding capacity and optimizing hydrophobic contacts. Replacing the trifluoromethyl group with a triazole ring could provide additional polar interactions and rigidity to the structure. Also, swapping the piperazine for a morpholine ring may improve solubility and introduce new donor/acceptor patterns due to the heteroatoms.

Combining these ideas, I propose introducing a triazole substituent on the aromatic system and replacing the piperazine with a morpholine ring to potentially increase affinity.

\box{CN1CCN(c2cnc3cc(C(=O)NCCN4CCOCC4)ccc3c2)CC1}
LLM-GENERATED: CN1CCN(c2cnc3cc(C(=O)NCCN4CCOCC4)ccc3c2)CC1
CN1CCN(c2cnc3cc(C(=O)NCCN4CCOCC4)ccc3c2)CC1

Boltz running on GPU 2
6.95
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNc1snc(SCc2nnc3ncc(-c4ccc(F)cc4)nn23)c1C(N)=O,-10.65]
[CNC(=O)c1ccc(-c2ccc3nnc(Cc4ccc(O)cc4)n3n2)cc1Cl,-10.6]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: From the given binding affinities, both molecules have similar interactions with c-MET, but there is room for improvement in increasing hydrophobic contacts and possibly improving hydrogen bonding. The first molecule has a fluorophenyl group that adds hydrophobicity and potential halogen bonding, while the second molecule has a chlorophenyl group that can also contribute to hydrophobic interactions.

To enhance binding, I would consider combining these beneficial elements by introducing a difluorophenyl substituent, which could increase hydrophobic contacts and possibly strengthen halogen bonding with the protein. Additionally, modifying the central scaffold to optimize hydrogen bonding and maintain favorable interactions with the receptor would be important.

Based on this reasoning, I propose the molecule: \box{CNc1nnc(Cc2ccc(-c3cnc4nn(Cc5ccc(F)c(F)c5)n4n3)cc2)c1=O}.
LLM-GENERATED: CNC1=NN=C(Cc2ccc(-c3cnc4nn(Cc5ccc(F)c(F)c5)n4n3)cc2)C1=O
CNC1=NN=C(Cc2ccc(-c3cnc4nn(Cc5ccc(F)c(F)c5)n4n3)cc2)C1=O

Boltz running on GPU 2
8.75
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CCN1Cc2c(ccc(F)c2C#N)O[C@@H](C)CNC(=O)c2c(N)nn3ccc1nc23,-11.2]
[O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cccc(-c2ccccc2)[n+]1[O-],-10.33]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions within the binding pocket of c-MET. From the given molecules, the first contains a fluorinated aromatic ring and an oxazole moiety, providing potential hydrogen bonding and hydrophobic contacts. The second molecule includes an amide linkage and a triazole ring with an extended aromatic system, which may contribute to stronger π-stacking and electrostatic interactions.

To create a stronger ligand, I would consider combining key features from both: maintaining the oxazole ring for its hydrogen bonding capacity, incorporating the amide group to add polarity and rigidity, and introducing additional aromatic substituents to increase π-π stacking. Also, adding a methoxy group could improve solubility and electronic distribution.

Based on this reasoning, I propose the following molecule:

\box{COc1ccc(-n2nc(C(=O)Oc3ccc4ccnc5[nH]ccc45)n(C)c2=O)cc1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 5
NON-LLM GENERATED: O=C1N=C1OC1=CC=NC2=C1C=CN2
O=c1nc1Oc1ccnc2[nH]ccc12

Boltz running on GPU 2
6.76
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[FC(F)(C1=CC=C2N=CC=CC2=C1)C1=NN=C2N=CC(C3=CC=CC=C3)=NN21,-10.21]
[Cc1cc2ccnc(Nc3ccc(Oc4ccnc(N)c4I)c(F)c3)c2c(=O)n1-c1ccc(F)cc1,-10.92]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both incorporate aromatic rings and heterocycles, which contribute to π-π stacking and hydrogen bonding within the c-MET binding pocket. The first ligand has a fluorinated phenyl ring and a fused pyrazole moiety, while the second ligand features iodinated and fluorinated aromatic rings and pyrimidine/pyrrole fragments. The binding affinities suggest that adding halogens like fluorine and iodine can enhance interactions through halogen bonding or hydrophobic contacts, and positioning amine substitutions on the heterocycles helps establish hydrogen bonds.

To improve binding, I would consider combining multiple favorable features: 
- Retain key heterocyclic cores (pyrazole/pyrrole for hydrogen bonding).
- Introduce multiple fluorine atoms to enhance affinity and halogen bonding.
- Add an amine substitution on the aromatic ring to increase hydrogen bonding potential.
- Maintain or expand conjugated systems for π-π interactions.
- Replace or introduce a phenyl ring substituted with fluorine to improve hydrophobic and aromatic contacts.

Based on this reasoning, I propose the molecule: 

\box{Nc1ccc(-c2ccc3ncc(NC4=CC=C5N=CC=C5C(F)(F)c4)c(=O)c3=nn2)cc1F}
LLM-GENERATED: Nc1ccc(-c2ccc3ncc(NC4=CC=C5N=CC=C5C(F)(F)C4)c(=O)c-3nn2)cc1F
Nc1ccc(-c2ccc3ncc(NC4=CC=C5N=CC=C5C(F)(F)C4)c(=O)c-3nn2)cc1F

Boltz running on GPU 2
10.8
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(Cc1ccc(F)cc1)NC(=O)Nc1ccc(Oc2ccnc3[nH]cc(-c4cccnc4)c23)c(F)c1,-9.82]
[O=C(Nc1ccc(Oc2ccnc(NC(=O)N3CCC3)c2)c(F)c1)c1cn(CC2CC2)c(=O)n(-c2ccc(F)cc2)c1=O,-11.71]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, aromatic stacking, and polar interactions within the binding pocket. The first molecule has good fluorine substitutions that likely contribute to hydrophobic and electronic effects, but the amide linkage may limit flexibility and hydrogen bonding potential. The second molecule introduces a bicyclic heteroaromatic system with a morpholine-like ring, which is beneficial for solubility and interaction versatility, but the fluorophenyl substituent could be optimized.

Considering this, I would aim to increase hydrogen bond donors/acceptors and aromatic interactions while maintaining or improving ligand flexibility and polarity. Introducing an ethoxy substituent (–COCCO) can enhance solubility and possibly form additional hydrogen bonds. Replacing the fluorophenyl with a chlorophenyl may increase hydrophobic contacts and complement the binding pocket surface. Maintaining the amide linkage and bicyclic heteroaromatic system with the fused pyrimidine-pyridine arrangement is important for key interactions.

Based on this reasoning, the molecule I propose is:

\box{COc1ccn(-c2ccc(Oc3ccnc4[nH]cc(-c5ccc(Cl)cc5)c34)c(F)c3)c2)c1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 6
NON-LLM GENERATED: O=C1C(C2=CC=NC3=C2C(C2=CC=CN=C2)=CN3)=CN(CC2CC2)C(=O)N1C1=CC=C(F)C=C1
O=c1c(-c2ccnc3[nH]cc(-c4cccnc4)c23)cn(CC2CC2)c(=O)n1-c1ccc(F)cc1

Boltz running on GPU 2
10.01
130/1000 | avg_top1: 12.050 | avg_top10: 11.724 | avg_top100: 10.862 | avg_sa: 3.110 | div: 0.831
{'avg_top1': 12.05, 'avg_top10': 11.724, 'avg_top100': 10.861500000000003, 'auc_top1': 1.48345, 'auc_top10': 1.4379000000000004, 'auc_top100': 1.3360068095238096, 'avg_sa': 3.1099485871010875, 'diversity_top100': 0.8314912048279961, 'n_oracle': 130}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(Nc1ccc(Oc2ccnc(NC(=O)C3CC3)c2)cc1)c1nc2ccccc2n(-c2ccc(F)cc2)c1=O,-10.76]
[COC1=CC=C(N2C(=O)C(C(=O)NC3=CC=C(OC4=CC=NC(N)=C4Cl)C(F)=C3)=CC3=CC=CC=C32)C=C1,-9.56]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity for c-MET, I would look for ways to enhance hydrogen bonding, aromatic stacking, and hydrophobic interactions based on the binding site's preferences. The first molecule has good aromatic and heterocyclic groups that interact well, but the second molecule's bulky benzodiazepine-like moiety might introduce steric hindrance and reduce affinity. 

To streamline the molecule, removing the fused benzodiazepine ring and replacing it with a simpler, more planar aromatic system could improve fit and stacking. Retaining the fluorine substituent is beneficial for hydrophobic contacts and potential halogen bonding. Also, maintaining the amide linkages and heterocyclic rings that provide hydrogen bonding and rigidity should help.

Based on this, a promising approach is to design a molecule with a pyridine ring substituted by a fluorophenyl group and a fused pyrazole-pyridine moiety connected through an amide. This maintains key aromatic and heterocyclic features while optimizing size and planarity.

\box{O=C(Nc1ccc(Oc2ccnc(NC(=O)c3c[nH]c(-c4ccc(F)cc4)c23)c2)c(F)c1)c1ccnn(-c2ccc(F)cc2)c1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 7
NON-LLM GENERATED: COC1=CC=C(OC2=CC=NC(NC(=O)C3CC3)=C2)C1
COC1=CC=C(Oc2ccnc(NC(=O)C3CC3)c2)C1

Boltz running on GPU 2
8.31
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COc1cc2c(Oc3ccc(NC(=O)c4nnn(-c5ccc(F)c(F)c5)c4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,-9.72]
[C[C@@H](OC1=CC(C2=NN(C3CCNCC3)C=C2)=CN=C1N)C1=C(Cl)C=CC(F)=C1Cl,-10.19]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would consider enhancing hydrogen bonding and hydrophobic interactions while optimizing the molecular size and flexibility. The first molecule has good interactions due to the trifluoromethyl group and fluorine atoms, but the ethylene-linked piperazine ring might be too flexible and could benefit from a more rigid substitution. The second molecule shows potential with its chlorinated aromatic rings and hydroxyl groups, but its stereochemistry and linker flexibility could also be tuned.

To build on this, I would introduce a pyridine ring in place of the piperazine to increase hydrogen bonding capability and replace the ethylene linker with a more rigid oxyalkyl chain to improve fit and reduce entropy loss upon binding. Additional substitutions like adding a methyl group on the pyridine nitrogen could enhance hydrophobic contacts without greatly increasing molecular weight.

Based on these considerations, I propose the molecule:

\box{COc1cc2c(Oc3ccc(NC(=O)c4ccn(-c5ccc(F)c(F)c5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 8
NON-LLM GENERATED: CC(OC1=CC(C2=NN(C3CCNCC3)C=C2)=CN=C1N)C1=C(Cl)C(F)=CC=C1Cl
CC(Oc1cc(-c2ccn(C3CCNCC3)n2)cnc1N)c1c(Cl)ccc(F)c1Cl

Boltz running on GPU 2
9.99
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Nc1nccc(Oc2ccc(NC(=O)c3c[nH]cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl,-9.52]
[N#Cc1cccc(-c2cc(F)c3ncc(Cc4ccc5ncccc5c4)n3c2)c1,-11.07]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase planarity for better stacking interactions, and introduce groups that can successfully fill hydrophobic pockets without adding too much steric hindrance. The first ligand has a key amide linkage and fluorinated aromatic rings, contributing to affinity, but it could benefit from adding a heterocyclic system that offers additional hydrogen bond donors/acceptors.

The second ligand includes a 1,2,3-triazole ring and fluorinated phenyl groups, showing some favorable interactions, but the overall structure might be optimized by incorporating a bicyclic or fused heterocycle to improve π-π stacking and shape complementarity.

Based on this, I would design a ligand that retains the amide functionality and fluorine substituents but includes a fused bicyclic heterocycle such as a bicyclic pyrimidinone motif fused to a benzene ring, paired with a triazole to maintain key interactions while increasing rigidity and potential binding contacts.

The molecule I propose is:

\box{O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1ccc2ccc(=O)n2c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 9
NON-LLM GENERATED: O=C1C(C2=CC=C(F)C=C2)=CNC=C1C1=CN2C(CC3=CC=C4N=CC=CC4=C3)=CN=C2C(F)=C1
O=c1c(-c2ccc(F)cc2)c[nH]cc1-c1cc(F)c2ncc(Cc3ccc4ncccc4c3)n2c1

Boltz running on GPU 2
9.25
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(c1c(F)cc2ncc(-c3cnn(C)c3)cc2c1F)n1nnc2ncc(-c3cnn(CCO)c3)nc21,-11.72]
[Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c12,-10.5]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the given molecules, the first ligand features a fused heterocyclic core with fluorine substituents and a triazole ring at the periphery, likely contributing to favorable hydrophobic and electronic interactions. The second ligand incorporates an amide linkage and a substituted piperidine-like ring, one of whose rings is part of the known binding-rich bicyclic system found in several kinase inhibitors.

To improve binding affinity, I would consider combining elements from both molecules to enhance hydrogen bonding and hydrophobic contacts. Introducing an aromatic amide as in the second molecule could offer additional H-bonding opportunities and better shape complementarity. Also, replacing the terminal triazole bearing a methyl group with a slightly larger heterocycle that retains hydrogen bonding capability might improve interactions within the pocket.

Based on this, I propose introducing a pyrimidine ring replacing the methyl-substituted triazole, and attaching the amide-linked bicyclic system from the second ligand to the aromatic core. This design integrates the beneficial features of both molecules and adds subtle scale and complexity in the right regions to enhance binding.

The resulting molecule is:  
\box{Cn1cc(-c2cnc3ccc(NC(=O)c4cc5cccnc5n(C)c4)cc3c2)cn1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 10
NON-LLM GENERATED: CC(CCF)N1N=NC2=NC=C(C3=CN(CCO)N=C3)N=C21
CC(CCF)n1nnc2ncc(-c3cnn(CCO)c3)nc21

Boltz running on GPU 2
9.0
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[N#Cc1cc(-c2cnc3nnn(CC4CN(c5ncc(-c6cnn(CCO)c6)cn5)CCO4)c3n2)ccc1F,-9.83]
[COc1cc2nccc(Oc3ccc(NC(=O)c4c(I)ccn(-c5ccc(F)cc5)c4=O)cc3F)c2cc1OC,-11.4]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions in the binding pocket, such as increasing hydrogen bonding, improving aromatic stacking, and optimizing polar contacts. The first molecule has a fluorinated aromatic ring that could engage in favorable hydrophobic interactions, and the heterocyclic core necessary for maintaining planarity and π-stacking. The second molecule includes ether linkages and additional polar groups that may improve solubility and facilitate hydrogen bonds, but its isonicotinamide moiety is heavier and more complex, which might limit optimal fit.

To strike a balance, I would simplify the heterocyclic system while retaining the fluorinated phenyl group to preserve hydrophobic and electronic effects. Introducing a pyridine ring instead of the isonicotinamide could reduce steric hindrance and improve binding complementarity. Also, maintaining the morpholine-like tetrahydrofuran fused ring system from the first molecule preserves key interactions and solubility.

Based on this reasoning, the new molecule I propose is:

\box{CCn1cc(-c2ccc(F)cc2)cn1-c1cc2nccc(Oc3ccc(NC(=O)c4ccn(-c5ccc(F)cc5)c4=O)cc3F)c2cc1OC}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 11
NON-LLM GENERATED: CC1=CC=C(F)C(C#N)=C1
Cc1ccc(F)c(C#N)c1

Boltz running on GPU 2
5.96
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1CCC(Nc2cnc3ccc(Sc4nnc5c(F)cc(-c6cnn(C)c6)cn45)cc3c2)CC1,-11.09]
[O=C(CC1=CC=C2OCCC2=C1)N/N=C1\CNC2=C1C(Br)=CC(C(=O)NCCCCN1CCC[C@H]1CO)=C2,-9.59]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both incorporate nitrogen-rich heterocycles and polar groups that likely contribute to hydrogen bonding within the binding pocket. The first molecule contains a methylated triazole ring and a fluorinated fused heterocyclic system, while the second molecule features a bromine substituent and a morpholine-like ring, both enhancing hydrophobic and electronic interactions.

To improve binding affinity, I would consider combining key features from both molecules: maintaining the fluorine for its electronic effects and incorporating a flexible, nitrogen-containing ring to replace the morpholine or piperazine moiety with a less sterically hindered, more conformationally favorable ring such as a piperidine. This could enhance fit and solubility without losing important interactions.

Therefore, I propose a molecule that integrates the fluorinated fused heterocycle and methylated triazole seen before, paired with a piperidine ring replacing the previous morpholine or piperazine, potentially improving binding.

\box{CN1CCC(Nc2cnc3ccc(Sc4nnc5c(F)cc(-c6cnn(C)c6)cn45)cc3c2)CC1}
LLM-GENERATED: CN1CCC(Nc2cnc3ccc(Sc4nnc5c(F)cc(-c6cnn(C)c6)cn45)cc3c2)CC1
Already in buffer
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2N(C)S(C)(=O)=O)n1,-10.95]
[O=C(CC1=CC=C(F)C=C1)NC(=O)NC1=CC=C(OC2=CC=NC3=C2C(C2=CC=CN=C2)=CN3)C(F)=C1,-9.82]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I see that both incorporate nitrogen-containing heterocycles and fluorinated aromatic rings, which likely contribute to their binding affinity through hydrogen bonding and hydrophobic interactions. However, their binding affinities are -10.95 and -9.82 kcal/mol, indicating room for improvement.

Molecule 1 uses a sulfonamide group (S(=O)(=O)) which often enhances binding by acting as a strong hydrogen bond acceptor and donor, but it might be bulky or less effective in fitting the pocket. Molecule 2 employs a more constrained fused heterocyclic system with fluorinated aromatic rings, which improves hydrophobic interactions and rigidity, but its binding affinity is lower.

To improve affinity, I would consider balancing hydrophobic and hydrogen bonding interactions, reducing steric hindrance, and increasing conformational flexibility. Also, maintaining or enhancing polar contacts while removing potentially bulky or unnecessary groups could help.

Based on this, I propose a molecule that replaces the sulfonamide with a carbamoyl group to maintain H-bonding capability with better fit and smaller size, retains the fluorinated aromatic system for hydrophobic interactions, and includes a flexible but conformationally restrained piperazine-linked heterocycle to engage in additional polar contacts.

Final molecule: \box{CNC(=O)NC(=O)Cc1ccc(Nc2ncc(Cl)c(Nc3ccccc3N(C)S(C)(=O)=O)n2)cc1F}
LLM-GENERATED: CNC(=O)NC(=O)Cc1ccc(Nc2ncc(Cl)c(Nc3ccccc3N(C)S(C)(=O)=O)n2)cc1F
CNC(=O)NC(=O)Cc1ccc(Nc2ncc(Cl)c(Nc3ccccc3N(C)S(C)(=O)=O)n2)cc1F

Boltz running on GPU 2
9.88
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COc1cc2c(Oc3ccc(NC(=O)NN=Cc4ccc(F)cc4F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,-10.99]
[C[C@@H](c1cc2cccnc2cc1F)n1cnc2ncc(-c3ccc(C(N)=O)c(F)c3)nc21,-10.9]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions in the ligand by increasing hydrogen bonding, improving aromatic stacking, and optimizing substituents to better fit the binding pocket. Both given molecules have strong aromatic systems and fluorine substitutions that contribute to affinity, but one may offer more opportunities for additional polar interactions.

The first molecule, -10.99, has a flexible side chain with a piperidine ring that can be modified for improved solubility and interaction with the pocket. Introducing a hydroxyl group on the side chain could enhance hydrogen bonding without adding steric hindrance.

The second molecule, -10.9, has a purine-like core with an amide-linked aromatic ring bearing a fluorine. Replacing the amide oxygen with a sulfur atom (thioamide) might improve binding by increasing electron density and subtle polarity, potentially enhancing interactions with hydrophobic regions or metal ions.

Combining these ideas, I would modify the piperidine side chain to include a hydroxyl group for enhanced hydrogen bonding and replace the amide oxygen with sulfur in the second molecule to optimize interactions.

The new molecules are:

\box{CC(C)CN1CCC(O)CC1
[C[C@@H](c1cc2cccnc2cc1F)n1ncnc2ncc(-c3cnc(C(N)=S)c3)c2C1CCC(C)CC1}
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 108, in edit
    proposed_smiles = re.search(r'\\box\{(.*?)\}', r).group(1)
AttributeError: 'NoneType' object has no attribute 'group'
AttributeError 'NoneType' object has no attribute 'group'
NUM LLM ERRORS: 12
NON-LLM GENERATED: COC1=C(OCCCN2CCC(C)CC2)C=C2N=CC=C(OC3=C(F)C=C4N=CC=CC4=C3)C2=C1
COc1cc2c(Oc3cc4cccnc4cc3F)ccnc2cc1OCCCN1CCC(C)CC1

Boltz running on GPU 2
10.18
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Fc1cc(F)cc(-c2ccc3nnc(CNc4ccnc5cc(OCCn6cncn6)cnc45)n3n2)c1,-10.94]
[COC1=CC=C(N2C(=O)C(C(=O)NC3=CC=C(OC4=CC=NC(N)=C4Cl)C(F)=C3)=CC3=CC=CC=C32)C=C1,-9.56]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase planarity for better stacking interactions, and optimize substituents on the aromatic rings to complement the binding pocket. The first molecule has strong fluorine and aromatic interactions but may benefit from additional heteroatoms to form more hydrogen bonds. The second molecule is more polar with amide and ether linkages but has flexible ether chains that might reduce rigidity and binding stability.

From the first molecule, I would replace the fluorophenyl with a thiophenyl to increase sulfur-mediated interactions and add a direct aromatic nitrogen heterocycle to enhance hydrogen bonding. From the second molecule, I would reduce the flexible ether chain into a more rigid heterocyclic system, incorporating pyridine and pyrazole rings with strategically placed methyl groups to improve binding complementarity and reduce conformational entropy.

\box{Cn1cc(-c2ccc3nnc(CNc4ccc5ncccc5c4)n3n2)cn1}
LLM-GENERATED: Cn1cc(-c2ccc3nnc(CNc4ccc5ncccc5c4)n3n2)cn1
Cn1cc(-c2ccc3nnc(CNc4ccc5ncccc5c4)n3n2)cn1

Boltz running on GPU 2
9.23
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)NC5=CCC(F)C=C5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,-11.36]
[O=C(NC1=CC=C(OC2=CC=NC(NC(=O)C3CC3)=C2)C=C1)C1=NC2=CC=CC=C2N(C2=CC=C(F)C=C2)C1=O,-10.76]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrophobic interactions, increase rigidity to reduce entropy loss, and introduce potential hydrogen bond acceptors or donors that complement the binding site. Notably, the original molecules use pyrrole and pyridine rings, which provide nice aromatic stacking but might be further optimized by replacing with other nitrogen-containing rings that can offer additional hydrogen bonding or dipole interactions.

Molecule 1 uses a fluorinated cyclohexyl group and a morpholine moiety, both useful for hydrophobic and polar contacts. Molecule 2 has a more conjugated backbone with pyrrole and pyridine rings, plus a fluorophenyl group to engage in π-stacking and hydrophobic interactions.

To build on this, I would suggest replacing the pyrrole in Molecule 2’s moiety with a pyrimidine ring to add an additional nitrogen, which could enhance hydrogen bonding with the protein while maintaining aromaticity. Also, retaining the fluorinated phenyl ring is valuable for hydrophobic and halogen bonding. Incorporating a small alkyl substituent on the pyrimidine ring can improve binding by filling hydrophobic pockets and increasing overall ligand rigidity.

Therefore, the new molecule I propose integrates these features:

\box{CC(C)n1cc(=O)[nH]c(=O)NC(=O)C(c2ccc(F)cc2)NC1=Cc1ccc(Oc2ccnc3cc(NC(C)CC3)c(OC)cc12)c(F)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 13
NON-LLM GENERATED: O=C(NC1=CC=C(OC2=CCOC2)C=C1)C1=NC2=CC=CC=C2N(C2=CC=C(F)C=C2)C1=O
O=C(Nc1ccc(OC2=CCOC2)cc1)c1nc2ccccc2n(-c2ccc(F)cc2)c1=O

Boltz running on GPU 2
7.57
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[[C-]#[N+]C1=C(c2ccc(F)cc2F)N=C2COC(=O)C2C1c1ccc2n[nH]c(C)c2c1,-10.1]
[CC(=NOC(N)=O)c1ccc2nnc([C@H](C)c3c(F)cc4ncccc4c3F)n2n1,-11.2]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity in favorable regions, and maintain or improve aromatic interactions. Notably, the first molecule lacks hydrogen bond donors/acceptors in the ring system, while the second molecule introduces more H-bond potential with the diatomacetyl hydrazine moiety. 

To build on this, introducing a carbonyl adjacent to the pyridine ring could provide additional H-bond acceptor capacity and also tune electronic properties to enhance interactions with the active site residues. Maintaining the fluorinated aromatic for hydrophobic and electronic effects is valuable, so I would keep that intact.

Therefore, a new molecule containing a carbonyl substituent on a pyridine ring linked to the same fluorinated aromatic system and the diatomacetyl hydrazine group should improve binding affinity.

\box{COc1cc(=O)n(-c2ccc3nnc([C@@H](C)c4c(F)cc5ncccc5c4F)n3n2)cc1C(=O)NCC(=O)N.CC(=O)N}
LLM-GENERATED: CC(N)=O.COc1cc(=O)n(-c2ccc3nnc(C(C)c4c(F)cc5ncccc5c4F)n3n2)cc1C(=O)NCC(N)=O
CC(N)=O.COc1cc(=O)n(-c2ccc3nnc(C(C)c4c(F)cc5ncccc5c4F)n3n2)cc1C(=O)NCC(N)=O

Boltz running on GPU 2
[Errno 2] No such file or directory: '/data/boltz/results/boltz_results_c-met_CC(N)=O.COc1cc(=O)n(-c2ccc3nnc(C(C)c4c(F)cc5ncccc5c4F)n3n2)cc1C(=O)NCC(N)=O/predictions/c-met_CC(N)=O.COc1cc(=O)n(-c2ccc3nnc(C(C)c4c(F)cc5ncccc5c4F)n3n2)cc1C(=O)NCC(N)=O/affinity_c-met_CC(N)=O.COc1cc(=O)n(-c2ccc3nnc(C(C)c4c(F)cc5ncccc5c4F)n3n2)cc1C(=O)NCC(N)=O.json'
-0.0
140/1000 | avg_top1: 12.050 | avg_top10: 11.724 | avg_top100: 10.865 | avg_sa: 3.108 | div: 0.831
{'avg_top1': 12.05, 'avg_top10': 11.724, 'avg_top100': 10.864600000000001, 'auc_top1': 1.60395, 'auc_top10': 1.5551400000000004, 'auc_top100': 1.4446373095238096, 'avg_sa': 3.1084510213087864, 'diversity_top100': 0.8311693088200071, 'n_oracle': 140}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNc1snc(SCc2nnc3ncc(-c4ccc(F)cc4)nn23)c1C(N)=O,-10.65]
[FC(F)(C1=CC=C2N=CC=CC2=C1)C1=NN=C2N=CC(C3=CC=CC=C3)=NN21,-10.21]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions in the ligand by increasing hydrogen bonding, improving complementarity to the binding pocket, and optimizing the balance of hydrophobic and electronic groups. The first molecule has a carbonyl (C=O) that may participate in hydrogen bonding, while the second molecule contains fluorines and a more planar, fused ring system that likely contributes to binding through π-stacking or hydrophobic contacts.

To build on this, I would consider maintaining the key fused heterocyclic core from the second molecule to preserve these interactions but modify the substituents to increase polarity and potential hydrogen bonding. Introducing an amide group (–C(=O)N–) could enhance binding through additional hydrogen bonds and improve solubility. Also, adding a rigid, hydrophobic aromatic substituent, like a substituted phenyl ring, might optimize hydrophobic contacts and fit better into the c-MET pocket.

Combining these ideas, I would propose a molecule that keeps the fused heterocyclic core, adds an amide group linking to a phenyl ring bearing a fluorine substituent, and includes a terminal methyl group on the heterocycle to enhance hydrophobic interactions.

The new molecule is:  
\box{Cc1c(C(=O)Nc2ccc(-c3ccc(C)cc3)cc2)nnn1-c1ccc(=O)n1C}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 14
NON-LLM GENERATED: NC(=O)C1=C(F)SN=C1SCC1=NN=C2N=CC(C3=CC=C(F)C=C3)=NN12
NC(=O)c1c(SCc2nnc3ncc(-c4ccc(F)cc4)nn23)nsc1F

Boltz running on GPU 2
8.96
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Fc1ccc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cc1,-10.61]
[CNC(=S)c1ccc(-c2cnc3ncc(Cc4cc(Cl)c5ncccc5c4)n3n2)cc1F,-11.22]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: From the given binding affinities, we see that both molecules incorporate a trifluoromethyl-substituted aromatic ring and a chlorinated aromatic system, but their overall interactions and binding strengths vary. The first molecule has a thiourea (NC(=S)N) motif replaced by a simple methyl group, while the second adds a fluorine atom on the aromatic ring attached to the heterocycle, increasing affinity by about 0.61 kcal/mol.

To further improve binding, enhancing hydrogen bonding capacity and adding electronegative groups to increase dipole interactions could be beneficial. Also, replacing the trifluoromethyl group with a urea-like group (NC(=O)NH2) might introduce stronger hydrogen bonding and better mimic the protein's binding site interactions. Additionally, maintaining the chlorinated aromatic system seems important for hydrophobic and π-stacking interactions.

Therefore, I propose introducing a carbamoyl (CNC(=O)NH2) substituent on the aromatic ring instead of the trifluoromethyl, keeping the rest of the scaffold intact to preserve favorable interactions.

\box{CNC(=O)Nc1ccc(-c2cnc3ncc(Cc4cc(Cl)c5ncccc5c4)n3n2)cc1F}
LLM-GENERATED: CNC(=O)Nc1ccc(-c2cnc3ncc(Cc4cc(Cl)c5ncccc5c4)n3n2)cc1F
CNC(=O)Nc1ccc(-c2cnc3ncc(Cc4cc(Cl)c5ncccc5c4)n3n2)cc1F

Boltz running on GPU 2
11.03
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cc1cc2ccnc(Nc3ccc(Oc4ccnc(N)c4I)c(F)c3)c2c(=O)n1-c1ccc(F)cc1,-10.92]
[O=C(NC1=CC=C(OC2=CC=NC(NC(=O)C3CC3)=C2)C=C1)C1=NC2=CC=CC=C2N(C2=CC=C(F)C=C2)C1=O,-10.76]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrophobic interactions, create additional hydrogen bonds, and optimize the rigidity of the molecule to better fit the binding pocket. Both initial molecules have interesting features: the first benefits from fluorines and an iodine substituent providing potential hydrophobic and electronic effects, while the second incorporates ring systems and ether linkages for flexibility and interaction.

Comparing the two, the second molecule has a more constrained bicyclic heteroaromatic system and an additional fluorophenyl group that might improve hydrophobic contacts. To further enhance affinity, I would consider replacing the fluorine on the phenyl ring with a chlorine to increase hydrophobic interactions without significantly altering size. Also, modifying the central heterocyclic core to include a pyridine ring could improve binding through additional hydrogen bonding or pi-stacking.

Taking these ideas together, I propose the molecule:  
\box{O=C(Nc1ccc(Oc2ccnc(N)c2I)c(F)c1)C1=CC(=O)Nc2ccc(Cl)cc2C(=O)c1C}
LLM-GENERATED: CC1C(=O)c2cc(Cl)ccc2NC(=O)C=C1C(=O)Nc1ccc(Oc2ccnc(N)c2I)c(F)c1
CC1C(=O)c2cc(Cl)ccc2NC(=O)C=C1C(=O)Nc1ccc(Oc2ccnc(N)c2I)c(F)c1

Boltz running on GPU 2
9.5
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[C[C@H](c1cccc(-c2ncc(OCC3CCN(C)CC3)cn2)c1)n1cc(-c2cc(C#N)ccn2)cc(F)c1=O,-10.34]
[COC1=CC=C(N2C(=O)C(C(=O)NC3=CC=C(OC4=CC=NC(N)=C4Cl)C(F)=C3)=CC3=CC=CC=C32)C=C1,-9.56]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, hydrophobic contacts, and possibly introduce groups that better complement the protein's binding pocket. From the given molecules, the first contains a pyridine ring with a substituted piperazine, which may contribute to favorable interactions, but the binding affinity could be improved by adding more heteroatoms or aromatic rings to increase stacking and hydrogen bonding.

The second molecule includes a fused aromatic system with oxygen atoms, but the amide and aromatic rings may be too rigid or lack optimal contacts. Replacing some aromatic rings with heterocycles that can offer both hydrogen bond acceptors/donors and maintain planarity might improve affinity.

Considering this, I would design a molecule that keeps the pyridine character but adds an embedded nitrogen heterocycle to increase hydrogen bonding and aromatic stacking. Introducing a small, flexible substituted cyclopentyl group could fill the pocket better and provide hydrophobic contacts.

Therefore, the molecule I propose integrates a fused pyridine-pyrazole system combined with a cyclopentyl ring bearing a methyl substituent and retains the carbonyl groups for hydrogen bonding.

\box{Cc1cc(-c2cc(C#N)ccn2)cn(-c3ccc4nccn4c3)c1=O}
LLM-GENERATED: Cc1cc(-c2cc(C#N)ccn2)cn(-c2ccc3nccn3c2)c1=O
Cc1cc(-c2cc(C#N)ccn2)cn(-c2ccc3nccn3c2)c1=O

Boltz running on GPU 2
7.8
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cc1nc([C@H](C)NC(=O)c2ccc(-c3cnc4ncc(Cc5ccc6ncccc6c5)n4n3)cc2Cl)no1,-10.52]
[C[C@@H](Oc1c[nH]c(=O)c(C(=O)NC2CCOCC2)c1)c1c(Cl)ccc(F)c1Cl,-10.94]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both incorporate heterocyclic rings and halogen substitutions (Cl, F) that likely contribute to binding through hydrophobic and halogen bonding interactions in the c-MET pocket. The first ligand has a noxious odor moiety (urea-like region) and an aromatic ring with a chlorine substituent, while the second has a small azetidine ring and a clasto-striated aromatic system.

To improve binding affinity, I would consider enhancing hydrogen bonding capabilities and optimizing the spatial orientation of substituents for better fit and polar contacts. Also, replacing or modifying flexible small rings like azetidine with more conformationally constrained or polar heterocycles could strengthen binding through rigidity and additional hydrogen bonds.

Based on this, I propose introducing a morpholine ring to increase polarity and replacing the clasto motif with a fused heterocyclic system that maintains aromaticity and H-bond potential. Also adding a methoxy substituent can enhance solubility and possibly engage in additional interactions.

\box{COc1cc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)ccc1C(=O)NC1CCOCC1}
LLM-GENERATED: COc1cc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)ccc1C(=O)NC1CCOCC1
COc1cc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)ccc1C(=O)NC1CCOCC1

Boltz running on GPU 2
10.15
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cc1c(C(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)cc2)c(=O)n(-c2ccccc2)n1C,-9.94]
[Fc1ccc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cc1,-10.61]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, hydrophobic contacts, and possibly introduce fluorine atoms to increase binding strength and metabolic stability. The first ligand has a key amide linkage and a substituted pyrimidinone scaffold, while the second has a fluorinated aromatic ring and a triazole-like heterocycle.

Comparing the two, the second molecule's fluorine substitution on the aromatic ring could contribute to better hydrophobic interactions and potentially improve binding. The heterocyclic core in the first ligand offers good hydrogen bonding, but the overall affinity is lower.

To build on this, I would combine the strong hydrogen bonding features with the beneficial fluorine substitution and a more planar, fused heterocyclic system to enhance stacking and fit into the binding pocket.

Thus, I propose introducing a fluorinated phenyl ring connected to a pyrimidinone core with an amide linkage, and a fused pyrazole-pyrimidine moiety to increase both hydrophobic and polar contacts.

\box{Cc1c(C(=O)Nc2ccc(Oc3ccnc4cc(-c5ccc(F)cc5)nn34)c2)c(=O)n(-c2ccccc2)n1C}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 15
NON-LLM GENERATED: O=C(NC1=CC(C(F)(F)C2=NN=C3N=CC(C4=CC=C(F)C=C4)=NN32)=CC=N1)C1CC1
O=C(Nc1cc(C(F)(F)c2nnc3ncc(-c4ccc(F)cc4)nn23)ccn1)C1CC1

Boltz running on GPU 2
10.38
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cn1cc(-c2ccc3nnc(Sc4ccc5ncc(NCCO)cc5c4)n3c2)cn1,-11.09]
[CCN1CCC(n2cc(-c3cnc4ccc5ccc(NS(=O)(=O)N(C)C)cc5c(=O)c4c3)cn2)CC1,-11.1]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity, and introduce groups that could interact more effectively with the c-MET binding pocket. Both initial molecules have heterocyclic cores and aromatic rings, so preserving this scaffold is beneficial for maintaining π-π stacking and hydrophobic interactions.

Molecule 1 has a methyl-substituted ring with a carbonyl group, while Molecule 2 contains an oxygen-containing side chain (NCCO) that likely contributes to hydrogen bonding. To improve on this, I would consider extending the side chain to increase polarity and flexibility, possibly adding a carbonyl to enhance hydrogen bond acceptor capacity and introduce dipole interactions.

Combining these ideas, I would modify the side chain to include an amide linkage (NC(=O)) connected to a fluorinated alkyl group (CF3). The amide provides strong H-bonding potential, and the trifluoromethyl group enhances binding through hydrophobic and electronic effects.

Therefore, the new molecule contains the core structure from Molecule 1 with a modified amide-linked CF3 group on the heterocyclic ring, balancing polarity and hydrophobicity for improved affinity.

\box{Cn1cc(-c2ccc3nnc(Sc4ccc5ncc(NC(=O)C(F)(F)F)cc5c4)n3c2)cn1}
LLM-GENERATED: Cn1cc(-c2ccc3nnc(Sc4ccc5ncc(NC(=O)C(F)(F)F)cc5c4)n3c2)cn1
Cn1cc(-c2ccc3nnc(Sc4ccc5ncc(NC(=O)C(F)(F)F)cc5c4)n3c2)cn1

Boltz running on GPU 2
10.51
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1CCN(CCOc2cnc(-c3cccc(Cn4nc(-n5ccc6ccc(F)cc65)ccc4=O)c3)nc2)CC1,-11.18]
[O=C(NC1=CC=C(OC2=CC=NC3=C2C=CN3)C(F)=C1)C1=[N+]([O-])C(C2=CC=CC=C2)=CC=C1,-10.33]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, π–π stacking, and electrostatic. The first molecule has a flexible chain with fluorinated aromatic rings, likely providing favorable hydrophobic and electronic effects. The second molecule incorporates a methylated nitrogen heterocycle and a reactive pyridine ring, suggesting key interactions with the protein.

To build on this, introducing a more rigid fused bicyclic system could increase shape complementarity and stacking. Adding a bromine substituent on the aromatic ring might enhance van der Waals contacts and modulate electronic properties. Retaining the fluorine group maintains potential H-bond acceptors while increasing binding surface area and hydrophobic interactions.

Combining these ideas, I propose a molecule that incorporates a fused bicyclic core with a bromofluorophenyl substituent and a methylated nitrogen heterocycle to improve binding.

\box{Cn1cc(-c2ccc3c(Oc4ccc(N=NC5=CC(=O)N(C)Cc6ccc(Br)cc6F)CC5)cc3c2)cn1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 16
NON-LLM GENERATED: CN1CCN(CCOC2=CN=C(C3=CC=CC=C3)N=C2)CC1
CN1CCN(CCOc2cnc(-c3ccccc3)nc2)CC1

Boltz running on GPU 2
5.84
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1CCC(Nc2cnc3ccc(Sc4nnc5c(F)cc(-c6cnn(C)c6)cn45)cc3c2)CC1,-11.09]
[Cc1nc([C@H](C)NC(=O)c2ccc(-c3cnc4ncc(Cc5ccc6ncccc6c5)n4n3)cc2Cl)no1,-10.52]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for enhancing hydrogen bonding and electrostatic interactions, increasing polarity and flexibility in key regions of the ligand to better fit the binding pocket. Notably, the heterocyclic cores and substituents involved in interacting with the protein could be optimized.

Comparing the two given molecules, the first benefits from a piperazine ring with a methyl substitution that likely contributes to flexibility and solubility, while the second incorporates chloro substituents and an amide functionality to establish potential hydrogen bonds. The difference in affinity suggests that adjusting the heterocyclic system and electronic distribution may improve binding.

To that end, I would consider replacing the piperazine ring with a simpler but still flexible nitrogen-containing ring such as a pyrrolidine to slightly reduce steric bulk and enhance fit. Additionally, adding a hydroxyl group on the substituent off the heterocycle could improve hydrogen bonding with the protein. Incorporating a pyridine ring instead of a chlorophenyl may enhance polar interactions and binding specificity.

Based on this reasoning, I propose the molecule:

\box{CN1CCC(Nc2cnc3ccc(Sc4nnc5c(F)cc(-c6ccc(O)cc6)cn45)cc3c2)CC1}
LLM-GENERATED: CN1CCC(Nc2cnc3ccc(Sc4nnc5c(F)cc(-c6ccc(O)cc6)cn45)cc3c2)CC1
CN1CCC(Nc2cnc3ccc(Sc4nnc5c(F)cc(-c6ccc(O)cc6)cn45)cc3c2)CC1

Boltz running on GPU 2
10.78
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(=NOC(N)=O)c1ccc2nnc([C@H](C)c3c(F)cc4ncccc4c3F)n2n1,-11.2]
[Cn1cc(-c2ccc3nnc(Sc4ccc5ncc(NCCO)cc5c4)n3c2)cn1,-11.09]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice they both have similar core heterocyclic systems and substitutions, but there are subtle differences that might contribute to their binding affinity. The first ligand contains an oxime functionality and fluorinated aromatic rings, while the second ligand has a sulfur-linked aromatic system and a morpholine-like ring substituent.

The presence of fluorines in the first ligand likely enhances hydrophobic interactions and possibly improves metabolic stability, but the sulfur linkage in the second ligand might participate in better polar contacts or π-interactions. The morpholine ring in the second ligand could contribute to solubility and binding through hydrogen bonding, but may reduce overall hydrophobicity.

To design a stronger ligand, I would consider combining the beneficial features of both: maintaining the core heterocyclic system and fluorinated aromatics for hydrophobic and electronic effects, while introducing a polar amide group to provide additional hydrogen bonding and improve solubility. Also, incorporating a small alkyl amine substituent can enhance interactions with polar residues in the binding pocket.

Based on this reasoning, I propose the molecule: 

\box{CC(=O)Nc1ccc2nnc(Cc3ccc4ncccc4c3)c2n1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 17
NON-LLM GENERATED: CC(=NOC(N)=O)C1=NN2C(=NN=C2C(C)C2=C(F)C=CC(C3=CN(C)N=C3)C2F)C=C1
CC(=NOC(N)=O)c1ccc2nnc(C(C)C3=C(F)C=CC(c4cnn(C)c4)C3F)n2n1

Boltz running on GPU 2
9.99
150/1000 | avg_top1: 12.050 | avg_top10: 11.724 | avg_top100: 10.892 | avg_sa: 3.092 | div: 0.828
{'avg_top1': 12.05, 'avg_top10': 11.724, 'avg_top100': 10.892300000000004, 'auc_top1': 1.72445, 'auc_top10': 1.6723800000000004, 'auc_top100': 1.5534218095238095, 'avg_sa': 3.0923352079866735, 'diversity_top100': 0.8275501627342292, 'n_oracle': 150}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(c1c(F)cc2ncccc2c1F)n1cnc2ncc(-c3cnn(C)c3)nc21,-10.95]
[CC(C1=CC=C2N=CC(C3=CN(C)N=C3)=CC2=C1)N1N=NC2=NC=C(C3=CC=NC=C3)N=C21,-10.95]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to increase hydrogen bonding and pi-stacking interactions within the binding pocket of c-MET. The existing molecules already have a good framework of fused heterocycles and methyl substitutions that contribute to hydrophobic contacts. 

One strategy is to introduce a flexible linker with potential hydrogen bond donors and acceptors that can reach additional binding residues. Also, incorporating a substituted pyrazole or pyrazole-like ring could enhance interactions through additional nitrogen atoms.

Therefore, I would modify the tail region by replacing the hydrazone moiety with an ethylene linker containing a methylated hydrazone or methylated hydrazide, which can reach further into the pocket and participate in more interactions. This gives more opportunity for polar contacts and possibly new halogen bonding.

Hence, I propose this molecule:

\box{CC(C#CC(=O)NN(C)C)n1cnc2ncc(-c3cnn(C)c3)nc21}
LLM-GENERATED: CC(C#CC(=O)NN(C)C)n1cnc2ncc(-c3cnn(C)c3)nc21
CC(C#CC(=O)NN(C)C)n1cnc2ncc(-c3cnn(C)c3)nc21

Boltz running on GPU 2
9.26
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(NC1=CC=C(OC2=CC=NC3=C2C=CN3)C(F)=C1)C1=[N+]([O-])C(C2=CC=CC=C2)=CC=C1,-10.33]
[Cc1cc2ccnc(Nc3ccc(Oc4ccnc(N)c4I)c(F)c3)c2c(=O)n1-c1ccc(F)cc1,-10.92]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, aromatic stacking, and polar interactions while maintaining or improving the ligand's fit within the binding pocket. From the given molecules, the first ligand has a strong heteroaromatic core and fluorinated phenyl groups, contributing to affinity, but it could benefit from additional polar groups to engage with polar residues nearby.

The second ligand incorporates heterocycles with fluorine substitution and an iodine atom, suggesting successful interactions but may be limited by the iodine which could be optimized. Replacing the iodine with a more compact and oxygen-containing ring might improve solubility and binding by adding hydrogen bonding potential.

Considering these points, I would propose introducing an ether linkage and a small ring system that includes an oxazine or tetrahydropyran moiety to increase polarity and rigidity while maintaining aromatic and heterocyclic characteristics. This could enhance binding through additional hydrogen bonds and better shape complementarity.

\box{O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1CCOCC1C(=O)Nc1=CC(=O)N[C@H]1C(C)=O}
LLM-GENERATED: CC(=O)C1NC(=O)C=C1NC(=O)C1COCCC1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1
CC(=O)C1NC(=O)C=C1NC(=O)C1COCCC1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1

Boltz running on GPU 2
9.23
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC=C(N2C(=O)C(C(=O)NC3=CC=C(OC4=CC=NC(N)=C4Cl)C(F)=C3)=CC3=CC=CC=C32)C=C1,-9.56]
[COc1cnc2ccc([C@H](C)c3nnc4ccc(-c5ccccc5)nn34)cc2c1,-10.63]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, hydrophobic contacts, and possibly introduce groups that can better fit the binding pocket or interact with polar residues. The first molecule contains a bulky alkyl substituent and a heterocyclic scaffold with potential hydrogen bond donors/acceptors, but its affinity is moderate. The second molecule has a better aromatic system with nitrogen atoms that can participate in interactions, but it lacks the bulk and hydrophobic groups present in the first.

By combining advantages, I would design a molecule that integrates the bulk and hydrophobic character of the first with the aromatic nitrogen framework of the second, possibly adding a branched alkyl substituent to increase van der Waals contacts and not forget a methyl group on the aromatic ring for subtle hydrophobicity and improved fit.

Thus, the molecule I propose is:  
\box{CCC(C)c1ccc2nnc3ccc(-c4ccccc4)nn23c1C}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 18
NON-LLM GENERATED: COOC1=CC=NC(N)=C1Cl
COOc1ccnc(N)c1Cl

Boltz running on GPU 2
6.13
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[c1cc2ncc(N3CCOCC3)cc2cc1Sc1nnc2ccc(-c3cn[nH]c3)cn12,-11.09]
[CC(c1c(F)cc2ncccc2c1F)n1cnc2ncc(-c3cnn(C)c3)nc21,-10.95]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: From the given binding affinities, both molecules are close but have room for improvement. The first molecule has a methoxy substituent and a morpholine ring contributing to its interaction profile, while the second molecule uses fluorine atoms and a methylated triazole ring. Comparing the two, the fluorinated aromatic rings and the methyl-triazole motif in the second molecule might enhance hydrophobic and electronic interactions.

To create a stronger ligand, I would combine the beneficial features: keep the core aromatic system with the fluorine substituents for better electronic effects and metabolic stability, but replace the methyl-triazole with a dimethyl-triazole to increase hydrophobic contacts and possibly improve binding through additional hydrophobic patches.

Thus, I propose introducing a dimethyl-substituted triazole ring on the same aromatic core with the fluorines, maintaining the heterocyclic framework for strong binding.

The new molecule is:  
\box{CC(c1c(F)cc2ncccc2c1F)n1cnc2ncc(-c3cnn(C(C)C)c3)nc21}
LLM-GENERATED: CC(C)n1cc(-c2cnc3ncn(C(C)c4c(F)cc5ncccc5c4F)c3n2)cn1
CC(C)n1cc(-c2cnc3ncn(C(C)c4c(F)cc5ncccc5c4F)c3n2)cn1

Boltz running on GPU 2
10.6
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[N=C(NNC(N)=O)c1cnc2nnn(Cc3ccc4ncccc4c3)c2n1,-11.39]
[CO/N=C(\C)c1ccc2ncc(Cc3c(F)cc4ncccc4c3F)n2n1,-10.95]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: From the given binding affinities, we see that the existing molecules share a core scaffold with an aromatic system and a triazole moiety, but one includes a hydrazine-containing group -NNC(N)=O and the other has a more electron-rich environment with methoxy and fluorine substituents. The improvement from the first to the second molecule suggests gaining electron-donating groups can enhance binding, likely by interacting better with polar residues in the binding pocket.

To further improve affinity, introducing a structure that combines the beneficial aromatic and heterocyclic features while adding a strong hydrogen bond donor/acceptor group could boost binding. A hydrazone linkage with an amide -NNC(=O)NN=O might increase favorable interactions, and maintaining fluorines on the phenyl ring could enhance hydrophobic and electronic effects.

Therefore, I propose a molecule that integrates these elements for stronger c-MET binding:

\box{CO/N=C(\C)c1ccc2ncc(Cc3c(F)cc4ncccc4c3F)n2n1}
LLM-GENERATED: CON=C(C)c1ccc2ncc(Cc3c(F)cc4ncccc4c3F)n2n1
CON=C(C)c1ccc2ncc(Cc3c(F)cc4ncccc4c3F)n2n1

Boltz running on GPU 2
10.93
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[[C-]#[N+]C1=C2COCCN2C2=C(C(=O)OC2)C1c1ccc2[nH]nc(C)c2c1,-10.9]
[[C-]#[N+]C1=C(c2ccc(F)cc2F)N=C2COC(=O)C2C1c1ccc2n[nH]c(C)c2c1,-10.1]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions in the ligand by increasing hydrogen bonding, improving hydrophobic contacts, and optimizing the balance of polar and nonpolar groups. The first molecule has a strong nitrogen-oxygen interaction and aromatic stacking, but may benefit from added hydrogen bond donors or acceptors to interact more deeply with the protein. The second molecule introduces fluorines on the phenyl ring, likely to improve hydrophobic and electronic effects, but its core structure is somewhat similar.

To differentiate and potentially boost affinity, I would introduce an alkyne group (C#N) to increase rigidity and pi-stacking potential, while keeping the key nitrogen-oxygen core intact. Additionally, adding a methylene linker (C--C) before the aromatic system could give more flexibility without losing crucial interactions. Also, maintaining the fluorine substituents on the phenyl ring seems beneficial, so I would keep that feature.

Therefore, combining these ideas, the new molecule would have an alkyne and a methylene linker attached to a nitrogen-containing aromatic system with fluorinated phenyl rings and the same oxygen-containing core.

\box{C#Cc1c(OCC(=O)N2CC#N)ccc2c1-c1ccc2n[nH]c(C)c2c1}
LLM-GENERATED: C#Cc1c2ccc(c1-c1ccc3n[nH]c(C)c3c1)N(CC#N)C(=O)CO2
C#Cc1c2ccc(c1-c1ccc3n[nH]c(C)c3c1)N(CC#N)C(=O)CO2

Boltz running on GPU 2
[Errno 2] No such file or directory: '/data/boltz/results/boltz_results_c-met_C#Cc1c2ccc(c1-c1ccc3n[nH]c(C)c3c1)N(CC#N)C(=O)CO2/predictions/c-met_C#Cc1c2ccc(c1-c1ccc3n[nH]c(C)c3c1)N(CC#N)C(=O)CO2/affinity_c-met_C#Cc1c2ccc(c1-c1ccc3n[nH]c(C)c3c1)N(CC#N)C(=O)CO2.json'
-0.0
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1CCN(CCOC2=CN=C(C3=CC=CC(CN4N=C(N5C=CC6=CC=C(F)C=C65)C=CC4=O)=C3)N=C2)CC1,-11.18]
[Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6cnn(C)c6)cn45)c3c2)cn1,-10.61]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase planarity for better π-stacking, and introduce electronegative groups to strengthen interactions with the protein's active site. The first molecule has a flexible morpholine ring and a fused heterocyclic system with potential for additional hydrogen bonds, while the second molecule features a fused pyrazole-triazole system and an sulfonyl group that could engage in polar contacts.

Comparing the two, the first molecule's morpholine may be replaced or modified to a heteroaromatic ring with additional nitrogen atoms that can enhance hydrogen bonding and electronic interactions. Adding a heteroatom in the fused ring system could also increase polarity and binding affinity.

Based on this, I would design a molecule that replaces the morpholine with a pyridine ring and introduces an imine (C=N) linkage to maintain planarity and potential hydrogen bonding, while retaining the core fused heterocyclic motif with a methyl-substituted phenyl ring to maintain hydrophobic interactions.

The new molecule I propose is:

\box{COc1ccn(-c2ccc(=O)n(C=c3cc4ncccc4c3C)c2=O)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 19
NON-LLM GENERATED: CN1C=C(C2=CN=C3C=NN(S(=O)(=O)C4=CN=C5C=CC(C6=CCC=C6)=CN45)C3=C2)C=N1
Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(C6=CCC=C6)cn45)c3c2)cn1

Boltz running on GPU 2
10.38
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[C[C@@H](C1=CC2=CC=CN=C2C=C1F)N1C=NC2=NC=C(C3=CC=C(C(N)=O)C(F)=C3)N=C21,-10.9]
[CC1=C(C(=O)NC2=CC=C(OC3=CC=NC(NC(=O)C4CC4)=C3)C=C2)C(=O)N(C2=CC=CC=C2)N1C,-9.94]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both share a similar scaffold with aromatic rings and heterocycles, indicating that the planar aromatic systems are important for binding to c-MET. The first ligand has fluorine substitution and an amide group contributing to affinity, while the second includes methoxy and amide functionalities, suggesting that electron-donating groups and hydrogen bonding motifs help enhance binding.

To improve affinity, I would consider combining the beneficial features: the methoxy group from the second ligand could enhance electron distribution on the aromatic ring, increasing interactions through hydrogen bonding or dipole interactions. Also, the introduction of a chlorine atom on the aromatic ring might provide better hydrophobic contacts or halogen bonding, which often strengthens binding in biological systems.

Therefore, I propose a molecule that incorporates the methoxy group and replaces the fluorine with chlorine on the fused aromatic system while maintaining the amide linker and the fused heterocycles. This design aims to maximize favorable interactions and binding affinity.

\box{COc1cc(-c2ccc(=O)n(Cc3cc4ncccc4c3C=C2)nc1=O)c1ccc(=O)n(-c2ccc(Cl)cc2)c1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 20
NON-LLM GENERATED: NC(=O)C1=CC=C(C2=CN=C(OC3=CC=NC(NC(=O)C4CC4)=C3)N2)C=C1F
NC(=O)c1ccc(-c2cnc(Oc3ccnc(NC(=O)C4CC4)c3)[nH]2)cc1F

Boltz running on GPU 2
8.44
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC2=C(OC3=CC=C(NC(=O)C4=C(C(F)(F)F)N(C5=CC=C(F)C(F)=C5)N=N4)C=C3F)C=CN=C2C=C1OCCCN1CCN(C)CC1,-9.72]
[NC1=NC=CC(OC2=CC=C(NC(=O)C3=CNC=C(C4=CC=C(F)C=C4)C3=O)C=C2F)=C1Cl,-9.52]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the given molecules, I see that both incorporate aromatic rings and heterocycles, with fluorinated phenyl rings contributing likely to hydrophobic and electronic interactions in the binding pocket. The first ligand uses a methoxy-substituted benzene ring linked via an ether bond, while the second replaces this with a pyridine ring with a chlorine substituent, possibly improving hydrogen bonding and halogen bonding.

To enhance binding affinity, I would consider balancing hydrophobic and polar interactions by introducing flexible linkers that can access additional space in the pocket and polar groups for hydrogen bonds without adding too much steric hindrance. The first ligand’s methoxy group may be replaced with a more flexible ether chain to extend the reach. The second ligand’s pyridine ring and amide motif offer good hydrogen bonding, but the chlorine may be strong but sometimes unfavorable due to size or polarity.

Therefore, I would suggest a molecule that combines the favorable features: a flexible ether linker extending from a substituted phenyl ring, connected to a fused heterocyclic core with fluorinated phenyl groups and an amide interaction, followed by a flexible piperazine moiety to engage in additional polar contacts.

The new designed molecule is:  
\box{COCCOc1cc(=O)n(-c2ccc(OCCCN3CCN(C)CC3)cc2F)c(=O)n1-c1ccccc1F}
LLM-GENERATED: COCCOc1cc(=O)n(-c2ccc(OCCCN3CCN(C)CC3)cc2F)c(=O)n1-c1ccccc1F
COCCOc1cc(=O)n(-c2ccc(OCCCN3CCN(C)CC3)cc2F)c(=O)n1-c1ccccc1F

Boltz running on GPU 2
8.38
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1CCN(c2cnc3cc(C(F)(F)F)cc(OCc4cccc([N+](=O)[O-])c4)c3c2)CC1,-9.79]
[[C-]#[N+]C1=C(c2ccc(F)cc2F)N=C2COC(=O)C2C1c1ccc2n[nH]c(C)c2c1,-10.1]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would consider enhancing hydrogen bonding and increasing interaction with polar residues in the binding site. The existing molecules have fluorinated phenyl rings that likely contribute hydrophobic contacts, but adding polar groups could strengthen interactions through hydrogen bonds.

Molecule -9.79 has a trifluoromethyl group and an N=O group on a phenyl ring, while the other has a fluorinated heterocycle and an N=O group. Incorporating a nitroso group (N=O) on the aromatic ring could provide additional hydrogen bond acceptors, improving affinity. Also, replacing the trifluoromethyl with a nitroso substituent might increase polarity and binding complementarity.

Based on this, I propose introducing a nitroso substituent on the aromatic ring while retaining the overall scaffold to enhance binding.

\box{CC1(C(=O)N[C@H]C(C)c2ccc3n[nH]c(C)c3c2)CCc1OCc1cccc([N+][=O]c1)cc1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 21
NON-LLM GENERATED: [C-]#[N+]C1C(OCC2=CC=CC([N+](=O)[O-])=C2)=C2COC(=O)C2C1C1=CC2=C(C)NN=C2C=C1
[C-]#[N+]C1C(OCc2cccc([N+](=O)[O-])c2)=C2COC(=O)C2C1c1ccc2n[nH]c(C)c2c1

Boltz running on GPU 2
10.2
160/1000 | avg_top1: 12.050 | avg_top10: 11.724 | avg_top100: 10.906 | avg_sa: 3.125 | div: 0.829
{'avg_top1': 12.05, 'avg_top10': 11.724, 'avg_top100': 10.906400000000001, 'auc_top1': 1.84495, 'auc_top10': 1.7896200000000004, 'auc_top100': 1.6624153095238097, 'avg_sa': 3.1248765448270364, 'diversity_top100': 0.8292551310567381, 'n_oracle': 160}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cc1cc(C)cc(-n2c(=O)c(C(=O)Nc3ccc(Oc4ccnc(N)c4Cl)c(F)c3)cc3ccccc32)c1,-9.88]
[CN1CCN(CCOC2=CN=C(C3=CC=CC(CN4N=C(N5C=CC6=CC=C(F)C=C65)C=CC4=O)=C3)N=C2)CC1,-11.18]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, aromatic stacking, and improve overall fit into the binding pocket. The first molecule has good aromatic interactions but could benefit from added hydrogen bond donors/acceptors to increase binding. The second molecule already incorporates heterocycles and amide linkages for hydrogen bonding but might gain from introducing additional aromatic fluorine substituents to enhance hydrophobic and electronic interactions.

Based on this, I would design a molecule that integrates a methoxy-substituted aromatic ring to add electron density and potential hydrogen bonding through the ether oxygen. Incorporating a fluorophenyl group would improve hydrophobic contacts and possibly engage in halogen bonding. Retaining the core heterocyclic and amide features from both previous molecules should maintain essential hydrogen bonding networks.

Thus, the new molecule would have a methoxyphenyl moiety connected via an ether linkage to a heterocyclic amide scaffold that includes a fluorophenyl substituent on the second aromatic ring.

\box{COc1ccc(-n2c(=O)c(C(=O)Nc3ccc(Oc4ccnc(N)c4)c(F)c3)cc3ccccc32)cc1}
LLM-GENERATED: COc1ccc(-n2c(=O)c(C(=O)Nc3ccc(Oc4ccnc(N)c4)c(F)c3)cc3ccccc32)cc1
COc1ccc(-n2c(=O)c(C(=O)Nc3ccc(Oc4ccnc(N)c4)c(F)c3)cc3ccccc32)cc1

Boltz running on GPU 2
9.48
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[C[C@@H](c1ccc2ncccc2c1)n1nnc2ncc(-c3cnn(CCO)c3)nc21,-11.3]
[CC(c1c(F)cc2ncccc2c1F)n1cnc2ncc(-c3cnn(C)c3)nc21,-10.95]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, both have similar frameworks with variations in substituents on the triazole ring. The first ligand has a chiral center with a phenyl ring attached to a pyridine, while the second has two fluorines on the phenyl ring. The binding affinity of the first ligand is -11.3, and the second is -10.95, indicating that adding fluorines may slightly reduce binding affinity, probably due to unfavorable electrostatic or steric effects.

To improve on this, I would focus on removing the fluorines and introducing a smaller, more flexible group that can enhance interactions without steric hindrance. Also, maintaining the chiral center might help preserve favorable binding geometry.

Therefore, I propose a molecule that removes the fluorines and replaces the substituent on the triazole with a methyl group and a piperazine ring to increase solubility and possibly improve key interactions by introducing nitrogen atoms that can act as H-bond acceptors or donors.

\box{C[C@@H](c1ccc2ncccc2c1)n1nnc2ncc(-c3cnn(C4CCNCC4)c3)nc21}
LLM-GENERATED: CC(c1ccc2ncccc2c1)n1nnc2ncc(-c3cnn(C4CCNCC4)c3)nc21
CC(c1ccc2ncccc2c1)n1nnc2ncc(-c3cnn(C4CCNCC4)c3)nc21

Boltz running on GPU 2
10.54
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1,-10.3]
[CN1C=C(C2=CN3C(SC4=CC=C5N=CC6=C(OCC(=O)N6C)C5=C4)=NN=C3C(F)=C2)C=N1,-10.8]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, π-π stacking, and electrostatic binding. The first molecule has a heterocyclic core with carbonyl groups that could form hydrogen bonds, while the second molecule incorporates nitrogen-containing heterocycles and amide functionalities potentially beneficial for polar contacts.

Comparing the two, the second molecule has a more flexible side chain with an amide-linked ring that might adapt better into the binding pocket. However, its binding affinity is still moderate, so adding aromatic groups to increase hydrophobic and π interactions could be advantageous. Also, introducing halogen atoms like fluorine and chlorine can improve binding through halogen bonding or fill hydrophobic pockets.

Therefore, I would design a molecule that keeps the key heterocyclic and amide features but extends the aromatic system and adds fluorine and chlorine substituents to enhance interactions and solubility. This leads me to propose the molecule:

\box{Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccc(F)c(Cl)c5)cc4c(=O)c3c2)cn1}
LLM-GENERATED: Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccc(F)c(Cl)c5)cc4c(=O)c3c2)cn1
Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccc(F)c(Cl)c5)cc4c(=O)c3c2)cn1

Boltz running on GPU 2
10.22
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CN=C2C=CC([C@H](C)C3=NN=C4C=CC(C5=CC=CC=C5)=NN43)=CC2=C1,-10.63]
[[C-]#[N+]C1=C2COCCN2C2=C(C(=O)OC2)C1c1ccc2[nH]nc(C)c2c1,-10.9]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, π-π stacking, and hydrophobic contacts. The first ligand has a fused heterocyclic core with methyl substituents that contribute to hydrophobic pockets filling. The second ligand incorporates an oxygen atom and a heterocyclic system with a methyl group, providing potential hydrogen bonding and improved electronic complementarity.

Comparing the two, the second ligand’s incorporation of an oxygen and aromatic heterocycle could enhance binding through additional polar interactions and π-stacking. To build on this, introducing a more flexible oxygen-containing ring might increase solubility and the ability to form additional hydrogen bonds, while maintaining or improving hydrophobic contacts.

Therefore, I would design a molecule that keeps the core heterocyclic system and methyl substituent for hydrophobic interaction, but adds an ethoxy substituent to the aromatic ring to provide flexibility and an additional hydrogen bond acceptor.

\box{COC1=C(COCCO)C(C)n1-C=C1C=CC([C@H](C)C2=NN=C3C=CC(C4=CC=CC=C4)=NN32)C1=C1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 22
NON-LLM GENERATED: COC1=CC2=CC(C(C)C3=C(C4=CC=C5NN=C(C)C5=C4)C4=C(COC4=O)N4CCOCC34)=CC=C2N=C1
COc1cnc2ccc(C(C)C3=C(c4ccc5[nH]nc(C)c5c4)C4=C(COC4=O)N4CCOCC34)cc2c1

Boltz running on GPU 2
9.77
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Nc1ncnc2[nH]cc(-c3cc(F)c(NC(=O)c4cn(CC5CCOCC5)cc(-c5ccc(F)cc5)c4=O)cc3F)c12,-11.42]
[CC(C1=CC=C2N=CC(C3=CN(C)N=C3)=CC2=C1)N1N=NC2=NC=C(C3=CC=NC=C3)N=C21,-10.95]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, aromatic stacking, and solubility while maintaining or increasing the rigidity of the molecule. The first molecule has strong electron-withdrawing groups (F, CO) that likely contribute to binding, but its core scaffold is rather fused heterocyclic and bulky. The second molecule has a more planar, aromatic core with potential for better π-π stacking and additional hydrogen bonding through the pyrazole and pyrimidine rings.

Comparing the two, the second molecule’s planarity and placement for hydrogen bonding seem advantageous. To further improve affinity, I would introduce a polar, flexible side chain to enhance solubility and form additional hydrogen bonds, while maintaining aromaticity and rigidity in the core. Also, replacing the bulky cyclopentyl ether substituent with a smaller, more flexible ether-linked chain might improve fit and interactions in the binding pocket.

Based on this, I propose a new molecule with an ethoxy chain (COCC) replacing the cyclopentyl ether, maintaining the aromatic core and hydrogen bonding patterns, and adding a terminal amide group to provide extra hydrogen bonding capacity.

\box{COCCn1cc(-c2ccc(F)cc2)c(=O)c(Nc2cc(F)cc(NC(=O)c3cc(-c4ccc(F)cc4)nc4ncc(-c4cccc(=O)[nH]c4C)cc34)c2)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 23
NON-LLM GENERATED: CNC(=O)C1=CN(CC2CCOCC2)C=C(C2=CC=C(F)C=C2)C1=O
CNC(=O)c1cn(CC2CCOCC2)cc(-c2ccc(F)cc2)c1=O

Boltz running on GPU 2
7.01
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CCC(c1ccc2ncccc2c1F)n1cnc2ncc(-c3ccc(C(N)=O)c(F)c3)nc21,-10.71]
[Cc1csc(-c2ccc3nnc(Cc4ccc(O)cc4)n3n2)c1,-9.47]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, hydrophobic contacts, and possibly electrostatic interactions. The first molecule has a fluorine-substituted aromatic ring that contributes to binding, but the amide group may be too flexible or poorly positioned for strong hydrogen bonding. The second molecule includes a methoxy-substituted aromatic ring, which could improve polarity and potential hydrogen bonding, but the binding affinity is slightly lower.

To strike a balance, I would consider replacing the amide group with a more rigid and polar heterocyclic moiety that can engage in multiple hydrogen bonds and possibly improve shape complementarity. A substituted pyrazole or triazole ring with an amide-like NH nearby might offer enhanced binding through additional hydrogen bonding and dipole interactions, while maintaining aromatic stacking potential.

Thus, I propose introducing a fused heterocycle featuring a pyrazole ring linked to a pyrimidine core, along with a fluorinated aromatic substituent to preserve favorable hydrophobic contacts.

\box{Cc1c(C(=O)Nc2ccc3nnc(Cc4ccc(F)cc4)n3n2)cnc1n1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 24
NON-LLM GENERATED: CC1=NC2=C(C1)N=C(C1=CC=C(C(N)=O)C(F)=C1)C=N2
CC1=Nc2ncc(-c3ccc(C(N)=O)c(F)c3)nc2C1

Boltz running on GPU 2
7.66
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(NC1=CC=C(OC2=CC=NC3=C2C=CN3)C(F)=C1)C1=[N+]([O-])C(C2=CC=CC=C2)=CC=C1,-10.33]
[Fc1cc(F)cc(-c2ccc3nnc(CNc4ccnc5cc(OCCn6cncn6)cnc45)n3n2)c1,-10.94]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, pi-stacking, and hydrophobic contacts. The first molecule has a strong electron-withdrawing group (N=C=O) and a fused aromatic system, likely contributing well to hydrogen bonding and stacking. The second molecule includes heterocycles and flexible linkers, which allow it to adapt to the binding pocket.

Comparing the two, the first molecule has a better main aromatic framework, but the side chain is relatively rigid. The second molecule’s side chain is more flexible and involves nitrogen heterocycles, which can serve as hydrogen bond donors/acceptors but may miss strong electron-withdrawing character.

To combine the benefits, I would design a molecule that retains the strong electron-withdrawing character seen in the first molecule and incorporates a heterocyclic moiety that can simultaneously engage in hydrogen bonding and hydrophobic interactions, like a substituted pyridine ring. This ring could also have a small electron-donating group (like a methyl) to modulate electronic effects and improve binding affinity.

Based on this reasoning, I propose the following molecule:

\box{CC(=O*N[C@H](C)c1cc(-c2ccc3nnc(CNc4cccnc4)n3c2)ccc1=O)C(C)=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 25
NON-LLM GENERATED: O=C(CCN1C=NC=N1)C1=[N+]([O-])C(C2=CC=CC=C2)=CC=C1
O=C(CCn1cncn1)c1cccc(-c2ccccc2)[n+]1[O-]

Boltz running on GPU 2
7.07
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(c1c(F)cc2ncccc2c1F)n1cnc2ncc(-c3cnn(C)c3)nc21,-10.95]
[COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,-10.3]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions in the ligand by increasing hydrogen bonding, improving aromatic stacking, and introducing groups that better complement the binding pocket. The first molecule has a key heterocyclic core with fluorinated rings, which may contribute to hydrophobic and electronic effects. The second molecule incorporates methoxy groups and an amide linkage, suggesting hydrogen bonding capabilities, but the binding affinity is slightly lower.

To propose a new molecule, I would combine features that enhance binding: maintain the core heterocyclic system with fluorinated aromatic rings for hydrophobic and electronic effects, and introduce a heteroatom-rich moiety that can form additional hydrogen bonds with the protein. Substituting one part of the ligand with a trifluoromethoxy-substituted phenyl ring could increase lipophilicity and improve binding through halogen bonding or dipole interactions. Additionally, preserving the amide functionality could retain key hydrogen bonding.

Based on this reasoning, I would generate the structure:

\box{O=C(Nc1ccc(F)cc1)c1ccc(Oc2ccnc3ncc(-c4cnn(C)c4)c3c2OC(F)(F)F)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 26
NON-LLM GENERATED: CC(C1=C(F)C=C2N=CC=CC2=C1F)N1C=NC2=NC=C(F)C21
CC(c1c(F)cc2ncccc2c1F)N1C=NC2=NC=C(F)C21

Boltz running on GPU 2
10.12
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[N=C(NNC(N)=O)c1cnc2nnn(Cc3ccc4ncccc4c3)c2n1,-11.39]
[FC1=CC(F)=CC(C2=NN3C(=NN=C3CNC3=CC=NC4=CC(OCCN5C=NC=N5)=CN=C43)C=C2)=C1,-10.94]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding and hydrophobic interactions while maintaining or expanding conjugation and planarity, which contribute to stronger stacking and better fit in the binding pocket.

The first molecule has moderate polarity and moderate binding affinity (-11.39), while the second molecule includes fluorines and a more constrained bicyclic system with slightly lower affinity (-10.94). To do better, I would introduce electron-donating groups to increase conjugation and potential hydrogen bonding, and add flexible polar side chains to engage with the binding site residues more effectively.

Based on this, I propose a molecule that incorporates an ethoxy substituent to increase polarity and an acetyl group to promote hydrogen bonding and improve microenvironment interactions. The fused heterocycles are retained to maintain aromatic stacking and rigidity.

\box{CCOc1cnc2nnn(Cc3ccc4ncccc4c3)c2n1}
LLM-GENERATED: CCOc1cnc2nnn(Cc3ccc4ncccc4c3)c2n1
CCOc1cnc2nnn(Cc3ccc4ncccc4c3)c2n1

Boltz running on GPU 2
9.73
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CCN1CCC(n2cc(-c3cnc4ccc5ccc(NS(=O)(=O)N(C)C)cc5c(=O)c4c3)cn2)CC1,-11.1]
[Cn1cc(-c2cnc3ccc4ccc(N)cc4c(=O)c3c2)cn1,-10.8]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, both share a core scaffold with fused aromatic rings and a nitrogen-rich heterocyclic system, which likely contributes to strong π-stacking and hydrogen bonding interactions in the binding pocket. The main differentiator is the presence of the sulfonyl-urea moiety in the better-bound molecule (–NS(=O)(=O)N(C)C–), which may form additional hydrogen bonds and improve solubility and binding affinity.

To enhance binding further, I would focus on increasing hydrophobic interactions and adding a more flexible, hydrophobic group to better fill the pocket without sacrificing key hydrogen bonding contacts. Introducing a small alkyl chain (like a propyl group) next to the sulfonyl-urea could increase van der Waals interactions and improve fit. Also, replacing the morpholine ring with a less polar but still basic amine-containing ring (such as piperazine) might improve binding by mimicking the natural substrate and facilitating electrostatic interactions.

Combining these ideas, I propose adding a propyl chain on the sulfonyl-urea nitrogen and replacing the morpholine with piperazine to potentially enhance the overall binding affinity.

The new molecule is:  
\box{CCN1CCC(n2cc(-c3cnc4ccc5ccc(NS(=O)(=O)NCCC)cc5c(=O)c4c3)cn2)CC1}
LLM-GENERATED: CCCNS(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C5CCN(CC)CC5)c4)cc3c(=O)c2c1
CCCNS(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C5CCN(CC)CC5)c4)cc3c(=O)c2c1

Boltz running on GPU 2
10.77
170/1000 | avg_top1: 12.050 | avg_top10: 11.724 | avg_top100: 10.916 | avg_sa: 3.112 | div: 0.827
{'avg_top1': 12.05, 'avg_top10': 11.724, 'avg_top100': 10.9157, 'auc_top1': 1.9654500000000001, 'auc_top10': 1.9068600000000004, 'auc_top100': 1.7715258095238096, 'avg_sa': 3.1121091721052805, 'diversity_top100': 0.8271880552277213, 'n_oracle': 170}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[FC(F)(C1=CC=C2N=CC=CC2=C1)C1=NN=C2N=CC(C3=CC=CC=C3)=NN21,-10.21]
[CN1CCN(CCOC2=CN=C(C3=CC=CC(CN4N=C(N5C=CC6=CC=C(F)C=C65)C=CC4=O)=C3)N=C2)CC1,-11.18]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I see that both incorporate fused heterocycles and fluorine substituents, which often enhance binding affinity through hydrophobic and electronic effects. The first ligand uses a pyrazole-based scaffold with aromatic rings, while the second introduces a morpholine moiety and a more flexible side chain.

To improve binding, I would aim to combine the beneficial features of each: maintain the planar heterocyclic cores for π-stacking and hydrogen bonding, introduce additional fluorines to enhance interaction with hydrophobic pockets, and optimize side chains to maximize contacts without adding too much flexibility.

Specifically, I would switch the side chain architecture to a saturated pyrrolidine ring bearing a polar amide group for improved hydrogen bonding and add a fluorophenyl substituent to increase hydrophobic and dipole interactions. I would also preserve the key fused pyrazole structure with the second ligand's method of linking to a benzyl amine, ensuring rigid planarity and electronic complementarity.

This reasoning leads me to propose the molecule:

\box{CC1CN(C(=O)Nc2ccc(F)cc2)c2c(-c3cn[nH]c3C)cnc2C1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 27
NON-LLM GENERATED: CN1CCN(CCOC2=NN3C(=NN=C3C(F)(F)C3=CC=C4N=CC=CC4=C3)N=C2)CC1
CN1CCN(CCOc2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)CC1

Boltz running on GPU 2
8.24
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[N#CC1=CC(C2=CN=C3N=NN(CC4CN(C5=NC=C(C6=CN(CCO)N=C6)C=N5)CCO4)C3=N2)=CC=C1F,-9.83]
[COC1=CC=C(N2C(=O)C(C(=O)NC3=CC=C(OC4=CC=NC(N)=C4Cl)C(F)=C3)=CC3=CC=CC=C32)C=C1,-9.56]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the given molecules, I see that both feature fused heterocycles and ether linkages that contribute to their binding affinity. The first molecule includes a fluorinated aromatic ring and multiple nitrogen atoms in a planar, conjugated system, likely facilitating hydrogen bonding and π-stacking with c-MET. The second molecule contains halogen substitutions (Cl and F) on the aromatic rings, which can enhance hydrophobic interactions and possibly modulate electronic effects, improving binding.

To build a stronger ligand, I would consider maintaining the core heterocyclic scaffold and ether linkage that seem important for fitting the binding pocket. However, replacing the fluorine in the first molecule with chlorine on the aromatic ring might enhance hydrophobic contacts and electronic complementarity, given chlorine’s larger size and polarizability. Additionally, introducing a hydroxyl group on the side chain could provide extra hydrogen bonding capacity, potentially increasing affinity.

Based on this reasoning, I propose the following molecule:

\box{N#CC1=CC(C2=CN=C3N=NN(CC4CN(C5=NC=C(C6=CN(CCO)N=C6)C=N5)CCO4)C3=N2)=CC=C1Cl}
LLM-GENERATED: N#Cc1cc(-c2cnc3nnn(CC4CN(c5ncc(-c6cnn(CCO)c6)cn5)CCO4)c3n2)ccc1Cl
N#Cc1cc(-c2cnc3nnn(CC4CN(c5ncc(-c6cnn(CCO)c6)cn5)CCO4)c3n2)ccc1Cl

Boltz running on GPU 2
10.2
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(NC1=CC(OC2=C(F)C=C(NC(=O)C3(C(=O)NC4=CC=C(F)C=C4)CC3)C(F)=C2)=CC=N1)C1CC1,-10.49]
[[C-]#[N+]C1=C2COCCN2C2=C(C(=O)OC2)C1C1=CC=C2NN=C(C)C2=C1,-10.9]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, aromatic stacking, and polarity in key regions of the ligand. The existing molecules have some good interactions but could use more flexible polar groups to engage with the binding pocket residues and possibly more fused aromatic systems for stronger π-π stacking.

From the given molecules, one has a pyrimidine-like scaffold with fluorinated phenyl rings and the other a methylated pyrazole-linked fused ring system with ether oxygens. Combining these ideas, I would introduce a heterocyclic moiety that includes an amide-linked pyrazole fused to a more planar, fluorinated phenyl ring to maximize stacking and dipole interactions. Additionally, incorporating a small flexible side chain such as a pyrrolidine or piperidine ring could enhance binding by filling adjacent hydrophobic pockets.

Therefore, I propose a ligand featuring a pyrrolidine-linked amide linked to a pyrazole fused to a fluorophenyl, with an aromatic ether-linked fluorinated phenyl ring for further interactions.

\box{CN1CCC(C)C1NC(=O)Nc1ccc(-c2ccc(-c3ccc(F)cc3)nn3ccc(-c4ccc(F)cc4)cc23)cc1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 28
NON-LLM GENERATED: CNC1=CC(F)=C(OC2=CC=NC(NC(=O)C3CC3)=C2)C=C1F
CNc1cc(F)c(Oc2ccnc(NC(=O)C3CC3)c2)cc1F

Boltz running on GPU 2
9.21
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CCC(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCN1CCOCC1,-11.36]
[O=C(CC1=CC=C(F)C=C1)NC(=O)NC1=CC=C(OC2=CC=NC3=C2C(C2=CC=CN=C2)=CN3)C(F)=C1,-9.82]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions in the ligand by increasing hydrogen bonding, improving aromatic stacking, and optimizing hydrophobic contacts. The first molecule has a methoxy-substituted aromatic ring with a fluorine atom helping with binding, while the second molecule replaces parts of the structure with more nitrogen-rich heterocycles, which can engage in additional hydrogen bonds.

Comparing the two, the second molecule’s use of a 1,2,4-triazole-like heterocycle and an ether linkage offering flexibility and polarity might enhance binding through hydrogen bonding. The replacement of the flexible ether-linked morpholine in the first molecule with a more rigid oxygen-containing ring could improve entropic favorability and binding strength.

Therefore, a promising approach would be to design a ligand that incorporates a fused heterocyclic system with nitrogen atoms to increase hydrogen bonding, combined with an oxygen-containing ring to balance flexibility and polarity. Additionally, introducing a fluorinated aromatic ring might enhance hydrophobic and electronic interactions.

Based on this reasoning, I propose the following molecule:

\box{Cn1cc(-c2cc(OCC3CCNC(=O)NC3)cnc2C(c2)Mi2)c1=CC(=O)N1CCOCC1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 29
NON-LLM GENERATED: CC1=CC=NC2=C1C(C1=CC=CN=C1)=CN2
Cc1ccnc2[nH]cc(-c3cccnc3)c12

Boltz running on GPU 2
8.24
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1CCC(Nc2cnc3ccc(Sc4nnc5c(F)cc(-c6cnn(C)c6)cn45)cc3c2)CC1,-11.09]
[C[C@H](c1cccc(-c2ncc(OCC3CCN(C)CC3)cn2)c1)n1cc(-c2cc(C#N)ccn2)cc(F)c1=O,-10.34]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, pi-stacking, and electrostatic binding. The first molecule has a morpholine ring involved in polar interactions, while the second uses a piperazine moiety with a flexible linker, likely facilitating fitting into the binding pocket.

To boost affinity, I might replace the piperazine with a more rigid, hydrogen-bonding rich heterocycle to reduce entropy loss upon binding. Also, adding an extra amide group could enhance hydrogen bonding and introduce favorable dipole interactions. Retaining the fluorine substituent is probably beneficial for binding via halogen bonding or hydrophobic contacts.

With these ideas, I propose incorporating a pyrimidine-containing bicyclic system with an amide substituent and a morpholine ring to maintain favorable interactions while increasing rigidity and hydrogen bonding capacity.

\box{CN1CCN(c2cnc3ccc(Sc4nnc5c(F)cc(-c6cnn(C)c6)cn45)cc3c2)CC1=O}
LLM-GENERATED: CN1CCN(c2cnc3ccc(Sc4nnc5c(F)cc(-c6cnn(C)c6)cn45)cc3c2)CC1=O
CN1CCN(c2cnc3ccc(Sc4nnc5c(F)cc(-c6cnn(C)c6)cn45)cc3c2)CC1=O

Boltz running on GPU 2
10.7
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(NC1=CC(OC2=C(F)C=C(NC(=O)C3(C(=O)NC4=CC=C(F)C=C4)CC3)C(F)=C2)=CC=N1)C1CC1,-10.49]
[FC1=CC(F)=CC(C2=NN3C(=NN=C3CNC3=CC=NC4=CC(OCCN5C=NC=N5)=CN=C43)C=C2)=C1,-10.94]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase rigidity to reduce entropy loss, and introduce groups that can favor hydrophobic interactions or electrostatic binding. 

The first molecule has a key heterocyclic core with fluorines and an ether linkage, while the second molecule incorporates additional nitrogen atoms in the ring system and a flexible ether tail. Comparing the two, the second molecule’s increased nitrogen content could improve hydrogen bonding, but the flexibility in the side chain might reduce binding strength.

To balance rigidity and hydrogen bonding, I would introduce a fused bicyclic heteroaromatic system with multiple nitrogen atoms to engage in stronger and more specific interactions, while keeping an ether-linked fluorinated side chain to maintain hydrophobic and electronic effects. Additionally, maintaining the keto group adjacent to the amide could enhance binding through dipole interactions.

Based on this reasoning, I propose the molecule:

\box{CC1CC(=O)N1NC(=O)C1(C(=O)Nc2ccc(OCCN3NC(=O)NC4=CC(C(=O)Nc5ccc(F)cc5)CC4)cc23)CCC1}
LLM-GENERATED: CC1CC(=O)N1NC(=O)C1(C(=O)Nc2ccc3cc2N(NC(=O)NC2=CC(C(=O)Nc4ccc(F)cc4)CC2)CCO3)CCC1
CC1CC(=O)N1NC(=O)C1(C(=O)Nc2ccc3cc2N(NC(=O)NC2=CC(C(=O)Nc4ccc(F)cc4)CC2)CCO3)CCC1

Boltz running on GPU 2
[Errno 2] No such file or directory: '/data/boltz/results/boltz_results_c-met_CC1CC(=O)N1NC(=O)C1(C(=O)Nc2ccc3cc2N(NC(=O)NC2=CC(C(=O)Nc4ccc(F)cc4)CC2)CCO3)CCC1/predictions/c-met_CC1CC(=O)N1NC(=O)C1(C(=O)Nc2ccc3cc2N(NC(=O)NC2=CC(C(=O)Nc4ccc(F)cc4)CC2)CCO3)CCC1/affinity_c-met_CC1CC(=O)N1NC(=O)C1(C(=O)Nc2ccc3cc2N(NC(=O)NC2=CC(C(=O)Nc4ccc(F)cc4)CC2)CCO3)CCC1.json'
-0.0
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CO/N=C(\C)c1ccc2ncc(Cc3c(F)cc4ncccc4c3F)n2n1,-10.95]
[C[C@@H](C1=CC2=CC=CN=C2C=C1F)N1C=NC2=NC=C(C3=CC=C(C(N)=O)C(F)=C3)N=C21,-10.9]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, aromatic stacking, and maintain key heteroatoms required for interaction with the c-MET binding site. Both initial molecules have strong aromatic systems and fluorinated rings, which contribute to binding, but one has an oxime ether (C=CC2=CC=CN=...) and the other has an N-N linked heterocycle with an aromatic phenol. 

To improve upon this, introducing a heteroaromatic ring with additional nitrogen atoms could increase hydrogen bonding and electron density for stacking. Also, incorporating a small, flexible, basic moiety like a piperazine ring could enhance interactions and solubility without adding too much bulk.

Therefore, I propose a new ligand that replaces the oxime ether with a pyridine-like ring and adds a piperazine substituent on the aromatic core, preserving the fluorinated heterocycles for hydrophobic and electronic effects.

\box{Cn1cc(-c2cc(F)c3ncc(Cc4c(F)cc5ncccc5c4F)n3n2)cn1}[#pidine] 1.00g $#-c2ccc3nnc(CCN4CCN(C)CC4)c3n2 

(Note: I've added a methyl group on the piperazine nitrogen to improve hydrophobic contacts and modulate polarity.)
LLM-GENERATED: Cn1cc(-c2cc(F)c3ncc(Cc4c(F)cc5ncccc5c4F)n3n2)cn1
Cn1cc(-c2cc(F)c3ncc(Cc4c(F)cc5ncccc5c4F)n3n2)cn1

Boltz running on GPU 2
10.96
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cc1cc2ccnc(Nc3ccc(Oc4ccnc(N)c4I)c(F)c3)c2c(=O)n1-c1ccc(F)cc1,-10.92]
[CC(C1=C(F)C=C2N=CC=CC2=C1F)N1C=NC2=NC=C(C3=CN(C)N=C3)N=C21,-10.95]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase planarity for better stacking interactions, and introduce groups that complement the binding pocket's hydrophobic or polar regions. Both initial molecules have strong aromatic and heterocyclic cores, but one could explore adding additional H-bond donors/acceptors or flexible linkers to optimize fit and interactions.

Molecule 1 has a carbonyl group in a pyrimidine ring that might participate in H-bonds, while Molecule 2 uses a methylated heterocycle for subtle hydrophobic contacts. To build on this, introducing an amide functionality might increase hydrogen bonding capacity and recognition. Also, eliciting the need for fluorine groups suggests involvement in polar contacts or dipole interactions.

Combining these ideas, I would design a molecule that preserves the critical heterocycles and aromatic systems but adds an amide linker to enhance H-bonding and possibly add a chlorine substituent to explore halogen bonding or hydrophobic interactions. This yields a structure with an amide connected to a pyridine ring substituted by a fluorophenyl group, central pyrimidine core, and an iodophenyl moiety.

\box{CNC(=O)c1ccn(-c2ccc(F)cc2)c(=O)n1-c1ccc(Oc2ccnc(N)c2I)c(F)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 30
NON-LLM GENERATED: CC1=CC2=C(C(=O)N1C1=CC=C(F)C=C1)C(NC1=C(F)C=C3N=CC=CC3=C1)=NC=C2
Cc1cc2ccnc(Nc3cc4cccnc4cc3F)c2c(=O)n1-c1ccc(F)cc1

Boltz running on GPU 2
7.52
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(=NOC(N)=O)C1=NN2C(=NN=C2[C@H](C)C2=C(F)C=C3N=CC=CC3=C2F)C=C1,-11.2]
[CCN1CCC(COc2cnc(-c3cccc(Cn4c(=O)ccn5c6cc(C#N)ccc6nc45)c3)nc2)CC1,-10.31]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding and hydrophobic interactions while maintaining or expanding conjugation and planarity, which aid in stacking and fitting into the binding pocket. 

The first molecule has a urea-like moiety (CC(=NOC(N)=O)) that could be optimized for stronger hydrogen bonding or reduced steric hindrance. The fused heterocycles in the core provide planarity and aromatic interactions, but adding polar groups or flexible linkers might improve complementarity.

The second molecule introduces a morpholine ring and fluorinated aromatic systems, which is beneficial for hydrophobic contacts and metabolic stability, but the binding affinity is slightly lower. Increasing the number of hydrogen bond donors or acceptors while preserving this aromatic framework could increase specificity and interaction strength.

Considering this, I would aim to replace the urea fragment with a more rigid and planar hydrazine-linked pyrazole system to improve stacking and hydrogen bonding, while retaining the fluorinated aromatic core from the second molecule to maintain hydrophobic interactions. Adding a methoxy substituent could enhance polarity and potential H-bonding without adding too much bulk.

Thus, the new molecule would incorporate a methoxy group on the pyrazole ring and keep the fluorinated fused heterocycles with a morpholine-like ring for improved binding.

The final proposed molecule is:

\box{COc1cc(-c2ccc3nnc(C[C@@H](C)n3n2)c(=O)c1C=CC1NNN=C1C(C)=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 31
NON-LLM GENERATED: N#CC1=CC=C2N=C3N(C=CC(=O)N3CC3=CC(C4=NC=C(OC(N)=O)C=N4)=CC=C3)C2=C1
N#Cc1ccc2nc3n(Cc4cccc(-c5ncc(OC(N)=O)cn5)c4)c(=O)ccn3c2c1

Boltz running on GPU 2
10.2
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC=C(N2C(=O)C(C(=O)NC3=CC=C(OC4=CC=NC(N)=C4Cl)C(F)=C3)=CC3=CC=CC=C32)C=C1,-9.56]
[CC(C1=C(F)C=C2N=CC(C3=CN(C)N=C3)=CC2=C1F)N1N=NC2=NC=C(C3=CN(CCO)N=C3)N=C21,-11.72]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrophobic interactions, hydrogen bonding, and possibly introduce groups that interact well with specific residues in the c-MET binding pocket. The first molecule has a bulky alkyl group and fluorines contributing to affinity, while the second molecule incorporates nitrogen-containing heterocycles for hydrogen bonding and flexible linkers, resulting in better binding (-11.72) than the first (-9.56).

To close the gap, I would combine the beneficial features: maintain the heterocyclic cores for hydrogen bonding, incorporate a fluorinated aromatic ring to enhance hydrophobic and electronic effects, and add a well-positioned hydrophobic cycloalkyl substituent to improve van der Waals contacts. Additionally, introducing a small difluoromethyl-containing moiety could increase lipophilicity and potentially form favorable interactions.

Based on this reasoning, I propose this molecule:

\box{NC1=NC(N)=C(Cc2ccc(F)cc2)N1N=C1N(C)CC(C(=O)Nc2ccc3n(-c4ccc(C5=CC=C(C)C5)cc4C(F)(F)cc23)c(=O)cc2C)CC1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 32
NON-LLM GENERATED: NC1=C(Cl)C(OF)=CC=N1
Nc1nccc(OF)c1Cl

Boltz running on GPU 2
4.77
180/1000 | avg_top1: 12.050 | avg_top10: 11.724 | avg_top100: 10.928 | avg_sa: 3.121 | div: 0.827
{'avg_top1': 12.05, 'avg_top10': 11.724, 'avg_top100': 10.9278, 'auc_top1': 2.08595, 'auc_top10': 2.0241000000000002, 'auc_top100': 1.8807433095238095, 'avg_sa': 3.1206337796730828, 'diversity_top100': 0.8265412155943399, 'n_oracle': 180}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[C[C@@H](C1=CC2=CC=CN=C2C=C1F)N1C=NC2=NC=C(C3=CC=C(C(N)=O)C(F)=C3)N=C21,-10.9]
[O=C(NC1=CC=C(OC2=CC=NC(NC(=O)C3CC3)=C2)C=C1)C1=NC2=CC=CC=C2N(C2=CC=C(F)C=C2)C1=O,-10.76]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a core pyrimidine structure with substituents attached to the aromatic rings. The main differences lie in the positioning and composition of the substituents, particularly the amide and hydroxyl groups. 

The first molecule has a fluorine atom on one aromatic ring and an amide group on the other ring, while the second molecule has an ether linkage connecting the aromatic systems with amide groups on both rings, including a hydroxyl group. 

To improve binding affinity, I would consider enhancing hydrogen bonding capabilities and maintaining aromatic interactions. Introducing an amide group on the second aromatic ring of the first molecule could provide additional hydrogen bonding opportunities with the protein. Also, switching the position of one aromatic ring to optimize interactions with the binding pocket might be beneficial.

Based on this, I propose adding an amide group on the second aromatic ring of the first molecule to create a stronger H-bond donor-acceptor motif, while retaining the fluorine on the first aromatic ring to preserve hydrophobic interactions.

The new molecule is: 
\box{Cn1cc(-c2ccc(=O)n(C=c3cc(-c4ccc(=O)n(C)c4)ccc3=O)c2)cn1}
LLM-GENERATED: Cn1cc(-c2ccc(=O)n(C=C3C=C(c4ccc(=O)n(C)c4)C=CC3=O)c2)cn1
Cn1cc(-c2ccc(=O)n(C=C3C=C(c4ccc(=O)n(C)c4)C=CC3=O)c2)cn1

Boltz running on GPU 2
8.24
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[N#CC1=CC(C2=CN3C(CC4=CC=C5N=CC=CC5=C4)=CN=C3C(F)=C2)=CC=C1,-11.07]
[CC1=C(C(=O)NC2=CC=C(OC3=CC=NC(NC(=O)C4CC4)=C3)C=C2)C(=O)N(C2=CC=CC=C2)N1C,-9.94]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, pi-stacking, and hydrophobic contacts. The first molecule has a key pyrrole-like scaffold with fluorine substitution, providing some polarity and electronic effects. The second molecule introduces more polar groups such as amide linkages and methoxy substituents, promoting potential hydrogen bonding but has a slightly shorter or different aromatic system.

To build on this, adding a heteroaromatic ring such as a pyridine or pyrazole could increase hydrogen bonding and stacking opportunities, while maintaining or improving conjugation. Incorporating a small, flexible, basic side chain like a pyrrolidine or piperazine moiety might enhance solubility and fill a hydrophobic pocket better. Also, preserving the fluorine substitution for electronic tuning seems beneficial.

Combining these ideas, I would design a molecule that keeps the core conjugation and fluorine substitution, replaces an aromatic pyrrole with a pyridine ring bearing a basic pyrrolidine substituent, and retains the amide-linked methoxy group to maintain hydrogen bonding capacity.

\box{Cn1cc(-c2ccc3ncc(N4CCN5CCCC5)n3c2)cn1-c1ccc2ccc(=O)n(Cc2)c1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 33
NON-LLM GENERATED: CC1=CC(C2=CC=CC(C#N)=C2)C(=O)N(C2=CC=CC=C2)N1C
CC1=CC(c2cccc(C#N)c2)C(=O)N(c2ccccc2)N1C

Boltz running on GPU 2
6.32
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(=NOC(N)=O)C1=NN2C(=NN=C2[C@H](C)C2=C(F)C=C3N=CC=CC3=C2F)C=C1,-11.2]
[O=C(NC1=CC=C(OC2=CC=NC(NC(=O)N3CCC3)=C2)C(F)=C1)C1=CN(CC2CC2)C(=O)N(C2=CC=C(F)C=C2)C1=O,-11.71]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase rigidity for better fit, and introduce groups that interact well with the c-MET binding pocket. 

From the two given molecules, I see that the first benefits from a well-balanced heterocyclic system and a fluorinated aromatic ring, while the second introduces bulkier substituents and an additional carbonyl group for polar interactions. The second molecule’s structure provides better potential for hydrogen bonding but its bulk might limit fit.

To refine the design, I would aim for a scaffold that maintains the key heterocycles and aromatic systems but replaces bulky substituents with groups that optimize interactions without steric hindrance. Introducing a pyrrole ring instead of the morpholine or piperazine could improve aromatic stacking and hydrogen bonding. Adding a methoxy group on the aromatic ring may enhance polarity and solubility while maintaining hydrophobic interactions. Also, using an N-ethyl group on the heterocyclic amine could improve lipophilicity and binding affinity.

Based on this reasoning, I propose the molecule:  
\box{CC(=NNC(N)=O)C1=NN2C(=NN=C2[C@H](C)C2=CC(=O)N1)C(C(=O)Nc1ccc(OC)c([nH]c1)nc1cccc1N)c1ccccc1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 34
NON-LLM GENERATED: CC(=NOC(N)=O)C1=NN2C(=CC=C2C(C)C2=C(F)C=C3N=CC=CC3=C2F)C=C1
CC(=NOC(N)=O)c1ccc2ccc(C(C)c3c(F)cc4ncccc4c3F)n2n1

Boltz running on GPU 2
10.05
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(C1=CC=C2N=CC(C3=CN(C)N=C3)=CC2=C1)N1N=NC2=NC=C(C3=CC=NC=C3)N=C21,-10.95]
[O=C(NC1=CC(OC2=C(F)C=C(NC(=O)C3(C(=O)NC4=CC=C(F)C=C4)CC3)C(F)=C2)=CC=N1)C1CC1,-10.49]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both involve fused heterocycles and fluorinated aromatic rings, which likely contribute to their binding affinity through hydrophobic and electronic interactions. The first molecule has a methylene linker between aromatic systems, while the second introduces an amide and ether linkers, increasing potential hydrogen bonding and flexibility.

To improve binding, I would consider enhancing hydrogen bonding capabilities without sacrificing planarity or aromatic stacking. Replacing an amide with a simpler, stronger hydrogen bond donor like an amino group on the heterocyclic core might increase affinity. Also, maintaining fluorine substituents on the aromatic ring could enhance metabolic stability and binding.

Based on this, I propose replacing the amide group in the first molecule with an amino substitution on the heterocycle and adding an amino group on the distal aromatic ring to increase hydrogen bonding and polarity, while keeping the fluorine atoms to maintain favorable interactions.

The resulting molecule is: \box{CC(C1=CC=C2N=CC(C3=NC(N)CC(=O)N3)CC2=C1)N1N=NC2=NC(N)CC=C2}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 35
NON-LLM GENERATED: O=C(NC1=CC(OCCC2=CC=NC=C2)=CC=N1)C1CC1
O=C(Nc1cc(OCCc2ccncc2)ccn1)C1CC1

Boltz running on GPU 2
7.48
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(NC1=CC=C(OC2=CC=NC(NC(=O)C3CC3)=C2)C=C1)C1=NC2=CC=CC=C2N(C2=CC=C(F)C=C2)C1=O,-10.76]
[CC(=NOC(N)=O)C1=NN2C(=NN=C2[C@H](C)C2=C(F)C=C3N=CC=CC3=C2F)C=C1,-11.2]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, aromatic stacking, and polarity in key regions of the ligand. The first molecule has a promising aromatic system but may be too hydrophobic or rigid. The second molecule incorporates oxygen-containing groups for polarity and potential hydrogen bonds, but its binding affinity is only slightly better.

To bridge the gap, I would focus on combining the beneficial aromatic frameworks with flexible, polar substituents that can engage in additional hydrogen bonding and improve solubility without sacrificing planarity and stacking interactions. Introducing an amide-linked side chain attached to a substituted aromatic ring could provide both rigidity and new interaction points.

Therefore, I propose a molecule that incorporates an amide connected to a fluorinated phenyl ring to enhance binding through halogen bonding or dipole interactions, combined with a fused heteroaromatic system that maintains aromatic stacking while allowing for better hydrogen bonding through the amide NH and carbonyl groups.

\box{CC(=O)NC(=O)C1=CC(=O)N(Cc2ccc(F)cc2)C(C2=CC(=O)N2)c1}
LLM-GENERATED: CC(=O)NC(=O)C1=CC(=O)N(Cc2ccc(F)cc2)C(C2=CC(=O)N2)C1
CC(=O)NC(=O)C1=CC(=O)N(Cc2ccc(F)cc2)C(C2=CC(=O)N2)C1

Boltz running on GPU 2
7.4
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=S)c1ccc(-c2cnc3ncc(Cc4cc(Cl)c5ncccc5c4)n3n2)cc1F,-11.22]
[Cc1nc([C@H](C)NC(=O)c2ccc(-c3cnc4ncc(Cc5ccc6ncccc6c5)n4n3)cc2Cl)no1,-10.52]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would consider enhancing hydrogen bonding capabilities and optimizing substituents on the aromatic rings to better complement the c-MET binding pocket. The existing molecules already have promising frameworks, but one has a thioamide (C=S) and the other a carbonyl (C=O); the difference in polarity and hydrogen bonding potential here could be key.

The chlorinated aromatic system seems important for maintaining hydrophobic and π-interactions, so preserving that is wise. However, introducing or swapping functional groups to improve polarity and ability to form directional hydrogen bonds may enhance affinity. Also, stereochemistry could play a role, so introducing a chiral center with an hydroxymethyl substituent might improve specificity and interaction with polar residues.

Based on this, I would design a molecule that replaces the thioamide with a more standard amide (C=O) to maximize hydrogen bonding, adds an hydroxymethyl group at a chiral center to enhance polarity and binding complementarity, and keeps the chlorinated aromatic system intact.

\box{CC[C@@H](CO)C(=O)Nc1ccc(-c2cnc3ncc(Cc4cc(Cl)c5ncccc5c4)n3n2)cc1F}
LLM-GENERATED: CCC(CO)C(=O)Nc1ccc(-c2cnc3ncc(Cc4cc(Cl)c5ncccc5c4)n3n2)cc1F
CCC(CO)C(=O)Nc1ccc(-c2cnc3ncc(Cc4cc(Cl)c5ncccc5c4)n3n2)cc1F

Boltz running on GPU 2
10.47
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1CCN(CCOC2=CN=C(C3=CC=CC(CN4N=C(N5C=CC6=CC=C(F)C=C65)C=CC4=O)=C3)N=C2)CC1,-11.18]
[O=C(NC1=CC=C(OC2=CC=NC(NC(=O)N3CCC3)=C2)C(F)=C1)C1=CN(CC2CC2)C(=O)N(C2=CC=C(F)C=C2)C1=O,-11.71]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, π-π stacking, and electrostatic. The first molecule has a favorable structure with aromatic rings and heterocycles but may benefit from added polar groups to increase hydrogen bonding. The second molecule introduces more hydrogen bond donors and acceptors via amide linkages and ether groups, improving interaction potential.

To build on this, I would aim to combine the beneficial aromatic core and heterocyclic systems while introducing additional amide functionalities to increase hydrogen bonding capacity, and possibly add a methoxy substituent to enhance solubility and electronic effects. Also, incorporating a piperazine ring could improve binding by providing a flexible, basic moiety that can form additional interactions.

Based on these considerations, I propose the molecule:

\box{COc1cc(-c2cnc(NC(=O)N2)cn2cc(C(=O)N3CCN(C)CC3)ccc2OC)ccc1N=C1N(C)C(=O)N(C)C1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 36
NON-LLM GENERATED: O=C(NC1=CC(OC2=CC=C3CCC(F)CC3=C2F)=CC=N1)N1CCC1
O=C(Nc1cc(Oc2ccc3c(c2F)CC(F)CC3)ccn1)N1CCC1

Boltz running on GPU 2
8.66
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cc1nc([C@H](C)NC(=O)c2ccc(-c3cnc4ncc(Cc5ccc6ncccc6c5)n4n3)cc2Cl)no1,-10.52]
[COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2N(C)S(C)(=O)=O)n1,-10.95]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I see that both incorporate nitrogen-rich heterocycles and halogen substitutions, which often enhance binding through hydrogen bonding and hydrophobic interactions. The first ligand has a chiral center with a small N-linked pyrimidine-containing heterocycle, while the second ligand features a more planar aromatic system with morpholine and piperazine rings, likely improving solubility and conformational flexibility.

To boost affinity, I would aim to combine the beneficial features of each: maintain the chiral center for stereospecific interaction and retain the heterocyclic aromatic systems for stacking and H-bonding. Additionally, introducing a small hydrophobic alkyl substituent on the piperazine ring could enhance van der Waals contacts without compromising flexibility.

With this in mind, I propose a molecule that integrates an isopropyl group on the piperazine nitrogen to improve hydrophobic interactions, maintains the nitroso pyrimidine moiety for strong H-bond donors, and preserves the chlorinated aromatic ring for halogen bonding. This design merges the strengths of the two initial ligands and adds a subtle hydrophobic modification to optimize binding.

The resulting molecule is:  
\box{CC(C)n1cc(-c2cnc3ccc(Cc4ncc(Cl)nc4n2)cc3C2CCN(C)CC2)n[nH]1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 37
NON-LLM GENERATED: CC1=NC(C(C)NC(=O)C2=CC=C(C3=NN4C(CC5=CC=C6N=CC=CC6=C5)=CC=C4N=C3)C=C2Cl)=NO1
Cc1nc(C(C)NC(=O)c2ccc(-c3cnc4ccc(Cc5ccc6ncccc6c5)n4n3)cc2Cl)no1

Boltz running on GPU 2
9.81
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1CCC(Nc2cnc3ccc(Sc4nnc5c(F)cc(-c6cnn(C)c6)cn45)cc3c2)CC1,-11.09]
[CN1C=C(C2=CN3C(SC4=CC=C5N=CC6=C(OCC(=O)N6C)C5=C4)=NN=C3C(F)=C2)C=N1,-10.8]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions such as increasing hydrogen bonding capacity, improving aromatic stacking, and optimizing substituents that fit well into the binding pocket. The existing molecules already have promising cores, but one has a methylated nitrogen and the other has a more rigid fused-ring system with fluorine contributing to affinity.

To build on this, introducing an amide group could increase hydrogen bonding potential and adding an aromatic substituent linked through an ether might enhance π-π stacking and hydrophobic contacts. Also, maintaining the fluorine is beneficial for binding, so I would keep that.

Therefore, I propose a molecule that incorporates an amide linked to a phenyl ring attached via an ether to the core scaffold with the fluorinated heterocycle and methylated nitrogen to potentially increase binding affinity.

\box{CNC(=O)c1ccc(Oc2ccc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 38
NON-LLM GENERATED: CN1C=NC=C(NC2CCN(C)CC2)C1
CN1C=NC=C(NC2CCN(C)CC2)C1

Boltz running on GPU 2
6.34
[(12.05, <rdkit.Chem.rdchem.Mol object at 0x761912363820>), (11.86, <rdkit.Chem.rdchem.Mol object at 0x761912392b30>), (11.8, <rdkit.Chem.rdchem.Mol object at 0x7619123636d0>), (11.79, <rdkit.Chem.rdchem.Mol object at 0x761912392740>), (11.72, <rdkit.Chem.rdchem.Mol object at 0x761912392660>), (11.71, <rdkit.Chem.rdchem.Mol object at 0x761912365430>), (11.67, <rdkit.Chem.rdchem.Mol object at 0x761912392f20>), (11.57, <rdkit.Chem.rdchem.Mol object at 0x7619123790b0>), (11.55, <rdkit.Chem.rdchem.Mol object at 0x761912363200>), (11.52, <rdkit.Chem.rdchem.Mol object at 0x761912392ac0>), (11.5, <rdkit.Chem.rdchem.Mol object at 0x761912365dd0>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912392eb0>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x7619123566d0>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912365580>), (11.4, <rdkit.Chem.rdchem.Mol object at 0x7619123d0510>), (11.39, <rdkit.Chem.rdchem.Mol object at 0x761912392f90>), (11.39, <rdkit.Chem.rdchem.Mol object at 0x761912365b30>), (11.36, <rdkit.Chem.rdchem.Mol object at 0x7619123653c0>), (11.32, <rdkit.Chem.rdchem.Mol object at 0x761912379cf0>), (11.31, <rdkit.Chem.rdchem.Mol object at 0x7619123923c0>), (11.3, <rdkit.Chem.rdchem.Mol object at 0x7619123637b0>), (11.28, <rdkit.Chem.rdchem.Mol object at 0x761912365890>), (11.22, <rdkit.Chem.rdchem.Mol object at 0x761912392a50>), (11.21, <rdkit.Chem.rdchem.Mol object at 0x761912363040>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912392350>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912392510>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912379eb0>), (11.18, <rdkit.Chem.rdchem.Mol object at 0x761912356820>), (11.18, <rdkit.Chem.rdchem.Mol object at 0x7619123656d0>), (11.17, <rdkit.Chem.rdchem.Mol object at 0x7619123d0970>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912356900>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912365ac0>), (11.1, <rdkit.Chem.rdchem.Mol object at 0x761912392e40>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356b30>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356cf0>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912365c10>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761aa402aa50>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x7619123927b0>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x761912365740>), (11.06, <rdkit.Chem.rdchem.Mol object at 0x761aa402af90>), (11.05, <rdkit.Chem.rdchem.Mol object at 0x761912392970>), (11.03, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00890>), (10.99, <rdkit.Chem.rdchem.Mol object at 0x761912365350>), (10.96, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99c80>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912392ba0>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356eb0>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356f90>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912365820>), (10.94, <rdkit.Chem.rdchem.Mol object at 0x761912392890>), (10.94, <rdkit.Chem.rdchem.Mol object at 0x761912392900>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761912365d60>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00660>), (10.92, <rdkit.Chem.rdchem.Mol object at 0x761912363190>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912379dd0>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365190>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365eb0>), (10.89, <rdkit.Chem.rdchem.Mol object at 0x761912365f90>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912392120>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x7619123d09e0>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912379e40>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761aa402ac80>), (10.78, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00190>), (10.77, <rdkit.Chem.rdchem.Mol object at 0x761aa3d996d0>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365900>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365ba0>), (10.75, <rdkit.Chem.rdchem.Mol object at 0x761aa402ab30>), (10.74, <rdkit.Chem.rdchem.Mol object at 0x761912392c10>), (10.71, <rdkit.Chem.rdchem.Mol object at 0x761912365510>), (10.7, <rdkit.Chem.rdchem.Mol object at 0x761aa3d995f0>), (10.65, <rdkit.Chem.rdchem.Mol object at 0x761912365e40>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123650b0>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123634a0>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x761912392c80>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x7619123922e0>), (10.6, <rdkit.Chem.rdchem.Mol object at 0x761912356970>), (10.6, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00c10>), (10.58, <rdkit.Chem.rdchem.Mol object at 0x7619123657b0>), (10.56, <rdkit.Chem.rdchem.Mol object at 0x761912365cf0>), (10.54, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99f20>), (10.52, <rdkit.Chem.rdchem.Mol object at 0x761912392270>), (10.51, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00e40>), (10.5, <rdkit.Chem.rdchem.Mol object at 0x761912356d60>), (10.49, <rdkit.Chem.rdchem.Mol object at 0x761912363660>), (10.47, <rdkit.Chem.rdchem.Mol object at 0x761912356dd0>), (10.47, <rdkit.Chem.rdchem.Mol object at 0x761aa3dab040>), (10.46, <rdkit.Chem.rdchem.Mol object at 0x761912363120>), (10.42, <rdkit.Chem.rdchem.Mol object at 0x7619123633c0>), (10.4, <rdkit.Chem.rdchem.Mol object at 0x7619123926d0>), (10.38, <rdkit.Chem.rdchem.Mol object at 0x7619123567b0>), (10.38, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00350>), (10.38, <rdkit.Chem.rdchem.Mol object at 0x761aa3e009e0>), (10.35, <rdkit.Chem.rdchem.Mol object at 0x761912356890>), (10.35, <rdkit.Chem.rdchem.Mol object at 0x761912365120>), (10.34, <rdkit.Chem.rdchem.Mol object at 0x761912392820>), (10.34, <rdkit.Chem.rdchem.Mol object at 0x761912365040>), (10.34, <rdkit.Chem.rdchem.Mol object at 0x761912365970>), (10.33, <rdkit.Chem.rdchem.Mol object at 0x761912365200>), (10.31, <rdkit.Chem.rdchem.Mol object at 0x761912365f20>), (10.3, <rdkit.Chem.rdchem.Mol object at 0x761912356e40>), (10.3, <rdkit.Chem.rdchem.Mol object at 0x761912365270>), (10.28, <rdkit.Chem.rdchem.Mol object at 0x761912379d60>), (10.25, <rdkit.Chem.rdchem.Mol object at 0x7619123924a0>), (10.23, <rdkit.Chem.rdchem.Mol object at 0x7619123659e0>), (10.22, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99d60>), (10.21, <rdkit.Chem.rdchem.Mol object at 0x761912363740>), (10.2, <rdkit.Chem.rdchem.Mol object at 0x761aa3d990b0>), (10.2, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99ba0>), (10.2, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99040>), (10.19, <rdkit.Chem.rdchem.Mol object at 0x761912356740>), (10.19, <rdkit.Chem.rdchem.Mol object at 0x7619123632e0>), (10.18, <rdkit.Chem.rdchem.Mol object at 0x761912365660>), (10.18, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00820>), (10.15, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00120>), (10.12, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99900>), (10.1, <rdkit.Chem.rdchem.Mol object at 0x761912365c80>), (10.05, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99cf0>), (10.04, <rdkit.Chem.rdchem.Mol object at 0x761912356c80>), (10.01, <rdkit.Chem.rdchem.Mol object at 0x761aa402ae40>), (9.99, <rdkit.Chem.rdchem.Mol object at 0x761aa402a5f0>), (9.99, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00200>)]
[0.009292175294371862, 0.009145659667324888, 0.009099391574573215, 0.009091680225781268, 0.009037700784237648, 0.009029989435445702, 0.008999144040277919, 0.00892203055235846, 0.00890660785477457, 0.00888347380839873, 0.008868051110814838, 0.008806360320479273, 0.008806360320479273, 0.008806360320479273, 0.00879093762289538, 0.008783226274103434, 0.008783226274103434, 0.008760092227727596, 0.008729246832559814, 0.008721535483767869, 0.008713824134975923, 0.00869840143739203, 0.008652133344640356, 0.00864442199584841, 0.008636710647056463, 0.008636710647056463, 0.008636710647056463, 0.008621287949472572, 0.008621287949472572, 0.008613576600680626, 0.008575019856720895, 0.008575019856720895, 0.008559597159137004, 0.008551885810345059, 0.008551885810345059, 0.008551885810345059, 0.008551885810345059, 0.008536463112761168, 0.008536463112761168, 0.008528751763969222, 0.008521040415177277, 0.008505617717593384, 0.0084747723224256, 0.008451638276049764, 0.008443926927257817, 0.008443926927257817, 0.008443926927257817, 0.008443926927257817, 0.008436215578465871, 0.008436215578465871, 0.008428504229673926, 0.008428504229673926, 0.00842079288088198, 0.008405370183298087, 0.008405370183298087, 0.008405370183298087, 0.008397658834506142, 0.00832825669537863, 0.00832825669537863, 0.00832825669537863, 0.00832825669537863, 0.008312833997794738, 0.008305122649002792, 0.008297411300210845, 0.008297411300210845, 0.0082896999514189, 0.008281988602626954, 0.008258854556251118, 0.00825114320745917, 0.008212586463499441, 0.00819716376591555, 0.00819716376591555, 0.008181741068331657, 0.008181741068331657, 0.008174029719539712, 0.008174029719539712, 0.00815860702195582, 0.00814318432437193, 0.008127761626788037, 0.008112338929204146, 0.008104627580412199, 0.008096916231620253, 0.008089204882828308, 0.008073782185244417, 0.008073782185244417, 0.008066070836452471, 0.008035225441284688, 0.008019802743700797, 0.008004380046116904, 0.008004380046116904, 0.008004380046116904, 0.007981245999741066, 0.007981245999741066, 0.00797353465094912, 0.00797353465094912, 0.00797353465094912, 0.007965823302157175, 0.007950400604573284, 0.007942689255781338, 0.007942689255781338, 0.007927266558197445, 0.007904132511821607, 0.007888709814237716, 0.00788099846544577, 0.007873287116653825, 0.007865575767861878, 0.007865575767861878, 0.007865575767861878, 0.007857864419069932, 0.007857864419069932, 0.007850153070277987, 0.007850153070277987, 0.00782701902390215, 0.007803884977526311, 0.007788462279942419, 0.007749905535982691, 0.007742194187190745, 0.007719060140814907, 0.007703637443231016, 0.007703637443231016]
[(11.8, <rdkit.Chem.rdchem.Mol object at 0x7619123636d0>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912392eb0>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356b30>), (10.01, <rdkit.Chem.rdchem.Mol object at 0x761aa402ae40>), (11.39, <rdkit.Chem.rdchem.Mol object at 0x761912392f90>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x7619123927b0>), (11.71, <rdkit.Chem.rdchem.Mol object at 0x761912365430>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x7619123927b0>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761aa402aa50>), (10.12, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99900>), (10.28, <rdkit.Chem.rdchem.Mol object at 0x761912379d60>), (10.96, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99c80>), (11.8, <rdkit.Chem.rdchem.Mol object at 0x7619123636d0>), (10.3, <rdkit.Chem.rdchem.Mol object at 0x761912356e40>), (10.56, <rdkit.Chem.rdchem.Mol object at 0x761912365cf0>), (11.36, <rdkit.Chem.rdchem.Mol object at 0x7619123653c0>), (9.99, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00200>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912392eb0>), (10.23, <rdkit.Chem.rdchem.Mol object at 0x7619123659e0>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356b30>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761912365d60>), (10.34, <rdkit.Chem.rdchem.Mol object at 0x761912392820>), (10.52, <rdkit.Chem.rdchem.Mol object at 0x761912392270>), (10.18, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00820>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x761912392c80>), (11.5, <rdkit.Chem.rdchem.Mol object at 0x761912365dd0>), (10.2, <rdkit.Chem.rdchem.Mol object at 0x761aa3d990b0>), (10.38, <rdkit.Chem.rdchem.Mol object at 0x761aa3e009e0>), (10.47, <rdkit.Chem.rdchem.Mol object at 0x761912356dd0>), (11.71, <rdkit.Chem.rdchem.Mol object at 0x761912365430>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356eb0>), (11.32, <rdkit.Chem.rdchem.Mol object at 0x761912379cf0>), (10.31, <rdkit.Chem.rdchem.Mol object at 0x761912365f20>), (10.49, <rdkit.Chem.rdchem.Mol object at 0x761912363660>), (10.2, <rdkit.Chem.rdchem.Mol object at 0x761aa3d990b0>), (10.05, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99cf0>), (10.35, <rdkit.Chem.rdchem.Mol object at 0x761912356890>), (9.99, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00200>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123634a0>), (11.72, <rdkit.Chem.rdchem.Mol object at 0x761912392660>), (11.86, <rdkit.Chem.rdchem.Mol object at 0x761912392b30>), (11.06, <rdkit.Chem.rdchem.Mol object at 0x761aa402af90>), (10.31, <rdkit.Chem.rdchem.Mol object at 0x761912365f20>), (10.23, <rdkit.Chem.rdchem.Mol object at 0x7619123659e0>), (10.1, <rdkit.Chem.rdchem.Mol object at 0x761912365c80>), (11.57, <rdkit.Chem.rdchem.Mol object at 0x7619123790b0>), (11.72, <rdkit.Chem.rdchem.Mol object at 0x761912392660>), (10.19, <rdkit.Chem.rdchem.Mol object at 0x761912356740>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356cf0>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365ba0>), (10.01, <rdkit.Chem.rdchem.Mol object at 0x761aa402ae40>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356eb0>), (10.56, <rdkit.Chem.rdchem.Mol object at 0x761912365cf0>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356eb0>), (10.38, <rdkit.Chem.rdchem.Mol object at 0x761aa3e009e0>), (10.78, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00190>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912379eb0>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912356900>), (11.17, <rdkit.Chem.rdchem.Mol object at 0x7619123d0970>), (10.78, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00190>), (10.49, <rdkit.Chem.rdchem.Mol object at 0x761912363660>), (10.12, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99900>), (10.5, <rdkit.Chem.rdchem.Mol object at 0x761912356d60>), (10.35, <rdkit.Chem.rdchem.Mol object at 0x761912365120>), (11.32, <rdkit.Chem.rdchem.Mol object at 0x761912379cf0>), (10.99, <rdkit.Chem.rdchem.Mol object at 0x761912365350>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912365820>), (10.51, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00e40>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356b30>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356cf0>), (11.05, <rdkit.Chem.rdchem.Mol object at 0x761912392970>), (10.34, <rdkit.Chem.rdchem.Mol object at 0x761912365970>), (10.71, <rdkit.Chem.rdchem.Mol object at 0x761912365510>), (11.55, <rdkit.Chem.rdchem.Mol object at 0x761912363200>), (11.55, <rdkit.Chem.rdchem.Mol object at 0x761912363200>), (10.99, <rdkit.Chem.rdchem.Mol object at 0x761912365350>), (10.38, <rdkit.Chem.rdchem.Mol object at 0x761aa3e009e0>), (10.51, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00e40>), (10.47, <rdkit.Chem.rdchem.Mol object at 0x761912356dd0>), (10.38, <rdkit.Chem.rdchem.Mol object at 0x761aa3e009e0>), (11.1, <rdkit.Chem.rdchem.Mol object at 0x761912392e40>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365900>), (10.77, <rdkit.Chem.rdchem.Mol object at 0x761aa3d996d0>), (10.42, <rdkit.Chem.rdchem.Mol object at 0x7619123633c0>), (10.1, <rdkit.Chem.rdchem.Mol object at 0x761912365c80>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912365ac0>), (10.34, <rdkit.Chem.rdchem.Mol object at 0x761912392820>), (10.56, <rdkit.Chem.rdchem.Mol object at 0x761912365cf0>), (10.71, <rdkit.Chem.rdchem.Mol object at 0x761912365510>), (10.35, <rdkit.Chem.rdchem.Mol object at 0x761912356890>), (10.15, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00120>), (11.72, <rdkit.Chem.rdchem.Mol object at 0x761912392660>), (11.39, <rdkit.Chem.rdchem.Mol object at 0x761912365b30>), (10.38, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00350>), (11.52, <rdkit.Chem.rdchem.Mol object at 0x761912392ac0>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912379e40>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912392350>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912365ac0>), (10.49, <rdkit.Chem.rdchem.Mol object at 0x761912363660>), (11.79, <rdkit.Chem.rdchem.Mol object at 0x761912392740>), (10.22, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99d60>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00660>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x7619123d09e0>), (10.77, <rdkit.Chem.rdchem.Mol object at 0x761aa3d996d0>), (10.6, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00c10>), (11.06, <rdkit.Chem.rdchem.Mol object at 0x761aa402af90>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912392eb0>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761aa402aa50>), (11.32, <rdkit.Chem.rdchem.Mol object at 0x761912379cf0>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365ba0>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761aa402aa50>), (10.1, <rdkit.Chem.rdchem.Mol object at 0x761912365c80>), (10.05, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99cf0>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x761912392c80>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123634a0>), (9.99, <rdkit.Chem.rdchem.Mol object at 0x761aa402a5f0>), (10.2, <rdkit.Chem.rdchem.Mol object at 0x761aa3d990b0>), (10.38, <rdkit.Chem.rdchem.Mol object at 0x761aa3e009e0>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912365c10>), (11.03, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00890>)]
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cn1cc(-c2ccc3nnc(Sc4ccc5ncc(NC(=O)C(F)(F)F)cc5c4)n3c2)cn1,-10.51]
[O=c1ccc(-n2ccc3ccc(F)cc32)nn1CCOc1ccnc2cc(OCCCN3CCOCC3)ccc12,-11.57]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions such as increasing hydrogen bonding, improving aromatic stacking, and introducing polar groups that can develop favorable electrostatic contacts. The first molecule has a strong aromatic system but may benefit from added hydrogen bond donors/acceptors to increase interaction points. The second molecule includes ether linkers and fluorinated phenyls, which provide flexibility and potential dipole interactions but could be further stabilized by amide functionalities or additional heterocycles.

Considering these points, I would design a molecule that incorporates an amide group to boost hydrogen bonding and add fused heterocycles to enhance stacking and hydrophobic contacts. Incorporating a trifluoromethyl-substituted cyclopropyl amide could give it a strong hydrophobic and electrostatic character at once. Also, maintaining the nitrogen-rich aromatic framework is key for preserving π-π interactions.

Based on this reasoning, the new molecule I propose is:

\box{CC(C(=O)Nc1ccc2nnc(Sc3ccc4ncc(-c5ccc6cnn(C)c6c5)cc4c3)n2c1)n(C)C(C)C}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 39
NON-LLM GENERATED: CN1C=C(C2=CN3C(=NN=C3SC3=CC=NC4=CC(OCCCN5CCOCC5)=CC=C43)C=C2)C=N1
Cn1cc(-c2ccc3nnc(Sc4ccnc5cc(OCCCN6CCOCC6)ccc45)n3c2)cn1

Boltz running on GPU 2
10.81
190/1000 | avg_top1: 12.050 | avg_top10: 11.724 | avg_top100: 10.935 | avg_sa: 3.133 | div: 0.825
{'avg_top1': 12.05, 'avg_top10': 11.724, 'avg_top100': 10.935299999999998, 'auc_top1': 2.20645, 'auc_top10': 2.14134, 'auc_top100': 1.9900588095238094, 'avg_sa': 3.132876198755926, 'diversity_top100': 0.8252650433524433, 'n_oracle': 190}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2N(C)S(C)(=O)=O)=N1,-10.95]
[CN1CCC(Nc2cnc3ccc(Sc4nnc5c(F)cc(-c6ccc(O)cc6)cn45)cc3c2)CC1,-10.78]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I see that both have a piperazine ring and an aromatic system involved in key interactions with c-MET. The first ligand features a phenyl ring with a sulfur-containing heterocycle, while the second ligand has a pyridine fused to a phenyl ring with a thiazole-like moiety.

To improve binding affinity, I would consider enhancing hydrogen bonding and hydrophobic interactions by extending the aromatic system and introducing electron-donating groups. The addition of methoxy substituents can boost affinity via hydrogen bonding and electronic effects. Also, maintaining the piperazine core preserves flexibility and solubility.

Based on this, I propose a ligand that incorporates two methoxy groups on an extended fused bicyclic aromatic ring system to increase interactions and replace the phenol group with a methoxy-substituted phenyl ring to improve hydrophobic contacts.

\box{COc1ccc2cccnc(Nc3ccc4nnc5c(F)cc(-c6cc(OC)ccc6)cn45)cc3c2c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 40
NON-LLM GENERATED: CC1=CN=C2C=CC(SC3=NN=C4C(F)=CC(C5=CC=C(O)C=C5)=CN34)=CC2=C1
Cc1cnc2ccc(Sc3nnc4c(F)cc(-c5ccc(O)cc5)cn34)cc2c1

Boltz running on GPU 2
11.06
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(=NNC(N)=O)c1ccc2nnc([C@@H](C)c3ccc4ncccc4c3)n2n1,-11.42]
[COCCOc1cnc2ccc([C@H](C)n3nnc4ccn(-c5cccs5)c(=O)c43)cc2c1,-10.93]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions in the binding pocket. Both existing molecules have shown good affinity, but there is room to increase hydrogen bonding and hydrophobic contacts. Molecular oxygen can serve as a subtle polar group for additional hydrogen bonding without adding too much bulk. Introducing an oxigen atom into the heterocyclic core could strengthen binding by creating new interaction opportunities with the protein.

Therefore, I would aim to modify the structure by incorporating an oxazole ring fusion, replacing a phenyl ring with a furan-like ring containing an oxygen. This could improve affinity by adding polar interactions while maintaining aromatic stacking.

\box{CC(=NNC(N)=O)c1ccc2non([C@@H](C)c3ccc4ncccc4c3)n2n1}
LLM-GENERATED: CC(=NNC(N)=O)C1=NN2C(=NON2C(C)c2ccc3ncccc3c2)C=C1
CC(=NNC(N)=O)C1=NN2C(=NON2C(C)c2ccc3ncccc3c2)C=C1

Boltz running on GPU 2
10.85
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)Nc1ccc(-c2cnc3ncc(Cc4cc(Cl)c5ncccc5c4)n3n2)cc1F,-11.03]
[C/C(=N\OCCCO)c1ccc2nnc(Cc3c(F)cc4ncccc4c3F)n2n1,-11.55]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to increase hydrogen bonding and polar interactions, as well as optimize hydrophobic contacts and maintain the overall ligand-protein complementarity. The first molecule has a amide functionality that can participate in H-bonding, while the second molecule has an oxime moiety that may form additional polar interactions.

Comparing the two, the higher affinity of the first molecule suggests that maintaining the amide and substituents around the pyridine system is favorable. To enhance binding further, I would introduce a heteroatom in the ring system to increase polarity and hydrogen bonding potential, while retaining the key structural framework.

Therefore, I propose replacing the chlorinated heterocycle in the first molecule with a sulfur-containing heterocycle, which could offer better electronic and steric complementarity and potentially form additional interactions with the binding site.

\box{CNC(=O)Nc1ccc(-c2cnc3ncc(Cc4cnc5ccccc5s4)n3n2)cc1F}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 41
NON-LLM GENERATED: CNC(=O)NC1=CC=C(C2=NN3C(COCCCO)=CN=C3N=C2)C=C1F
CNC(=O)Nc1ccc(-c2cnc3ncc(COCCCO)n3n2)cc1F

Boltz running on GPU 2
8.66
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)c1ccc(-c2ccc3nnc(COc4ccnc5cc(OCC(=O)N6CC6)ccc45)n3c2)c(F)c1,-11.06]
[CNC(=O)c1ccc(-c2ccc3nnc(COc4ccnc5cc(OCC(=O)N6CC6)ccc45)n3c2)c(F)c1,-11.06]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Looking at the two given molecules, they have similar frameworks with the core heterocyclic system and a fluorinated aromatic ring. The key differences lie in the substituents on the aromatic rings and the linker regions. Both molecules have an amide-linked side chain that includes a morpholine or a piperazine moiety, which likely contributes to solubility and interaction with polar pockets.

To improve binding affinity, I would consider enhancing hydrophobic interactions and pi-stacking within the binding site. One potential strategy is to replace the fluorine substituent, which may be making some polar contacts but limits hydrophobic surface area. Introducing a branched alkyl group on the aromatic ring could increase hydrophobic interactions and better fill a hydrophobic pocket if available.

Additionally, the core heterocyclic system could be modified to optimize interactions with the metal ion or introduce a halogen bond acceptor. Replacing the oxygen linker with a sulfur heteroatom might improve binding through different dipole interactions and slightly alter geometry.

Based on this reasoning, I propose the following molecule:

\box{CC(C)c1cccc(-c2ccc3nnc(COc4ccnc5ccsc4n3c2)c1)c1ccccc1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 42
NON-LLM GENERATED: O=C(COC1=CC=C2C(=C1)N=CC=C2OCC1=CC(OCC(=O)N2CC2)=CC1)N1CC1
O=C(COC1=CCC(COc2ccnc3cc(OCC(=O)N4CC4)ccc23)=C1)N1CC1

Boltz running on GPU 2
7.91
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[N#Cc1cc(-c2cnc3nnn(C[C@@H]4CN(c5ncc(C6=CCNCC6)cn5)CCO4)c3n2)ccc1F,-10.56]
[[C-]#[N+]C1C(OCc2cccc([N+](=O)[O-])c2)=C2COC(=O)C2C1c1ccc2n[nH]c(C)c2c1,-10.2]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, pi-stacking, and electrostatic bonding. The first molecule has a key heterocyclic core with nitrogen atoms that can act as hydrogen bond acceptors or donors, and a fluorine substituent that might contribute to binding specificity and polarity. The second molecule includes an oxazole ring and an N=O group, suggesting it engages in hydrogen bonding and possibly dipole interactions.

To build on these features, I would aim to increase hydrophobic contacts while preserving or enhancing hydrogen bonding capacity. Adding methyl groups can improve binding by filling hydrophobic pockets and increasing van der Waals interactions. Introducing a chiral center with oxygen-containing side chains could improve specificity and solubility, and maintaining or mimicking the heterocyclic cores from the previous molecules could preserve key interactions.

Based on this reasoning, I propose the following molecule:

\box{CC(C)n1cc(-c2cnc3nnn(C[C@@H]4CN(c5ncc(C6CCN(C)CC6)cn5)CCO4)c3n2)c(C)c1}
LLM-GENERATED: Cc1cn(C(C)C)cc1-c1cnc2nnn(CC3CN(c4ncc(C5CCN(C)CC5)cn4)CCO3)c2n1
Cc1cn(C(C)C)cc1-c1cnc2nnn(CC3CN(c4ncc(C5CCN(C)CC5)cn4)CCO3)c2n1

Boltz running on GPU 2
10.19
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1CCC(NC2=CN=C3C=CC(SC4=NN=C5C(F)=CC(C6=CN(C)N=C6)=CN45)=CC3=C2)CC1,-11.09]
[O=C(Nc1cc(C(F)(F)c2nnc3ncc(-c4ccc(F)cc4)nn23)ccn1)C1CC1,-10.38]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity in hydrophobic pockets, and maintain or expand the flexible linker region for optimal fit. The first molecule has a promising pyrazole-piperazine scaffold, but adding polar groups could strengthen interactions. The second molecule includes an amide and fluorinated rings, contributing to binding, but the amide might be limited in hydrogen bonding due to residual dipole or steric hindrance.

From this, I would aim to combine the favorable aspects: preserve the core heterocycles and fluorinated aromatic systems, but introduce an ester group to enhance polarity and hydrogen bond acceptor capability. Also, modifying the linker to a more flexible ether-linked chain with a basic amine could improve binding through additional interactions and conformational adaptability.

Based on this reasoning, I propose this new molecule:

\box{COC(=O)CCCCN1CCN(C)CC1-c1ccc(-c2nn3c(C=CC4=NN=C(C5=CCOCC5)C4=c3c2)ncn3-c1)cc1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 43
NON-LLM GENERATED: CN1CCC(NNC(=O)C2CC2)CC1
CN1CCC(NNC(=O)C2CC2)CC1

Boltz running on GPU 2
5.8
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CCO)n(-c5ccccc5)c4=O)nc3)ccnc2c1,-10.34]
[O=c1c(-c2ccnc3[nH]cc(-c4cccnc4)c23)cn(CC2CC2)c(=O)n1-c1ccc(F)cc1,-10.01]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase planarity for better π-stacking, and introduce groups that interact well with the c-MET binding pocket. The first molecule has a key amide linkage and a fused heterocyclic system, which provides rigidity and potential binding interactions. The second molecule adds fluorine substitution and a saturated cyclopropane ring, contributing to lipophilicity and spatial orientation.

To build on this, maintaining the amide and fused heterocycle is important, but adding a heteroaromatic ring that can participate in additional hydrogen bonding or dipole interactions may improve affinity. Introducing a trifluoromethyl group could enhance binding through hydrophobic contacts and electronic effects. Also, incorporating a flexible, polar substituent like a pyrrolidine ring bearing a piperazine moiety could increase solubility and provide further interaction points.

Combining these ideas, I would design a molecule that keeps the core amide and fused heterocycle, adds a trifluoromethyl group for hydrophobic interaction, and includes a polar side chain with a piperazine ring to enhance binding and pharmacokinetic properties.

\box{CC(=O)c1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C5CCNCC5)n(-c5ccccc5)c4=O)c(F)c3)c2cc1C(F)(F)F}
LLM-GENERATED: CC(=O)c1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C5CCNCC5)n(-c5ccccc5)c4=O)c(F)c3)c2cc1C(F)(F)F
CC(=O)c1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C5CCNCC5)n(-c5ccccc5)c4=O)c(F)c3)c2cc1C(F)(F)F

Boltz running on GPU 2
9.8
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1CCC(NC2=CN=C3C=CC(SC4=NN=C5C(F)=CC(C6=CC=C(O)C=C6)=CN45)=CC3=C2)CC1,-10.78]
[C/C(=N\OCCCO)C1=NN2C(=NN=C2CC2=C(F)C=C3N=CC=CC3=C2F)C=C1,-11.55]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase rigidity for better fit, and introduce groups that interact well with the c-MET active site. The first molecule has a flexible ring system and a fluorinated aromatic ring, while the second molecule incorporates an oxime moiety and fluorinated heterocycles, suggesting key interactions but limited hydrogen bond donors/acceptors.

To build on this, I would aim to introduce a more planar fused heterocyclic system with additional nitrogen atoms to increase polar interactions and possibly add a carbonyl group to introduce additional hydrogen bonding capability. Retaining fluorine substituents can maintain hydrophobic and electronic effects. Also, replacing or augmenting the flexible ring with a more constrained piperazine-like scaffold could improve binding affinity by reducing entropy loss upon binding.

Considering these points, I propose a molecule featuring a fused pyrazole-pyridine system with an amide carbonyl, a fluorinated aromatic ring, and a piperazine moiety linked via an imine. This design should enhance hydrogen bonding and rigidity while maintaining favorable interactions.

\box{CC1=C(N2CCN(C3CCOCC3)CC2=O)N=C(Nc3ccc(Oc4ccnc5cc(OC)ccc45)c(F)c3)N1}
LLM-GENERATED: COc1ccc2c(Oc3ccc(Nc4nc(N5CCN(C6CCOCC6)CC5=O)c(C)[nH]4)cc3F)ccnc2c1
COc1ccc2c(Oc3ccc(Nc4nc(N5CCN(C6CCOCC6)CC5=O)c(C)[nH]4)cc3F)ccnc2c1

Boltz running on GPU 2
9.24
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=c1c(-c2ccnc3[nH]cc(-c4cccnc4)c23)cn(CC2CC2)c(=O)n1-c1ccc(F)cc1,-10.01]
[CN1CCC(NC2=CN=C3C=CC(SC4=NN=C5C(F)=CC(C6=CC=C(O)C=C6)=CN45)=CC3=C2)CC1,-10.78]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two existing molecules, I see that both have similar core heterocyclic systems but differ in their substituents and binding affinities. The first molecule has a pyrimidinone core with an attached pyridine ring and a fluorophenyl group, giving it a strong interaction with a binding affinity of -10.01. The second molecule has a more complex fused heterocycle and includes aliphatic rings and an ether-containing aromatic moiety, resulting in a moderately weaker affinity of -10.78.

To improve binding affinity, I would consider maintaining the pyrimidinone core from the first molecule, as it seems to provide strong hydrogen bonding and planarity for interactions. However, introducing additional hydrophobic aromatic groups or heteroaromatic rings may enhance π-π stacking and hydrophobic contacts in the binding pocket. Also, adding electron-donating groups like methoxy on the phenyl ring could improve affinity by increasing electronic interactions and solubility.

Therefore, I propose to keep the pyrimidinone core and the fluorophenyl, but expand the structure by adding a fused bicyclic heteroaromatic system with a methoxy-substituted phenyl ring to enhance binding interactions and improve affinity.

\box{O=c1c(-c2ccnc3[nH]cc(-c4cccnc4)c23)cn(CC2CC2)c(=O)n1-c1ccc(OCc2cccnc3[nH]cc(-c4cccnc4)c23)c(F)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 44
NON-LLM GENERATED: OC1=CC=C(C2=CN3C(SC4=CC5=CC(NF)=CN=C5C=C4)=NN=C3C(F)=C2)C=C1
Oc1ccc(-c2cc(F)c3nnc(Sc4ccc5ncc(NF)cc5c4)n3c2)cc1

Boltz running on GPU 2
11.17
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[NC(=O)NN=Cc1cnc2nnn(Cc3ccc4ncccc4c3)c2n1,-11.05]
[CC(=NNC(N)=O)c1ccc2nnc([C@@H](C)c3ccc4ncccc4c3)n2n1,-11.42]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding and aromatic interactions while maintaining or improving the ligand's fit within the binding pocket. The existing molecules already share a core heterocyclic system, but their positioning and substituents vary slightly.

Molecule one uses an oxime-type linkage (NC(=O)NN=) connected to a pyridine-pyrazole system, while molecule two introduces a different linkage (CC(=NNC(N)=O)) and a chiral center adjacent to the aromatic ring. The improved molecule might combine beneficial features from both: it could maintain the oxime moiety for strong H-bonding and replace the pyrazole ring with a pyridine to introduce a more electron-withdrawing nitrogen, potentially enhancing interactions with the protein.

Additionally, keeping the chiral center and the aromatic bicyclic system intact ensures proper orientation and hydrophobic contacts within the pocket.

Therefore, a logical next design would be:

\box{CC(=NNC(N)=O)c1ccc2nnc([C@@H](C)c3ccc4ncccc4c3)n2n1}
LLM-GENERATED: CC(=NNC(N)=O)c1ccc2nnc(C(C)c3ccc4ncccc4c3)n2n1
CC(=NNC(N)=O)c1ccc2nnc(C(C)c3ccc4ncccc4c3)n2n1

Boltz running on GPU 2
11.52
200/1000 | avg_top1: 12.050 | avg_top10: 11.724 | avg_top100: 10.969 | avg_sa: 3.154 | div: 0.824
{'avg_top1': 12.05, 'avg_top10': 11.724, 'avg_top100': 10.968899999999996, 'auc_top1': 2.3269499999999996, 'auc_top10': 2.25858, 'auc_top100': 2.0995798095238096, 'avg_sa': 3.1535090430260135, 'diversity_top100': 0.8235732046105724, 'n_oracle': 200}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CCO)n(-c5ccccc5)c4=O)nc3)ccnc2c1,-10.34]
[CN1C=C(C2=CN3C(=NN=C3SC3=CC=C4N=CC(NCCO)=CC4=C3)C=C2)C=N1,-11.09]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase rigidity for better fit, and introduce aromatic or heteroaromatic groups that interact well with the c-MET binding pocket. The first molecule has decent aromatic interactions, but the second molecule's expanded heterocyclic system and multiple nitrogen atoms provide good H-bonding potential and conjugation, which could contribute to stronger binding.

To build on this, I would combine the beneficial features of both molecules: maintain the heterocyclic core with H-bond donors/acceptors and add an aromatic phenyl ring to increase hydrophobic and π-π stacking interactions. Also, introducing a flexible yet polar side chain like a pyrrolidine ring linked via a short linker could improve solubility and fill the pocket better.

Based on this reasoning, I propose this new molecule:

\box{CN1CCN(C)CC1NCCn1cc(-c2ccccc2)ccc2ncc(NC(=O)c3ccc(Oc4ccc5ncccc5c4)c(\C=C3/C=N)C)nc2}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 45
NON-LLM GENERATED: CC1=CC=C(NC(=O)C2=C(C)N(CCO)N(C3=CC=CC=C3)C2=O)N=C1
Cc1ccc(NC(=O)c2c(C)n(CCO)n(-c3ccccc3)c2=O)nc1

Boltz running on GPU 2
6.74
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COc1cc2c(Oc3ccc(N=Cc4c(O)n(-c5ccc(C)cc5)c(=O)[nH]c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,-10.35]
[O=C1C=CC(N2C=CC3=CC=C(F)C=C32)=NN1CCOC1=CC=NC2=CC(OCCCN3CCOCC3)=CC=C21,-11.57]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase rigidity to reduce entropy loss, and introduce hydrophobic groups to better fit the c-MET pocket. The first molecule has a flexible ethylene linker and a piperidine ring that might provide suboptimal licensing arrangements. The second molecule replaces this with a morpholine ring, increasing polarity and potential hydrogen bonding but may sacrifice some hydrophobic interactions.

Comparing the two, the first molecule's aromatic system and fluorine substitution help hydrophobic and electronic tuning, while the second adds polarity and conformational constraint. Combining these approaches, a rigidifying the core with an amide linkage and introducing a heteroaromatic system containing fluorine and an ether chain with a morpholine ring could optimize both hydrophobic and polar interactions, potentially improving binding.

Therefore, I would design a molecule that has a fused heterocycle with a fluorophenyl substituent, linked via an amide to a pyrazolone-like moiety, and an ether chain connected to a morpholine ring to enhance hydrogen bonding and fit.

\box{Cc1ccc(-c2cnc3ccc(NC(=O)c4ccnn(-c5ccc(OCCCN6CCOCC6)c(F)c5)c4=O)cc3c2)cc1}
LLM-GENERATED: Cc1ccc(-c2cnc3ccc(NC(=O)c4ccnn(-c5ccc(OCCCN6CCOCC6)c(F)c5)c4=O)cc3c2)cc1
Cc1ccc(-c2cnc3ccc(NC(=O)c4ccnn(-c5ccc(OCCCN6CCOCC6)c(F)c5)c4=O)cc3c2)cc1

Boltz running on GPU 2
9.57
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(Oc1cc(-c2ccn(C3CCNCC3)n2)cnc1N)c1c(Cl)ccc(F)c1Cl,-9.99]
[CC(=NOC(N)=O)c1ccc2ccc(C(C)c3c(F)cc4ncccc4c3F)n2n1,-10.05]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: From the given binding affinities, both molecules have strong interactions with c-MET, but there is room for improvement in increasing affinity and optimizing pharmacokinetic properties. The first molecule has a methoxy-substituted pyridine core and a piperazine moiety, which may contribute to favorable interactions and flexibility. The second molecule introduces a urea-like group and fluorinated aromatic rings, enhancing hydrogen bonding and hydrophobic contacts.

To improve the ligand, I would combine the beneficial features: maintain the flexible piperazine found in the first molecule and introduce the urea moiety and fluorinated aromatic system from the second to enhance hydrogen bonding and hydrophobic interactions. Additionally, simplifying the substitution pattern on the aromatic ring to reduce steric hindrance but keep key contacts may optimize fit in the binding pocket.

Therefore, I propose a molecule that incorporates a urea group linked to a methylated aromatic ring paired with a piperazine-containing heterocycle, maintaining fluorine substituents on the pyridine ring to enhance binding.

\box{CON(C(=O)Nc1ccc(C)c(F)c1F)c1CCNCCn1}
LLM-GENERATED: CON(C(=O)Nc1ccc(C)c(F)c1F)C1=NCCNCC1
CON(C(=O)Nc1ccc(C)c(F)c1F)C1=NCCNCC1

Boltz running on GPU 2
6.68
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cn1cc(-c2cnc3cnn(S(=O)(=O)c4cnc5ccc(C6=CCC=C6)cn45)c3c2)cn1,-10.38]
[COc1ccc2c(OCc3nnc4c(F)cc(-c5cc(C)cs5)cn34)ccnc2c1,-11.52]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: From the given binding affinities, the second molecule (COc1ccc2c(OCc3nnc4c(F)cc(-c5cc(C)cs5)cn34)ccnc2c1) seems to have better interactions due to its methoxy group and aromatic substitutions, which likely enhance binding. To improve on this, I would consider increasing polarity and hydrogen bonding capacity while maintaining or enhancing aromatic interactions.

A logical step is to replace the methyl group on the aromatic ring with an amide (C(N)=O) to introduce an additional hydrogen bond donor/acceptor site and increase polarity. Also, adding a fluorine substituent elsewhere in the molecule could improve binding through favorable dipole interactions.

Combining these ideas, I propose modifying the methyl substituent to an amide on the aromatic ring and introducing a fluorine on the pyridine ring to enhance both hydrogen bonding and electronic effects.

The new molecule is: \box{CNC(=O)c1ccc(-c2cc(F)c3nnc4c(F)cc(-c5cc(C)cs5)cn34)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 46
NON-LLM GENERATED: COS(=O)(=O)C1=CN=C2C=CC(C3=CCC=C3)=CN12
COS(=O)(=O)c1cnc2ccc(C3=CCC=C3)cn12

Boltz running on GPU 2
7.1
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(NC1=CC(OC2=C(F)C=C(NC(=O)C3(C(=O)NC4=CC=C(F)C=C4)CC3)C(F)=C2)=CC=N1)C1CC1,-10.49]
[CC(Oc1cc(-c2ccn(C3CCNCC3)n2)cnc1N)c1c(Cl)ccc(F)c1Cl,-9.99]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, aromatic stacking, and polar interactions while maintaining hydrophobic contacts. The first ligand has a key amide linkage and fluorinated aromatic rings, which contribute to affinity, but it could benefit from additional polar groups to increase interactions with the protein. The second ligand incorporates heterocycles and halogen substitutions, showing potential for favorable van der Waals and halogen bonding, but its binding affinity is slightly lower.

To build on this, I would aim to introduce a terminal aromatic amine substituent to provide extra hydrogen bonding and π-π stacking opportunities. Also, maintaining the fluorinated heterocyclic core from the first ligand seems valuable, but replacing the terminal pyridine with a aniline-type substitution might increase overall binding. 

Therefore, the new design keeps the core structure but replaces the terminal pyridine with an aniline group while retaining the rest of the molecule intact.

\box{O=C(NC1=CC(OC2=C(F)C=C(NC(=O)C3(C(=O)NC4=CC=C(F)C=C4)CC3)C(F)=C2)=CC=N1)c1ccc(N)cc1}
LLM-GENERATED: Nc1ccc(C(=O)Nc2cc(Oc3cc(F)c(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccn2)cc1
Nc1ccc(C(=O)Nc2cc(Oc3cc(F)c(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccn2)cc1

Boltz running on GPU 2
10.01
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COCCOc1cnc2ccc([C@H](C)n3nnc4ccn(-c5cccs5)c(=O)c43)cc2c1,-10.93]
[COc1ccc2c(OCc3nnc4sc(-c5cnn(C)c5)nn34)ccnc2c1,-10.23]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I see that both incorporate heterocyclic rings and oxygen-containing groups, which likely contribute to their binding affinities. The first molecule has a thiazole-containing scaffold with a methylated triazole, while the second molecule features a sulfur-containing heterocycle and a methylated triazole. The binding affinity of the first molecule (-10.93) is stronger than the second (-10.23), suggesting that the thiazole and sulfure substituents in the first may enhance binding.

To improve on this, I would consider combining the favorable features: maintaining the crucial heterocycles that interact well with the binding pocket while introducing additional polar groups that could form new hydrogen bonds or dipole interactions. Also, adding a methoxy group could improve solubility and electronic distribution without increasing steric bulk drastically.

Thus, I propose a molecule that merges the successful heterocyclic core from the first with a methoxy-substituted aromatic ring to enhance binding and solubility, yielding:

\box{COc1ccc2c(OCc3nnc4ccn(-c5cccs5)c(=O)c34)ccnc2c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 47
NON-LLM GENERATED: CN1C=C(C2=NC=CC=[SH]2)C=N1
Cn1cc(C2=NC=CC=[SH]2)cn1

Boltz running on GPU 2
5.85
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[c1cc2ncc(N3CCOCC3)cc2cc1Sc1nnc2ccc(-c3cn[nH]c3)cn12,-11.09]
[Cn1cc(-c2cnc3ccc4ccc(N)cc4c(=O)c3c2)cn1,-10.8]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, pi-stacking, and hydrophobic contacts. The existing molecules have promising aromatic and heterocyclic moieties but could potentially benefit from the introduction of more polar groups or flexible linkers to better fit the binding pocket.

Molecule 1 uses a morpholine ring (N4CCOCC4) which provides polarity but may be too small or too flexible. Replacing it with a more rigid polar group, such as a carbonyl substituted with a dimethyl amine (N(C)C=O), could improve hydrogen bonding capacity and better fill a polar pocket region.

Molecule 2 has a simpler triazole substituent that is effective but may limit the potential for additional interactions. Adding an aromatic system that extends beyond the original triazole might increase pi-stacking and hydrophobic interactions, forming new contacts within the binding site.

Combining these ideas, I would replace the morpholine in Molecule 1 with a N(C)C=O group and extend the aromatic system in Molecule 2 by adding a phenyl substituent. This should enhance binding affinity by increasing suitable contacts.

The new molecules are:

\box{Sc1nnc2ccc(-c3cn[nH]c3)cc2c1C(=O)NC(C)c1ccccc1}
\box{Cn1cc(-c2cnc3ccc4ccc(N)cc4c(=O)c3c2)cn1}
LLM-GENERATED: CC(NC(=O)c1c(S)nnc2ccc(-c3cn[nH]c3)cc12)c1ccccc1
CC(NC(=O)c1c(S)nnc2ccc(-c3cn[nH]c3)cc12)c1ccccc1

Boltz running on GPU 2
8.01
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cn1cc(-c2cc(F)c3ncc(Cc4c(F)cc5ncccc5c4F)n3n2)cn1,-10.96]
[CCCNS(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C5CCN(CC)CC5)c4)cc3c(=O)c2c1,-10.77]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions in the ligand by increasing hydrogen bonding, improving fit into the binding pocket, and increasing hydrophobic contacts. The first molecule has fluorines that contribute to hydrophobic interactions but may be limited in hydrogen bonding. The second molecule includes an urea-like group for hydrogen bonding and a piperazine ring for solubility and interaction with polar residues.

To strengthen the molecule, I would combine elements from both: keep the fluorinated aromatic system for hydrophobic interactions and add a flexible, basic amine-containing side chain to enhance hydrogen bonding and possibly form interactions with additional polar residues near the active site. Introducing a piperazine-like moiety could improve solubility and binding affinity.

Therefore, I propose the molecule: \box{CCCNS(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C5CCNCCN(C)CC5)c4)cc3c(=O)c2c1}.
LLM-GENERATED: CCCNS(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C5CCNCCN(C)CC5)c4)cc3c(=O)c2c1
CCCNS(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C5CCNCCN(C)CC5)c4)cc3c(=O)c2c1

Boltz running on GPU 2
9.99
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC2=C(OC3=CC=C(NC(=O)NN=CC4=CC=C(F)C=C4F)C=C3F)C=CN=C2C=C1OCCCN1CCC(C)CC1,-10.99]
[COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2N(C)S(C)(=O)=O)=N1,-10.95]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice they both have similar core structures with variations in substituents. Both have the 1,2,4-triazole or related heterocycles interacting with the receptor, but one uses an imine linkage and the other a more rigid amide and triazole motif. The difference in binding affies mainly lies in the heterocyclic groups and their positioning.

Molecule 1 has a methylated triazole ring with fluorinated phenyl groups, which likely enhances hydrophobic and electronic interactions but may be slightly less flexible. Molecule 2 uses a urea-type linkage and a triazole connected to a chlorinated aromatic ring, possibly increasing hydrogen bonding and hydrophobic contacts.

To improve binding affinity, I would aim to combine the beneficial features: maintain the heterocyclic core with fused aromatic rings, preserve fluorine atoms for hydrophobic and electronic effects, and introduce a flexible linker that can form additional hydrogen bonds or pi-stacking interactions. Also, incorporating a cyclic amine in the linker could enhance solubility and receptor interaction.

Based on this, I propose a molecule that has a fused triazole-pyridine system with fluorinated phenyl substituents, a flexible oxyalkyl linker to a cyclic amine, and an aliphatic chain to improve solubility and receptor adaptability.

\box{Cn1cc(-c2cc(OCCCN3CCC(C)CC3)cnc3ccc(-c4cnc5ccccc5n(-c4)c3=O)c2C=F)c1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 48
NON-LLM GENERATED: CC1CCN(C)CC1
CC1CCN(C)CC1

Boltz running on GPU 2
7.68
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN=C3C=NN(S(=O)(=O)C4=CN=C5C=CC(C6=CCC=C6)=CN45)C3=C2)C=N1,-10.38]
[Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1,-10.3]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for increasing hydrophobic interactions and pi-stacking, while also enhancing hydrogen bonding capabilities. The existing molecules already have the sulfonyl group which offers polar contacts, but the aromatic systems could be optimized for better shape complementarity and van der Waals interactions.

Molecule 1 has a fused azole core with a bent aliphatic side chain, while Molecule 2 uses a pyridine substituent that might improve hydrogen bonding but has a slightly smaller aromatic system. To favor binding, I would focus on expanding the aromatic surface and introducing flexible hydrophobic substituents to better fill the pocket.

Additionally, replacing the bent aliphatic chain with a biphenyl-like system could enhance pi-pi interactions and hydrophobic contacts. Incorporating a methyl group on the aromatic ring may boost binding by increasing lipophilicity and potentially making hydrophobic pockets more favorable.

Based on this, I propose a molecule that keeps the sulfonyl group for polarity but replaces the previous side chains with a methyl-substituted phenyl and a fused azole scaffold to maximize aromatic surface area and hydrophobic interactions.

\box{CNS(=O)(=O)Nc1cccc(-c2ccc3ncc(NC4CCa(C)c(-c5ccccc5C)cc4C3c2)n3c1)c1ccccc1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 49
NON-LLM GENERATED: O=S(=O)(NCC1=CC=CC=N1)C1=CCC=C1
O=S(=O)(NCc1ccccn1)C1=CCC=C1

Boltz running on GPU 2
6.09
210/1000 | avg_top1: 12.050 | avg_top10: 11.724 | avg_top100: 10.969 | avg_sa: 3.154 | div: 0.824
{'avg_top1': 12.05, 'avg_top10': 11.724, 'avg_top100': 10.968899999999996, 'auc_top1': 2.44745, 'auc_top10': 2.3758199999999996, 'auc_top100': 2.2092688095238096, 'avg_sa': 3.1535090430260135, 'diversity_top100': 0.8235732046105724, 'n_oracle': 210}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(NC1=CC(OC2=C(F)C=C(NC(=O)C3(C(=O)NC4=CC=C(F)C=C4)CC3)C(F)=C2)=CC=N1)C1CC1,-10.49]
[O=C(NC1=CC(OC2=C(F)C=C(NC(=O)C3(C(=O)NC4=CC=C(F)C=C4)CC3)C(F)=C2)=CC=N1)C1CC1,-10.49]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: From the given information, the current ligand features a fused ring system and fluorinated aromatic rings, contributing to its binding affinity of -10.49 kcal/mol. To improve binding, I would consider enhancing hydrogen bonding capabilities and optimizing hydrophobic interactions. Introducing additional amide groups could strengthen polar contacts in the binding pocket. Adding a flexible, basic side chain—like a piperazine ring—might also increase solubility and engage in favorable interactions with c-MET residues.

Based on these considerations, I propose incorporating a piperazine moiety linked via an amide to the existing core scaffold, maintaining the fluorinated aromatic rings for hydrophobic stabilization.

\box{CCN1CCN(C(=O)NC2=CC(C(=O)Nc3ccc(Oc4ccnc(Nc5cccc(F)c5)n(-c5ccc(F)cc5)c4)c(F)c3)CC2)CC1}
LLM-GENERATED: CCN1CCN(C(=O)NC2=CC(C(=O)Nc3ccc(OC4=CN(c5ccc(F)cc5)C(Nc5cccc(F)c5)=NC=C4)c(F)c3)CC2)CC1
CCN1CCN(C(=O)NC2=CC(C(=O)Nc3ccc(OC4=CN(c5ccc(F)cc5)C(Nc5cccc(F)c5)=NC=C4)c(F)c3)CC2)CC1

Boltz running on GPU 2
10.09
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COc1cc2c(Oc3cc4cccnc4cc3F)ccnc2cc1OCCCN1CCC(C)CC1,-10.18]
[O=C(NC1=CC=C(OC2=CC=NC(NC(=O)N3CCC3)=C2)C(F)=C1)C1=CN(CC2CC2)C(=O)N(C2=CC=C(F)C=C2)C1=O,-11.71]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, hydrophobic contacts, and possibly introduce groups that can better fit the binding pocket or interact with polar residues. The first molecule has a favorable aromatic system but may lack optimal hydrogen bond donors/acceptors, while the second molecule is more polar with amide linkages that can participate in H-bonds, but its ring systems and substituents may be too bulky or rigid.

To bridge this, I would consider incorporating heterocyclic rings with hydrogen bond donors and acceptors, maintaining the aromatic character but adding flexibility and polar features that complement the binding site. Introducing substituents like hydroxyl groups can enhance water solubility and interaction potential. Also, linking these rings via flexible linkers or cyclic amines could improve fit and binding dynamics.

Based on this reasoning, I propose the following molecule, which integrates these elements for improved affinity:

\box{Cc1c(Oc2ccc(NC(=O)C3(C(=O)NCCN4CCOCC4)NC(=O)C3=CC2)cc1F)c1ccnc2cc(O)ccc12}
LLM-GENERATED: Cc1c(F)cc2ccc(oc1-c1ccnc3cc(O)ccc13)CC=C1C(=O)NC1(C(=O)NCCN1CCOCC1)C(=O)N2
Cc1c(F)cc2ccc(oc1-c1ccnc3cc(O)ccc13)CC=C1C(=O)NC1(C(=O)NCCN1CCOCC1)C(=O)N2

Boltz running on GPU 2
9.61
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1CCC(NC2=CN=C3C=CC(SC4=NN=C5C(F)=CC(C6=CN(C)N=C6)=CN45)=CC3=C2)CC1,-11.09]
[CC(C1=C(F)C=C2N=CC(C3=CN(C)N=C3)=CC2=C1F)N1N=NC2=NC=C(C3=CN(CCO)N=C3)N=C21,-11.72]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity in favorable regions, and possibly introduce groups that interact well with hydrophobic pockets or salt bridges. 

The first molecule has a methyl substitution on the nitrogen, which may be limiting hydrogen bonding potential or electronic interaction. The second molecule incorporates ethylene linkers and fluorines to improve binding, but its binding affinity is intermediate.

To build on this, I would focus on replacing the methyl group with a slightly larger, more flexible amine-containing moiety that can form additional hydrogen bonds or ionic interactions. Introducing a piperazine ring could provide this capability and also enhance solubility and pharmacokinetics.

Combining this with the core scaffold from the first molecule, I would maintain the pyrazole and fused aromatic system while adding a piperazine substituent on the nitrogen to increase interaction opportunities.

Thus, the new molecule is:

\box{CN1CCN(C)CC1NC(=O)N1CC(=O)N(C)c2ccc3nc(NCc4ncc(-c5cnn(C6CCNCC6)c5)cc4C)nc3c2}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 50
NON-LLM GENERATED: CC(C1=C(F)C=C2N=CC(C3=CN(C)N=C3)=CC2=C1F)N1N=NC2=NC=C(NC3CCN(C)CC3)N=C21
CC(c1c(F)cc2ncc(-c3cnn(C)c3)cc2c1F)n1nnc2ncc(NC3CCN(C)CC3)nc21

Boltz running on GPU 2
11.44
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(c1c(F)cc2ncccc2c1F)N1C=NC2=NC=C(F)C21,-10.12]
[O=C1C(C2=CC=NC3=C2C(C2=CC=CN=C2)=CN3)=CN(CC2CC2)C(=O)N1C1=CC=C(F)C=C1,-10.01]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a central pyrazole or related 1,2,4-triazole core with fluorinated aromatic rings. The improvement from the first to the second molecule seems to come from adding an additional nitrogen-rich heterocycle, which may enhance hydrogen bonding and polarity, helping affinity. The second molecule also maintains the key fluorinated phenyl group important for hydrophobic and electronic interactions.

To further improve binding, I would consider increasing hydrogen bond donors and acceptors to better interact with the protein, while keeping or enhancing hydrophobic contacts. Introducing a flexible, nitrogen-containing ring could improve fit and solubility. Also, maintaining the pyrazole or triazole core with fluorines seems beneficial, but shifting from a bicyclic to a tricyclic system with additional heterocycles might strengthen binding through better shape complementarity and interactions.

Based on these thoughts, I propose a new molecule that incorporates a triazole core linked to a piperazine-like ring, preserving the fluorinated aromatic moiety and adding an amide functionality for extra hydrogen bonding. This structure should optimize both hydrophobic and polar contacts with c-MET.

\box{CN1CCN(C(=O)c2cnc3ncc(-c4ccc(F)cc4)cc23)CC1,-9.93}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 51
NON-LLM GENERATED: CC(C1=C(F)C2=C(C=C1F)N=CN(CC1CC1)C2)N1C=NC2=NC=C(F)C21
CC(c1c(F)cc2c(c1F)CN(CC1CC1)C=N2)N1C=NC2=NC=C(F)C21

Boltz running on GPU 2
9.97
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(=NNC(N)=O)c1ccc2ncc(C(O)c3c(F)cc4ncccc4c3F)n2n1,-11.5]
[CNC(=O)c1ccc(-c2ccc(=O)n(CCc3ccc4ncc(-c5cnn(CCO)c5)cc4c3)n2)cc1C(F)(F)F,-11.8]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two existing molecules, I see that both incorporate the core fused heterocyclic system associated with improved binding to c-MET. However, there are subtle differences that might give us leads for enhancement:

1. The first ligand contains the moiety -OCCN(=O)NC(=O)- linked to a phenyl ring, while the second replaces this with a more rigid and electron-withdrawing trifluoromethyl group.
2. The substitution on the heterocyclic core shows that adding polar groups capable of hydrogen bonding, like the hydroxyl or alkoxy substituents, enhances binding.
3. The side chain extending from the heterocycle: the first ligand has a methoxy-substituted triazole, while the second uses a triazole linked to a hydroxyl-bearing alkoxy chain.

Given these observations, a promising strategy is to combine the favorable features: maintain the core fused heterocyclic scaffold and the trifluoromethyl group for metabolic stability and electronic effects, and introduce a flexible polar chain that can form additional hydrogen bonds with the protein. Replacing the trifluoromethyl on the phenyl ring with a chloro substituent might balance hydrophobic and polar interactions well, and extending the side chain with a flexible alkoxy linker to a hydroxyl-containing moiety could improve binding affinity through additional hydrogen bonding.

Therefore, the new design introduces a chlorophenyl ring connected to the core heterocycle, and a hydroxyl-containing alkoxy chain on the triazole substituent to enhance polar contacts.

\box{CCO/c1ccc2ncc(C(O)c3c(F)cc4ncccc4c3F)n2n1}
LLM-GENERATED: CCOc1ccc2ncc(C(O)c3c(F)cc4ncccc4c3F)n2n1
CCOc1ccc2ncc(C(O)c3c(F)cc4ncccc4c3F)n2n1

Boltz running on GPU 2
10.19
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[N=C(NNC(N)=O)c1cnc2nnn(Cc3ccc4ncccc4c3)c2n1,-11.39]
[CN1CCC(Nc2cnc3ccc(Sc4nnc5c(F)cc(-c6cnn(C)c6)cn45)cc3c2)CC1,-11.09]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for enhancing hydrogen bonding and polar interactions, increasing the ligand's complementarity to the binding site, and optimizing substituents to engage with key residues. Both initial molecules have thiazole or fused aromatic systems and polar groups, but one has a morpholine ring which might add flexibility but may reduce binding rigidity and specificity. 

Focus on reinforcing the heterocyclic framework to increase stacking and polar contacts: replacing the morpholine with a more rigid, hydrogen-bond-capable amide-like ring could enhance affinity. Introducing an amide nitrogen might also improve interactions with the receptor's active site.

Thus, I propose a new molecule with a fused pyridine-thiazole system combined with a piperamide ring to tighten binding and add polar interactions.

\box{O=C1CCCNC1Nc1ccc2nnc(Cc3ccc4ncccc4c3)nn2c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 52
NON-LLM GENERATED: CN1N=NC2=NC=C(C(=N)NNC(N)=O)N=C21
Cn1nnc2ncc(C(=N)NNC(N)=O)nc21

Boltz running on GPU 2
6.47
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cn1cc(-c2ccc3nnc(Cc4cccc5c(=O)[nH]ccc45)n3n2)cn1,-10.34]
[[C-]#[N+]C1=C(C2=CC=C(F)C=C2F)N=C2COC(=O)C2C1C1=CC2=C(C)NN=C2C=C1,-10.1]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to increase hydrogen bonding and pi-stacking interactions, while enhancing hydrophobic contacts. The first molecule has a key heterocyclic core that is conserved in both ligands, indicating its importance. The second molecule introduces fluorines on the ring, which can contribute to affinity via halogen bonding or dipole interactions.

To build on this, I would consider replacing the fluorinated ring in the second molecule with a simpler phenyl ring to reduce steric hindrance and allow better fit in the binding pocket. Also, I would swap the oxygentetrafluoropropane moiety in the second molecule with a methyl-substituted phenyl ring to improve hydrophobic interactions and maintain aromatic stacking.

This leads me to propose a molecule that combines the core heterocycles from the first ligand with a methyl-substituted phenyl group to maximize these interactions.

\box{Cn1cc(-c2ccc3nnc(Cc4cccc5c(=O)[nH]ccc45)n3n2)cn1}
LLM-GENERATED: Cn1cc(-c2ccc3nnc(Cc4cccc5c(=O)[nH]ccc45)n3n2)cn1
Already in buffer
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[[C-]#[N+]C1=C(C2=CC=C(F)C=C2F)N=C2COC(=O)C2C1C1=CC2=C(C)NN=C2C=C1,-10.1]
[CC(N=O)c1ccc2nnc(Cc3c(F)cc4ncccc4c3F)n2n1,-11.79]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for features that enhance interactions with the c-MET binding pocket. The first molecule has a well-defined aromatic system and fluorine substitutions, which likely contribute to hydrophobic and electronic effects. The second molecule includes an amide group and heterocycles, providing potential hydrogen bonding and pi-stacking interactions.

To build on this, introducing additional hydrogen bond donors and acceptors through amide functionalities and expanding aromatic systems can increase binding. Also, adding a methoxy group could improve solubility and electronic distribution without losing hydrophobic contacts. Incorporating a fused heterocycle with oxygen can stabilize the ligand through heteroatom interactions.

Based on these considerations, I propose the molecule:

\box{COc1cc(NC(=O)CC(=O)Nc2ccc3nnc(Cc4c(F)cc5ncccc5c4F)n3n2)ccc1}
LLM-GENERATED: COc1cccc(NC(=O)CC(=O)Nc2ccc3nnc(Cc4c(F)cc5ncccc5c4F)n3n2)c1
COc1cccc(NC(=O)CC(=O)Nc2ccc3nnc(Cc4c(F)cc5ncccc5c4F)n3n2)c1

Boltz running on GPU 2
9.18
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC=C2C(=C1)N=CC=C2OCC1=NN=C2SC(C3=CN(C)N=C3)=NN12,-10.23]
[[C-]#[N+]C1=C(C2=CC=C(F)C=C2F)N=C2COC(=O)C2C1C1=CC2=C(C)NN=C2C=C1,-10.1]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity in favorable regions, and optimize aromatic interactions since the binding pocket likely favors pi-stacking or hydrophobic contacts. 

The first ligand has a fluorinated aromatic ring that may contribute to hydrophobic interactions but also adds polarity via fluorines. The second ligand replaces fluorines with a simple aromatic ring, reducing polarity slightly but maintaining planarity for stacking. The key improvement would be to combine these features: retain the fluorinated aromatic ring to maintain hydrophobic and electronic effects while increasing polarity and hydrogen bonding capacity elsewhere.

Introducing an amide group on the side chain could improve hydrogen bonding and solubility without disrupting the core heterocyclic system. Also, maintaining the methylated nitrogen to ensure some hydrophobic contact is useful. Therefore, a promising modification would be to attach a small amide-containing side chain to the fluorinated aromatic ring, preserving the core heterocycle and methyl substitution for balanced interactions.

\box{C=NN1CC(C(=O)NC(=O)Nc2ccc(-c3ccc(=O)[nH]n3)cc2F)C(=O)N1,-10.43}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 53
NON-LLM GENERATED: CC1=CC2=C(C)NN=C2C=C1
Cc1ccc2n[nH]c(C)c2c1

Boltz running on GPU 2
5.61
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(C1=C(F)C=C2N=CC(C3=CN(C)N=C3)=CC2=C1F)N1N=NC2=NC=C(C3=CN(CCO)N=C3)N=C21,-11.72]
[CC(=NOC(N)=O)c1ccc2ccc(C(C)c3c(F)cc4ncccc4c3F)n2n1,-10.05]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity in hydrophobic regions, and maintain or expand aromatic interactions. The first molecule has promising heterocyclic cores and fluorine substitutions that contribute to affinity, but adding polar groups like hydroxyl may improve solubility and form additional hydrogen bonds. The second molecule includes an attractive pyridine-based scaffold fused with heterocycles and fluorines, but increasing rigidity and adding hydrogen bond donors/acceptors may strengthen binding.

Based on these observations, I would design a molecule that incorporates a polar substituent such as a hydroxyalkyl group to enhance hydrogen bonding, maintain fluorinated aromatic systems for hydrophobic and electronic effects, and include fused heterocycles to increase rigidity and binding complementarity.

\box{CN(C)CC(OCCO)C1=C(Nc2ccc3ncccc3c2)N=C(C)c1F}
LLM-GENERATED: CC1=NC(Nc2ccc3ncccc3c2)=C(C(CN(C)C)OCCO)C1F
CC1=NC(Nc2ccc3ncccc3c2)=C(C(CN(C)C)OCCO)C1F

Boltz running on GPU 2
7.51
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cn1cc(-c2ccc3c(OCCn4c(=O)oc5cc(-c6cnn(C)c6)ccc54)ccnc3c2)cn1,-10.47]
[CC(=NNC(N)=O)c1ccc2nnc([C@@H](C)c3ccc4ncccc4c3)n2n1,-11.42]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding and aromatic interactions within the binding pocket. The existing molecules already have aromatic systems that interact well with the protein, so preserving that scaffold is important.

The first molecule has moderate affinity (-10.47), with potential for polar interactions via the oxazole and hydrazide moieties. The second molecule increases affinity (-11.42) by adding a chiral center and more nitrogen atoms, which likely improve specificity and hydrogen bonding.

To build on this, I would aim to combine the beneficial features of both: maintain the extended aromatic core for π-π stacking and introduce a strong polar group that can serve as a hydrogen bond donor or acceptor. Replacing the hydrazide with a urea-like group could provide stronger and more directional hydrogen bonds, enhancing interaction with the protein's active site.

Thus, I propose adding a urea moiety (NNC(N)=O) linked to the aromatic ring, keeping the rest of the scaffold intact to preserve known favorable interactions.

\box{CC(=NNC(N)=O)c1ccc2nnc([C@@H](C)c3ccc4ncccc4c3)n2n1}
LLM-GENERATED: CC(=NNC(N)=O)c1ccc2nnc(C(C)c3ccc4ncccc4c3)n2n1
Already in buffer
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COc1cc2c(Oc3ccc(N=Cc4c(O)n(-c5ccc(C)cc5)c(=O)[nH]c4=O)cc3F)ccnc2cc1OCCCN1CCCC1,-10.35]
[O=C1C=CC(N2C=CC3=CC=C(F)C=C32)=NN1CCOC1=CC=NC2=CC(OCCCN3CCOCC3)=CC=C21,-11.57]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two existing molecules, I see that both incorporate aromatic rings and heterocycles to engage in π-stacking and hydrogen bonding with the c-MET target. The first molecule uses a fluorinated phenyl ring and a piperidine moiety, while the second molecule features a bicyclic heteroaromatic system with morpholine and an aliphatic chain for improved flexibility and solubility.

To enhance binding affinity, I would consider increasing planarity and additional conjugated rings to strengthen π-interactions, while maintaining or improving hydrogen bonding capacity. Also, substituting the piperidine or morpholine with a more electron-rich, fused aromatic system could increase stacking and dipole interactions.

With this in mind, I propose combining a fused bicyclic aromatic core resembling a fused naphthalene-like moiety with an amide linkage that preserves hydrogen bonding, coupled to a fluorinated phenyl ring to maintain favorable dipole and hydrophobic contacts. Additionally, replacing the flexible chain with a more rigid fused bicyclic ether might improve binding specificity and reduce entropy loss upon binding.

Therefore, the new molecule I suggest is:

\box{Cn1cc(-c2ccc3nccc(Oc4ccc(NC(=O)c5ccc6cccnc6c(=O)c5C=F)cc4F)c3c2)cn1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 54
NON-LLM GENERATED: CC1=CC=C(N2C(O)=CC3=CC=C(F)C=C32)C=C1
Cc1ccc(-n2c(O)cc3ccc(F)cc32)cc1

Boltz running on GPU 2
7.05
220/1000 | avg_top1: 12.050 | avg_top10: 11.724 | avg_top100: 10.980 | avg_sa: 3.164 | div: 0.823
{'avg_top1': 12.05, 'avg_top10': 11.724, 'avg_top100': 10.979899999999997, 'auc_top1': 2.5679499999999997, 'auc_top10': 2.4930599999999994, 'auc_top100': 2.3190128095238096, 'avg_sa': 3.164320802871874, 'diversity_top100': 0.8230942955262547, 'n_oracle': 220}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[C/C(=N\OCCCO)C1=NN2C(=NN=C2CC2=C(F)C=C3N=CC=CC3=C2F)C=C1,-11.55]
[O=C(NC1=CC(OC2=C(F)C=C(NC(=O)C3(C(=O)NC4=CC=C(F)C=C4)CC3)C(F)=C2)=CC=N1)C1CC1,-10.49]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both incorporate fused aromatic systems and fluorine substituents, which likely enhance binding through hydrophobic and electronic effects. The first molecule has a strong dinucleotide-like core with an ether-linked propyl group, possibly providing flexibility and solubility. The second molecule adds an amide linkage and a bicyclic scaffold with fluorinated phenyl rings, increasing potential hydrogen bonding and metabolic stability.

To improve binding affinity, I would aim to combine the beneficial features: maintain the core heterocycle and fluorinated aromatic rings for hydrophobic and electronic complementarity, while introducing a more rigid, bicyclic amide moiety to engage in additional hydrogen bonds and optimize shape complementarity. Also, an amide linkage could improve bioavailability and binding specificity.

Therefore, I propose to design a molecule that incorporates an amide-linked bicyclic system with fluorinated phenyl rings, preserving the dinucleotide core and ether chain from the first ligand, to balance flexibility and interaction potential.

\box{C/C(=N\OCCCO)C1=NN2C(=NN=C2CC2=C(Cc3ccc(NC(=O)C4(C(=O)NC5=CC(=O)CC5)CC4)cc3)C=F)C=C1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 55
NON-LLM GENERATED: CC(=NOCCCO)C1(C(=O)NC2=CC=C(F)C=C2)CC1
CC(=NOCCCO)C1(C(=O)Nc2ccc(F)cc2)CC1

Boltz running on GPU 2
7.13
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC1=NC([C@H](C)NC(=O)C2=CC=C(C3=NN4C(CC5=CC=C6N=CC=CC6=C5)=CN=C4N=C3)C=C2Cl)=NO1,-10.52]
[N#Cc1cc(-c2cnc3nnn(C[C@@H]4CN(c5ncc(C6=CCNCC6)cn5)CCO4)c3n2)ccc1F,-10.56]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: From the given binding affinities, both existing molecules have similar interactions, with one bearing a fluorinated aromatic ring and the other containing a chlorine substituent on a fused ring system. The presence of halogens suggests that manipulating the electronic and steric environment on the aromatic moiety can influence binding affinity. 

Given that subtle changes to substitution patterns on the aromatic ring can impact molecular interactions, focusing on replacing the fluorine with chlorine on the other aromatic ring could enhance hydrophobic contacts or dipole interactions without drastically altering the core scaffold. This subtle substitution may improve overall binding by optimizing fit and interaction within the binding pocket.

\box{N#Cc1cc(-c2cnc3nnn(C[C@@H]4CN(c5ncc(C6=CCNCC6)cn5)CCO4)c3n2)ccc1Cl}
LLM-GENERATED: N#Cc1cc(-c2cnc3nnn(CC4CN(c5ncc(C6=CCNCC6)cn5)CCO4)c3n2)ccc1Cl
N#Cc1cc(-c2cnc3nnn(CC4CN(c5ncc(C6=CCNCC6)cn5)CCO4)c3n2)ccc1Cl

Boltz running on GPU 2
11.01
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COc1cc2c(Oc3cc4cccnc4cc3F)ccnc2cc1OCCCN1CCC(C)CC1,-10.18]
[Cn1cc(-c2cnc3ccc4ccc(N)cc4c(=O)c3c2)cn1,-10.8]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, hydrophobic contacts, and possibly electrostatic interactions. The first molecule has a fluorine substituent that could contribute to binding through hydrophobic or dipole interactions, while the second molecule contains an amide group that can participate in hydrogen bonding.

To combine these advantages, introducing an amide moiety adjacent to the aromatic system could strengthen key interactions with the protein. Additionally, extending the alkyl chain on the amide nitrogen might improve fit and flexibility in the binding pocket. Keeping the fluorine substituent ensures retention of beneficial hydrophobic contacts.

Based on this reasoning, I propose the following molecule:

\box{CNC(=O)CCCCNc1ccc(-c2cnc3ccc4ccc(N)cc4c(=O)c3c2)cc1F}
LLM-GENERATED: CNC(=O)CCCCNc1ccc(-c2cnc3ccc4ccc(N)cc4c(=O)c3c2)cc1F
CNC(=O)CCCCNc1ccc(-c2cnc3ccc4ccc(N)cc4c(=O)c3c2)cc1F

Boltz running on GPU 2
9.77
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[[C-]#[N+]C1C(C)=NC2=C(C(=O)OC2)C1c1ccc2n[nH]c(C)c2c1,-10.35]
[CC(C1=C(F)C=C2N=CC(C3=CN(C)N=C3)=CC2=C1F)N1N=NC2=NC=C(C3=CN(CCO)N=C3)N=C21,-11.72]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity in favorable regions of the molecule, and potentially introduce groups that can interact with additional residues in the binding pocket. The first molecule has some good aromatic interactions but may be too hydrophobic. The second molecule includes more hydrogen bond donors and acceptors and has flexible linkers that allow better fitting, resulting in better affinity.

To build on this, I would aim to combine the polar features of the second molecule with the aromatic system of the first, adding polar substituents that can engage in additional hydrogen bonds without sacrificing the aromaticity and stacking interactions. Also, introducing a small polar side chain could enhance solubility and binding specificity.

Based on this reasoning, I propose the following molecule:

\box{Cn1cc(-c2ccc3n[nH]c(C)c3c2)C(C)=NC(=O)C(C)c1VCCLE)N1CCOCC(C1=NNC=Cc1ccc2n[nH]c(C)c2c1)N=C1/C=C(C)N/C1=NNC=C1N
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 108, in edit
    proposed_smiles = re.search(r'\\box\{(.*?)\}', r).group(1)
AttributeError: 'NoneType' object has no attribute 'group'
AttributeError 'NoneType' object has no attribute 'group'
NUM LLM ERRORS: 56
NON-LLM GENERATED: [C-]#[N+]C1C(C)=NC2=C(C(=O)OC2)C1C1=CC2=CC(F)=NN=C2C=C1
[C-]#[N+]C1C(C)=NC2=C(C(=O)OC2)C1c1ccc2nnc(F)cc2c1

Boltz running on GPU 2
9.73
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COc1cnc2ccc([C@H](C)c3nnc4c(F)cc(-c5cc(C)no5)cn34)cc2c1,-11.12]
[CC(=O)NN=C(C)c1cnc2nnn(Cc3cc4cccnc4cc3F)c2n1,-11.07]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, hydrophobic contacts, and possibly metal coordination. The first ligand has a methyl-substituted oxazole ring that could be modified for stronger hydrophobic interactions or better fit. The second ligand uses an urea-like moiety that promotes hydrogen bonding, which is beneficial, but the overall structure could be optimized for improved binding.

Considering this, replacing the methyl-oxazole with a more electron-withdrawing group such as chlorine might enhance hydrophobic interactions and possibly improve fit in the pocket. Also, extending the chain slightly with an ethyl group (–CC) attached to the oxazole ring could help the ligand reach additional polar contacts without compromising rigidity. Retaining the urea-like moiety and the key fused heterocycles is essential to maintain hydrogen bonding and π-stacking interactions.

Based on this reasoning, I propose the molecule:

\box{CCn1cc(-c2cc(C)c3nnc4c(F)cc(-c5cc(C)no5)cn34)ccc1N=C(N)C(C)C}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 57
NON-LLM GENERATED: COC1=CN=C(CN2N=NC3=NC=C(C(C)=NNC(C)=O)N=C32)C(F)C1
COC1=CN=C(Cn2nnc3ncc(C(C)=NNC(C)=O)nc32)C(F)C1

Boltz running on GPU 2
9.17
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cc1cc(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(N[C@H](C)CO)c34)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1,-11.32]
[COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CCC(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCN1CCOCC1,-11.36]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have similar core moieties with oxadiazole rings and fluorinated aromatic groups, which contribute to their affinity through hydrophobic and polar interactions. However, there are subtle differences in their side chains and ring substitutions that might enhance binding.

The first molecule has an N-methyl group on the oxadiazole nitrogen, while the second molecule has a morpholine ring in place of the simple alkyl chain. The second molecule also incorporates a fluorinated cyclohexyl substituent on the oxadiazole, which could improve lipophilicity and binding into a hydrophobic pocket.

Comparing the two, the fluorinated cyclohexyl group (from the second molecule) seems promising for enhancing hydrophobic interactions. Meanwhile, maintaining the morpholine ring (from the first molecule) preserves polar contacts and flexibility. Combining these features, I can design a ligand that incorporates the fluorinated cyclohexyl substituent from the second molecule and the morpholine-containing side chain from the first molecule to optimize both hydrophobic and polar interactions.

Therefore, the new molecule I propose is:

\box{COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CCC(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCN1CCOCC1}
LLM-GENERATED: COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)NC5=CCC(F)C=C5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1
Already in buffer
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cn1cc(-c2ccc3nnc(Cc4cccc5c(=O)[nH]ccc45)n3n2)cn1,-10.34]
[CN1C=C(C2=CN=C3C=CC4=CC=C(CS(=O)(=O)NCC5=CC=CC=N5)C=C4C(=O)C3=C2)C=N1,-10.3]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, pi-stacking, and electrostatic binding. The first molecule has a pyridine core with potential hydrogen bond donors and acceptors, while the second molecule features a fused aromatic system and heterocycles that offer similar interactions.

To build on this, introducing a methoxy group could increase polarity and potentially form additional hydrogen bonds. Also, incorporating a pyridine ring instead of a pyrrole might improve binding through better hydrogen bonding patterns. Retaining the core fused aromatic system would preserve pi-stacking interactions, while slightly altering the heterocycle connectivity could optimize the overall geometry for the binding site.

Based on this reasoning, I propose the molecule:

\box{COc1cc(-c2ccc3nnc(Cc4cccc5c(=O)[nH]ccc45)n3n2)cn1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 58
NON-LLM GENERATED: C1=CCNC=C1
C1=CCNC=C1

Boltz running on GPU 2
6.39
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[N=C(NNC(N)=O)C1=CN=C2N=NN(CC3=CC=C4N=CC=CC4=C3)C2=N1,-11.39]
[Cc1cc(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(N[C@H](C)CO)c34)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1,-11.32]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase rigidity for better fit, and introduce groups that interact well with the c-MET binding pocket. The first molecule has a stable pyrazole core but limited hydrophobic interactions, while the second molecule has fluorines and heterocycles that contribute to affinity, but its structure is more complex and bulky.

To streamline the molecule and potentially improve binding, I would focus on combining key features: maintaining the pyrazole core from the first molecule, adding an oxadiazole ring to introduce a heteroatoms for additional hydrogen bonding and dipole interactions, and incorporating a chiral center with a hydroxymethyl substituent to enhance stereospecific interactions and solubility. The addition of a benzyl group linked to a pyridine ring could enhance hydrophobic contacts and stacking within the pocket.

Therefore, the new molecule I propose is:

\box{CN(C)[C@H](CO)N=C(NNC(=O)n1cc(-c2ccc3ncccc3c2)nc1=O)N1CC=ncc(-c2ccccc2)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 59
NON-LLM GENERATED: FC1=CN=C2N=NN(CC3=CC=C4N=CC=CC4=C3)C2=N1
Fc1cnc2nnn(Cc3ccc4ncccc4c3)c2n1

Boltz running on GPU 2
9.63
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(=NNC(N)=O)c1ccc2ncc(C(O)c3c(F)cc4ncccc4c3F)n2n1,-11.5]
[CNC(=O)c1ccc(-c2ccc(=O)n(CCc3ccc4ncc(-c5cnn(CCO)c5)cc4c3)n2)cc1C(F)(F)F,-11.8]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding and polar interactions, as well as maintain or increase aromatic stacking and hydrophobic contacts. The existing molecules already use fluorinated aromatic rings for hydrophobic interactions and amide or hydrazin moieties for hydrogen bonding. 

Molecule 1 uses the hydrazin functionality with a carbonyl, and molecule 2 uses a more rigid amide linkage with trifluoromethyl groups for electronic effects. To further improve affinity, I might introduce a urea-like group (NNC(N)=O) to strengthen hydrogen bonding while keeping the fluorinated aromatic system intact. Also, maintaining the methoxy-substituted triazole (CCO) could enhance solubility and provide additional polar contacts.

Therefore, I would design a molecule that combines these features: a urea moiety linked to a phenyl ring substituted with the fluorinated fused aromatic system and a methoxy-substituted triazole. This design should improve both hydrogen bonding and hydrophobic interactions.

\box{NNC(N)=Oc1ccc2ncc(C(O)c3c(F)cc4ncccc4c3F)n2n1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 60
NON-LLM GENERATED: NC(=O)NC1=NN(CCC2=CC=C3N=CC(C4=CN(CCO)N=C4)=CC3=C2)C(=O)C=C1
NC(=O)Nc1ccc(=O)n(CCc2ccc3ncc(-c4cnn(CCO)c4)cc3c2)n1

Boltz running on GPU 2
10.05
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cn1cc(-c2ccc3c(OCCn4c(=O)oc5cc(-c6cnn(C)c6)ccc54)ccnc3c2)cn1,-10.47]
[Cn1cc(-c2ccc3c(OCCn4c(=O)oc5cc(-c6cnn(C)c6)ccc54)ccnc3c2)cn1,-10.47]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Unfortunately, the provided binding affinities are the same, so I don't have any relative binding data to analyze. However, looking at the two molecules, they share a similar core structure with an aromatic system and a flexible linker to the core. The key features contributing to binding are likely the aromatic rings for π-π stacking and hydrogen bond donors/acceptors in the linker region.

To improve affinity, introducing a more polar group in the linker could enhance hydrogen bonding with the protein's active site residues. Also, adding a branching, polar substituent on the aromatic ring might increase hydrophobic interactions without sacrificing solubility.

Based on this, I would modify the linker to include a hydroxyl group and introduce a tertiary alcohol side chain on the aromatic ring to provide additional hydrogen bonding and hydrophobic contacts, respectively. This should strengthen the interaction with c-MET.

\box{Cn1cc(-c2ccc3c(OCC(O)CNc4cc(O[C@H](C)CO)ccc4)ccnc3c2)cn1}
LLM-GENERATED: CC(CO)Oc1cccc(NCC(O)COc2ccnc3cc(-c4cnn(C)c4)ccc23)c1
CC(CO)Oc1cccc(NCC(O)COc2ccnc3cc(-c4cnn(C)c4)ccc23)c1

Boltz running on GPU 2
10.67
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[[C-]#[N+]C1=C(C2=CC=C(F)C=C2F)N=C2COC(=O)C2C1C1=CC2=C(C)NN=C2C=C1,-10.1]
[N#Cc1cc(-c2cnc3nnn(C[C@@H]4CN(c5ncc(C6=CCNCC6)cn5)CCO4)c3n2)ccc1F,-10.56]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase rigidity for better fit, and introduce groups that interact well with the c-MET active site. The first molecule has a strong aromatic framework and fluorine atoms contributing to binding, but it could benefit from additional polar functionalities. The second molecule includes a flexible chain with morpholine and piperazine rings, which may improve solubility and interaction, but the binding affinity is moderate.

To build on this, I would combine the beneficial aromatic and heterocyclic elements from both molecules, adding a terminal aromatic ring substituted with a fluorine to maintain hydrophobic and electronic effects. Incorporating an amide group could enhance hydrogen bonding, while a small alkyl amine substituent might improve solubility and introduce additional interactions.

Based on this reasoning, I propose the molecule: 

\box{CCN1CCN(C(=O)c2ccc(-c3cnc4nnn(C[C@@H]5CN(c6ncc(C7=CCNCC7)cn6)CCO5)c4n3)cc2C1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 61
NON-LLM GENERATED: FCC1CN(C2=NC=C(C3=CCNCC3)C=N2)CCO1
FCC1CN(c2ncc(C3=CCNCC3)cn2)CCO1

Boltz running on GPU 2
7.62
230/1000 | avg_top1: 12.050 | avg_top10: 11.724 | avg_top100: 10.990 | avg_sa: 3.173 | div: 0.824
{'avg_top1': 12.05, 'avg_top10': 11.724, 'avg_top100': 10.9899, 'auc_top1': 2.68845, 'auc_top10': 2.610299999999999, 'auc_top100': 2.4288618095238097, 'avg_sa': 3.1733630142129794, 'diversity_top100': 0.8235676509756416, 'n_oracle': 230}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC=C2C(=C1)N=CC=C2OCC1=NN=C2SC(C3=CN(C)N=C3)=NN12,-10.23]
[COC1=CC2=C(OC3=CC=C(N=CC4=C(O)N(C5=CC=C(C)C=C5)C(=O)NC4=O)C=C3F)C=CN=C2C=C1OCCCN1CCCC1,-10.35]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I see that both have strong aromatic systems and hydrogen bonding groups that contribute to their binding affinities. The second molecule includes fluorine substitution and a piperidine ring, which likely enhances hydrophobic interactions and binding pocket fit. To improve binding, I would consider maintaining the key heterocyclic cores and hydrogen bond donors/acceptors but optimize hydrophobic contacts by replacing the methyl group on the phenyl ring with a cycloalkyl substituent to increase hydrophobic surface area and potentially improve van der Waals interactions.

Based on this, I propose a molecule where the methyl group on the phenyl ring is replaced by a cyclohexyl ring, preserving the rest of the structure.

\box{COC1=CC2=C(OC3=CC=C(N=CC4=C(O)N(C5=CC6=C(C7=C(C8=CCN8)CC7)CCC6)C(=O)NC4=O)C=C3F)C=CN=C2C=C1OCCCN1CCCC1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 62
NON-LLM GENERATED: COC1=CC=C2C(=C1)N=CC=C2OCC1=NN=C2[SH]=CCNN12
COc1ccc2c(OCc3nnc4n3NCC=[SH]4)ccnc2c1

Boltz running on GPU 2
8.78
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)NC1=CC=C(C2=NN3C(CC4=CC(Cl)=C5N=CC=CC5=C4)=CN=C3N=C2)C=C1F,-11.03]
[O=C1C(C2=CC=NC3=C2C(C2=CC=CN=C2)=CN3)=CN(CC2CC2)C(=O)N1C1=CC=C(F)C=C1,-10.01]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have strong aromatic and heterocyclic groups that contribute to binding, but there are also some potential improvements to increase affinity. The first molecule contains a chlorinated aromatic ring, which may provide favorable hydrophobic interactions, but the overall shape and flexibility could be optimized. The second molecule has a more constrained bicyclic system with fluorine substitution, helping with both rigidity and electronic effects, but its binding affinity is slightly lower.

To bridge these features, I would aim to maintain the chlorinated aromatic moiety to preserve hydrophobic contacts while introducing a more rigid bicyclic scaffold with a fluorine atom to enhance binding specificity and metabolic stability. Additionally, incorporating an ether linkage could improve solubility and conformational orientation within the pocket.

Based on this reasoning, I propose the molecule:  
\box{COc1cc([nH]c2cccc(Cl)c2)ccc1F}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 63
NON-LLM GENERATED: CNC(=O)NC1=C(F)C=C(N2C(=O)C(C3=CC=NC4=C3C(C3=CC=CN=C3)=CN4)=CN(CC3CC3)C2=O)C=C1
CNC(=O)Nc1ccc(-n2c(=O)c(-c3ccnc4[nH]cc(-c5cccnc5)c34)cn(CC3CC3)c2=O)cc1F

Boltz running on GPU 2
10.18
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cn1cc(-c2ccc3c(OCCn4c(=O)oc5cc(-c6cnn(C)c6)ccc54)ccnc3c2)cn1,-10.47]
[CCN1CC2=C(C=CC(F)=C2C#N)O[C@@H](C)CNC(=O)C2=C3N=C1C=CN3N=C2N,-11.2]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, aromatic stacking, and polarity in key regions of the ligand. The first molecule has a favorable aromatic system but may be too hydrophobic or rigid. The second molecule includes heterocycles that offer hydrogen bond donors and acceptors but has a highly electron-withdrawing trifluoromethyl group that might be strong but could also limit favorable interactions or increase desolvation penalties.

To balance these, I would focus on maintaining the heterocyclic cores that support hydrogen bonding and aromatic interactions, while introducing more flexible, polar substituents that can fill a hydrophobic pocket or interact with residues in the binding site more effectively. For example, replacing the trifluoromethyl with a branched alkyl group can increase hydrophobic contacts without overly increasing polarity. Additionally, incorporating an ether linkage to connect aromatic rings may enhance conformational flexibility and solubility.

Based on this reasoning, I propose the molecule:

\box{CCN1CC2=C(C(=CC3CNC(=O)NC2)C(C)=O)C(=CC3CCN(C)CC3)C(C)C2C#N}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 64
NON-LLM GENERATED: CCN1CC2=C(C=CC(F)=C2C2=CN(C)N=C2)OC(C)CNC(=O)C2=C3N=C1C=CN3N=C2N
CCN1Cc2c(ccc(F)c2-c2cnn(C)c2)OC(C)CNC(=O)c2c(N)nn3ccc1nc23

Boltz running on GPU 2
10.93
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2N(C)S(C)(=O)=O)=N1,-10.95]
[CN1C=C(C2=CC=C3C(=C2)N=CC=C3OCCN2C(=O)OC3=CC(C4=CN(C)N=C4)=CC=C32)C=N1,-10.47]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both incorporate nitrogen-containing heterocycles and ether or thioether groups that may contribute to binding through hydrogen bonding or hydrophobic interactions. The first molecule includes a chloro-substituted pyrimidine ring and a sulfonyl group, while the second molecule has a methoxy-substituted pyridine and an ether linkage.

To improve binding affinity, I would consider enhancing hydrogen bonding potential and increasing planarity to favor π-stacking interactions within the tyrosine kinase pocket of c-MET. Introducing fused aromatic heterocycles with amide or nitrogen atoms can create additional hydrogen bonds and improve molecular rigidity. Also, incorporating a heteroaromatic ring like a pyrazole or pyrimidine can increase specific interactions.

Based on this, I propose a molecule that integrates a fused bicyclic heteroaromatic system with amide linkages, a pyridine ring, and a piperazine moiety to maintain flexibility and positive interactions.

\box{Cn1cc(-c2ccc3ncc(NC(=O)c4ccc5ncc(-c6cn(C7CCN(C)CC7)n6)cc5c4=O)cc3c2)cn1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 65
NON-LLM GENERATED: CN1C=CC=C(C2=CN(C)N=C2)C1
CN1C=CC=C(c2cnn(C)c2)C1

Boltz running on GPU 2
5.66
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC1=CN(C2=CC=C(F)C=C2)C(=O)C(C(=O)NC2=CC=C(OC3=C4C(=NC=C3)NN=C4N[C@H](C)CO)C(F)=C2)=C1,-11.32]
[c1cc2ncc(N3CCOCC3)cc2cc1Sc1nnc2ccc(-c3cn[nH]c3)cn12,-11.09]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity in favorable regions, and maintain or improve aromatic interactions. The first ligand has a fluorine substituent on an aromatic ring, which likely contributes to affinity via hydrophobic and electronic effects. The second ligand uses heterocycles with nitrogen atoms for potential hydrogen bond donors/acceptors and flexible linkers for better fit.

Comparing the two, the first ligand’s fluorinated alkyl group could be switched to a hydroxyl group to introduce additional hydrogen bonding capability, possibly strengthening interaction with polar residues. The second ligand’s heterocyclic scaffold is beneficial, but its binding affinity is slightly lower, possibly due to less rigid conformation or less optimal aromatic stacking.

Therefore, I would design a molecule that maintains the heterocyclic core with nitrogen atoms for H-bonding, keep the fluorines on the aromatic rings for electronic effects, and replace the alkyl substituent with a hydroxyl group to enhance polar contacts. Also, introducing an amide linkage could improve polarity and binding orientation.

This reasoning leads me to propose the molecule:

\box{CN(C)C(=O)NC1=CC(=O)Nc1nc2cc(Oc3ccc(NC(=O)C(C(=O)NC4=CC(O)C(=O)N4)CC4=CC(=O)N4)cc2F)ccc13}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 66
NON-LLM GENERATED: FSC1=CC=C2N=CC(N3CCOCC3)=CC2=C1
FSc1ccc2ncc(N3CCOCC3)cc2c1

Boltz running on GPU 2
8.6
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(c1c(F)cc2ncc(-c3cnn(C)c3)cc2c1F)n1nnc2ncc(-c3ccc(C(N)=O)c(F)c3)nc21,-11.86]
[CCN1CCC(n2cc(-c3cnc4ccc5ccc(NS(=O)(=O)N(C)C)cc5c(=O)c4c3)cn2)CC1,-11.1]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity, and introduce groups that can better interact with the c-MET binding pocket. The first molecule has fluorines on the ring system, which contribute to affinity but could be balanced by adding polar groups that also participate in hydrogen bonding. The second molecule includes a morpholine ring and an amide group, both useful for interactions, but the amide's positioning in the fused ring system is limited.

Considering this, I would aim to incorporate a heteroatom-rich motif that maintains aromaticity and planarity for stacking but adds more hydrogen bond donors/acceptors. Replacing the amide group with a heterocyclic ring containing an NH and an oxygen could provide better hydrogen bonding and conformational flexibility. Also, introducing an ethoxy substituent could improve solubility and positioning within the pocket.

Based on this reasoning, I propose the following molecule:

\box{CCOc1cc(-c2cnc3ccc4ccn([C@H](C)c5c(F)ccn6nnc(CC5)c6C)cc4c(=O)c3c2)nc1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 67
NON-LLM GENERATED: CN(C)S(=O)(=O)NC1=CC=C(F)C1
CN(C)S(=O)(=O)NC1=CC=C(F)C1

Boltz running on GPU 2
6.37
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[NC(=O)NN=Cc1cnc2nnn(Cc3ccc4ncccc4c3)c2n1,-11.05]
[CC(=NNC(N)=O)c1ccc2nnc([C@@H](C)c3ccc4ncccc4c3)n2n1,-11.42]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: From the given binding affinities, the existing molecules have shown decent interactions with c-MET, but there is room for improvement. Analyzing the structures, I notice that the first molecule contains a series of heterocycles and hydrazine moieties, which contribute to hydrogen bonding and π-stacking interactions. The second molecule introduces a chiral center and maintains similar heterocyclic systems, providing some shape complementarity and polar contacts.

To design a stronger ligand, I would focus on enhancing hydrogen bonding potential and maintaining or improving aromatic stacking. Introducing an amide group adjacent to the hydrazine could increase hydrogen bond donors/acceptors and stabilize interactions with the active site residues. Also, incorporating a phenyl ring substituted with a fluorine atom might improve binding via hydrophobic contacts and electronic effects.

Combining these ideas, I propose adding a benzamide moiety linked to the hydrazine, replacing the methyl group with a fluorophenyl ring to optimize both hydrogen bonding and hydrophobic interactions while keeping the core heterocyclic system intact.

The resulting molecule is: \box{CC(=NNC(N)=O)c1ccc2nnc(Cc3ccc4ncccc4c3)c2n1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 68
NON-LLM GENERATED: CC1=CN=C2N=NN(CC3=CC=C4N=CC=CC4=C3)C2=N1
Cc1cnc2nnn(Cc3ccc4ncccc4c3)c2n1

Boltz running on GPU 2
9.74
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CCN1CCC(COC2=CN=C(C3=CC=CC(CN4C(=O)C=CN5C6=CC(C#N)=CC=C6N=C54)=C3)N=C2)CC1,-10.31]
[CC(=NNC(N)=O)C1=NN2C(=NN=C2[C@@H](C)C2=CC=C3N=CC=CC3=C2)C=C1,-11.42]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase rigidity for better fit, and introduce groups that interact well with the c-MET binding pocket. The first molecule has decent flexibility and some hydrogen bond donors/acceptors, but it could benefit from added polarity and potential cation-pi interactions. The second molecule is more polar and has good aromatic interactions, but might lack the hydrophobic contacts the first molecule has.

A promising approach is to combine the strong hydrogen bonding capability of the second molecule with the aromatic system and hydrophobic tail of the first. Specifically, I would introduce a hydroxyl group on the aromatic ring to add hydrogen bonding without losing rigidity or introducing desolvation penalties. Also, extending the alkyl chain on the ring could improve hydrophobic contacts and better fill the pocket.

Therefore, the new molecule would keep the core aromatic system and hydrophobic tail, but add a hydroxyl group on the ring like the second molecule has, and extend the alkyl chain slightly. This should increase binding affinity through a combination of hydrogen bonding, aromatic stacking, and hydrophobic interactions.

\box{CC(=NNC(N)=O)C1=NN2C(=NN=C2[C@@H](C)C2=CC(C(O)CCCN3CCC(C)CC3)C=C2)C=C1}
LLM-GENERATED: CC(=NNC(N)=O)c1ccc2nnc(C(C)C3=CC(C(O)CCCN4CCC(C)CC4)C=C3)n2n1
CC(=NNC(N)=O)c1ccc2nnc(C(C)C3=CC(C(O)CCCN4CCC(C)CC4)C=C3)n2n1

Boltz running on GPU 2
9.16
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[[C-]#[N+]C1=C(C2=CC=C(F)C=C2F)N=C2COC(=O)C2C1C1=CC2=C(C)NN=C2C=C1,-10.1]
[CNC(=O)C1=CC=C(C2=NN(CCC3=CC=C4N=CC(C5=CN(CCO)N=C5)=CC4=C3)C(=O)C=C2)C=C1C(F)(F)F,-11.8]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I see that both feature fused heterocycles and fluorinated aromatic rings, which are likely contributing to their binding affinity through hydrophobic and electronic interactions. The better bound molecule has additional substitutions including methyl groups and heterocycles with nitrogen atoms, which may improve polar contacts and rigidity factor in the binding pocket.

To further enhance affinity, I would aim to increase heterocyclic complexity while maintaining or improving ligand rigidity and introducing potential hydrogen bond donors or acceptors. Incorporating a methoxy-substituted pyridine ring could provide favorable interactions through both hydrophobic and polar contacts. Also, maintaining the fluorinated phenyl ring would preserve hydrophobic interactions.

Based on this, I propose a molecule that incorporates a fused heterocycle with a methoxy-pyridine substituent and fluorinated aromatic rings to balance these factors. This is the molecule:

\box{COc1ccnc2c(C(=O)C(=CC(=O)Nc3ccc4cc(NC5=CC(=O)NCC5)ccc4c3=CC2)C(F)F)c(=O)n(-c3ccc(F)cc3)c2=O1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 69
NON-LLM GENERATED: CNC(=O)C1=CC=C(C2=NN(CCCCC3=CC4=C(C)NN=C4C=C3)C(=O)C=C2)C=C1C(F)(F)F
CNC(=O)c1ccc(-c2ccc(=O)n(CCCCc3ccc4n[nH]c(C)c4c3)n2)cc1C(F)(F)F

Boltz running on GPU 2
10.46
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(C1=C(F)C=C2N=CC(C3=CN(C)N=C3)=CC2=C1F)N1N=NC2=NC=C(C3=CC=C(C(N)=O)C(F)=C3)N=C21,-11.86]
[CC(=NOC(N)=O)c1ccc2nnc(C(C)C3=C(F)C=CC(c4cnn(C)c4)C3F)n2n1,-9.99]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both leverage the 1,2,3-triazole (or similar fused/ring altered versions) and fluorinated aromatic systems, which are known to engage well with the binding pocket of c-MET. However, their binding affinities suggest room for improvement, with the first molecule around -11.86 kcal/mol and the second around -9.99 kcal/mol.

To enhance binding affinity, I consider introducing a carbonyl group (C=O) to provide additional hydrogen bonding opportunities and polarity, potentially improving interactions with polar residues in the pocket. Also, maintaining the fluorinated aromatic system is beneficial for hydrophobic and halogen bonding. Incorporating a heteroaromatic ring with nitrogen atoms can increase hydrogen bonding and π-stacking. Finally, adding a substituted acyl group could better occupy the binding site and add rigidity.

Based on these considerations, I propose a molecule featuring a carbonyl group attached to a triazole fused to a fluorinated aromatic system, combined with a heteroaromatic ring that includes an amide substituent to maximize hydrogen bonding and hydrophobic contacts.

\box{C=C1N(C)C=C(C)c2nnn(-c3ccc(C(=O)Nc4ccc5ncc(C)cc5c4)c(F)c3)c2C1=O}
LLM-GENERATED: C=C1C(=O)c2c(nnn2-c2ccc(C(=O)Nc3ccc4ncc(C)cc4c3)c(F)c2)C(C)=CN1C
C=C1C(=O)c2c(nnn2-c2ccc(C(=O)Nc3ccc4ncc(C)cc4c3)c(F)c2)C(C)=CN1C

Boltz running on GPU 2
10.46
240/1000 | avg_top1: 12.050 | avg_top10: 11.724 | avg_top100: 10.998 | avg_sa: 3.173 | div: 0.823
{'avg_top1': 12.05, 'avg_top10': 11.724, 'avg_top100': 10.997600000000004, 'auc_top1': 2.80895, 'auc_top10': 2.727539999999999, 'auc_top100': 2.5387993095238097, 'avg_sa': 3.1734260709672766, 'diversity_top100': 0.8227431584855883, 'n_oracle': 240}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(=NOC(N)=O)c1ccc2ccc(C(C)c3c(F)cc4ncccc4c3F)n2n1,-10.05]
[CN1C=C(C2=NN3C(=NN=C3CC3=CC=CC4=C3C=CNC4=O)C=C2)C=N1,-10.34]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for increasing interactions such as additional hydrogen bonds, better hydrophobic contacts, and possibly introducing groups that enhance overall ligand-protein stability. Notably, the first molecule has a methyl group on the aromatic ring that could be optimized for better interaction, while the second molecule has a complex fused ring system that provides rigidity and potential pi-stacking but might benefit from simpler or more electron-donating groups to enhance binding.

One strategy is to maintain the core fused ring system from the second molecule for its rigidity and aromatic interactions, but replace the N-ethyl or methyl substituents with a more electron-donating group such as a methoxy group on the phenyl ring. This could improve hydrogen bonding potential and electronic distribution without losing the planar stacking motifs.

Therefore, I propose the molecule:

\box{COc1ccc2ccc(C(C)c3c(F)cc4ncccc4c3F)n2n1}
LLM-GENERATED: COc1ccc2ccc(C(C)c3c(F)cc4ncccc4c3F)n2n1
COc1ccc2ccc(C(C)c3c(F)cc4ncccc4c3F)n2n1

Boltz running on GPU 2
9.48
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CN=C2C=CC([C@H](C)C3=NN=C4C(F)=CC(C5=CC(C)=NO5)=CN43)=CC2=C1,-11.12]
[CC(N=O)c1ccc2nnc(Cc3c(F)cc4ncccc4c3F)n2n1,-11.79]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for features that enhance interactions like hydrogen bonding, hydrophobic contacts, and electronic effects. The first ligand has a methyl-substituted oxazole ring that could contribute hydrophobic interactions, while the second ligand has a nitro group and heterocyclic rings that provide potential hydrogen bonding and π-stacking.

Comparing the two, the second ligand’s nitro group could contribute to stronger polar interactions, but its binding affinity is over 0.6 units lower than the first ligand, possibly due to steric hindrance or electronic factors. The first ligand’s methylated oxazole may offer favorable hydrophobic contacts.

To combine the benefits, I would focus on increasing polar interactions without sacrificing hydrophobic contacts. Introducing a polar substituent such as a hydroxyl group on the phenyl ring of the second ligand might enhance hydrogen bonding with the protein and improve solubility. Maintaining the core heterocyclic system could preserve binding shape and electronic complementarity.

Therefore, my proposed molecule is:

\box{CC(N=O)c1ccc2nnc(C(CO)c3c(F)cc4ncccc4c3F)n2n1}
LLM-GENERATED: CC(N=O)c1ccc2nnc(C(CO)c3c(F)cc4ncccc4c3F)n2n1
CC(N=O)c1ccc2nnc(C(CO)c3c(F)cc4ncccc4c3F)n2n1

Boltz running on GPU 2
10.28
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(NC1=CC(OC2=C(F)C=C(NC(=O)C3(C(=O)NC4=CC=C(F)C=C4)CC3)C(F)=C2)=CC=N1)C1CC1,-10.49]
[CNC(=O)C1=CC=C(C2=NN(CCC3=CC=C4N=CC(C5=CN(CCO)N=C5)=CC4=C3)C(=O)C=C2)C=C1C(F)(F)F,-11.8]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, aromatic stacking, and polarity in key regions of the ligand. The first molecule has strong electron-withdrawing groups (fluorines) that likely contribute to binding, but its core scaffold could be optimized for better interaction versatility. The second molecule includes a flexible linker with nitrogen atoms, facilitating hydrogen bonding, but may lack sufficient hydrophobic contacts.

To build on this, I would introduce a fused bicyclic heteroaromatic system with multiple amide groups to increase hydrogen bonding potential and polarity. Adding a substituted pyridine ring could enhance π-stacking and solubility. Incorporating a small hydrophobic substituent, like a methyl, on the aromatic system might improve van der Waals interactions without compromising binding.

Based on this reasoning, I propose the molecule:

\box{CC1CN(C(=O)c2ccc(-n3cc(C(=O)NC4=CC=C(C5=CCNCC6=CCNC(=O)C6C(F)(F)F)C5)ccc3=O)cc2)CC1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 70
NON-LLM GENERATED: CNC(=O)C1=CC=C(C2=NN(CCC3=CC=C4N=CC(C5=CN(CCO)N=C5)=CC4=C3)C(=O)C=C2)C=C1C(F)(F)F
Already in buffer
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccc(F)c(Cl)c5)cc4c(=O)c3c2)cn1,-10.22]
[CNC(=O)C1=CC=C(C2=CN3C(=NN=C3COC3=CC=NC4=CC(OCC(=O)N5CC5)=CC=C43)C=C2)C(F)=C1,-11.06]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity in hydrophobic pockets, and maintain or expand conjugation to stabilize interactions. The first molecule has good aromatic stacking and halogen interactions but might benefit from additional H-bond donors/acceptors. The second molecule already incorporates amide and ether linkers that support H-bonding but could use a more rigid scaffold to reduce entropy loss upon binding.

Based on this, I would introduce a uracil-like moiety that can engage in multiple H-bonds and improve interaction with polar residues in the binding site. Also, modifying the aromatic ring with an amino group can increase hydrogen bonding capacity. Maintaining the fluorochlorophenyl unit linked via the thioamide is important for hydrophobic and halogen bonding. The new molecule should also preserve the bicyclic heteroaromatic core from the first ligand.

\box{n1ccc2ccc(CS(=O)(=O)NCc3ccc(-c4cnc(N)c(=O)n(-c5ccc(A)cc5)c4=O)cc3F)c2c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 71
NON-LLM GENERATED: CNC(=O)C1=CC=C(C2=CN3C(C)=NN=C3C=C2)C(F)=C1
CNC(=O)c1ccc(-c2ccc3nnc(C)n3c2)c(F)c1

Boltz running on GPU 2
6.73
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(=NOC(N)=O)c1ccc2ccc(C(C)c3c(F)cc4ncccc4c3F)n2n1,-10.05]
[CC(=NNC(N)=O)C1=NN2C(C(O)C3=C(F)C=C4N=CC=CC4=C3F)=CN=C2C=C1,-11.5]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding and aromatic stacking within the binding pocket. The existing molecules already use nitrogen-rich heterocycles and fluorinated aromatic rings, which interact well with c-MET. However, adding a flexible linker with polar groups could allow better formation of hydrogen bonds, and introducing a methoxy substituent on the aromatic ring might increase hydrophobic and electronic interactions.

Considering these points, I propose adding an ethylene linker bearing an amide group to increase hydrogen bonding capability, and a methoxy substitution on the fused aromatic system to enhance interactions.

\box{COCC(=NNC(N)=O)c1ccc2ccc(C(C)c3c(OC)cccc4ncccc4c3)n2n1}
LLM-GENERATED: COCC(=NNC(N)=O)c1ccc2ccc(C(C)C3=C(OC)C=CC=c4ncccc4=C3)n2n1
COCC(=NNC(N)=O)c1ccc2ccc(C(C)C3=C(OC)C=CC=c4ncccc4=C3)n2n1

Boltz running on GPU 2
9.44
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC2=C(OC3=CC=C(NC(=O)NN=CC4=CC=C(F)C=C4F)C=C3F)C=CN=C2C=C1OCCCN1CCC(C)CC1,-10.99]
[NC(=O)NN=CC1=CN=C2N=NN(CC3=CC=C4N=CC=CC4=C3)C2=N1,-11.05]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase ligand flexibility in key regions, and optimize interactions with the binding pocket. The first molecule has a methoxy substituent and a piperidine ring, while the second molecule has a more planar pyrazole-based core with fluorinated aromatic rings that likely engage in hydrophobic and π-stacking interactions.

Notably, the second molecule's pyrazole motif combined with the fluorinated aromatic system seems beneficial for affinity, so incorporating a similar motif could maintain crucial interactions. However, adding additional hydrogen bond donors or acceptors and introducing a more flexible, hydrophilic side chain might improve binding by better complementing the c-MET pocket's polar regions.

Therefore, I would design a molecule that keeps the pyrazole core but replaces the fluorinated aromatic group with a phenyl ring to retain hydrophobic interactions while adding a morpholine-containing side chain to enhance solubility and possible hydrogen bonding.

The resulting molecule is:

\box{O=C(NNNC1=CC(=O)Nc2ccc(-c3ccc4ncc(N5CCOCC5)nc4c3)cc2)c1=O}
LLM-GENERATED: O=C(C=C1NNNC(=O)C1=O)Nc1ccc(-c2ccc3ncc(N4CCOCC4)nc3c2)cc1
O=C(C=C1NNNC(=O)C1=O)Nc1ccc(-c2ccc3ncc(N4CCOCC4)nc3c2)cc1

Boltz running on GPU 2
9.15
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[[C-]#[N+]C1=C(C2=CC=C(F)C=C2F)N=C2COC(=O)C2C1C1=CC2=C(C)NN=C2C=C1,-10.1]
[CN1CCC(NC2=CN=C3C=CC(SC4=NN=C5C(F)=CC(C6=CN(C)N=C6)=CN45)=CC3=C2)CC1,-11.09]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules and their binding affinities, I notice that both ligands share some key features: they both contain fused heterocycles and fluorinated aromatic rings, which likely contribute to strong π-stacking and hydrophobic interactions within the binding pocket. However, the optimal positioning and connectivity of these groups vary.

Molecule 1 has a better binding affinity (-10.1) with a planar fused heterocycle combined with a fluorinated biphenyl moiety. Molecule 2 introduces a morpholine-like ring and a more flexible side chain, but its binding affinity is slightly lower (-11.09).

To improve binding, I would aim to maintain the beneficial fused heterocycles and fluorinated aromatic system but increase rigidity and reduce potential conformational entropy penalties. Also, introducing a heteroatom in the ring could enhance polar interactions or hydrogen bonding.

Therefore, I propose a molecule that replaces the fluorinated biphenyl with a fused bicyclic heteroaromatic system containing a nitrogen atom in the ring, which may improve binding through additional interactions while maintaining the planar, rigid scaffold seen in the more successful ligand.

\box{C1=CC2=C(C)NN=C3C(C1)C(C2=CC3)C1=CC2=NCC(-c3ccc4ncccc4c2C1)C(C3)=O}
LLM-GENERATED: CC1=C2C=CCC3C(=NN1)CC=C2C3C1=CC2=NCC3C(=O)CC3=CC=c3ncccc3=C2C1
CC1=C2C=CCC3C(=NN1)CC=C2C3C1=CC2=NCC3C(=O)CC3=CC=c3ncccc3=C2C1

Boltz running on GPU 2
9.76
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(c1c(F)cc2ncccc2c1F)n1cnc2ncc(-c3cnn(CCO)c3)nc21,-11.12]
[Cn1cc(-c2cc(F)c3ncc(Cc4c(F)cc5ncccc5c4F)n3n2)cn1,-10.96]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for increasing hydrophobic interactions and π-stacking within the binding pocket, as well as introducing polar groups to form additional hydrogen bonds. The existing molecules already have fluorinated aromatic rings that contribute to hydrophobic and electronic effects. To enhance binding, adding a small alkyl substituent on the aromatic ring of the triazole moiety could improve hydrophobic contacts and fill the pocket better. Introducing a terminal alkyne (C#C) on the heterocycle where the ethoxy group is currently present might increase binding through potential π-interactions or dipole interactions.

Based on this reasoning, I propose adding a methyl group on the pyrimidine ring and replacing the ethoxy group with an alkyne-linked methyl.

\box{Cn1cc(-c2cc(F)c3ncc(Cc4c(F)cc5ncccc5c4F)n3n2)cn1}
LLM-GENERATED: Cn1cc(-c2cc(F)c3ncc(Cc4c(F)cc5ncccc5c4F)n3n2)cn1
Already in buffer
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2N(C)S(C)(=O)=O)=N1,-10.95]
[CC1=CN(C2=CC=C(F)C=C2)C(=O)C(C(=O)NC2=CC=C(OC3=C4C(=NC=C3)NN=C4N[C@H](C)CO)C(F)=C2)=C1,-11.32]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both incorporate heterocyclic rings and have partial rotaxyl or constrained linkers, likely contributing to their binding affinity. The first molecule features a morpholine and piperazine moiety, while the second has a fluorinated aromatic ring and a chiral center with a hydroxymethyl substituent. Both ligands use nitrogen-rich heterocycles for strong hydrogen bonding and π-stacking interactions.

To improve affinity, I would consider enhancing hydrogen bonding capacity and increasing rigidity without sacrificing conformational flexibility. Introducing a bicyclic heterocycle with embedded nitrogen atoms can create additional polar contacts and fill the binding pocket more effectively. Also, replacing or augmenting the piperazine with a more planar, nitrogen-rich scaffold like a pyrimidine or pyrazole ring could strengthen interactions.

Combining these ideas, I propose a molecule that retains the key aromatic and heterocyclic features but incorporates a fused bicyclic nitrogen-rich system to increase binding interactions and rigidity.

\box{Cn1cc(-c2ccc3ncc(NC4=CC5NC(=O)NC(Nc6ccc7ncc(-c8cn[nH]c8)n7)c6=O)CC5=O)c(=O)n2C)nn1-c1ccc2ncccc2c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 72
NON-LLM GENERATED: CC1=CC=C(N2C=C(C)C=C(C(=O)NC3=CC=C(OC4=CC=NC5=C4C(NC(C)CO)=NN5)C(F)=C3)C2=O)C=C1
Cc1ccc(-n2cc(C)cc(C(=O)Nc3ccc(Oc4ccnc5[nH]nc(NC(C)CO)c45)c(F)c3)c2=O)cc1

Boltz running on GPU 2
10.44
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2N(C)S(C)(=O)=O)=N1,-10.95]
[O=[N+]([O-])c1cccc(CNc2cc(C(F)(F)F)cc3ncc(N4CCOCC4)cc23)c1,-10.28]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I see that both incorporate nitrogen-containing heterocycles and aromatic rings, with electron-donating and acceptor groups that likely engage in hydrogen bonding or dipole interactions within the binding site. The first molecule has a methoxy-substituted phenyl ring linked to a bicyclic heteroaromatic system, while the second molecule features a fluorinated phenyl ring connected to a fused heterocyclic system containing an oxygen atom.

To improve binding affinity, I would consider enhancing hydrogen bonding potential and increasing ligand rigidity to reduce entropic penalties upon binding. Also, incorporating keto or amide groups could introduce additional polar contacts and potentially form more stable interactions with c-MET residues. Furthermore, appending a small, rigid ring like a cyclopropane may increase hydrophobic interactions without adding too much bulk.

Combining these ideas, I propose a molecule that replaces the methoxy group with a amide functionality attached to a substituted pyridine ring, and introduces a fused heterocycle containing an amide and a cyclopropane moiety to enhance both hydrogen bonding and hydrophobic contacts.

\box{CN(C(=O)c1ccc(-c2ccc3ncc(N4CCC(N5CC5)CC4=O)c(C3=O)c2C2CC2)c1)cn1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 73
NON-LLM GENERATED: CC1=CC=CC([N+](=O)[O-])=C1
Cc1cccc([N+](=O)[O-])c1

Boltz running on GPU 2
6.15
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(=NNC(N)=O)C1=NN2C(=NN=C2[C@@H](C)C2=CC=C3N=CC=CC3=C2)C=C1,-11.42]
[COC1=CN=C2C=CC([C@H](C)C3=NN=C4C=CC(C5=CC=CC=C5)=NN43)=CC2=C1,-10.63]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions in the ligand by increasing hydrogen bonding potential, improving conformational rigidity, and increasing hydrophobic contacts with the protein, especially in the key binding pocket.

The first molecule has strong hydrogen bonding through the hydrazinyl (NNC(N)=O) and pyrazole rings but may lack optimal hydrophobic interactions. The second molecule adds aromatic rings for hydrophobic contacts but has a smaller core and fewer hydrogen bonding groups.

To combine the benefits, I would introduce a bulky, hydrophobic substituent on the core diazine ring to increase van der Waals interactions and add a methoxy group to enhance polarity and potential hydrogen bonding without losing rigidity. Also, maintaining the chiral center with a methyl substituent can optimize fit in the binding pocket.

Therefore, the molecule I propose incorporates a methoxy substituent on the diazine ring, a methylated core for improved hydrophobic and steric complementarity, and preserves the chiral center with a methyl substituent to optimize interactions.

\box{COC1=NNC(N)=CC1C(C(=NNC(N)=O)c1cc(-c2ccc(C)cc2)ccc1=NNC1=CC(C)C1)C[C@H](C)C1=CC=CC=CC1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 74
NON-LLM GENERATED: CC(C1=CC=CC=C1)C1=CC=C2N=CC=CC2=C1
CC(c1ccccc1)c1ccc2ncccc2c1

Boltz running on GPU 2
6.65
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cn1cc(-c2cnc3nnn(CC4CCCN(c5ncc(-c6cnn(CCO)c6)cn5)C4)c3n2)cn1,-10.76]
[CON=C(C)c1ccc2ncc(Cc3c(F)cc4ncccc4c3F)n2n1,-10.93]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would consider enhancing hydrogen bonding capabilities and increasing rigidity to reduce entropy loss upon binding. The first ligand has strong aromatic interactions but may benefit from additional H-bond donors/acceptors. The second ligand includes fluorinated aromatic rings and amide functionality, which can improve binding through hydrophobic contacts and potential hydrogen bonding, but its overall rigidity may allow some flexibility.

To improve on this, I would introduce a polar amide group to increase hydrogen bonding and add a flexible but polar side chain (like a piperazine-linked morpholine) to enhance solubility and fill the binding pocket better, while retaining the aromatic core for π-π stacking.

Based on this reasoning, I propose this molecule:

\box{CC(=O)N1CCN(Cc2ccc3ncc(Cc4c(F)cc5ncccc5c4F)n3n2)CC1OCC1CCN(C)CCO1}
LLM-GENERATED: CC(=O)N1CCN(Cc2ccc3ncc(Cc4c(F)cc5ncccc5c4F)n3n2)CC1OCC1CCN(C)CCO1
CC(=O)N1CCN(Cc2ccc3ncc(Cc4c(F)cc5ncccc5c4F)n3n2)CC1OCC1CCN(C)CCO1

Boltz running on GPU 2
10.59
250/1000 | avg_top1: 12.050 | avg_top10: 11.724 | avg_top100: 11.000 | avg_sa: 3.194 | div: 0.822
{'avg_top1': 12.05, 'avg_top10': 11.724, 'avg_top100': 11.000300000000005, 'auc_top1': 2.9294499999999997, 'auc_top10': 2.8447799999999988, 'auc_top100': 2.64878880952381, 'avg_sa': 3.1940960609248124, 'diversity_top100': 0.8222917448833152, 'n_oracle': 250}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COc1cc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)ccc1C(=O)NC1CCOCC1,-10.15]
[COC1=CC=C2C(=C1)N=CC=C2OCC1=NN=C2C(F)=CC(C3=CC(C)=CS3)=CN12,-11.52]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: From the given binding affinities, the second molecule (-11.52 kcal/mol) appears to have improvements over the first (-10.15 kcal/mol), possibly due to its increased heterocyclic complexity and fluorine substitution, which may enhance binding interactions such as hydrogen bonding and hydrophobic contacts in the c-MET pocket.

To further improve affinity, I would consider reducing the number of flexible ether linkers (like -OCC-) in favor of more rigid heterocycles that can better lock into place and increase π-π stacking or hydrogen bonding with the protein. Also, incorporating amide functionalities can enhance interaction specificity and binding stability.

Based on this, I propose a molecule that replaces flexible chains with fused heterocycles, incorporates an amide group for stronger hydrogen bonding, and keeps the crucial fluorine substitution for hydrophobic interactions. This molecule should have better shape complementarity and stronger polar interactions with c-MET.

\box{Cn1cc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1C(=O)NC1CCN(C)CC1}
LLM-GENERATED: CN1CCC(NC(=O)c2cc(-c3cnc4ncc(Cc5ccc6ncccc6c5)n4n3)cn2C)CC1
CN1CCC(NC(=O)c2cc(-c3cnc4ncc(Cc5ccc6ncccc6c5)n4n3)cn2C)CC1

Boltz running on GPU 2
9.82
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN3C(=NN=C3SC3=CC=C4N=CC(NCCO)=CC4=C3)C=C2)C=N1,-11.09]
[COCCOc1cnc2ccc([C@H](C)n3nnc4ccn(-c5cc(C)ns5)c(=O)c43)cc2c1,-11.39]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for features that enhance interactions like hydrogen bonding, hydrophobic contacts, and rigidity to reduce entropy loss upon binding. Both given molecules have heterocyclic cores and substituents that engage with the protein, but one has a methyl-substituted thiazole ring that might offer hydrophobic interactions, while the other incorporates oxygen atoms contributing to hydrogen bonding.

To combine these beneficial elements, introducing a more electron-rich heteroaromatic ring with both methyl groups could increase hydrophobic contacts and potentially π-stacking. Also, maintaining the oxygen linker from the second molecule can preserve key hydrogen bonding interactions. This approach aims to synergize hydrophobic and polar contacts for stronger binding.

Based on this reasoning, I propose the molecule:

\box{Cc1cc(-c2cc(C)ns2)cn2ncnc(OCCO)c1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 75
NON-LLM GENERATED: CC1=CC=C2N=CC(NCCO)=CC2=C1
Cc1ccc2ncc(NCCO)cc2c1

Boltz running on GPU 2
7.64
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC1=CN(C2=CC=C(F)C=C2)C(=O)C(C(=O)NC2=CC=C(OC3=C4C(=NC=C3)NN=C4N[C@H](C)CO)C(F)=C2)=C1,-11.32]
[Cn1cc(-c2cnc3nnn(CC4CCCN(c5ncc(-c6cnn(CCO)c6)cn5)C4)c3n2)cn1,-10.76]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, pi-stacking, and electrostatic binding. The first molecule has strong aromatic and heterocyclic systems that fit well into the pocket, but its binding affinity is slightly lower than the second molecule, which incorporates morpholine and methylated nitroso groups for potentially improved solubility and electronic effects.

The second molecule's use of heterocycles with fluorine substituents seems beneficial for affinity and specificity, so maintaining those motifs could be advantageous. However, the overall scaffold in the first molecule might offer better spatial orientation for key groups when modified. 

Considering this, I would retain the fluorinated aromatic rings and heterocyclic cores but simplify the linker to reduce potential steric hindrance and improve flexibility. Also, eliminating the morpholine and methylated nitroso substituents while keeping a pyrazole-based heterocycle might balance hydrophobic and polar interactions better.

Thus, a promising modification is to have a fused pyrazole-pyrimidine system linked via an ether to a fluorinated phenyl ring, which is attached through a double bond to a bicyclic heterocycle with a methyl-substituted nitrogen, preserving key aromatic and heterocyclic features from both original molecules but optimizing spatial arrangement and flexibility.

\box{Cn1cc(-c2cnc3nnn(CC4CCCN(c5ncc(-c6ccc(F)cc6)cn5)C4)c3n2)cn1}
LLM-GENERATED: Cn1cc(-c2cnc3nnn(CC4CCCN(c5ncc(-c6ccc(F)cc6)cn5)C4)c3n2)cn1
Cn1cc(-c2cnc3nnn(CC4CCCN(c5ncc(-c6ccc(F)cc6)cn5)C4)c3n2)cn1

Boltz running on GPU 2
9.94
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN=C3C=NN(S(=O)(=O)C4=CN=C5C=CC(C6=CCC=C6)=CN45)C3=C2)C=N1,-10.38]
[Cn1cc(-c2cnc3nnn(CC4CCCN(c5ncc(-c6cnn(CCO)c6)cn5)C4)c3n2)cn1,-10.76]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase ligand rigidity, and introduce groups that could strengthen hydrophobic interactions or electrostatic contacts within the binding pocket. The first molecule has a sulfonyl group that offers polarity and potential hydrogen bonding, but the second molecule's nitrogen-rich heterocycles and flexible side chains might provide better interaction versatility.

Comparing the two, the second molecule contains a longer flexible chain and multiple heterocycles that could improve binding through additional hydrogen bonds and pi-stacking. However, this flexibility might also reduce binding specificity. To balance rigidity with interaction potential, introducing a fused heterocyclic system could enhance binding by restricting conformational freedom and adding additional H-bond donors/acceptors in a well-oriented way.

Therefore, I would propose a molecule that incorporates a fused heterocycle with an amide group to provide hydrogen bonding capability and a cyclic amines to maintain favorable interactions while avoiding excessive flexibility.

\box{CC1CN(C)c2ccc3ncc(NC(=O)C4CC5ccc6ncccc6c5C4=C3I2)nc3n1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 76
NON-LLM GENERATED: CN1C=CN=C2C=CC(C3=CCC=C3)=CN21
CN1C=CN=C2C=CC(C3=CCC=C3)=CN21

Boltz running on GPU 2
7.25
[(12.05, <rdkit.Chem.rdchem.Mol object at 0x761912363820>), (11.86, <rdkit.Chem.rdchem.Mol object at 0x761912392b30>), (11.8, <rdkit.Chem.rdchem.Mol object at 0x7619123636d0>), (11.8, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9c190>), (11.79, <rdkit.Chem.rdchem.Mol object at 0x761912392740>), (11.72, <rdkit.Chem.rdchem.Mol object at 0x761912392660>), (11.71, <rdkit.Chem.rdchem.Mol object at 0x761912365430>), (11.67, <rdkit.Chem.rdchem.Mol object at 0x761912392f20>), (11.57, <rdkit.Chem.rdchem.Mol object at 0x7619123790b0>), (11.55, <rdkit.Chem.rdchem.Mol object at 0x761912363200>), (11.52, <rdkit.Chem.rdchem.Mol object at 0x761912392ac0>), (11.52, <rdkit.Chem.rdchem.Mol object at 0x761912363430>), (11.5, <rdkit.Chem.rdchem.Mol object at 0x761912365dd0>), (11.44, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabeb0>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912392eb0>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x7619123566d0>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912365580>), (11.4, <rdkit.Chem.rdchem.Mol object at 0x7619123d0510>), (11.39, <rdkit.Chem.rdchem.Mol object at 0x761912392f90>), (11.39, <rdkit.Chem.rdchem.Mol object at 0x761912365b30>), (11.36, <rdkit.Chem.rdchem.Mol object at 0x7619123653c0>), (11.36, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabdd0>), (11.32, <rdkit.Chem.rdchem.Mol object at 0x761912379cf0>), (11.31, <rdkit.Chem.rdchem.Mol object at 0x7619123923c0>), (11.3, <rdkit.Chem.rdchem.Mol object at 0x7619123637b0>), (11.28, <rdkit.Chem.rdchem.Mol object at 0x761912365890>), (11.22, <rdkit.Chem.rdchem.Mol object at 0x761912392a50>), (11.21, <rdkit.Chem.rdchem.Mol object at 0x761912363040>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912392350>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912392510>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912379eb0>), (11.18, <rdkit.Chem.rdchem.Mol object at 0x761912356820>), (11.18, <rdkit.Chem.rdchem.Mol object at 0x7619123656d0>), (11.17, <rdkit.Chem.rdchem.Mol object at 0x7619123d0970>), (11.17, <rdkit.Chem.rdchem.Mol object at 0x7619123652e0>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912356900>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912365ac0>), (11.1, <rdkit.Chem.rdchem.Mol object at 0x761912392e40>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356b30>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356cf0>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912365c10>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x7619123927b0>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x761912365740>), (11.06, <rdkit.Chem.rdchem.Mol object at 0x761aa402af90>), (11.06, <rdkit.Chem.rdchem.Mol object at 0x761912365a50>), (11.05, <rdkit.Chem.rdchem.Mol object at 0x761912392970>), (11.03, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00890>), (11.01, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabf20>), (10.99, <rdkit.Chem.rdchem.Mol object at 0x761912365350>), (10.96, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99c80>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912392ba0>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356eb0>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356f90>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912365820>), (10.94, <rdkit.Chem.rdchem.Mol object at 0x761912392890>), (10.94, <rdkit.Chem.rdchem.Mol object at 0x761912392900>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761912365d60>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00660>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9cb30>), (10.92, <rdkit.Chem.rdchem.Mol object at 0x761912363190>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912379dd0>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365190>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365eb0>), (10.89, <rdkit.Chem.rdchem.Mol object at 0x761912365f90>), (10.85, <rdkit.Chem.rdchem.Mol object at 0x7619123654a0>), (10.81, <rdkit.Chem.rdchem.Mol object at 0x761912379f90>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912392120>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x7619123d09e0>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912379e40>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761aa402ac80>), (10.78, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00190>), (10.77, <rdkit.Chem.rdchem.Mol object at 0x761aa3d996d0>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365900>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365ba0>), (10.75, <rdkit.Chem.rdchem.Mol object at 0x761aa402ab30>), (10.74, <rdkit.Chem.rdchem.Mol object at 0x761912392c10>), (10.71, <rdkit.Chem.rdchem.Mol object at 0x761912365510>), (10.7, <rdkit.Chem.rdchem.Mol object at 0x761aa3d995f0>), (10.67, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabcf0>), (10.65, <rdkit.Chem.rdchem.Mol object at 0x761912365e40>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123650b0>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123634a0>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x761912392c80>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x7619123922e0>), (10.6, <rdkit.Chem.rdchem.Mol object at 0x761912356970>), (10.6, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00c10>), (10.59, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9c5f0>), (10.58, <rdkit.Chem.rdchem.Mol object at 0x7619123657b0>), (10.56, <rdkit.Chem.rdchem.Mol object at 0x761912365cf0>), (10.54, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99f20>), (10.52, <rdkit.Chem.rdchem.Mol object at 0x761912392270>), (10.51, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00e40>), (10.5, <rdkit.Chem.rdchem.Mol object at 0x761912356d60>), (10.49, <rdkit.Chem.rdchem.Mol object at 0x761912363660>), (10.47, <rdkit.Chem.rdchem.Mol object at 0x761912356dd0>), (10.47, <rdkit.Chem.rdchem.Mol object at 0x761aa3dab040>), (10.46, <rdkit.Chem.rdchem.Mol object at 0x761912363120>), (10.46, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9ca50>), (10.46, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9cac0>), (10.44, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9c510>), (10.42, <rdkit.Chem.rdchem.Mol object at 0x7619123633c0>), (10.4, <rdkit.Chem.rdchem.Mol object at 0x7619123926d0>), (10.38, <rdkit.Chem.rdchem.Mol object at 0x7619123567b0>), (10.38, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00350>), (10.38, <rdkit.Chem.rdchem.Mol object at 0x761aa3e009e0>), (10.35, <rdkit.Chem.rdchem.Mol object at 0x761912356890>), (10.35, <rdkit.Chem.rdchem.Mol object at 0x761912365120>), (10.34, <rdkit.Chem.rdchem.Mol object at 0x761912392820>), (10.34, <rdkit.Chem.rdchem.Mol object at 0x761912365040>), (10.34, <rdkit.Chem.rdchem.Mol object at 0x761912365970>), (10.34, <rdkit.Chem.rdchem.Mol object at 0x761aa3dab430>), (10.33, <rdkit.Chem.rdchem.Mol object at 0x761912365200>), (10.31, <rdkit.Chem.rdchem.Mol object at 0x761912365f20>), (10.3, <rdkit.Chem.rdchem.Mol object at 0x761912356e40>), (10.3, <rdkit.Chem.rdchem.Mol object at 0x761912365270>), (10.28, <rdkit.Chem.rdchem.Mol object at 0x761912379d60>), (10.28, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9c740>), (10.25, <rdkit.Chem.rdchem.Mol object at 0x7619123924a0>), (10.23, <rdkit.Chem.rdchem.Mol object at 0x7619123659e0>), (10.22, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99d60>)]
[0.009206274018435106, 0.009061112851340652, 0.00901527248278451, 0.00901527248278451, 0.009007632421358486, 0.00895415199137632, 0.008946511929950296, 0.0089159516842462, 0.008839551069985963, 0.008824270947133915, 0.008801350762855842, 0.008801350762855842, 0.008786070640003795, 0.008740230271447652, 0.008724950148595605, 0.008724950148595605, 0.008724950148595605, 0.008709670025743558, 0.008702029964317534, 0.008702029964317534, 0.008679109780039461, 0.008679109780039461, 0.008648549534335366, 0.008640909472909342, 0.008633269411483319, 0.008617989288631271, 0.008572148920075129, 0.008564508858649105, 0.00855686879722308, 0.00855686879722308, 0.00855686879722308, 0.008541588674371032, 0.008541588674371032, 0.008533948612945009, 0.008533948612945009, 0.00849574830581489, 0.00849574830581489, 0.008480468182962842, 0.008472828121536819, 0.008472828121536819, 0.008472828121536819, 0.008457547998684771, 0.008457547998684771, 0.008449907937258748, 0.008449907937258748, 0.008442267875832724, 0.008426987752980675, 0.008411707630128627, 0.00839642750727658, 0.008373507322998509, 0.008365867261572485, 0.008365867261572485, 0.008365867261572485, 0.008365867261572485, 0.008358227200146461, 0.008358227200146461, 0.008350587138720438, 0.008350587138720438, 0.008350587138720438, 0.008342947077294414, 0.008327666954442366, 0.008327666954442366, 0.008327666954442366, 0.008320026893016343, 0.008289466647312246, 0.008258906401608151, 0.008251266340182127, 0.008251266340182127, 0.008251266340182127, 0.008251266340182127, 0.00823598621733008, 0.008228346155904056, 0.008220706094478033, 0.008220706094478033, 0.008213066033052009, 0.008205425971625985, 0.008182505787347914, 0.008174865725921888, 0.008151945541643817, 0.00813666541879177, 0.008121385295939722, 0.008121385295939722, 0.008106105173087675, 0.008106105173087675, 0.008098465111661651, 0.008098465111661651, 0.008090825050235628, 0.008083184988809604, 0.008067904865957556, 0.008052624743105507, 0.00803734462025346, 0.008029704558827436, 0.008022064497401412, 0.008014424435975389, 0.007999144313123341, 0.007999144313123341, 0.00799150425169732, 0.00799150425169732, 0.00799150425169732, 0.00797622412884527, 0.007960944005993223, 0.007945663883141175, 0.007930383760289128, 0.007930383760289128, 0.007930383760289128, 0.007907463576011055, 0.007907463576011055, 0.007899823514585031, 0.007899823514585031, 0.007899823514585031, 0.007899823514585031, 0.007892183453159007, 0.00787690333030696, 0.007869263268880938, 0.007869263268880938, 0.007853983146028889, 0.007853983146028889, 0.007831062961750818, 0.00781578283889877, 0.0078081427774727465]
[(10.77, <rdkit.Chem.rdchem.Mol object at 0x761aa3d996d0>), (10.89, <rdkit.Chem.rdchem.Mol object at 0x761912365f90>), (10.28, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9c740>), (10.65, <rdkit.Chem.rdchem.Mol object at 0x761912365e40>), (10.58, <rdkit.Chem.rdchem.Mol object at 0x7619123657b0>), (10.28, <rdkit.Chem.rdchem.Mol object at 0x761912379d60>), (11.01, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabf20>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912365c10>), (11.79, <rdkit.Chem.rdchem.Mol object at 0x761912392740>), (11.36, <rdkit.Chem.rdchem.Mol object at 0x7619123653c0>), (11.22, <rdkit.Chem.rdchem.Mol object at 0x761912392a50>), (11.36, <rdkit.Chem.rdchem.Mol object at 0x7619123653c0>), (10.54, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99f20>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365eb0>), (10.67, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabcf0>), (10.46, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9ca50>), (11.22, <rdkit.Chem.rdchem.Mol object at 0x761912392a50>), (11.1, <rdkit.Chem.rdchem.Mol object at 0x761912392e40>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x7619123922e0>), (11.05, <rdkit.Chem.rdchem.Mol object at 0x761912392970>), (11.8, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9c190>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912392ba0>), (10.34, <rdkit.Chem.rdchem.Mol object at 0x761912365040>), (11.01, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabf20>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356b30>), (10.23, <rdkit.Chem.rdchem.Mol object at 0x7619123659e0>), (10.74, <rdkit.Chem.rdchem.Mol object at 0x761912392c10>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x761912365740>), (11.52, <rdkit.Chem.rdchem.Mol object at 0x761912363430>), (10.49, <rdkit.Chem.rdchem.Mol object at 0x761912363660>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x7619123922e0>), (10.34, <rdkit.Chem.rdchem.Mol object at 0x761aa3dab430>), (11.3, <rdkit.Chem.rdchem.Mol object at 0x7619123637b0>), (11.5, <rdkit.Chem.rdchem.Mol object at 0x761912365dd0>), (10.6, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00c10>), (11.31, <rdkit.Chem.rdchem.Mol object at 0x7619123923c0>), (11.39, <rdkit.Chem.rdchem.Mol object at 0x761912365b30>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912365ac0>), (10.46, <rdkit.Chem.rdchem.Mol object at 0x761912363120>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365eb0>), (11.72, <rdkit.Chem.rdchem.Mol object at 0x761912392660>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912365820>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123650b0>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365eb0>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912392120>), (11.28, <rdkit.Chem.rdchem.Mol object at 0x761912365890>), (10.42, <rdkit.Chem.rdchem.Mol object at 0x7619123633c0>), (10.81, <rdkit.Chem.rdchem.Mol object at 0x761912379f90>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x7619123922e0>), (10.25, <rdkit.Chem.rdchem.Mol object at 0x7619123924a0>), (10.96, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99c80>), (10.38, <rdkit.Chem.rdchem.Mol object at 0x761aa3e009e0>), (12.05, <rdkit.Chem.rdchem.Mol object at 0x761912363820>), (11.8, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9c190>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912379e40>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912356900>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912392350>), (11.18, <rdkit.Chem.rdchem.Mol object at 0x761912356820>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912365ac0>), (10.6, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00c10>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912392120>), (10.49, <rdkit.Chem.rdchem.Mol object at 0x761912363660>), (10.46, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9cac0>), (10.42, <rdkit.Chem.rdchem.Mol object at 0x7619123633c0>), (11.01, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabf20>), (10.99, <rdkit.Chem.rdchem.Mol object at 0x761912365350>), (10.34, <rdkit.Chem.rdchem.Mol object at 0x761aa3dab430>), (10.7, <rdkit.Chem.rdchem.Mol object at 0x761aa3d995f0>), (11.57, <rdkit.Chem.rdchem.Mol object at 0x7619123790b0>), (10.89, <rdkit.Chem.rdchem.Mol object at 0x761912365f90>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912365c10>), (10.23, <rdkit.Chem.rdchem.Mol object at 0x7619123659e0>), (11.86, <rdkit.Chem.rdchem.Mol object at 0x761912392b30>), (10.77, <rdkit.Chem.rdchem.Mol object at 0x761aa3d996d0>), (10.6, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00c10>), (11.18, <rdkit.Chem.rdchem.Mol object at 0x7619123656d0>), (10.28, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9c740>), (10.38, <rdkit.Chem.rdchem.Mol object at 0x7619123567b0>), (10.34, <rdkit.Chem.rdchem.Mol object at 0x761912365970>), (11.8, <rdkit.Chem.rdchem.Mol object at 0x7619123636d0>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912392120>), (11.17, <rdkit.Chem.rdchem.Mol object at 0x7619123d0970>), (10.42, <rdkit.Chem.rdchem.Mol object at 0x7619123633c0>), (10.75, <rdkit.Chem.rdchem.Mol object at 0x761aa402ab30>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365eb0>), (11.5, <rdkit.Chem.rdchem.Mol object at 0x761912365dd0>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365eb0>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365ba0>), (10.3, <rdkit.Chem.rdchem.Mol object at 0x761912365270>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912379e40>), (10.28, <rdkit.Chem.rdchem.Mol object at 0x761912379d60>), (10.28, <rdkit.Chem.rdchem.Mol object at 0x761912379d60>), (10.71, <rdkit.Chem.rdchem.Mol object at 0x761912365510>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9cb30>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912365820>), (10.35, <rdkit.Chem.rdchem.Mol object at 0x761912365120>), (11.8, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9c190>), (11.5, <rdkit.Chem.rdchem.Mol object at 0x761912365dd0>), (11.52, <rdkit.Chem.rdchem.Mol object at 0x761912363430>), (10.54, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99f20>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356b30>), (10.75, <rdkit.Chem.rdchem.Mol object at 0x761aa402ab30>), (10.78, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00190>), (11.06, <rdkit.Chem.rdchem.Mol object at 0x761912365a50>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365190>), (10.74, <rdkit.Chem.rdchem.Mol object at 0x761912392c10>), (10.31, <rdkit.Chem.rdchem.Mol object at 0x761912365f20>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x7619123d09e0>), (10.77, <rdkit.Chem.rdchem.Mol object at 0x761aa3d996d0>), (11.67, <rdkit.Chem.rdchem.Mol object at 0x761912392f20>), (10.3, <rdkit.Chem.rdchem.Mol object at 0x761912356e40>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365190>), (10.47, <rdkit.Chem.rdchem.Mol object at 0x761912356dd0>), (11.72, <rdkit.Chem.rdchem.Mol object at 0x761912392660>), (10.99, <rdkit.Chem.rdchem.Mol object at 0x761912365350>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912392510>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912379eb0>), (10.49, <rdkit.Chem.rdchem.Mol object at 0x761912363660>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365900>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912392ba0>)]
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CO/N=C(\C)c1ccc2ncc(Cc3c(F)cc4ncccc4c3F)n2n1,-10.95]
[OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1,-10.74]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to increase hydrogen bonding and polar interactions, as well as optimize hydrophobic contacts. The existing molecules already have a good framework of fused heterocycles that interact well with the binding pocket, so preserving that scaffold is important.

Molecule 1 has a carbonyl group adjacent to a pyridine ring, likely participating in hydrogen bonding, but the methylene linker to the core heterocycle might be flexible and reduce binding rigidity. Molecule 2 replaces the carbonyl with an ether linkage, increasing polarity but potentially sacrificing key hydrophobic interactions.

A strategic modification would be to combine strong hydrogen bonding and maintain hydrophobic contacts by introducing an amide group directly attached to the heterocyclic core, increasing binding affinity through both H-bonding and rigidity. Also, adding a fluorine substituent on the phenyl ring may improve binding by enhancing dipole interactions and possibly fitting better into a hydrophobic pocket.

Therefore, I propose the amide-linked heterocycle with a fluorophenyl substituent to improve affinity while preserving the core scaffold:

\box{CNC(=O)c1ccc2ncc(Cc3c(F)cc4ncccc4c3)n2n1}
LLM-GENERATED: CNC(=O)c1ccc2ncc(Cc3cc4cccnc4cc3F)n2n1
CNC(=O)c1ccc2ncc(Cc3cc4cccnc4cc3F)n2n1

Boltz running on GPU 2
9.35
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(=NNC(N)=O)c1cnc2nnn(Cc3cc4cccnc4cc3F)c2n1,-11.67]
[O=[N+]([O-])C1=CC=CC(CNC2=CC(C(F)(F)F)=CC3=NC=C(N4CCOCC4)C=C23)=C1,-10.28]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase ligand flexibility in key regions, and introduce groups that can strengthen interactions with the c-MET active site. The first molecule has a strong hydrazone moiety (NNC(N)=O) that likely contributes to binding, while the second molecule incorporates fluorinated aromatic rings and a morpholine-like ring for improved solubility and potential H-bonding.

Comparing the two, the first molecule’s hydrazone linked to the pyridine-containing heterocycle is promising, but the second molecule’s fluorinated aromatic system and morpholine ring add favorable lipophilic and conformational dynamics.

To combine these advantages, I would design a molecule that maintains the hydrazone core (NNC(N)=O) but replaces the aromatic portion with a flexible, polar side chain containing a heterocyclic amine (a piperazine-like ring) to enhance hydrogen bonding and solubility. Additionally, I would keep the trifluoromethyl-substituted aromatic system from the second molecule to retain hydrophobic and electronic effects.

This design can be seen in the molecule:

\box{CC(=NNC(N)=O)Cc1cnc2nnn(Cc3ccc4c(c3F)cccc4F)c2n1}
LLM-GENERATED: CC(Cc1cnc2nnn(Cc3ccc4c(F)cccc4c3F)c2n1)=NNC(N)=O
CC(Cc1cnc2nnn(Cc3ccc4c(F)cccc4c3F)c2n1)=NNC(N)=O

Boltz running on GPU 2
9.78
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(=NNC(N)=O)C1=NN2C(C(O)C3=C(F)C=C4N=CC=CC4=C3F)=CN=C2C=C1,-11.5]
[CC(=NNC(N)=O)c1cnc2nnn(Cc3cc4cccnc4cc3F)c2n1,-11.67]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, aromatic stacking, and electrostatic contacts. The existing molecules have similar core heterocycles and substituents, but one has a more expanded aromatic system with fluorines, which likely contribute to favorable electronic effects and hydrophobic contacts.

To build on this, introducing additional hydrogen bond donors/acceptors and expanding the aromatic system could strengthen binding. Also, incorporating a basic amine might improve electrostatic interactions with c-MET residues.

Based on this reasoning, I chose to design a molecule that keeps the key heterocyclic core but adds an ethylene linker connecting to a substituted pyridine ring bearing a methyl group and an N-methylated nitrogen to promote better solubility and potential H-bonding. This structure balances the size and complexity of the original molecules while introducing new features to enhance affinity.

\box{C/C(=NNC(N)=O)\C1=NN2C(C(O)C3=C(Cn4cc(-c5ccnc(N(C)C)c5C)ccc4=CC3=CC2)C(=O)N(C)Cc4cccnc4)c1}
LLM-GENERATED: CC(=NNC(N)=O)C1=NN2CC=C3C=C4C=CC(c5ccnc(N(C)C)c5C)=CN4CC(C(=O)N(C)Cc4cccnc4)=C3C(O)C2C1
CC(=NNC(N)=O)C1=NN2CC=C3C=C4C=CC(c5ccnc(N(C)C)c5C)=CN4CC(C(=O)N(C)Cc4cccnc4)=C3C(O)C2C1

Boltz running on GPU 2
10.29
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[N#Cc1cc(-c2cnc3nnn(CC4CN(c5ncc(C6=CCNCC6)cn5)CCO4)c3n2)ccc1Cl,-11.01]
[COC1=CC2=C(OC3=CC=C(NC(=O)NN=CC4=CC=C(F)C=C4F)C=C3F)C=CN=C2C=C1OCCCN1CCC(C)CC1,-10.99]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase rigidity to reduce entropy loss upon binding, and introduce groups that complement the binding pocket’s electronic or hydrophobic characteristics. Both initial molecules have fluorinated aromatic rings, which likely contribute to affinity via hydrophobic contacts and possibly halogen bonding. 

Molecule 1 has a chlorinated core with a different linker and a saturated ring system involving nitrogen heterocycles, maintaining a flexible chain with amine groups. Molecule 2 replaces some heterocycles with oxygen-containing rings and adds a tertiary amine in the side chain, increasing polarity and potentially improving solubility and hydrogen bonding.

To build on these, I would aim to combine the beneficial fluorinated aromatic systems with a rigidified nitrogen-containing bicyclic core to optimize binding geometry and enhance interactions. Introducing a cyclic amine in place of the flexible chain might reduce entropy loss while maintaining key hydrogen bond donors and acceptors. Also, adding an amide linkage could improve backbone rigidity and interaction potential.

Based on this reasoning, I propose the following molecule:  
\box{O=C(Nc1ccc2ccc(-c3cn4cc(C5CCNCC5)cn4n3)cc2c1F)c1ccnn(-c2ccc(F)c(F)c2)c1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 77
NON-LLM GENERATED: CC1=CN=C(N2CCOC(CN3N=NC4=NC=C(C5=CC(C#N)=C(Cl)C=C5)N=C43)C2)N=C1
Cc1cnc(N2CCOC(Cn3nnc4ncc(-c5ccc(Cl)c(C#N)c5)nc43)C2)nc1

Boltz running on GPU 2
7.72
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(NC1=CC=C(OC2=CC=NC(NC(=O)C3CC3)=C2)C=C1)C1=NC2=CC=CC=C2N(C2=CC=C(F)C=C2)C1=O,-10.76]
[CC(C1=CC=C2N=CC(C3=CN(C)N=C3)=CC2=C1)N1N=NC2=NC=C(C3=CC=NC=C3)N=C21,-10.95]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both share similar core heterocycles and aromatic rings but differ in their substitution patterns. The first molecule has a fluorine substitution on one aromatic ring, which might enhance binding affinity through electronic effects or hydrophobic interactions. The second molecule has a methyl group on a nitrogen heterocycle, potentially improving solubility or adjusting electronic distribution.

To improve binding, I would consider merging the beneficial features from both molecules: maintain the fluorine substitution to preserve potential favorable interactions, and expand the heterocyclic core to increase diversity and interaction sites. Also, shifting the fluorine to a different position might optimize binding geometry and protein contacts.

Therefore, I propose a new molecule that incorporates the fluorine on a different aromatic ring and introduces a fused pyrazole-pyridine system, combining the strengths of both previous ligands.

\box{CC(C1=CC=C2N=CC(C3=CN(C)N=C3)=CC2=C1)N1N=NC2=NC(C3=CC=C(F)C=C3)=C12}
LLM-GENERATED: CC(c1ccc2ncc(-c3cnn(C)c3)cc2c1)n1nnc2c1=C(c1ccc(F)cc1)N=2
CC(c1ccc2ncc(-c3cnn(C)c3)cc2c1)n1nnc2c1=C(c1ccc(F)cc1)N=2

Boltz running on GPU 2
10.29
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CCN1CCC(COC2=CN=C(C3=CC=CC(CN4C(=O)C=CN5C6=CC(C#N)=CC=C6N=C54)=C3)N=C2)CC1,-10.31]
[C[C@@H](C1=CC2=CC=CN=C2C=C1F)N1C=NC2=NC=C(C3=CC=C(C(N)=O)C(F)=C3)N=C21,-10.9]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a core heterocyclic system similar to the purine or pyrimidine structure that interacts with the binding site in c-MET. However, there are key differences in their substituents that might affect binding affinity:

1. The first molecule contains a piperazine ring linked to an alkyl group and an oxygen-linked aromatic system with a pyrazole ring and a fluorinated phenyl ring. This fluorine likely enhances hydrophobic and electronic interactions but may be less optimal for solubility or metabolism.

2. The second molecule has a chiral center with a fluorinated aromatic ring and an amidated pyrazole system, including an carbonyl group and an amino substituent. This suggests potential hydrogen bonding and dipole interactions, but the overall affinity is only slightly better.

Considering these points, I would aim to combine the beneficial features of both molecules: maintain the chiral center for specificity, keep the fluorine for hydrophobic and electronic effects, but introduce a more polar amide functionality similar to the first molecule to enhance hydrogen bonding and possibly improve solubility and pharmacokinetics.

Therefore, I propose introducing an amide-linked piperazine substituent connected to the pyrazole core, maintaining the fluorinated aromatic ring and the chiral center for precise positioning in the binding site.

The resulting molecule is:

\box{CNC(=O)N1CCN(Cc2ccc3ncc(N4C(C)[nH]c5ncccc(-c6ccc(F)cc6)c4=O)c(=O)n3c2C)CC1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 78
NON-LLM GENERATED: CCN1CCC(CN)CC1
CCN1CCC(CN)CC1

Boltz running on GPU 2
5.98
260/1000 | avg_top1: 12.050 | avg_top10: 11.724 | avg_top100: 11.000 | avg_sa: 3.194 | div: 0.822
{'avg_top1': 12.05, 'avg_top10': 11.724, 'avg_top100': 11.000300000000005, 'auc_top1': 3.04995, 'auc_top10': 2.9620199999999985, 'auc_top100': 2.75879180952381, 'avg_sa': 3.1940960609248124, 'diversity_top100': 0.8222917448833152, 'n_oracle': 260}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(=NNC(N)=O)c1cnc2nnn(Cc3cc4cccnc4cc3F)c2n1,-11.67]
[CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C(C)=O)CC3)ncc1Cl,-11.28]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: From the given binding affinities, both molecules have good interactions with c-MET, but there is room for improvement. The first molecule contains a oxime-type moiety (NNC(N)=O) connected to a pyridine ring, while the second molecule has a more conventional amide (CNC(=O)c1ccccc1N) linked to a chlorinated pyrimidine. 

To enhance binding, increasing hydrogen bonding potential and adding polar groups near the oxime or amide region could improve interactions with the active site residues. Also, incorporating a flexible linker may allow better accommodation into the binding pocket.

Therefore, I would introduce an acetamide group to increase hydrogen bonding and add an ethoxyethyl side chain to increase flexibility and solubility, while keeping the biaryl pyridine-caffeine-like scaffold that seems important for affinity.

The new molecule I propose is: \box{CCOC[C@H](C)N(Cc1cc2cccnc2cc1F)c1ncccc1N/C=N/NC(=O)NC(C)C}
LLM-GENERATED: CCOCC(C)N(Cc1cc2cccnc2cc1F)c1ncccc1NC=NNC(=O)NC(C)C
CCOCC(C)N(Cc1cc2cccnc2cc1F)c1ncccc1NC=NNC(=O)NC(C)C

Boltz running on GPU 2
8.63
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CCC(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCN1CCOCC1,-11.36]
[CC(C)n1cc(-c2cnc3ncn(C(C)c4c(F)cc5ncccc5c4F)c3n2)cn1,-10.6]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, pi-stacking, and hydrophobic contacts. The first ligand has flexible ethoxy and morpholine moieties that may provide solubility and conformational adaptability but could also introduce entropy penalties. The second ligand has a fused heterocyclic system with fluorinated aromatic rings, which likely contributes to strong stacking and hydrophobic interactions.

To strengthen the molecule, I would combine the beneficial features: maintain the fluorinated aromatic core for stacking, improve hydrogen bonding capacity by adding an amide linkage with a substituted pyridine or pyrimidine ring, and introduce a small hydrophobic alkyl group to enhance van der Waals contacts. Also, introducing a cyclic amine like a pyrrolidine could help bind in a more rigid and oriented manner.

Based on this reasoning, I propose the molecule:

\box{CC(C)n1cc(-c2cnc3cc(C(=O)Nc4ccc5ncccc5c4)ccc3=O2)cc1C}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 79
NON-LLM GENERATED: COC1=CC2=C(OC)C=CN=C2C=C1OCCCN1CCOCC1
COc1cc2c(OC)ccnc2cc1OCCCN1CCOCC1

Boltz running on GPU 2
7.91
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C1C=CC(N2C=CC3=CC=C(F)C=C32)=NN1CCOC1=CC=NC2=CC(OCCCN3CCOCC3)=CC=C21,-11.57]
[CC(C)N1C=C(C2=CN=C3N=CN(C(C)C4=C(F)C=C5N=CC=CC5=C4F)C3=N2)C=N1,-10.6]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both share a key heterocyclic core with nitrogen atoms positioned to interact with the protein through hydrogen bonding or dipole interactions. However, there are subtle differences in their side chains that might affect binding affinity.

The first molecule has a morpholine ring in the side chain, which could contribute to solubility and flexibility but may reduce hydrophobic interactions. The second molecule replaces morpholine with a more compact alkyl chain, potentially enhancing hydrophobic contacts.

To improve binding affinity, I would consider balancing hydrophobic and polar interactions by introducing a flexible, polar side chain that can form additional hydrogen bonds without sacrificing hydrophobic contacts. Also, incorporating a small electron-donating group like a methoxy on the aromatic ring might enhance π-stacking or dipole interactions.

Based on this, I propose a molecule that retains the core structure but replaces the morpholine with an ethoxyethyl chain to improve polarity and flexibility, and adds a methoxy group on the aromatic ring to boost interactions.

\box{COCC1=CC(Nc2cc(OCCCN3CCOCC3)ccc2=CC2C(=O)NCC(=O)N1)ccc1OC}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 80
NON-LLM GENERATED: O=C1C=CC(N2C=CC3=CC=C(F)C=C32)=NN1CC1=C(F)C=C2N=CC=CC2=C1F
O=c1ccc(-n2ccc3ccc(F)cc32)nn1Cc1c(F)cc2ncccc2c1F

Boltz running on GPU 2
10.31
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[FC(F)(c1ccc2ncccc2c1)c1nnc2ncc(C=Cc3ccncc3)nn12,-10.75]
[C[C@H](c1cccc(-c2ncc(OCC3CCN(C)CC3)cn2)c1)n1cc(-c2cc(C#N)ccn2)cc(F)c1=O,-10.34]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions in the binding pocket, such as increasing hydrogen bonding, improving aromatic stacking, and optimizing polarity to complement the protein's environment. The existing molecules already have strong aromatic systems and polar groups, but the new design could focus on modifying the heterocyclic cores and adding flexible linkers with hydrogen bond donors or acceptors to better fit the c-MET pocket.

Specifically, replacing the pyridine ring in the first molecule with a pyrimidine or pyrazine ring could increase hydrogen bonding capacity. Introducing an exocyclic pyrazole or imidazole moiety might also enhance specific interactions. Adding a small, constrained ring system via a flexible linker could improve conformational fit and binding specificity.

Considering these ideas, I propose the molecule:

\box{Cn1cc(-c2cc(C#N)ccn2)cn1-C=Cc1ccc2nnc([C@@H](C)c3ccc(-c4cnn([C@@H]5CCNC5)c4)cc3C)c2n1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 81
NON-LLM GENERATED: FC1=CC=C(C=CC2=NN3C(=NN=C3C(F)(F)C3=CC=C4N=CC=CC4=C3)N=C2)C1
FC1=CC=C(C=Cc2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)C1

Boltz running on GPU 2
10.72
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[[C-]#[N+]C1=C2COCCN2C2=C(C(=O)OC2)C1C1=CC=C2NN=C(C)C2=C1,-10.9]
[CCN1CCC(N2C=C(C3=CN=C4C=CC5=CC=C(NS(=O)(=O)N(C)C)C=C5C(=O)C4=C3)C=N2)CC1,-11.1]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity in favorable regions, and maintain or enhance aromatic interactions. The first ligand has a methyl group on the pyrazole ring which could be optimized for better interaction by replacing it with a more polar substituent capable of additional hydrogen bonding, such as a hydroxy or amide group. The second ligondoes have a morpholine ring and a carbonyl group providing polarity and potential H-bonding sites, but the heterocycle attachment might be refined to improve fit and interaction with the binding pocket.

Based on this, I would focus on modifying the heterocyclic system to include polar groups such as amides or hydroxyls, and replacing methyl substituents with groups that can engage in stronger intermolecular interactions. Also, maintaining the core fused aromatic system for pi-stacking interactions is important.

Taking these into account, the molecule I propose to generate is:

\box{CCN1CCN(C(=O)c2cc(-c3cn(-c4cn(C(C)=O)c(=O)n(-c5ccc6ccccc6c5)c4=O)cc3=O)ccc2)CC1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 82
NON-LLM GENERATED: [C-]#[N+]C1=CC=C2C=CC3=NC=C(C4=CN(C5CCN(CC)CC5)N=C4)C=C3C(=O)C2=C1
[C-]#[N+]c1ccc2ccc3ncc(-c4cnn(C5CCN(CC)CC5)c4)cc3c(=O)c2c1

Boltz running on GPU 2
10.5
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[N#Cc1cccc(-c2ccc(=O)n(Cc3cccc(-c4ncc(OCCN5CCOCC5)cn4)c3)n2)c1,-10.38]
[Cc1csc(-c2ccc3nnc(Cc4ccc5ncccc5c4)n3n2)c1,-11.2]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding and increase interactions with polar residues in the binding site. The existing molecules have promising core heterocycles, but one has a stronger nitrogen-rich scaffold (pyrazole vs pyrimidine), which could influence polarity and binding. Also, the inclusion of morpholine (OCCN5CCOCC5) in one molecule suggests beneficial solubility and potential H-bond donors/acceptors, but it may not be optimal in strength or placement.

Considering this, I would focus on incorporating an acetylated amine side chain to increase polar interactions and improve target specificity. Adding a terminal polar group like an amide (CNC(=O)N) could engage in additional hydrogen bonds with c-MET's binding pocket, while maintaining the core heterocyclic system that provides π-stacking and shape complementarity.

Based on this reasoning, I propose a variation that maintains the core pyrimidine-pyrazole scaffold but introduces an acetyl-amide substituent on the side chain to enhance binding affinity.

\box{CNC(=O)Nc1ccc(-c2ccc3nnc(Cc4ccc5ncccc5c4)n3n2)cc1}
LLM-GENERATED: CNC(=O)Nc1ccc(-c2ccc3nnc(Cc4ccc5ncccc5c4)n3n2)cc1
CNC(=O)Nc1ccc(-c2ccc3nnc(Cc4ccc5ncccc5c4)n3n2)cc1

Boltz running on GPU 2
10.54
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CCn1cc(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(N[C@@H](C)COC)c34)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O,-10.63]
[CC(C)N1C=C(C2=CN=C3N=CN(C(C)C4=C(F)C=C5N=CC=CC5=C4F)C3=N2)C=N1,-10.6]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, hydrophobic contacts, and possibly introduce groups that can better fit the binding pocket or interact with polar residues. Both current molecules have similar core structures, but one has a fluorinated aromatic ring and the other has a saturated ring with alkyl substituents.

From the given bindings (both around -10.6), it seems small subtle changes can slightly affect affinity. To improve, I would consider maintaining the core fused heterocyclic system that interacts well with the receptor but increase polarity and hydrogen bonding capacity without losing hydrophobic interactions.

One approach is to introduce a small polar moiety like an ethylene glycol unit linked to an amine, which can engage in additional hydrogen bonds and improve solubility. Adding this to the saturated ring in the second molecule could enhance binding by providing a new interaction site.

Therefore, I propose the following modification to the second molecule:

\box{CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(N[C@H](C)COC)c34)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O}
LLM-GENERATED: COCC(C)Nc1n[nH]c2nccc(Oc3ccc(NC(=O)c4cn(C(C)C)c(=O)n(-c5ccc(F)cc5)c4=O)cc3F)c12
COCC(C)Nc1n[nH]c2nccc(Oc3ccc(NC(=O)c4cn(C(C)C)c(=O)n(-c5ccc(F)cc5)c4=O)cc3F)c12

Boltz running on GPU 2
10.69
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC2=C(OC3=CC=C(NC(=O)NN=CC4=CC=C(F)C=C4F)C=C3F)C=CN=C2C=C1OCCCN1CCC(C)CC1,-10.99]
[Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1,-10.42]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, hydrophobic contacts, and possibly introduce groups that can better fit the binding pocket or interact with nearby residues. The first molecule has a flexible alkyl chain and fluorinated aromatic rings, while the second molecule has a fused heterocyclic system with trifluoromethyl-substituted phenyl rings.

From comparing the two, the second molecule’s fused heterocycles and fluorinated phenyl rings might provide better rigidity and stronger π-π stacking or hydrophobic interactions. To further improve affinity, I would consider adding polar groups that can form additional hydrogen bonds without sacrificing hydrophobic contacts. Introducing an amide linked to a fluorinated aromatic ring could achieve this, also maintaining the core heterocyclic system for affinity.

Therefore, I propose a molecule that keeps the core heterocycles and replaces the trifluoromethyl group with an amide linked to a para-fluorophenyl ring to optimize both hydrophobic and hydrogen bonding interactions.

\box{Cn1cc(-c2ccc3nnc(C(=O)Nc4ccc(F)cc4)c3n2)cn1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 83
NON-LLM GENERATED: CC(=O)NN=CC1=CC=C(F)C=C1F
CC(=O)NN=Cc1ccc(F)cc1F

Boltz running on GPU 2
7.3
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN=C3C=NN(S(=O)(=O)C4=CN=C5C=CC(C6=CCC=C6)=CN45)C3=C2)C=N1,-10.38]
[N#Cc1cccc(-c2ccc(=O)n(Cc3cccc(-c4ncc(OCCN5CCOCC5)cn4)c3)n2)c1,-10.38]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase ligand flexibility in key regions, and introduce groups that may interact better with the c-MET binding pocket. Both initial molecules have similar core structures but differ in their substituents.

The first ligand has a chloro-substituted aromatic ring that might offer hydrophobic interactions but could be less optimal for hydrogen bonding. The second ligand includes a morpholine moiety (OCCN5CCOCC5) which enhances solubility and can participate in H-bonding, but its position may limit interaction with some residues.

To improve affinity, I would consider swapping the heterocyclic substituent on the core ring to extend conjugation and introduce a carbonyl group for additional hydrogen bond acceptors. Also, adding a benzyl substitution on the heterocycle could increase hydrophobic contacts and possibly reach additional sub-pockets.

Based on this, I propose introducing a benzyl amine substituent on the pyrazole ring attached to the core, replacing the morpholine and adjusting the linker to preserve binding geometry while adding more interaction options.

\box{Cn1cc(-c2ccc(=O)n(Cc3cccc(-c4cc(Cc5cccc(-c6ncc(-c7cccc(Cc8ccccc8)n6)cn7)c4)c5)c3)n2)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 84
NON-LLM GENERATED: CN1C=C(COC2=CN=C(C3=CC=CC(CN4N=C(C5=CC=CC(C#N)=C5)C=CC4=O)=C3)N=C2)C=N1
Cn1cc(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)cn1

Boltz running on GPU 2
10.31
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[C[C@@H](C1=CC2=CC=CN=C2C=C1F)N1C=NC2=NC=C(C3=CC=C(C(N)=O)C(F)=C3)N=C21,-10.9]
[CC(c1ccc2ncccc2c1)n1nnc2ncc(-c3cnn(C4CCNCC4)c3)nc21,-10.54]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both share a similar pyridine-pyrazole core recognized by c-MET, but there are subtle differences in their side chains that could affect binding affinity.

Molecule 1 has an N-methylated side chain with a carbonyl group, while Molecule 2 has a piperazine moiety linked via a triazole ring. The carbonyl in Molecule 1 might form important hydrogen bonds, but the piperazine ring in Molecule 2 could enhance solubility and provide additional interactions.

Considering these points, introducing a carbonyl substituent on the piperazine ring in Molecule 2 could combine the benefits of both groups—maintaining the favorable interactions of the carbonyl and increasing the molecule’s flexibility and solubility through the piperazine scaffold.

Thus, I propose this modified version of Molecule 2 with a carbonyl amide on the piperazine ring:

\box{CC(c1ccc2ncccc2c1)n1nnc2ncc(-c3cnn(C4CCN(C(=O)N)CC4)c3)nc21}
LLM-GENERATED: CC(c1ccc2ncccc2c1)n1nnc2ncc(-c3cnn(C4CCN(C(N)=O)CC4)c3)nc21
CC(c1ccc2ncccc2c1)n1nnc2ncc(-c3cnn(C4CCN(C(N)=O)CC4)c3)nc21

Boltz running on GPU 2
10.56
270/1000 | avg_top1: 12.050 | avg_top10: 11.724 | avg_top100: 11.009 | avg_sa: 3.208 | div: 0.821
{'avg_top1': 12.05, 'avg_top10': 11.724, 'avg_top100': 11.008600000000001, 'auc_top1': 3.1704499999999998, 'auc_top10': 3.0792599999999983, 'auc_top100': 2.86883630952381, 'avg_sa': 3.2083023761881253, 'diversity_top100': 0.8211618210147956, 'n_oracle': 270}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN3C(=NN=C3SC3=CC=C4N=CC(NCCO)=CC4=C3)C=C2)C=N1,-11.09]
[CC(CO)Oc1cccc(NCC(O)COc2ccnc3cc(-c4cnn(C)c4)ccc23)c1,-10.67]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity, and maintain or enhance aromatic interactions. The first ligand has a methylated heterocycle with potential for hydrogen bonding, but it could benefit from additional polar groups. The second ligand includes an ether-linked aromatic system with hydroxyl groups that form good interactions, but it may be less rigid and could use stronger H-bond donors/acceptors.

Considering this, I would introduce a carbonyl group to increase hydrogen bond acceptor capacity and replace one aromatic ring with a heterocycle bearing a hydroxyl substituted side chain to boost polarity and potential hydrogen bonding. This could improve complementarity with the binding site while maintaining aromatic stacking.

\box{CCOc1cccc(NCC(=O)c2cc3nccc(OCC(O)CO)c3c2)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 85
NON-LLM GENERATED: OCCNC1=CC2=CC(SC3=NN=C4C=CCCN43)=CC=C2N=C1
OCCNc1cnc2ccc(Sc3nnc4n3CCC=C4)cc2c1

Boltz running on GPU 2
9.31
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN3C(SC4=CC=C5N=CC6=C(OCC(=O)N6C)C5=C4)=NN=C3C(F)=C2)C=N1,-10.8]
[CC(=NNC(N)=O)C1=NN2C(C(O)C3=C(F)C=C4N=CC=CC4=C3F)=CN=C2C=C1,-11.5]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both incorporate fused aromatic systems and heterocycles, targeting key pockets in the c-MET binding site. The stronger binder, -11.5 kT, includes a CC(=NNC(N)=O) moiety, suggesting that hydrazone linkages and amide functionalities enhance binding through hydrogen bonding and possibly metal coordination.

The weaker ligand, at -10.8 kT, contains a similar core but replaces the hydrazone with a different nitrogen-rich ring system, possibly affecting binding interaction patterns.

To improve affinity, I would focus on retaining the hydrazone-based linker due to its potential for strong hydrogen bonding and dipole interactions. Additionally, expanding the aromatic system to better π-stacking with the protein while introducing halogen substituents (like fluorine) can enhance binding via halogen bonding and hydrophobic contacts.

Therefore, I propose introducing a methoxy-substituted phenyl ring to increase polarity and potential hydrogen bonding, while adding a fluorine to maintain hydrophobic and halogen bond interactions. Keeping the hydrazone-amide scaffold, I also incorporate a fused pyridine-pyrrole system to enlarge π-stacking surface area.

The resulting molecule is:

\box{COc1ccc(-n2nc(C(=O)NN3CC(C(=O)Nc4ncccc4F)=C3C2=O)cc1)cc1ccc2ncccc2}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 86
NON-LLM GENERATED: CC1=CN=C2C=CC(C(C)=NNC(N)=O)=NN12
CC(=NNC(N)=O)c1ccc2ncc(C)n2n1

Boltz running on GPU 2
7.53
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[N#CC1=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCCN5CCOCC5)C=N4)=C3)C(=O)C=C2)=CC=C1,-10.38]
[Cc1c(OCC(O)CN2CCC(O)CC2)cn2ncnc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12,-10.89]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase rigidity for better fit, and introduce groups that interact well with the c-MET binding pocket. The first ligand has a strong aromatic system but may benefit from additional H-bond donors/acceptors. The second ligand includes heterocycles and hydroxyl groups that contribute to affinity, but its flexibility might reduce binding strength.

From comparing the two, I see potential in combining the favorable aromatic cores with polar functional groups that can engage in additional H-bonds, while maintaining a balanced lipophilic profile. Introducing an amide linkage and a cyclic amine could improve interactions and rigidity. Also, adding a fluorine-substituted phenyl ring may enhance binding through hydrophobic and electronic effects.

Based on this reasoning, I propose the following molecule:

\box{CC1=C(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c34)c(F)c2)c1}
LLM-GENERATED: CC1=C(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c34)c(F)c2)C1
CC1=C(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c34)c(F)c2)C1

Boltz running on GPU 2
9.57
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(c1ccc2ncccc2c1)n1nnc2ncc(-c3cnn(C4CCNCC4)c3)nc21,-10.54]
[CCN1CCC(N2C=C(C3=CN=C4C=CC5=CC=C(NS(=O)(=O)N(C)C)C=C5C(=O)C4=C3)C=N2)CC1,-11.1]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both involve fused heterocycles and amine-containing rings, which seems essential for strong binding to c-MET. However, there are subtle differences in their structures and polarities that might influence affinity.

The first molecule has a NK1-like scaffold with two linked heterocycles, including a pyridine and a triazole group, while the second molecule incorporates a piperazine ring linked via azo-derived moieties and fused bicyclic heterocycles with carbonyl and nitrogen functionalities. The second molecule's additional amide and carbonyl groups could improve hydrogen bonding, but its binding affinity is only slightly better.

To propose an improved molecule, I would combine the beneficial elements observed: maintain the core heterocyclic systems that interact well with the receptor, introduce a flexible amine-containing linker to enhance solubility and reach inside the binding site, and add a polar group such as a primary amine to strengthen hydrogen bonding and possibly form new interactions.

With this rationale, I suggest introducing a piperazine-like moiety linked through an ethylene bridge to the fused heterocycle scaffold to preserve and potentially enhance binding, adding a terminal amine to increase polarity and interaction potential.

The molecule I propose is:  
\box{CN1CCN(CCCn2nnc3ncc(-c4cnn(C5CCNCC5)c4)nc23)CC1}
LLM-GENERATED: CN1CCN(CCCn2nnc3ncc(-c4cnn(C5CCNCC5)c4)nc32)CC1
CN1CCN(CCCn2nnc3ncc(-c4cnn(C5CCNCC5)c4)nc32)CC1

Boltz running on GPU 2
7.85
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(C1=C(F)C=C2N=CC(C3=CN(C)N=C3)=CC2=C1F)N1N=NC2=NC=C(C3=CN(CCO)N=C3)N=C21,-11.72]
[CNC(=O)c1ccc(-c2ccc(=O)n(CCCCc3ccc4n[nH]c(C)c4c3)n2)cc1C(F)(F)F,-10.46]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both feature fused heterocycles and aliphatic chains that interact with the binding pocket of c-MET. The first molecule has a series of nitrogen-containing rings and unsaturated groups, while the second molecule incorporates a carbonyl group and fluorinated phenyl rings, likely for enhanced binding and solubility.

To improve binding affinity, I would consider extending the interactive regions by adding flexible linkers that can reach deeper into the pocket, while maintaining key heterocycles for hydrogen bonding and π-stacking. Incorporating a small alcohol group on the side chain could also boost solubility and form additional hydrogen bonds.

With these factors in mind, I propose introducing a short ethoxy chain to increase flexibility and polarity, combined with a fused pyridine-pyrrole system that retains the nitrogen-rich core important for interactions.

\box{COC1CCN=C(C)c2ccc(-c3ccc(=O)n(C[C@@H]4CCCN(c5n[nH]c6c(c45)CC6)C4)cc3=c2O)cc1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 87
NON-LLM GENERATED: CC1=CN(CCO)N=C1
Cc1cnn(CCO)c1

Boltz running on GPU 2
4.72
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CCN1CCC(N2C=C(C3=CN=C4C=CC5=CC=C(NS(=O)(=O)N(C)C)C=C5C(=O)C4=C3)C=N2)CC1,-11.1]
[CNC(=S)c1ccc(-c2cnc3ncc(Cc4cc(Cl)c5ncccc5c4)n3n2)cc1F,-11.22]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase planarity for better π-stacking, and introduce groups that complement the protein's hydrophobic pocket. Both initial molecules have heterocycles and halogens contributing to affinity, but one may offer stronger interactions or better spatial fit.

Molecule one has a piperazine ring with an ethylene linker to a fused heterocyclic system containing a small carbonyl group and a methylated N. This part seems promising for hydrogen bonding and rigidity. The second molecule includes a chlorinated heteroaromatic system substituted with a thiourea moiety, which can act as a hydrogen bond donor/acceptor, but the overall binding affinity is only slightly better.

To propose a new molecule, I would expand on the piperazine scaffold to add an additional aromatic ring to increase π-stacking potential and introduce a carbonyl group to create more hydrogen bonding opportunities. I would also maintain the heterocyclic core with methylated nitrogen to retain favorable interactions from the original molecule while replacing the piperazine nitrogen with a secondary amine to potentially improve conformational flexibility and binding orientation.

Thus, the new molecule would be a substituted piperazine linked through a carbonyl-amino moiety to the known heterocyclic core with methylated nitrogen, enhancing both hydrogen bonding and aromatic interactions.

\box{CCN1CCN(c2ccc(-c3cnc4ncc(Cc5ccc6ncccc6c5)n4n3)cc2C(=O)NCC1)C(C)(C)O}
LLM-GENERATED: CCN1CCNC(=O)c2cc(-c3cnc4ncc(Cc5ccc6ncccc6c5)n4n3)ccc2N(C(C)(C)O)CC1
CCN1CCNC(=O)c2cc(-c3cnc4ncc(Cc5ccc6ncccc6c5)n4n3)ccc2N(C(C)(C)O)CC1

Boltz running on GPU 2
9.38
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN3C(SC4=CC=C5N=CC6=C(OCC(=O)N6C)C5=C4)=NN=C3C(F)=C2)C=N1,-10.8]
[Cn1cc(-c2cc(F)c3ncc(Cc4c(F)cc5ncccc5c4F)n3n2)cn1,-10.96]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for increasing hydrogen bonding and polar interactions, as well as enhancing aromatic stacking and hydrophobic contacts. The existing molecules already have strong aromatic systems and fluorine substitutions contributing to affinity, but one of the molecules could likely be improved by introducing additional hydrogen bond donors or acceptors to increase interactions with the protein.

Molecule 1 has a fused azole ring system with sulfur and fluorine substituents, while Molecule 2 uses a pyridine-like core with fluorinated aromatic rings. To improve binding, I would consider replacing or modifying the central scaffold to incorporate a carbonyl group or amide, which can participate in hydrogen bonding and improve solubility. Additionally, adding a substituted pyrimidine-like ring could enhance stacking and interaction versatility.

Combining these ideas, I propose introducing a carbonyl group in place of one nitrogen in the fused azole system of Molecule 1 to increase hydrogen bonding capacity, while retaining the fluorinated aromatic rings for hydrophobic and π-π interactions. This leads me to generate:

\box{CC(=O)c1c(-c2cc(F)c3ncc(Cc4c(F)cc5ncccc5c4F)n3n2)nn1}
LLM-GENERATED: CC(=O)C1=C(c2cc(F)c3ncc(Cc4c(F)cc5ncccc5c4F)n3n2)N=N1
CC(=O)C1=C(c2cc(F)c3ncc(Cc4c(F)cc5ncccc5c4F)n3n2)N=N1

Boltz running on GPU 2
10.79
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=NN3C(=NN=C3C(F)(F)C3=CC=C4N=CC=CC4=C3)C=C2)C=N1,-10.42]
[CC(C)N1C=C(C2=CN=C3N=CN(C(C)C4=C(F)C=C5N=CC=CC5=C4F)C3=N2)C=N1,-10.6]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a core similar to each other and both to the previous dataset, with variations in substituents that seem to affect binding affinity. The stronger binder, [CC(C)N1C=C(C2=CN=C3N=CN(C(C)C4=C(F)C=C5N=CC=CC5=C4F)C3=N2)C=N1], has an ethyl group and a difluorophenyl ring, while the weaker one has a methyl and a trifluoromethyl-substituted ring. 

The difference in affinity suggests that the fluorine placement and ring electronics might significantly influence binding, possibly through interactions with the protein's hydrophobic pocket or hydrogen bonding sites.

To improve binding, I would consider adjusting the fluorine substitution pattern on the phenyl ring to optimize hydrophobic contacts and possibly enhance pi-stacking or dipole interactions. Moving from a 3,4-difluorophenyl to a 2,4-difluorophenyl could better fit the binding site and modulate electronic properties favorably.

Thus, I propose a molecule that maintains the core but replaces the 3,4-difluorophenyl with a 2,4-difluorophenyl ring to potentially improve affinity.

\box{CC(C)N1C=C(C2=CN=C3N=CN(C(C)C4=C(F)C=CC5=CC(N)=CC5=C4F)C3=N2)C=N1}
LLM-GENERATED: CC(C)n1cc(-c2cnc3ncn(C(C)c4c(F)ccc5cc(N)cc-5c4F)c3n2)cn1
CC(C)n1cc(-c2cnc3ncn(C(C)c4c(F)ccc5cc(N)cc-5c4F)c3n2)cn1

Boltz running on GPU 2
10.8
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC2=C(OC3=CC=C(N=CC4=C(O)N(C5=CC=C(C)C=C5)C(=O)NC4=O)C=C3F)C=CN=C2C=C1OCCCN1CCCC1,-10.35]
[CC(=NNC(N)=O)c1ccc2nnc(C(C)c3ccc4ncccc4c3)n2n1,-11.52]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, π-π stacking, and hydrophobic contacts. The first ligand has decent aromatic systems for π interactions but could benefit from added polar groups to engage in hydrogen bonds. The second ligand already uses nitrogen-rich heterocycles for strong H-bonding and aromatic interactions, but its binding affinity might be limited by hydrophobicity or conformational rigidity.

By combining elements from both, I would aim to maintain the nitrogen-rich heterocyclic core for H-bonding while extending the aromatic system to increase π-π stacking opportunities. Introducing flexible side chains capable of forming additional hydrophobic or H-bond interactions, such as substituted cycloalkyl amines, could improve fit and affinity. Also, incorporating amide functionalities could add new polar contacts without compromising hydrophobic interactions.

Taking these considerations, I propose a molecule that retains the nitrogen-rich fused ring system, adds an amide linker for H-bonding, and includes a branched cycloalkyl amine side chain for improved hydrophobic contacts and conformational adaptability.

\box{CC(=NNC(N)=O)c1ccc2nnc(Cc3ccc4ncccc4c3)n2n1,-6.70}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 88
NON-LLM GENERATED: CC=NC1=CC=C(OC2=CC=NC3=CC(OCCCN4CCCC4)=C(OC)C=C32)C(F)=C1
CC=Nc1ccc(Oc2ccnc3cc(OCCCN4CCCC4)c(OC)cc23)c(F)c1

Boltz running on GPU 2
10.2
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN=C3C=NN(S(=O)(=O)C4=CN=C5C=CC(C6=CCC=C6)=CN45)C3=C2)C=N1,-10.38]
[CNC(=S)c1ccc(-c2cnc3ncc(Cc4cc(Cl)c5ncccc5c4)n3n2)cc1F,-11.22]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase aromatic stacking interactions, and introduce groups that complement the binding pocket's hydrophobic and polar regions. The first ligand has a fused heterocyclic core with sulfur-containing rings, which contributes to binding, but could benefit from additional polar groups to increase interactions. The second ligand includes a chlorinated aromatic ring and fluorine substituents, suggesting hydrophobic and electronic tuning, but the sulfonyl group might be overplayed.

To optimize, I would focus on combining the beneficial heterocyclic frameworks from both molecules but introduce a pyridine ring in place of the pyrazole to enhance hydrogen bonding capability and add a methoxy group to increase polarity and solubility. Also, preserving the chlorinated aromatic system could maintain favorable hydrophobic and π-stacking interactions.

Based on this reasoning, I propose this molecule:

\box{COc1ccn(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1-c1ccc(=O)n2cc(C(C)C3=CC(=O)N3C)ccc2o1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 89
NON-LLM GENERATED: ClC1=C2N=CC=CC2=CC(CC2=CN=C3N=CC(C4=CCC=C4)=NN23)=C1
Clc1cc(Cc2cnc3ncc(C4=CCC=C4)nn23)cc2cccnc12

Boltz running on GPU 2
10.2
280/1000 | avg_top1: 12.050 | avg_top10: 11.724 | avg_top100: 11.015 | avg_sa: 3.215 | div: 0.821
{'avg_top1': 12.05, 'avg_top10': 11.724, 'avg_top100': 11.0152, 'auc_top1': 3.2909499999999996, 'auc_top10': 3.196499999999998, 'auc_top100': 2.97895530952381, 'avg_sa': 3.214587759086845, 'diversity_top100': 0.8208196127973963, 'n_oracle': 280}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(C)N1C=C(C2=CN=C3N=CN(C(C)C4=C(F)C=C5N=CC=CC5=C4F)C3=N2)C=N1,-10.6]
[C[C@@H](c1ccc2ncccc2c1)n1nnc2ncc(-c3cnn(CCO)c3)nc21,-11.3]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for enhancing hydrogen bonding and π-π stacking interactions, increasing polarity and H-bond donors/acceptors in key positions. The existing molecules already have aromatic systems that interact well with the binding pocket, so retaining those is important.

Molecule 1 has a methyl substitution on the nitrogen heterocycle, while Molecule 2 introduces a chiral center with an aromatic ring and an heterocyclic side chain. To further enhance binding, I would consider increasing hydrogen bonding potential on the heterocyclic ring adjacent to the central pyrazole-pyrimidine core, and adding electron-donating groups to stabilize aromatic stacking.

Specifically, replacing the methyl on the nitrogen of the pyrazole-pyrimidine system with an amino group could introduce additional H-bonds. Also, attaching a methoxy-substituted phenyl ring on the adjacent heterocycle may increase hydrophobic and electronic interactions.

Based on this reasoning, I propose the structure:

\box{CC1CN(-c2ccc3nnc(Cc4ccc(Oc5ccnc6ncnc(N)nc56)c4)n3c2)C=C(C)c1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 90
NON-LLM GENERATED: CCCN1C=C(C2=CN=C3N=NN(C(C)C4=CC=C5N=CC=CC5=C4)C3=N2)C=N1
CCCn1cc(-c2cnc3nnn(C(C)c4ccc5ncccc5c4)c3n2)cn1

Boltz running on GPU 2
10.57
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(c1ccc2ncccc2c1)n1nnc2ncc(-c3cnn(C4CCNCC4)c3)nc21,-10.54]
[CC(N=O)c1ccc2nnc(Cc3c(F)cc4ncccc4c3F)n2n1,-11.79]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for features that enhance interactions like hydrogen bonding, hydrophobic contacts, and electronic effects. The nitro group in the second molecule likely contributes to binding, but the presence of fluorines in the other may provide favorable dipole interactions and improved solubility.

From the first molecule, the fused heterocyclic core is stable and effective, while the second molecule's addition of fluorines and an NO2 group improves affinity significantly. To further improve, introducing polarity and hydrogen bond donors/acceptors near the core could strengthen interactions without sacrificing hydrophobic contacts. Also, incorporating a flexible, basic side chain might enhance solubility and binding through electrostatics.

Therefore, I would design a sulfonamide group attached to the heterocyclic core to improve hydrogen bonding and add a piperazine moiety to provide polar interactions and flexibility. This side chain can also introduce favorable electrostatic contacts within the binding pocket.

\box{CS(=O)(=O)N1CCN(c2cnc3ccc(-c4cnc5cc(CS6CCNCC6)ccc45)cc3c2)CC1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 91
NON-LLM GENERATED: CC(C1=CC=C(F)C1)N1N=NC2=NC=C(C3=CN(C4CCNCC4)N=C3)N=C21
CC(C1=CC=C(F)C1)n1nnc2ncc(-c3cnn(C4CCNCC4)c3)nc21

Boltz running on GPU 2
9.32
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=[N+]([O-])C1=CC=CC(CNC2=CC(C(F)(F)F)=CC3=NC=C(N4CCOCC4)C=C23)=C1,-10.28]
[CC(N=O)c1ccc2nnc(C(CO)c3c(F)cc4ncccc4c3F)n2n1,-10.28]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: From the given ligands, one is a bifocal heterocyclic system with fluorinated aromatic rings and polar chains, while the other contains a nitroso group and fluorinated aromatic rings integrated into a fused heterocyclic framework. Both show similar binding affinities, indicating that there is room for optimization in both size, flexibility, and electronic distribution.

To improve binding, extending the polar chain to enhance hydrogen bonding and introducing a branching alkoxy group could increase solubility and interaction with the binding pocket. Also, replacing the trifluoromethyl group with a more flexible alkyl chain may reduce steric hindrance while maintaining hydrophobic contacts.

Based on this, I propose adding an ethoxy branch to the alkoxy chain and replacing the trifluoromethyl with a methyl group to strike a better balance between hydrophobicity and flexibility.

\box{COC[C@H]1CC[C@H](Cn2cc(-c3cnc4ccc5ncccc5c4c3)cc2=O)[C@@H](C#CCO)C1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 92
NON-LLM GENERATED: O=[N+]([O-])C1=CC(CNC2=C3C=C(N4CCOCC4)C=NC3=CC(C(F)(F)F)=C2)=CC=C1
Already in buffer
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(N=O)C1=NN2C(=NN=C2C(CO)C2=C(F)C=C3N=CC=CC3=C2F)C=C1,-10.28]
[CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C(C)=O)CC3)ncc1Cl,-11.28]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have strong aromatic and heterocyclic groups that contribute to binding, but there are also opportunities for improved hydrogen bonding and increased polarity. The first molecule has a diazine core with fluorinated phenyl rings, while the second molecule has a chlorinated heterocycle with an N-methylated side chain and phenyl substitutions.

To enhance binding affinity, I would consider increasing hydrogen bond donors/acceptors and maintaining aromaticity for π-stacking. Also, incorporating small polar groups like ethers or amines could improve interactions with the active site without adding too much bulk.

Based on this, I propose combining a methoxy-substituted phenyl ring (adding polarity and potential H-bond acceptors) with the diazine core from the first ligand, keeping the fluorinated heterocycle to maintain aromatic interactions. This retains the key aromatic system and adds features that improve solubility and interaction potential.

Final choice: \box{COc1cccc(-c2cnc3c(NC(=O)c4ccccc4N)c(=O)n(-c5ccc(F)cc5F)c2=O)c3=nn1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 93
NON-LLM GENERATED: CNC(=O)C1=CC=CC=C1NC1=NN=C2C=CC(C(C)N=O)=NN2C1Cl
CNC(=O)c1ccccc1NC1=NN=C2C=CC(C(C)N=O)=NN2C1Cl

Boltz running on GPU 2
7.77
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C1NCCCCn2cc(cn2)-c2cnc3ccc(cc3c2)CCn2nc(ccc2=O)-c2ccc1c(C(F)(F)F)c2,-12.05]
[CC(C1=C(F)C=C2N=CC(C3=CN(C)N=C3)=CC2=C1F)N1N=NC2=NC=C(C3=CN(CCO)N=C3)N=C21,-11.72]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase planarity for better stacking interactions, and introduce polar groups to interact more effectively with the binding site. The first molecule has strong aromatic and heterocyclic systems but may benefit from additional hydrogen bond donors or acceptors to complement the protein's key residues. The second molecule already incorporates multiple nitrogen atoms for this purpose but has a bulky trifluoromethyl group that might be limiting flexibility or solubility.

Based on this, I would aim to replace the trifluoromethyl with a hydroxyl group to increase polarity and hydrogen bonding potential, while maintaining the aromatic system and linker structure that seems important for binding. Additionally, incorporating a hydroxyl into an aromatic ring can enhance π-interactions and solubility simultaneously.

\box{O=C1NCCCCn2cc(cn2)-c2cnc3ccc(CC(O)c4c(=O)nc(N)n(C)c4=O)cc3c2}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 94
NON-LLM GENERATED: CC(C1=C(F)C2=C(C=C1F)N=CC=C2)N1N=NC2=NC=C(C3=CN(CCO)N=C3)N=C21
CC(c1c(F)cc2ncccc2c1F)n1nnc2ncc(-c3cnn(CCO)c3)nc21

Boltz running on GPU 2
11.87
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COc1cc2nccc(Oc3ccc(NC(=O)C(OC(=O)c4ccc(F)cc4)C(C)(C)C)cc3F)c2cc1OC,-10.46]
[CN1C=C(C2=CN=C3C=NN(S(=O)(=O)C4=CN=C5C=CC(C6=CN(C)N=C6)=CN45)C3=C2)C=N1,-10.61]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase hydrophobic interactions, and optimize steric fit into the binding pocket. The first molecule has a ester linkage with a fluorophenyl group that contributes to affinity, but replacing the fluorophenyl with a para-substituted hydrophobic aromatic ring like a methylphenyl could enhance van der Waals contacts. The second molecule has a fused bicyclic system with carbonyl groups that introduce polarity, but adding a methylene linker between the heterocycle and the functional group may improve flexibility and allow better accommodation in the binding site.

Based on these considerations, I propose introducing a methylene linker connected to a N-methylated heterocycle fused with a carbonyl substituent, while retaining the ester-methylphenyl motif. This structure should balance polarity and hydrophobicity for stronger binding.

\box{COC(=O)c1ccc(C(C)(C)C(=O)Nc2ccc(Oc3ccnc4cc(OCCN5CCN(C)CC5)c5c(c34)OCCO5C(=O)CC(=O)N5C)cc2)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 95
NON-LLM GENERATED: COC1=C(OC)C=C2C(=C1)N=CC1=C2N(S(=O)(=O)C2=CN=C3C=CC(C4=CN(C)N=C4)=CN23)N=C1
COc1cc2ncc3cnn(S(=O)(=O)c4cnc5ccc(-c6cnn(C)c6)cn45)c3c2cc1OC

Boltz running on GPU 2
9.98
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(=NNC(N)=O)C1=NN2C(C(O)C3=C(F)C=C4N=CC=CC4=C3F)=CN=C2C=C1,-11.5]
[CN1C=C(C2=CC=C3C(=C2)N=CC=C3OCCN2C(=O)OC3=CC(C4=CN(C)N=C4)=CC=C32)C=N1,-10.47]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding and hydrophobic interactions while maintaining or expanding conjugation and planarity, which support strong π-stacking and shape complementarity. 

The first molecule has good binding affinity (-11.5), featuring multiple hydrogen bond donors/acceptors and fused aromatic systems that likely engage in stacking interactions. The second molecule is slightly less effective (-10.47), but introduces flexible side chains that may compromise binding geometry.

Comparing the two, I see an opportunity to combine the beneficial planar heterocyclic cores and hydrogen bonding motifs from the first molecule with a more flexible linker and additional methyl substitution on the heterocycle to optimize hydrophobic contacts and potentially improve binding.

Thus, I propose introducing a methyl group on the heterocycle and modifying the linker to a methoxy-containing side chain that retains hydrogen bonding capability and adds conformational flexibility.

The new molecule I generate is:  
\box{COc1cc(-c2ccc3ncccc3c2)ccc1C(=NNC(N)=O)C1=NN2C(C(O)C3=C(F)C=C4N=CC=CC4=C3F)=CN=C2C=C1}
LLM-GENERATED: COc1cc(-c2ccc3ncccc3c2)ccc1C(=NNC(N)=O)c1ccc2ncc(C(O)c3c(F)cc4ncccc4c3F)n2n1
COc1cc(-c2ccc3ncccc3c2)ccc1C(=NNC(N)=O)c1ccc2ncc(C(O)c3c(F)cc4ncccc4c3F)n2n1

Boltz running on GPU 2
11.31
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CCN1CC2=C(C=CC(F)=C2C#N)O[C@@H](C)CNC(=O)C2=C3N=C1C=CN3N=C2N,-11.2]
[O=C(NC1=CC(OC2=C(F)C=C(NC(=O)C3(C(=O)NC4=CC=C(F)C=C4)CC3)C(F)=C2)=CC=N1)C1CC1,-10.49]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, aromatic stacking, and polar interactions, especially in the region interacting with the enzyme's active site. The existing molecules already use heterocycles and fluorines to contribute to these interactions, but I think introducing additional hydrogen bond donors and acceptors while maintaining rigidity and aromaticity could strengthen affinity.

Specifically, replacing the methyl group on the oxazole ring with an ethyl chain containing a terminal hydroxyl group might provide more hydrogen bonding opportunities without compromising hydrophobic contacts. Also, incorporating a pyridine ring instead of a pyrrole could offer an additional nitrogen for interaction and increase polarity.

Therefore, I propose the molecule:

\box{CCOCC1(NC(=O)C2=C(OCCO)C(=O)Nc3ccc(-c4cc(n[-c5ccc(OCC6CCOC6)n(C)c5]n4)nc3)cc2C2=CC(=O)N.C2CC2)CC1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 96
NON-LLM GENERATED: CC(=O)C1CC1
CC(=O)C1CC1

Boltz running on GPU 2
6.8
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[FC(F)(C1=CC=C2N=CC=CC2=C1)C1=NN=C2N=CC(C=CC3=CC=NC=C3)=NN21,-10.75]
[C[C@H](C1=CC=CC(C2=NC=C(OCC3CCN(C)CC3)C=N2)=C1)N1C=C(C2=CC(C#N)=CC=N2)C=C(F)C1=O,-10.34]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase ligand rigidity, and introduce groups that interact well with the c-MET binding pocket. The first molecule has strong aromatic interactions but limited polarity and flexibility. The second molecule adds polarity via an oxygen and sets stereochemistry, but its binding affinity is only slightly better.

To build on this, introducing a small polar side chain such as an amide-capped alkoxy substituent on the pyridine ring could provide additional hydrogen bonding without sacrificing aromatic stacking. This side chain would increase interaction specificity and possibly improve solubility and binding orientation.

Therefore, I propose the following molecule:

\box{C[C@@H](C1=CC=CC(C2=NC(=O)C(C)C(=O)NC(C)C(C)C2)=C1)N1C=CC2=CC(NC(=O)CCN(C)C(C)C2)CC2=CC=C1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 97
NON-LLM GENERATED: N#CC1=CC=NC(C=CC(F)(F)C2=CC=C3N=CC=CC3=C2)=C1
N#Cc1ccnc(C=CC(F)(F)c2ccc3ncccc3c2)c1

Boltz running on GPU 2
7.62
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1,-10.74]
[CC(C)N1C=C(C2=CN=C3N=CN(C(C)C4=C(F)C=C5N=CC=CC5=C4F)C3=N2)C=N1,-10.6]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a core pyrazole or pyrimidine structure with an aromatic substituent containing nitrogen-rich heterocycles. The small alkyl groups on the core nitrogen atoms seem to contribute to hydrophobic interactions, but there is potential to enhance binding affinity by increasing hydrogen bonding and pi-stacking interactions.

Molecule 1 has a pyrazole ring with an attached pyridine, while molecule 2 has a pyrazole fused to a pyrimidine with a fluorinated aromatic system. The fluorines likely improve metabolic stability and binding, but the overall planaricity and aromatic surface could be leveraged for better stacking with the protein.

To improve binding, I would introduce a fused bicyclic system with increased aromatic surface area and maintain the fluorines to preserve favorable electronic effects. Also, switching the pyrazole to a pyridazine or pyrimidine ring might increase hydrogen bonding capability and overall ligand rigidity.

Based on this, I propose a molecule that combines these ideas with a bicyclic fluorinated aromatic substituent and a pyridazine core to enhance stacking and interaction potential.

\box{Fc1ccc2ncccc(-c3cnc4nccn(Cc5ccc6ncccc6c5)c4n3)c2c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 98
NON-LLM GENERATED: CCCN1C=C(C2=CN=C3N=NN(CC4=CC=C5N=CC=CC5=C4)C3=N2)C=N1
CCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1

Boltz running on GPU 2
10.92
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[[C-]#[N+]C1=C2COCCN2C2=C(C(=O)OC2)C1C1=CC=C2NN=C(C)C2=C1,-10.9]
[CC(C)N1C=C(C2=CN=C3N=CN(C(C)C4=C(F)C=C5N=CC=CC5=C4F)C3=N2)C=N1,-10.6]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, π-π stacking, and electrostatic contacts. The first molecule has a fluorine substituent that could contribute to hydrophobic and electronic effects, while the second molecule shows a branched alkyl group and multiple nitrogen atoms for hydrogen bonding.

Comparing the two, the second molecule has a higher binding affinity (-10.6 vs. -10.9), suggesting that the fused ring system and the substitution patterns on the heterocycles are beneficial. To further improve affinity, I would consider expanding the hydrophobic pockets by adding electron-withdrawing groups such as trifluoromethyl (CF3) to increase lipophilicity and potential halogen bonding, while maintaining the hydrogen bonding capacity of the nitrogens.

Also, incorporating a pyridine ring could provide an additional site for polar interactions and improve solubility and binding complementarity. Connecting these ideas leads me to design a molecule that keeps the core fused heterocycles but adds a trifluoromethyl group on one aromatic ring and introduces a pyridine substituent to enhance binding and interactions.

Therefore, the new proposed molecule is:  
\box{CC(C)N1C=C(C2=CN=C3N=CN(C(C)C4=CC(=O)Nc5ccc(-c6ccccc6)cc5C(F)(F)F)C3=N2)C=N1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 99
NON-LLM GENERATED: CC1=NNC2=CC=C(CCC3=CN(C(C)C)N=C3)C=C21
Cc1n[nH]c2ccc(CCc3cnn(C(C)C)c3)cc12

Boltz running on GPU 2
7.51
290/1000 | avg_top1: 12.050 | avg_top10: 11.759 | avg_top100: 11.042 | avg_sa: 3.241 | div: 0.815
{'avg_top1': 12.05, 'avg_top10': 11.758999999999999, 'avg_top100': 11.042299999999997, 'auc_top1': 3.41145, 'auc_top10': 3.313914999999998, 'auc_top100': 3.0892428095238103, 'avg_sa': 3.2410573573676307, 'diversity_top100': 0.8152842869681557, 'n_oracle': 290}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C1NCCCCN2C=C(C=N2)C2=CN=C3C=CC(=CC3=C2)CCN2N=C(C=CC2=O)C2=CC=C1C(C(F)(F)F)=C2,-12.05]
[O=C(NC1=CC(OC2=C(F)C=C(NC(=O)C3(C(=O)NC4=CC=C(F)C=C4)CC3)C(F)=C2)=CC=N1)C1CC1,-10.49]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a similar core scaffold with aromatic and heterocyclic rings, but there are subtle differences that might contribute to their binding affinity.

The first molecule has a trifluoromethyl group attached to an aromatic ring, which could enhance hydrophobic interactions and metabolic stability. The second molecule, on the other hand, contains ether linkages and fluorinated aromatic rings, which might improve solubility and binding specificity.

To propose a new molecule that binds better to c-MET, I want to combine these beneficial features: maintaining the core heterocyclic system for key hydrogen bonding and stacking interactions, incorporating an ether linkage to enhance flexibility and solubility, and positioning fluorine atoms on aromatic rings to enhance binding and metabolic stability.

With this in mind, I propose the following molecule:

\box{COC(=O)N1CC=C(C(=O)Nc2ccc(-c3ccc4c(c3)NCCN4C=C3)cc2)C(=O)N1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 100
NON-LLM GENERATED: O=C(NC1=CC=C(F)C=C1)C1(C(=O)NC2=CC(F)=C(OC3=CC=CC=C3)C=C2F)CC1
O=C(Nc1ccc(F)cc1)C1(C(=O)Nc2cc(F)c(Oc3ccccc3)cc2F)CC1

Boltz running on GPU 2
7.57
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cn1cc(-c2cnc3ccc4ccc(N)cc4c(=O)c3c2)cn1,-10.8]
[Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12,-10.58]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, aromatic stacking, and polar interactions while maintaining or increasing hydrophobic contacts. Both existing molecules have successful use of fluorine substituents and amide linkages that likely contribute to specificity and affinity.

Molecule 1 uses a pyrimidine-pyridine core with an amide group and a fluorophenyl substituent, while Molecule 2 incorporates a fused heterocyclic system with a fluorinated aromatic ring and maintains the amide motif. Comparing the two, I see that maintaining the amide and fluorophenyl group is beneficial, but the heterocyclic complexity in Molecule 2 might provide better shape complementarity and additional interactions.

To leverage this, I would focus on simplifying the structure slightly to reduce entropy penalty while keeping the key functional groups that enhance binding. Introducing a pyridine ring instead of the fused system might improve solubility and binding by allowing better access to the active site, while preserving the important amide-fluoro substituent for polar contacts.

Therefore, I propose a molecule that combines a pyridine ring connected to a pyrazole group, with the same amide-fluorophenyl motif integrated to maintain strong interactions.

\box{O=C(Nc1ccc(F)cc1)C1(C(=O)Nc2ccc(-c3ccnn3)cc2)CC1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 101
NON-LLM GENERATED: CN1C=C(C2=CC(NC(=O)C3(C(=O)NC4=CC=C(F)C=C4)CC3)=CC=C2C2=CC=CC3=C2C(N)=NN3)C=N1
Cn1cc(-c2cc(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)ccc2-c2cccc3[nH]nc(N)c23)cn1

Boltz running on GPU 2
10.5
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=NN3C(=NN=C3C(F)(F)C3=CC=C4N=CC=CC4=C3)C=C2)C=N1,-10.42]
[O=C(NC1=CC=C(OC2=CC=NC(NC(=O)C3CC3)=C2)C=C1)C1=NC2=CC=CC=C2N(C2=CC=C(F)C=C2)C1=O,-10.76]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a core scaffold with aromatic rings and heterocycles, which is consistent with the need for π-π stacking and hydrophobic interactions in the binding pocket. The improvement from the first to the second molecule suggests that adding polar groups capable of hydrogen bonding, such as amides, can enhance binding affinity.

The second molecule incorporates an amide linkage with a saturated cyclopropane ring, likely increasing rigidity and positioning important groups for interaction. The addition of fluorine atoms on the aromatic rings may improve binding through halogen bonding or simply by enhancing hydrophobic interactions.

To build on this, I would consider maintaining the amide motif and saturated ring for rigidity but also introduce a nitrogen-containing saturated ring to add hydrogen bonding potential and possibly improve solubility. Furthermore, positioning a pyridine ring as part of the heterocyclic system could enhance stacking and interaction with polar residues in the pocket.

Therefore, I propose a molecule that combines these features: a pyridine core connected to a saturated piperazine-like ring, an amide linkage, and a fused aromatic heterocycle with fluorines to maintain hydrophobic interactions.

\box{O=C(N1CCCN(c2ccc(-c3cnc4ccn(-c5ccc6c(c5)CN(C)C6=O)c(=O)[nH]c3=CC=C4)cc2)CC1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 102
NON-LLM GENERATED: O=C(F)C1=NC2=CC=CC=C2N(C2=CC=C(F)C=C2)C1=O
O=C(F)c1nc2ccccc2n(-c2ccc(F)cc2)c1=O

Boltz running on GPU 2
6.47
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=[N+]([O-])C1=CC=CC(CNC2=CC(C(F)(F)F)=CC3=NC=C(N4CCOCC4)C=C23)=C1,-10.28]
[CN1C=C(C2=CN=C3N=NN(CC4CCCN(C5=NC=C(C6=CN(CCO)N=C6)C=N5)C4)C3=N2)C=N1,-10.76]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrophobic interactions, introduce halogen bonding or dipole interactions, and increase ligand rigidity to reduce entropic penalties. The existing molecules already provide good aromatic stacking and heterocyclic motifs essential for binding.

Molecule 1 has a strong nitrogen-rich scaffold but may benefit from adding halogens to increase binding through halogen bonding and hydrophobic contacts. Molecule 2 incorporates oxygen-containing rings and flexible linkers but could gain from adding fluorine substituents to improve metabolism and interaction with hydrophobic pockets.

Considering these points, I would design a molecule that keeps the core heterocyclic framework to maintain planarity and stacking, adds fluorine atoms on aromatic rings to enhance binding and lipophilicity, and incorporates an amide group to introduce a strong dipole interaction and improve hydrogen bonding.

\box{CC1=C(C(=O)Nc2ccc(F)cc2)C(C#N)C(C#N)=CC1F}
LLM-GENERATED: CC1=C(C(=O)Nc2ccc(F)cc2)C(C#N)C(C#N)=CC1F
CC1=C(C(=O)Nc2ccc(F)cc2)C(C#N)C(C#N)=CC1F

Boltz running on GPU 2
8.49
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1CCC(NC2=CN=C3C=CC(SC4=NN=C5C(F)=CC(C6=CC=C(O)C=C6)=CN45)=CC3=C2)CC1,-10.78]
[CN1CCN(CCOC2=CN=C(C3=CC=CC(CN4N=C(N5C=CC6=CC=C(F)C=C65)C=CC4=O)=C3)N=C2)CC1,-11.18]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two existing molecules, I see that both have strong interactions with the c-MET binding site, but there's room for improvement in enhancing hydrophobic contacts and hydrogen bonding. The first molecule has a morpholine ring with a substituted pyrimidine, while the second has a piperazine moiety with a methoxy-substituted pyrimidine. The key differences lie in the aromatic substituents and the heterocyclic cores.

To increase binding affinity, I would focus on improving interactions in the pocket by adding electron-withdrawing groups to enhance hydrophobic contacts and potentially engage in halogen bonding or dipole interactions. Introducing a chloro substituent on the aromatic ring could strengthen van der Waals interactions and modulate electronics without disrupting the core scaffold. Also, retaining the methoxy group maintains solubility and H-bonding potential.

Therefore, I propose modifying the core morpholine/piperazine distinction less important and focusing on the aromatic system, adding a chlorine substituent to the aromatic ring to improve binding.

\box{COc1cccc(-c2CC(=O)NCC3=CC(=O)N(Cc4ccc(Cl)cc4)c2=O)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 103
NON-LLM GENERATED: OC1=CC=C(C2=CN3C(F)=NN=C3C(F)=C2)C=C1
Oc1ccc(-c2cc(F)c3nnc(F)n3c2)cc1

Boltz running on GPU 2
7.51
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[FC(F)(C1=CC=C2N=CC=CC2=C1)C1=NN=C2N=CC(C=CC3=CC=NC=C3)=NN21,-10.75]
[CN1C=C(C2=CN=C3C=NN(S(=O)(=O)C4=CN=C5C=CC(C6=CN(C)N=C6)=CN45)C3=C2)C=N1,-10.61]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a core pyrazole structure with substituted aromatic rings and flexible linkers. The first ligand has a fluorinated phenyl ring attached via a triazole moiety, while the second ligand uses a thiadiazole ring with a tertiary amine substitution. Both molecules have moderate binding affinities, but there is room for improvement by optimizing hydrogen bonding and electronic interactions.

To enhance binding, I would consider increasing hydrogen bond donors or acceptors to interact better with the protein's active site, possibly by introducing a hydroxyl group or an amine-containing side chain. Additionally, maintaining or improving rigidity in the molecule to reduce entropy loss upon binding could strengthen affinity. Incorporating a basic amine moiety may also improve solubility and interact favorably via ionic or hydrogen bonds.

Based on these considerations, I propose a molecule that replaces the fluorinated phenyl with a hydroxyethyl group to add hydrogen bonding potential, preserves the triazole core, and introduces a piperazine-like ring to increase polarity and potential interactions. This also maintains the fused pyrazole structure and geometric constraints.

\box{CC(OCC1)CCN2CC=C(C=CC3=CC=NC3)N2}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 104
NON-LLM GENERATED: CN1C=C(C2=CN3C(S(=O)(=O)N4N=CC5=NC=C(C6=CN(C7=CC=NC=C7)N=C6)C=C54)=CN=C3C=C2)C=N1
Cn1cc(-c2ccc3ncc(S(=O)(=O)n4ncc5ncc(-c6cnn(-c7ccncc7)c6)cc54)n3c2)cn1

Boltz running on GPU 2
10.97
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CCN1Cc2c(ccc(F)c2-c2cnn(C)c2)OC(C)CNC(=O)c2c(N)nn3ccc1nc23,-10.93]
[CC(C1=CC=C2N=CC=CC2=C1)N1N=NC2=NC=C(C3=CN(C4CCNCC4)N=C3)N=C21,-10.54]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions in the ligand by increasing hydrogen bonding, improving ligand flexibility to better fit the binding pocket, and introducing groups that can strengthen hydrophobic contacts or π-π stacking with the protein.

The first molecule has a fluorine atom that may contribute to affinity via halogen bonding or dipole interactions, while the second molecule has a flexible pyridine ring that allows for better adaptation to the binding site. However, the second molecule’s flexibility may also reduce binding specificity.

To balance rigidity and flexibility, I would consider replacing the bulky substituents in the first molecule with a group that maintains hydrogen bonding ability but improves conformational constraint to reduce entropic penalty upon binding. Introducing a hydroxyl group on the fused ring system could promote additional hydrogen bonds with polar residues in c-MET. Also, shifting the substituents to the pyrazole moiety may enhance key interactions via hydrogen bonding networks.

Based on this reasoning, I propose the following molecule:

\box{CCN1Cc2c(ccc(F)c2-c2cnn(C)c2)OC(C)CNC(=O)c2c(nn3ccc4ncccc4c2=O)CCO4CCO4C1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 105
NON-LLM GENERATED: CCCN1C=C(C2=CN=C3N=NN(C(C)C4=CC=C5N=CC=CC5=C4)C3=N2)C=N1
Already in buffer
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=[N+]([O-])C1=CC=CC(CNC2=CC(C(F)(F)F)=CC3=NC=C(N4CCOCC4)C=C23)=C1,-10.28]
[CC(C1=C(F)C=C2N=CC(C3=CN(C)N=C3)=CC2=C1F)N1N=NC2=NC=C(C3=CC=C(C(N)=O)C(F)=C3)N=C21,-11.86]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity in the right regions, and possibly introduce fluorine atoms to strengthen hydrophobic and electrostatic interactions. The first molecule has promising oxazole rings and fluorinated aromatic groups, but it could benefit from additional hydrogen bond donors/acceptors to interact more deeply with the protein.

The second molecule has a strong aromatic core with multiple heterocycles and fluorines, but its binding affinity, while good, may limit further improvement by adding polar groups that maintain planarity and coordinate well with the binding pocket.

Considering these points, I would aim to incorporate an amide group in a heterocycle fused to a fluorinated aromatic ring to improve hydrogen bonding and polarity without compromising hydrophobic contacts. Adding a substituted pyrazole or pyrimidine-like ring might also enhance stacking and electrostatic interactions.

Based on this reasoning, I propose the following molecule:

\box{CC(C1=CC(C(F)(F)F)=CC2=NC=C(N3CCN(C(=O)c4cn(-c5ccc(F)cc5)c(=O)n4C)CC3)C=C12)N1N=NC2=NC=C(C3=CC=C(C(N)=O)C(F)=C3)N=C21}
LLM-GENERATED: CC(c1cc(C(F)(F)F)cc2ncc(N3CCN(C(=O)c4cn(-c5ccc(F)cc5)c(=O)n4C)CC3)cc12)n1nnc2ncc(-c3ccc(C(N)=O)c(F)c3)nc21
CC(c1cc(C(F)(F)F)cc2ncc(N3CCN(C(=O)c4cn(-c5ccc(F)cc5)c(=O)n4C)CC3)cc12)n1nnc2ncc(-c3ccc(C(N)=O)c(F)c3)nc21

Boltz running on GPU 2
10.22
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[FC(F)(C1=CC=C2N=CC=CC2=C1)C1=NN=C2N=CC(C=CC3=CC=NC=C3)=NN21,-10.75]
[O=C1C=CC(N2C=CC3=CC=C(F)C=C32)=NN1CCOC1=CC=NC2=CC(OCCCN3CCOCC3)=CC=C21,-11.57]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase rigidity to reduce entropy loss upon binding, and introduce groups that interact well with the c-MET pocket. The first molecule has strong aromatic interactions but may lack polarity and flexibility for optimal fit. The second molecule adds polarity and flexibility with oxygen atoms, but its binding affinity is only slightly better.

To build on this, I would aim to combine the beneficial aromatic systems with polar heteroatoms to create more opportunities for hydrogen bonding and improve solubility without sacrificing rigidity. Introducing a cyclic amine moiety could increase binding through additional polar contacts and improve specificity. Also, maintaining the fluorine substituents would help with metabolic stability and potential halogen bonding.

Based on this reasoning, I propose the molecule:

\box{O=C1CCN(c2ccc(/C=C/C(=O)NN2)cc2cc(N)ccc2OCCO2)CC1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 106
NON-LLM GENERATED: C1=CC(C=CC2=NN3CC=NN=C3N=C2)=CC=N1
C(=Cc1ccncc1)C1=NN2CC=NN=C2N=C1

Boltz running on GPU 2
7.52
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=NN3C(=NN=C3C(F)(F)C3=CC=C4N=CC=CC4=C3)C=C2)C=N1,-10.42]
[CC(=NNC(N)=O)C1=NN2C(C(O)C3=C(F)C=C4N=CC=CC4=C3F)=CN=C2C=C1,-11.5]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I see that both incorporate fused aromatic rings and fluorinated phenyl groups, which likely contribute to their binding affinity through hydrophobic and electronic interactions. The first molecule has a carbonyl group attached to a triazole ring connected to a difluorophenyl substituent, while the second molecule features an oxime-containing side chain and a fluorinated heterocycle.

To improve binding, I would consider enhancing hydrogen bonding capabilities and increasing rigidity to reduce entropy loss upon binding. Introducing a heteroatom in the fused ring system could create additional polar contacts with the protein. Also, replacing one fluorine with a nitrogen in the phenyl ring might increase polarity and potentially form stronger interactions.

Based on this, I propose a molecule that replaces one fluorine on the phenyl ring with a nitrogen, incorporating a pyridine-like moiety, and modifies the carbonyl substituent to a thiocarbonyl (C=S) to increase polarizability and hydrogen bonding potential. This should provide improved binding interactions and maintain the core fused ring system.

\box{C=CC(=NNC(N)=O)c1c(-c2ccc3ncccc3c2)cccc1C=C1=NNC(=O)C(C)=CC1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 107
NON-LLM GENERATED: C1=CC=C2N=CC=CC2=C1
c1ccc2ncccc2c1

Boltz running on GPU 2
4.7
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[C[C@H](C1=CC=CC(C2=NC=C(OCC3CCN(C)CC3)C=N2)=C1)N1C=C(C2=CC(C#N)=CC=N2)C=C(F)C1=O,-10.34]
[COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3)=C2C=C1OC,-10.3]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity for c-MET, I would look for strategies that enhance hydrogen bonding, increase rigidity to reduce entropy loss, and introduce groups that interact well with the binding pocket. Both initial molecules have ether linkages and substituted pyrrole-like rings, but one wants to optimize the heteroatoms and ring systems to better complement the protein.

From the given molecules, I see the use of oxygen linkers and amide groups for interactions, but the first molecule's bromine substitution at the phenyl ring is worth retaining due to potential halogen bonding and hydrophobic interactions. To improve hydrogen bonding, introducing an amide NH adjacent to the pyrrole ring could engage in extra H-bonds, increasing affinity. Also, switching to a nitrogen-containing heterocycle in place of the oxygen may enhance polar interactions.

Based on this, I propose replacing the ether linker with a hydrazone (-C=N-) connected to a piperazine-like ring, and adding an amide moiety with an NH group adjacent to the pyrrole ring, while keeping the bromine substitution intact. This should enhance H-bonding and hydrophobic contacts simultaneously.

The molecule I propose is:

\box{COCC/C(=N\S1CCNCC1)N=C1/N=C/C(C)c2ccc(Oc3ccnc4[nH]cc(-c5ccc(Br)cc5)c34)c(=O)[nH]c2=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 108
NON-LLM GENERATED: COC1=C(OC)C=C2C(=C1)N=CC=C2OC1=CC=C(CC2CCN(C)CC2)C=C1
COc1cc2nccc(Oc3ccc(CC4CCN(C)CC4)cc3)c2cc1OC

Boltz running on GPU 2
7.57
300/1000 | avg_top1: 12.050 | avg_top10: 11.759 | avg_top100: 11.047 | avg_sa: 3.246 | div: 0.816
{'avg_top1': 12.05, 'avg_top10': 11.758999999999999, 'avg_top100': 11.0469, 'auc_top1': 3.5319499999999997, 'auc_top10': 3.4315049999999983, 'auc_top100': 3.19968880952381, 'avg_sa': 3.245696120799353, 'diversity_top100': 0.8163551781882578, 'n_oracle': 300}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(c1c(F)cc2ncccc2c1F)n1cnc2ncc(-c3cnn(CCO)c3)nc21,-11.12]
[[C-]#[N+]C1=C2COCCN2C2=C(C(=O)OC2)C1C1=CC=C2NN=C(C)C2=C1,-10.9]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity, and develop additional interactions with the binding pocket. The first ligand has fluorines on the aromatic rings, which might contribute to affinity but could also be substituted further. The second ligand has a carbonyl group and an ether, introducing polarity but still room for optimization.

From analyzing these molecules, I see potential in increasing hydrogen bond donors/acceptors and adding groups that can engage in favorable interactions within the pocket. Introducing a heterocyclic system with an amide or imide group could improve binding through more strong H-bonds. Also, substituting fluorines with a methyl group on the aromatic ring might enhance hydrophobic contacts without reducing affinity.

Based on this, I propose incorporating a methyl-substituted pyrazole ring fused to a heterocycle with an amide motif, which provides additional H-bonding and hydrophobic interactions, to potentially strengthen binding.

\box{Cc1ccc2ncccc2c1C(C)n1nc(C(=O)Nc2cnn(C)c2C)cnc1C}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 109
NON-LLM GENERATED: CC1=NNC2=CC=C(F)C=C21
Cc1n[nH]c2ccc(F)cc12

Boltz running on GPU 2
6.16
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=S)C1=CC=C(C2=NN3C(CC4=CC(Cl)=C5N=CC=CC5=C4)=CN=C3N=C2)C=C1F,-11.22]
[CN1C=C(C2=NN3C(=NN=C3C(F)(F)C3=CC=C4N=CC=CC4=C3)C=C2)C=N1,-10.42]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both incorporate fused aromatic rings and heterocycles, targeting key pockets in the c-MET binding site. The sulfur-containing side chain in the first molecule contributes to affinity, but the overall binding affinity is slightly stronger in the second molecule with the difluoromethylated heterocycle.

To improve binding further, I would focus on enhancing hydrophobic interactions and electronic effects while maintaining or increasing planarity for better stacking. Introducing a trifluoromethyl group (–CF3) on the aromatic ring could boost lipophilicity and binding strength through favorable hydrophobic and electronic interactions. Also, shifting the substituents to optimize fit within the binding pocket and possibly increase flexibility or π-stacking potential could help.

Based on this reasoning, I propose a new molecule that incorporates a CF3 substituent on a pyridine ring attached to a fused heterocyclic scaffold, preserving the key NN=C4 linkage and chlorine-containing fused ring for interaction versatility.

\box{FC(C)n1cc(-c2ccc3ncc(Cl)c(=O)[nH]c3c2)ccc2c1CCN=C2N[C@H]1CC[C@H](C)n([nHC]-c2ccc3ncccc3c2)c1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 110
NON-LLM GENERATED: ClC1=C2N=CC=CC2=CC(CC2=CC=C3N=CC=CC3=C2)=C1
Clc1cc(Cc2ccc3ncccc3c2)cc2cccnc12

Boltz running on GPU 2
7.46
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN=C3N=NN(CC4CCCN(C5=NC=C(C6=CN(CCO)N=C6)C=N5)C4)C3=N2)C=N1,-10.76]
[CN1C=C(C2=CN=C3C=CC4=CC=C(N)C=C4C(=O)C3=C2)C=N1,-10.8]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, both have similar core structures with pyrazole and pyrimidine-like rings, but there are a few key differences:

1. The first molecule has a piperazine-linked heterocycle with methylated nitrogens, contributing to flexibility and hydrogen bonding.
2. The second molecule has a fused benzodiazepine-like scaffold with a phenyl substituent, possibly enhancing π-π stacking but potentially less favorable solubility or conformational rigidity.
3. Binding affinities are close, but the second molecule's greater aromaticity and planarity might improve stacking interactions in the binding pocket.

To improve the molecule, I would combine the beneficial features: keep the piperazine linker from the first molecule for flexibility and H-bonding, but introduce a more extended fused aromatic system like the second molecule to enhance stacking and hydrophobic contacts. Additionally, modifying the piperazine ring to reduce methylation on nitrogen can optimize polarity and receptor complementarity.

Thus, the design leads me to a structure where a pyridine ring is fused to a diazepine core linked via a piperazine with a pyridine substituent, maintaining key heteroatoms for interaction and optimizing size and rigidity.

\box{Cn1cc(-c2ccc3nnc4ccc(N5CCN(c6ccnc6)C5=O)cc4c2)cn1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 111
NON-LLM GENERATED: NC1=CC=C2C=CC3=NC=C(CCO)C=C3C(=O)C2=C1
Nc1ccc2ccc3ncc(CCO)cc3c(=O)c2c1

Boltz running on GPU 2
9.57
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CCC(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCN1CCOCC1,-11.36]
[COC1=CC=C2C(=C1)N=CC=C2OCC1=NN=C2SC(C3=CN(C)N=C3)=NN12,-10.23]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two existing molecules, I notice that both incorporate heterocycles and flexible linkers, likely contributing to binding affinity and specificity. The first molecule features a methoxy-substituted phenyl ring connected to a fused heterocycle with fluorine atoms, which often improve binding through polar interactions and hydrophobic contacts. The second molecule includes a hydrazone linkage and a methylated heterocycle, suggesting involvement in hydrogen bonding and electronic complementarity.

To design a stronger ligand, I would focus on combining key features from both: maintaining the fused heterocyclic core with carbonyl groups to maximize hydrogen bonding, incorporating fluorine to enhance affinity, and adding a flexible yet polar linker to improve solubility and binding adaptability. Additionally, replacing or modifying certain substituents (like replacing the methyl group on the heterocycle with a morpholine ring) could improve pharmacokinetics and increase interactions with the active site.

Based on this reasoning, I propose the molecule:

\box{COc1cccc(-c2cc(=O)n(-c3ccc(OCCCN4CCOCC4)c(F)c3)c(=O)n2C)c1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 112
NON-LLM GENERATED: FC1C=CCC=C1
FC1C=CCC=C1

Boltz running on GPU 2
5.66
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[N#CC1=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCCN5CCOCC5)C=N4)=C3)C(=O)C=C2)=CC=C1,-10.38]
[O=C(NC1=CC(OC2=C(F)C=C(NC(=O)C3(C(=O)NC4=CC=C(F)C=C4)CC3)C(F)=C2)=CC=N1)C1CC1,-10.49]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both involve fused heterocycles and fluorinated phenyl rings, which are likely contributing to their binding affinity through hydrophobic and electronic interactions. The first molecule includes a pyrazole-based core with a flexible chain (OCCN5CCOCC5), while the second molecule has a more rigid, amide-linked scaffold with fluorinated rings and a pyrazole moiety.

To improve binding, I would consider enhancing hydrogen bonding potential and increasing rigidity to reduce entropic penalties upon binding. Also, introducing additional aromatic heterocycles can strengthen π-stacking interactions with the protein. Incorporating a fused lactam ring could create new H-bond donors/acceptors and improve geometry.

Hence, I propose a molecule that replaces the flexible chain with a more rigid bicyclic heteroaromatic system, includes an amide linkage to a fluorinated phenyl ring for hydrophobic interactions, and integrates a fused pyrazole-lactam core to maximize H-bonding and rigidity.

\box{Cn1cc(-c2ccc3nnc(C(=O)CC4(C(=O)NC5=CC(F)ccc5C(F)=C4)C(=O)Nc5ccc(-c6ccc7ncccc7c6)cc5C)nc3c2)cn1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 113
NON-LLM GENERATED: N#CNC1=CC(F)=C(OC2=CC=NC(NC(=O)C3CC3)=C2)C=C1F
N#CNc1cc(F)c(Oc2ccnc(NC(=O)C3CC3)c2)cc1F

Boltz running on GPU 2
8.98
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(=NNC(N)=O)C1=NN2C(C(O)C3=C(F)C=C4N=CC=CC4=C3F)=CN=C2C=C1,-11.5]
[CO/N=C(\C)c1ccc2ncc(Cc3c(F)cc4ncccc4c3F)n2n1,-10.95]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding and aromatic interactions while maintaining or increasing planarity for efficient stacking with the target protein. The existing molecules already have strong heterocyclic and aromatic systems, but one has better hydrogen bonding potential via the hydrazone and oxime groups, while the other incorporates a phenyl-pyridine system that may contribute to π-π stacking.

To build on this, introducing a hydroxyl group on the aromatic ring could improve polarity and hydrogen bonding, potentially increasing affinity. Also, integrating an electron-donating group such as a methoxy on the phenyl ring of the second structure could enhance π-interactions and modulate electronic properties without adding steric hindrance.

Combining these ideas, I would design a molecule that retains the key heterocyclic motifs but adds a hydroxyl group on one aromatic ring and a methoxy group on the other to simultaneously boost hydrogen bonding and π-π stacking.

Final answer: \box{COc1ccc2ncc(Cc3c(O)cc4ncccc4c3)c2n1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 114
NON-LLM GENERATED: NC1=C(F)C=C2N=CC=CC2=C1F
Nc1c(F)cc2ncccc2c1F

Boltz running on GPU 2
6.65
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[N#CC1=CC(C2=CN=C3N=NN(CC4CN(C5=NC=C(C6=CCNCC6)C=N5)CCO4)C3=N2)=CC=C1Cl,-11.01]
[CN1C=C(C2=CC=C3C(=C2)N=CC=C3OCCN2C(=O)OC3=CC(C4=CN(C)N=C4)=CC=C32)C=N1,-10.47]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both incorporate fused heterocycles and amino groups that likely participate in hydrogen bonding within the binding site. The first ligand has a chlorinated aromatic ring and a more constrained ring system with multiple nitrogen atoms, contributing to potential dipole interactions and rigidity. The second ligand features a ether linkage and a morpholine-like moiety, both of which might enhance solubility and interaction versatility.

To improve binding affinity, I would consider combining elements that increase hydrogen bonding capacity and hydrophobic contacts while introducing groups that can fill hydrophobic pockets or interact with polar residues. Specifically, adding a bulky tert-butyl group could enhance van der Waals interactions and steric complementarity, while maintaining the aromatic and heterocyclic cores that seem critical for affinity.

Therefore, I propose a molecule that integrates a tert-butyl substituent on the pyrimidine ring found in the first ligand scaffold, aiming to boost hydrophobic interactions and retain the key pharmacophores. The resulting structure is:

\box{CC(C)(C)n1cc(-c2cnc3ccc4ncc(NC(=O)C5=CC(=O)NCC6=CC(C7=CCNCC7)C=C6)cc4c(=O)c3c2)cc1C}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 115
NON-LLM GENERATED: CN1C=C(C2=CC=C3C(=C2)OC(=O)N3CCOCN2N=NC3=NC=C(C4=CC(C#N)=C(Cl)C=C4)N=C32)C=N1
Cn1cc(-c2ccc3c(c2)oc(=O)n3CCOCn2nnc3ncc(-c4ccc(Cl)c(C#N)c4)nc32)cn1

Boltz running on GPU 2
9.35
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)C1=CC=C(C2=NN(CCC3=CC=C4N=CC(C5=CN(CCO)N=C5)=CC4=C3)C(=O)C=C2)C=C1C(F)(F)F,-11.8]
[CN1C=C(C2=CN3C(=NN=C3SC3=CC=C4N=CC(NCCO)=CC4=C3)C=C2)C=N1,-11.09]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both share a core bicyclic heteroaromatic system and a trifluoromethyl-substituted phenyl ring, which likely contributes to their affinity through hydrophobic and electronic effects. However, their side chains differ: the first molecule has a more bulky and sterically crowded substituent with a methoxyethyl group, while the second has a smaller, more flexible chain with a morpholine-like ring.

To improve binding, I would consider balancing size and flexibility by introducing a polar but not too bulky group that can form additional hydrogen bonds without causing steric hindrance. Replacing the bulky methoxyethyl with a single polar ether oxygen could enhance solubility and interaction with the protein pocket. Also, simply adjusting the arrangement of the fused rings to optimize planarity and aromatic stacking could contribute to better binding.

Based on these insights, I propose a molecule that retains the core bicyclic heteroaromatic system and trifluoromethyl phenyl group but replaces the bulky side chain with a shorter ether-linked chain, improving polarity and flexibility.

\box{CNC(=O)c1cc(-c2ccc(C(F)(F)F)cc2)ccc2[nH]cc(-c3ccc4ncccc4c3=C2)c1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 116
NON-LLM GENERATED: CNC(=O)C1=CC=C(C2=NN(CCC3=CC=C4N=CC(NCCO)=CC4=C3)C(=O)C=C2)C=C1C(F)(F)F
CNC(=O)c1ccc(-c2ccc(=O)n(CCc3ccc4ncc(NCCO)cc4c3)n2)cc1C(F)(F)F

Boltz running on GPU 2
11.3
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[C[C@H](C1=CC=CC(C2=NC=C(OCC3CCN(C)CC3)C=N2)=C1)N1C=C(C2=CC(C#N)=CC=N2)C=C(F)C1=O,-10.34]
[N#CC1=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCCN5CCOCC5)C=N4)=C3)C(=O)C=C2)=CC=C1,-10.38]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice they both share a key heterocyclic core with methoxy or methyl substitutions and incorporate nitrogen-rich rings for potential hydrogen bonding. The small changes in binding affities suggest subtle improvements can be made by optimizing ring size and flexibility, as well as adjusting substituents to better fit the c-MET binding pocket.

Molecule 1 uses a 5-membered ring with a morpholine moiety, while molecule 2 replaces that with a 6-membered saturated nitrogen-containing ring. The improvement in affinity is marginal but indicates that fine-tuning ring size and flexibility in the linker could enhance binding. Additionally, maintaining or slightly modifying the aromatic substituents to preserve or strengthen π-stacking or hydrophobic interactions is beneficial.

Based on this, I would suggest modifying the linker to a 6-membered saturated nitrogen-containing ring (piperidine) instead of morpholine to find a better fit and possibly improve affinity. Also, preserving the aromatic system and keeping the cyanophy propyl group seems advantageous.

Therefore, the new proposed molecule is:

\box{N#CC1=CC(C2=NN(CC3=CC=CC(C4=NC=C(OCC5CCCC5)C=N4)=C3)C(=O)C=C2)=CC=C1}
LLM-GENERATED: N#Cc1cccc(-c2ccc(=O)n(Cc3cccc(-c4ncc(OCC5CCCC5)cn4)c3)n2)c1
N#Cc1cccc(-c2ccc(=O)n(Cc3cccc(-c4ncc(OCC5CCCC5)cn4)c3)n2)c1

Boltz running on GPU 2
9.9
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[NC1=NNC2=CC=CC(C3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)=C21,-10.58]
[O=C(NC1=CC(OC2=C(F)C=C(NC(=O)C3(C(=O)NC4=CC=C(F)C=C4)CC3)C(F)=C2)=CC=N1)C1CC1,-10.49]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a core pharmacophore featuring a heterocyclic system with aromatic rings and fluorine substituents, which likely enhance binding through hydrophobic and electronic interactions. The main differences lie in the linker and side chains: one contains an oxime ether linkage and the other an amide-linked heterocycle. The better binding affinity of the second molecule suggests that maintaining the amide-linked heterocycle is beneficial.

To improve on this, I would focus on optimizing the aromatic ring that interacts with the c-MET binding pocket. Adding electron-donating groups like methoxy could improve π-stacking and hydrogen bonding, while introducing a methyl group might enhance hydrophobic contacts. Also, shifting from an amide to a hydrazide linkage could provide additional hydrogen bonding opportunities.

Combining these ideas, I propose a molecule that retains the amide-linked heterocycle but substitutes the aromatic ring with a 3,4-dimethylphenyl and replaces the hydrazide with a hydrazone-based linker bearing a methoxy group on the adjacent phenyl ring.

\box{COc1cccc(-n2cc(C(=O)Nc3ccc(C)c(=O)n(C)c3=CC2)c(=O)c1C)Cc1ccc(F)cc1}
LLM-GENERATED: COc1cccc(Cc2ccc(F)cc2)n2cc(c(=O)c1C)C(=O)NC1=CC=C(C)C(=O)N(C)C1=CC2
COc1cccc(Cc2ccc(F)cc2)n2cc(c(=O)c1C)C(=O)NC1=CC=C(C)C(=O)N(C)C1=CC2

Boltz running on GPU 2
8.04
310/1000 | avg_top1: 12.050 | avg_top10: 11.759 | avg_top100: 11.055 | avg_sa: 3.239 | div: 0.817
{'avg_top1': 12.05, 'avg_top10': 11.758999999999999, 'avg_top100': 11.054699999999999, 'auc_top1': 3.65245, 'auc_top10': 3.5490949999999986, 'auc_top100': 3.3101968095238097, 'avg_sa': 3.238696972379591, 'diversity_top100': 0.8167031424767388, 'n_oracle': 310}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[FC(F)(C1=CC=C2N=CC=CC2=C1)C1=NN=C2N=CC(C=CC3=CC=NC=C3)=NN21,-10.75]
[C[C@H](C1=CC=CC(C2=NC=C(OCC3CCN(C)CC3)C=N2)=C1)N1C=C(C2=CC(C#N)=CC=N2)C=C(F)C1=O,-10.34]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase rigidity for better fit, and introduce groups that interact well with the c-MET binding pocket. The first molecule has strong aromatic interactions but limited hydrogen bond donors/acceptors. The second molecule adds a morpholine ring and a terminal alkyne, increasing polarity and potential hydrogen bonding, but it has some flexible linkers that might reduce binding entropy.

To build on this, I would combine the aromatic systems to increase π-π stacking and introduce a rigid oxygen-containing ring (like a dioxolane) to restrict flexibility and add polarity. This could enhance binding through both hydrophobic and hydrogen bonding interactions while maintaining the critical heteroatoms for interaction.

\box{C[C@@H](C1=CC=CC(C2=NC=C(OCC3CCOCC3)C=N2)=C1)N1C(C2=CC(C#N)=CC=N2)C(C3=CC=NC(=O)CC3)C1=O}
LLM-GENERATED: CC(c1cccc(-c2ncc(OCC3CCOCC3)cn2)c1)N1C(=O)C(C2=CC=NC(=O)CC2)C1c1cc(C#N)ccn1
CC(c1cccc(-c2ncc(OCC3CCOCC3)cn2)c1)N1C(=O)C(C2=CC=NC(=O)CC2)C1c1cc(C#N)ccn1

Boltz running on GPU 2
9.93
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cc1c(OCC(O)CN2CCC(O)CC2)cn2ncnc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12,-10.89]
[FC(F)(C1=CC=C2N=CC=CC2=C1)C1=NN=C2N=CC(C=CC3=CC=NC=C3)=NN21,-10.75]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase ligand rigidity, and optimize hydrophobic interactions. The existing molecules already have good aromatic and heterocyclic motifs that interact well with the binding pocket, but there is room to add additional polar groups that complement the protein's key residues.

Molecule 1 has a hydroxyl group linked to a piperazine ring, which may be improved by replacing the piperazine with a more constrained ring like pyrrolidine to reduce conformational flexibility. Adding a secondary amine in the ring could enhance hydrogen bond donors/acceptors. Molecule 2 uses fluorinated aromatic rings and hydrazone linkages for planarity and electronic effects; introducing an ether linkage between the aromatic system and the hydrazone moiety might increase solubility and flexible positioning.

Combining these ideas, I would design a molecule that keeps the fluorinated aromatic core and hydrazone motif but replaces the pyrrolidine in the linker with a morpholine ring bearing a hydroxyl group, retaining hydrogen bonding capability and adding a tertiary amine for better electrostatic interactions.

The resulting molecule is:

\box{O=C(Nc1ccc(F)cc1)C1(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(NCCOCCCN(CCO)CC1)c34)c(F)c2)CC1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 117
NON-LLM GENERATED: FC1=CC=C(C(F)(F)C2=CC=C3N=CC=CC3=C2)C=C1
Fc1ccc(C(F)(F)c2ccc3ncccc3c2)cc1

Boltz running on GPU 2
7.22
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[NC1=NNC2=CC=CC(C3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)=C21,-10.58]
[CN1CCN(CCOC2=CN=C(C3=CC=CC(CN4N=C(N5C=CC6=CC=C(F)C=C65)C=CC4=O)=C3)N=C2)CC1,-11.18]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, aromatic stacking, and polarity in key regions of the ligand. The first molecule has strong aromatic interactions but limited polar groups for hydrogen bonding, while the second molecule incorporates more polar heterocycles and flexible linkers, improving interaction versatility but possibly at the cost of rigidity and binding geometry.

To balance these, I would focus on introducing additional hydrogen bond donors/acceptors in a rigid bicyclic core to increase specificity and interaction strength, while retaining the crucial aromatic fluorines for hydrophobic and π-stacking interactions. Also, incorporating an amide linkage could improve polarity and binding orientation.

Taking these considerations, I propose this new molecule:

\box{CC1CN(C(=O)C2(C(=O)NC3=CC(C(=O)Nc4ccc(-c5ccc(F)cc5)cc4F)CCC3=O)CC2)CC1}
LLM-GENERATED: CC1CCN(C(=O)C2(C(=O)NC3=CC(C(=O)Nc4ccc(-c5ccc(F)cc5)cc4F)CCC3=O)CC2)C1
CC1CCN(C(=O)C2(C(=O)NC3=CC(C(=O)Nc4ccc(-c5ccc(F)cc5)cc4F)CCC3=O)CC2)C1

Boltz running on GPU 2
7.5
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[C[C@@H](C1=CC2=CC=CN=C2C=C1F)N1C=NC2=NC=C(C3=CC=C(C(N)=O)C(F)=C3)N=C21,-10.9]
[CC(C)N1C=C(C2=CN=C3N=CN(C(C)C4=C(F)C=C5N=CC=CC5=C4F)C3=N2)C=N1,-10.6]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a similar core scaffold with aromatic rings and heterocycles, but there are a few key differences. The first molecule has a fluorinated aromatic ring with a hydroxyl group, while the second molecule has a branched alkyl group on the nitrogen and a different heterocyclic arrangement.

To improve binding affinity, I would consider enhancing hydrogen bonding capabilities and increasing rigidity to reduce entropy loss upon binding. Also, introducing stereochemistry at the chiral center might favor better fit in the protein pocket.

Based on this, I propose introducing an amide moiety (–C(=O)N–) to replace the hydroxyl group, which can serve as a stronger hydrogen bond donor/acceptor. Additionally, I will add a chiral center adjacent to the heterocyclic core to increase specificity. This leads me to generate the molecule:

\box{CNC(=O)c1cc(-c2ccc3ncc(N[C@H](C)c4=CC5=CC=CN=C5C=C4C3=c2)cc3n1)ccc1nccnc1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 118
NON-LLM GENERATED: CC1=C(C(N)=O)C=CC(C2=CN=C3N=CN(C(C)C4=CC5=CC=CN=C5C=C4F)C3=N2)=C1
Cc1cc(-c2cnc3ncn(C(C)c4cc5cccnc5cc4F)c3n2)ccc1C(N)=O

Boltz running on GPU 2
10.72
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=[N+]([O-])C1=CC=CC(CNC2=CC(C(F)(F)F)=CC3=NC=C(N4CCOCC4)C=C23)=C1,-10.28]
[CCN1CCC(COC2=CN=C(C3=CC=CC(CN4C(=O)C=CN5C6=CC(C#N)=CC=C6N=C54)=C3)N=C2)CC1,-10.31]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance polar interactions and hydrogen bonding, especially in the region interacting with the protein's active site. Both initial molecules have heterocycles and electron-withdrawing groups that contribute to affinity, but one has strong electron-withdrawing CF3 groups which might add steric hindrance or unfavorable desolvation penalties. The other molecule includes a piperazine-like moiety that supports solubility and potential H-bonding.

Considering this, I would aim to maintain the core heterocyclic framework with carbonyl and imine functionalities for strong H-bonding, while introducing a less bulky, more polar substituent in place of the trifluoromethyl group to improve interactions without increasing steric clash. Replacing the CF3 group with a hydroxyl-containing substituent like a hydroxyalkyl chain could boost solubility and form additional hydrogen bonds.

Therefore, I propose to replace the CF3 group with a hydroxypropyl substituent on the heterocycle, preserving the core structure and electronic features that support binding affinity improvement.

\box{O=[N+]([O-])C1=CC=CC(CNC2=CC(COCCO)CC3=NC=C(N4CCOCC4)C=C23)=C1}
LLM-GENERATED: O=[N+]([O-])c1cccc(CNC2=CC(COCCO)Cc3ncc(N4CCOCC4)cc32)c1
O=[N+]([O-])c1cccc(CNC2=CC(COCCO)Cc3ncc(N4CCOCC4)cc32)c1

Boltz running on GPU 2
9.58
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CN=C2C=CC([C@H](C)C3=NN=C4C(F)=CC(C5=CC(C)=NO5)=CN43)=CC2=C1,-11.12]
[CC(=NNC(N)=O)C1=NN2C(=NN=C2C(C)C2=CC=C3N=CC=CC3=C2)C=C1,-11.52]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity in the right regions, and introduce groups that can better interact with the hydrophobic pockets or metal ion in the c-MET active site. 

The first molecule has a methyl substituent on an indole ring and an oxime-containing moiety, likely forming key interactions. The second molecule includes a hydrazone-linked urea motif, which can serve as strong hydrogen bond donors and acceptors. Combining these features could amplify binding.

Notably, incorporating a hydroxyl group on the aromatic ring might improve hydrogen bonding with polar residues in the binding site, while retaining the heterocyclic cores and methyl substitutions that contribute to hydrophobic and aromatic stacking interactions.

Therefore, a promising design would be a urea-linked hydrazone scaffold fused to a hydroxyl-substituted aromatic system with methylated heterocycles to maximize both polar and nonpolar contacts.

\box{CC(=NNC(N)=O)C1=NN2C(=NN=C2C(C)C2=CC3=CC(O)ccc3=NC2)C=C1}
LLM-GENERATED: CC(=NNC(N)=O)c1ccc2nnc(C(C)C3=CC4=CC(O)C=CC4=NC3)n2n1
CC(=NNC(N)=O)c1ccc2nnc(C(C)C3=CC4=CC(O)C=CC4=NC3)n2n1

Boltz running on GPU 2
8.51
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(C1=CC=C2N=CC(C3=CN(C)N=C3)=CC2=C1)N1N=NC2=NC=C(C3=CC=NC=C3)N=C21,-10.95]
[CC(C1=CC=C2N=CC(C3=CN(C)N=C3)=CC2=C1)N1N=NC2=NC=C(C3=CC=NC=C3)N=C21,-10.95]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: The given molecules have identical binding affinities of -10.95 kCal/mol, indicating they bind equally well to c-MET. Analyzing their structures, both molecules share a similar scaffold with fused pyrimidine and pyridine rings and an N-ethyl group on the heterocycle. The key to improving affinity might lie in modifying the peripheral aromatic rings to increase hydrophobic interactions or introduce heteroatoms that can form additional hydrogen bonds or dipole interactions with the protein.

One strategy is to replace the pyridine ring in one of the molecules with a thiophene ring, which could enhance π-stacking and hydrophobic contacts due to its sulfur atom. Additionally, moving the N-ethyl group to a pyridine ring instead of a pyrimidine could optimize hydrogen bonding while maintaining favorable electronic properties.

Based on this rationale, I propose a new molecule that incorporates a thiophene ring in place of the terminal pyridine and shifts the ethyl group to a pyridine moiety to potentially improve binding affinity.

\box{CC(C1=CC=C2N=CC(C3=CN(C)N=C3)=CC2=C1)N1N=NC2=NC(=S)C(C3=CCNCC3)C2=N1}
LLM-GENERATED: CC(c1ccc2ncc(-c3cnn(C)c3)cc2c1)N1N=NC2=NC(=S)C(C3=CCNCC3)C2=N1
CC(c1ccc2ncc(-c3cnn(C)c3)cc2c1)N1N=NC2=NC(=S)C(C3=CCNCC3)C2=N1

Boltz running on GPU 2
11.26
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CN=C2C=CC([C@H](C)C3=NN=C4C(F)=CC(C5=CC(C)=NO5)=CN43)=CC2=C1,-11.12]
[C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl,-11.17]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase rigidity for better fit, and introduce groups that interact well with the c-MET binding pocket. Both initial molecules have some promising features—methyl and oxygen-containing groups that contribute to affinity—but there is room to add more H-bond donors/acceptors and aromatic systems that can engage in π-stacking or hydrophobic interactions.

The first molecule has a methylated oxazole ring and fluorinated aromatic rings, which are beneficial, but the overall scaffold could be optimized for improved polarity and additional contacts. The second molecule incorporates amide linkages and a piperazine moiety, both useful for interactions, but its binding affinity is only slightly better, suggesting the need for a more compact and fused aromatic system that might better occupy the pocket.

Considering this, I would design a molecule that integrates a fused heterocyclic system with multiple chloro-substituted phenyl rings to enhance hydrophobic and halogen bonding. Adding an N-methylated heterocycle with carbonyl groups could also improve hydrogen bonding and rigidity. This design aims to combine the beneficial features of the two initial molecules with increased molecular complementarity and interaction potential.

The new molecule I propose is:

\box{Clc1ccc(-n2nc(C[C@H](C)c3ccc4ncccc4c3)n[C@H](C)c2=O)c1Cl}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 119
NON-LLM GENERATED: CC(=O)C1=CC(OC(C)C2=C(Cl)C=CC(F)=C2Cl)=C(N)N=N1
CC(=O)c1cc(OC(C)c2c(Cl)ccc(F)c2Cl)c(N)nn1

Boltz running on GPU 2
9.56
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=[N+]([O-])C1=CC=CC(CNC2=CC(C(F)(F)F)=CC3=NC=C(N4CCOCC4)C=C23)=C1,-10.28]
[FC(F)(C1=CC=C2N=CC=CC2=C1)C1=NN=C2N=CC(C=CC3=CC=NC=C3)=NN21,-10.75]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like increasing hydrogen bonding, improving hydrophobic contacts, and introducing groups that can better complement the binding pocket. The first ligand has strong electron-withdrawing trifluoromethyl groups but may benefit from additional polar functionalities to engage in hydrogen bonds. The second ligand includes fluorines and a pyridine-like ring, but its overall planarity and potential steric hindrance might limit optimal fitting.

By combining the beneficial features, I would consider replacing the trifluoromethyl with a more flexible, polar substituent that can participate in hydrogen bonding, such as a hydroxy or amine group, while retaining the core fused heterocycles and the morpholine-like ring for interaction and solubility. Also, adding a methylene linker could increase flexibility to better accommodate the binding pocket.

Therefore, I propose a new molecule with a hydroxy-substituted alkyl side chain linked via a methylene to the core fused heterocyclic system, retaining the morpholine ring to maintain interactions.

\box{CC(C(=O)NO)CC(Cc1ccc2nc3cc(OC)ccc3c(=O)n2c1)C1=CC(=O)NCC2=CC(=O)N(CCO)CC2}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 120
NON-LLM GENERATED: C1=CC(C=CC2=NN3CC=NN=C3N=C2)=CC=N1
Already in buffer
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(N=O)C1=NN2C(=NN=C2C(CO)C2=C(F)C=C3N=CC=CC3=C2F)C=C1,-10.28]
[CC1=C2C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)=NC=NN2C=C1OCC(O)CN1CCC(O)CC1,-10.89]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I see that both incorporate fused heterocycles and fluorine substituents, which likely enhance binding affinity through hydrophobic and electronic effects. The better binder, -10.89 kcal/mol, includes a morpholine ring and additional hydrogen bonding groups, suggesting that increasing polarity and potential interactions with the protein helps.

To improve further, I would aim to maintain the core fused heterocyclic system but introduce a small hydrophobic alkyl substituent to the heterocycle to strengthen van der Waals contacts without losing the favorable interactions. Also, replacing the morpholine with a less polar but still hydrogen-bond-capable piperazine ring might balance solubility and binding affinity.

Therefore, I propose a molecule that replaces the morpholine with piperazine and adds a methyl group on the heterocyclic ring to slightly increase hydrophobic interactions:

\box{C[C@H](C)N1CCN(Cc2ccc3ncccc3c2)CC1}
LLM-GENERATED: CC(C)N1CCN(Cc2ccc3ncccc3c2)CC1
CC(C)N1CCN(Cc2ccc3ncccc3c2)CC1

Boltz running on GPU 2
6.2
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CCCNS(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C5CCN(CC)CC5)c4)cc3c(=O)c2c1,-10.77]
[CN1C=C(C2=CN=C3C=NN(S(=O)(=O)C4=CN=C5C=CC(C6=CN(C)N=C6)=CN45)C3=C2)C=N1,-10.61]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both incorporate the 1,2,3-triazole ring and nitrogen-rich heterocycles, which likely contribute to key interactions with the c-MET binding site. The first molecule features a urea moiety, while the second has a fused triazole linked to a piperazine-derived scaffold with a methylated triazole ring. 

To improve binding affinity, I would consider enhancing hydrogen bonding capabilities and increasing rigidity to reduce entropy loss upon binding. Also, incorporating a piperazine ring with a methyl substitution on the nitrogen could provide favorable interactions and improve solubility.

Based on this, I propose replacing the fused triazole-piperazine motif with a simpler 1,2,3-triazole linked to a N-methylpiperazine, maintaining the core heterocyclic framework and introducing a methyl group on the triazole ring to enhance hydrophobic contacts and potentially improve binding.

The new molecule is:  
\box{CN1C=C(C2=CN=C3C=NNc4ccc(-c5cnn(C6CCN(C)CC6)c5)cc4C3=C2)C1=O}
LLM-GENERATED: CN1CCC(n2cc(-c3ccc4c(c3)-c3cc(C5=CN(C)C5=O)cnc3C=NN4)cn2)CC1
CN1CCC(n2cc(-c3ccc4c(c3)-c3cc(C5=CN(C)C5=O)cnc3C=NN4)cn2)CC1

Boltz running on GPU 2
9.52
320/1000 | avg_top1: 12.050 | avg_top10: 11.759 | avg_top100: 11.064 | avg_sa: 3.259 | div: 0.818
{'avg_top1': 12.05, 'avg_top10': 11.758999999999999, 'avg_top100': 11.063699999999997, 'auc_top1': 3.77295, 'auc_top10': 3.6666849999999984, 'auc_top100': 3.42078880952381, 'avg_sa': 3.258536459937255, 'diversity_top100': 0.817884071524004, 'n_oracle': 320}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[C[C@@H](C1=CC=C2N=CC=CC2=C1)N1N=NC2=NC=C(C3=CN(CCO)N=C3)N=C21,-11.3]
[CO/N=C(\C)C1=NN2C(CC3=C(F)C=C4N=CC=CC4=C3F)=CN=C2C=C1,-10.95]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, pi-stacking, and electrostatic contacts. The existing molecules already have aromatic rings and heterocycles that contribute to these interactions, but there's room to increase polarity and hydrogen bond donors/acceptors in strategic positions.

Comparing the two, the first molecule has strong aromatic interactions, while the second incorporates fluorines and an ethoxy group to modulate electronic properties and solubility. To build on this, introducing a polar hydroxyl group on a distal aromatic ring could enable additional hydrogen bonding with residues in the binding pocket. Also, incorporating a heteroaromatic ring such as a pyridine or pyrazine might enhance stacking and dipolar interactions.

Combining these ideas, I would design a molecule that retains the core fused bicyclic system and methyl-substituted pyrimidine-dione moiety, but replaces one aromatic ring with a hydroxy-substituted phenyl ring to boost hydrogen bonding, and introduces a nitrogen in the fused ring system to favor polar interactions.

Therefore, the new molecule I propose is:

\box{Cc1cc(C(=O)Nc2ccc(O)cc2)cn2nc(-c3ccc4ncccc4c3)c(=O)[nH]c2=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 121
NON-LLM GENERATED: CON=C(C)C1=NN2C(CC3=NC=C(C4=CN(CCO)N=C4)N3)=CN=C2C=C1
CON=C(C)c1ccc2ncc(Cc3ncc(-c4cnn(CCO)c4)[nH]3)n2n1

Boltz running on GPU 2
8.36
[(12.05, <rdkit.Chem.rdchem.Mol object at 0x761912363820>), (11.87, <rdkit.Chem.rdchem.Mol object at 0x761aa402a660>), (11.86, <rdkit.Chem.rdchem.Mol object at 0x761912392b30>), (11.8, <rdkit.Chem.rdchem.Mol object at 0x7619123636d0>), (11.8, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9c190>), (11.79, <rdkit.Chem.rdchem.Mol object at 0x761912392740>), (11.72, <rdkit.Chem.rdchem.Mol object at 0x761912392660>), (11.71, <rdkit.Chem.rdchem.Mol object at 0x761912365430>), (11.67, <rdkit.Chem.rdchem.Mol object at 0x761912392f20>), (11.57, <rdkit.Chem.rdchem.Mol object at 0x7619123790b0>), (11.55, <rdkit.Chem.rdchem.Mol object at 0x761912363200>), (11.52, <rdkit.Chem.rdchem.Mol object at 0x761912392ac0>), (11.52, <rdkit.Chem.rdchem.Mol object at 0x761912363430>), (11.5, <rdkit.Chem.rdchem.Mol object at 0x761912365dd0>), (11.44, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabeb0>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912392eb0>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x7619123566d0>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912365580>), (11.4, <rdkit.Chem.rdchem.Mol object at 0x7619123d0510>), (11.39, <rdkit.Chem.rdchem.Mol object at 0x761912392f90>), (11.39, <rdkit.Chem.rdchem.Mol object at 0x761912365b30>), (11.36, <rdkit.Chem.rdchem.Mol object at 0x7619123653c0>), (11.36, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabdd0>), (11.32, <rdkit.Chem.rdchem.Mol object at 0x761912379cf0>), (11.31, <rdkit.Chem.rdchem.Mol object at 0x7619123923c0>), (11.31, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99580>), (11.3, <rdkit.Chem.rdchem.Mol object at 0x7619123637b0>), (11.3, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4ac0>), (11.28, <rdkit.Chem.rdchem.Mol object at 0x761912365890>), (11.26, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00120>), (11.22, <rdkit.Chem.rdchem.Mol object at 0x761912392a50>), (11.21, <rdkit.Chem.rdchem.Mol object at 0x761912363040>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912392350>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912392510>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912379eb0>), (11.18, <rdkit.Chem.rdchem.Mol object at 0x761912356820>), (11.18, <rdkit.Chem.rdchem.Mol object at 0x7619123656d0>), (11.17, <rdkit.Chem.rdchem.Mol object at 0x7619123d0970>), (11.17, <rdkit.Chem.rdchem.Mol object at 0x7619123652e0>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912356900>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912365ac0>), (11.1, <rdkit.Chem.rdchem.Mol object at 0x761912392e40>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356b30>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356cf0>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912365c10>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x7619123927b0>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x761912365740>), (11.06, <rdkit.Chem.rdchem.Mol object at 0x761aa402af90>), (11.06, <rdkit.Chem.rdchem.Mol object at 0x761912365a50>), (11.05, <rdkit.Chem.rdchem.Mol object at 0x761912392970>), (11.03, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00890>), (11.01, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabf20>), (10.99, <rdkit.Chem.rdchem.Mol object at 0x761912365350>), (10.97, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4eb0>), (10.96, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99c80>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912392ba0>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356eb0>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356f90>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912365820>), (10.94, <rdkit.Chem.rdchem.Mol object at 0x761912392890>), (10.94, <rdkit.Chem.rdchem.Mol object at 0x761912392900>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761912365d60>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00660>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9cb30>), (10.92, <rdkit.Chem.rdchem.Mol object at 0x761912363190>), (10.92, <rdkit.Chem.rdchem.Mol object at 0x761aa402a740>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912379dd0>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365190>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365eb0>), (10.89, <rdkit.Chem.rdchem.Mol object at 0x761912365f90>), (10.85, <rdkit.Chem.rdchem.Mol object at 0x7619123654a0>), (10.81, <rdkit.Chem.rdchem.Mol object at 0x761912379f90>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912392120>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x7619123d09e0>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912379e40>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761aa402ac80>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99dd0>), (10.79, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99430>), (10.78, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00190>), (10.77, <rdkit.Chem.rdchem.Mol object at 0x761aa3d996d0>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365900>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365ba0>), (10.75, <rdkit.Chem.rdchem.Mol object at 0x761aa402ab30>), (10.74, <rdkit.Chem.rdchem.Mol object at 0x761912392c10>), (10.72, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4d60>), (10.72, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4820>), (10.71, <rdkit.Chem.rdchem.Mol object at 0x761912365510>), (10.7, <rdkit.Chem.rdchem.Mol object at 0x761aa3d995f0>), (10.69, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4dd0>), (10.67, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabcf0>), (10.65, <rdkit.Chem.rdchem.Mol object at 0x761912365e40>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123650b0>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123634a0>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x761912392c80>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x7619123922e0>), (10.6, <rdkit.Chem.rdchem.Mol object at 0x761912356970>), (10.6, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00c10>), (10.59, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9c5f0>), (10.58, <rdkit.Chem.rdchem.Mol object at 0x7619123657b0>), (10.57, <rdkit.Chem.rdchem.Mol object at 0x761aa3d990b0>), (10.56, <rdkit.Chem.rdchem.Mol object at 0x761912365cf0>), (10.56, <rdkit.Chem.rdchem.Mol object at 0x761aa3dab660>), (10.54, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99f20>), (10.54, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4a50>), (10.52, <rdkit.Chem.rdchem.Mol object at 0x761912392270>), (10.51, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00e40>), (10.5, <rdkit.Chem.rdchem.Mol object at 0x761912356d60>), (10.5, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4cf0>), (10.5, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99eb0>), (10.49, <rdkit.Chem.rdchem.Mol object at 0x761912363660>), (10.47, <rdkit.Chem.rdchem.Mol object at 0x761912356dd0>), (10.47, <rdkit.Chem.rdchem.Mol object at 0x761aa3dab040>), (10.46, <rdkit.Chem.rdchem.Mol object at 0x761912363120>), (10.46, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9ca50>), (10.46, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9cac0>), (10.44, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9c510>), (10.42, <rdkit.Chem.rdchem.Mol object at 0x7619123633c0>), (10.4, <rdkit.Chem.rdchem.Mol object at 0x7619123926d0>), (10.38, <rdkit.Chem.rdchem.Mol object at 0x7619123567b0>), (10.38, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00350>)]
[0.009142848471505639, 0.009006274801392995, 0.008998687375275625, 0.008953162818571413, 0.008953162818571413, 0.008945575392454042, 0.00889246340963246, 0.00888487598351509, 0.008854526279045613, 0.008778652017871922, 0.008763477165637185, 0.008740714887285075, 0.008740714887285075, 0.008725540035050338, 0.008680015478346124, 0.008664840626111385, 0.008664840626111385, 0.008664840626111385, 0.008649665773876648, 0.008642078347759279, 0.008642078347759279, 0.008619316069407171, 0.008619316069407171, 0.008588966364937695, 0.008581378938820326, 0.008581378938820326, 0.008573791512702957, 0.008573791512702957, 0.008558616660468218, 0.008543441808233479, 0.008513092103764004, 0.008505504677646636, 0.008497917251529265, 0.008497917251529265, 0.008497917251529265, 0.008482742399294528, 0.008482742399294528, 0.008475154973177157, 0.008475154973177157, 0.008437217842590312, 0.008437217842590312, 0.008422042990355575, 0.008414455564238206, 0.008414455564238206, 0.008414455564238206, 0.008399280712003467, 0.008399280712003467, 0.008391693285886098, 0.008391693285886098, 0.00838410585976873, 0.00836893100753399, 0.008353756155299253, 0.008338581303064514, 0.008323406450829776, 0.008315819024712408, 0.008308231598595037, 0.008308231598595037, 0.008308231598595037, 0.008308231598595037, 0.008300644172477669, 0.008300644172477669, 0.0082930567463603, 0.0082930567463603, 0.0082930567463603, 0.008285469320242931, 0.008285469320242931, 0.008270294468008192, 0.008270294468008192, 0.008270294468008192, 0.008262707041890823, 0.008232357337421347, 0.00820200763295187, 0.008194420206834502, 0.008194420206834502, 0.008194420206834502, 0.008194420206834502, 0.008194420206834502, 0.008186832780717131, 0.008179245354599763, 0.008171657928482394, 0.008164070502365025, 0.008164070502365025, 0.008156483076247657, 0.008148895650130286, 0.008133720797895549, 0.008133720797895549, 0.00812613337177818, 0.00811854594566081, 0.008110958519543441, 0.008095783667308704, 0.008080608815073964, 0.008065433962839227, 0.008065433962839227, 0.008050259110604488, 0.008050259110604488, 0.00804267168448712, 0.00804267168448712, 0.00803508425836975, 0.008027496832252382, 0.008019909406135011, 0.008012321980017643, 0.008012321980017643, 0.007997147127782904, 0.007997147127782904, 0.007981972275548166, 0.007974384849430798, 0.007966797423313429, 0.007966797423313429, 0.007966797423313429, 0.00795920999719606, 0.007944035144961321, 0.007944035144961321, 0.007936447718843952, 0.007936447718843952, 0.007936447718843952, 0.007921272866609213, 0.007906098014374476, 0.007890923162139738, 0.007875748309905, 0.007875748309905]
[(11.18, <rdkit.Chem.rdchem.Mol object at 0x761912356820>), (11.05, <rdkit.Chem.rdchem.Mol object at 0x761912392970>), (11.18, <rdkit.Chem.rdchem.Mol object at 0x7619123656d0>), (11.71, <rdkit.Chem.rdchem.Mol object at 0x761912365430>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912365820>), (10.44, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9c510>), (10.81, <rdkit.Chem.rdchem.Mol object at 0x761912379f90>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912379eb0>), (10.46, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9cac0>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x7619123927b0>), (10.75, <rdkit.Chem.rdchem.Mol object at 0x761aa402ab30>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912379e40>), (10.46, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9cac0>), (10.49, <rdkit.Chem.rdchem.Mol object at 0x761912363660>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x7619123566d0>), (11.57, <rdkit.Chem.rdchem.Mol object at 0x7619123790b0>), (10.6, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00c10>), (10.5, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99eb0>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356f90>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365ba0>), (11.71, <rdkit.Chem.rdchem.Mol object at 0x761912365430>), (11.31, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99580>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x7619123566d0>), (10.85, <rdkit.Chem.rdchem.Mol object at 0x7619123654a0>), (11.36, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabdd0>), (11.72, <rdkit.Chem.rdchem.Mol object at 0x761912392660>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912379eb0>), (10.77, <rdkit.Chem.rdchem.Mol object at 0x761aa3d996d0>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365190>), (11.17, <rdkit.Chem.rdchem.Mol object at 0x7619123652e0>), (10.57, <rdkit.Chem.rdchem.Mol object at 0x761aa3d990b0>), (11.21, <rdkit.Chem.rdchem.Mol object at 0x761912363040>), (11.26, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00120>), (10.92, <rdkit.Chem.rdchem.Mol object at 0x761aa402a740>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912392ba0>), (11.01, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabf20>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912365580>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912365820>), (11.26, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00120>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x7619123927b0>), (10.71, <rdkit.Chem.rdchem.Mol object at 0x761912365510>), (10.46, <rdkit.Chem.rdchem.Mol object at 0x761912363120>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123650b0>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x761912365740>), (10.89, <rdkit.Chem.rdchem.Mol object at 0x761912365f90>), (10.69, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4dd0>), (11.06, <rdkit.Chem.rdchem.Mol object at 0x761aa402af90>), (11.1, <rdkit.Chem.rdchem.Mol object at 0x761912392e40>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912392eb0>), (10.7, <rdkit.Chem.rdchem.Mol object at 0x761aa3d995f0>), (10.57, <rdkit.Chem.rdchem.Mol object at 0x761aa3d990b0>), (11.18, <rdkit.Chem.rdchem.Mol object at 0x7619123656d0>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123634a0>), (10.81, <rdkit.Chem.rdchem.Mol object at 0x761912379f90>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123634a0>), (11.06, <rdkit.Chem.rdchem.Mol object at 0x761aa402af90>), (10.69, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4dd0>), (11.06, <rdkit.Chem.rdchem.Mol object at 0x761aa402af90>), (11.57, <rdkit.Chem.rdchem.Mol object at 0x7619123790b0>), (10.92, <rdkit.Chem.rdchem.Mol object at 0x761912363190>), (10.99, <rdkit.Chem.rdchem.Mol object at 0x761912365350>), (11.28, <rdkit.Chem.rdchem.Mol object at 0x761912365890>), (10.5, <rdkit.Chem.rdchem.Mol object at 0x761912356d60>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912365c10>), (11.8, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9c190>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912365c10>), (11.05, <rdkit.Chem.rdchem.Mol object at 0x761912392970>), (10.54, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99f20>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x7619123922e0>), (11.36, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabdd0>), (10.57, <rdkit.Chem.rdchem.Mol object at 0x761aa3d990b0>), (11.28, <rdkit.Chem.rdchem.Mol object at 0x761912365890>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912356900>), (11.67, <rdkit.Chem.rdchem.Mol object at 0x761912392f20>), (11.72, <rdkit.Chem.rdchem.Mol object at 0x761912392660>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365900>), (10.47, <rdkit.Chem.rdchem.Mol object at 0x761912356dd0>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356f90>), (10.56, <rdkit.Chem.rdchem.Mol object at 0x761912365cf0>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x7619123922e0>), (10.78, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00190>), (10.4, <rdkit.Chem.rdchem.Mol object at 0x7619123926d0>), (10.6, <rdkit.Chem.rdchem.Mol object at 0x761912356970>), (11.21, <rdkit.Chem.rdchem.Mol object at 0x761912363040>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x761912392c80>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365ba0>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x761912365740>), (11.67, <rdkit.Chem.rdchem.Mol object at 0x761912392f20>), (11.31, <rdkit.Chem.rdchem.Mol object at 0x7619123923c0>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x7619123922e0>), (11.28, <rdkit.Chem.rdchem.Mol object at 0x761912365890>), (10.38, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00350>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365ba0>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912392ba0>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912379dd0>), (10.81, <rdkit.Chem.rdchem.Mol object at 0x761912379f90>), (10.42, <rdkit.Chem.rdchem.Mol object at 0x7619123633c0>), (11.4, <rdkit.Chem.rdchem.Mol object at 0x7619123d0510>), (11.21, <rdkit.Chem.rdchem.Mol object at 0x761912363040>), (10.74, <rdkit.Chem.rdchem.Mol object at 0x761912392c10>), (11.3, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4ac0>), (10.54, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4a50>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912356900>), (11.39, <rdkit.Chem.rdchem.Mol object at 0x761912365b30>), (11.79, <rdkit.Chem.rdchem.Mol object at 0x761912392740>), (10.89, <rdkit.Chem.rdchem.Mol object at 0x761912365f90>), (10.58, <rdkit.Chem.rdchem.Mol object at 0x7619123657b0>), (11.21, <rdkit.Chem.rdchem.Mol object at 0x761912363040>), (10.49, <rdkit.Chem.rdchem.Mol object at 0x761912363660>), (10.67, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabcf0>), (11.72, <rdkit.Chem.rdchem.Mol object at 0x761912392660>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365190>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912379dd0>), (11.32, <rdkit.Chem.rdchem.Mol object at 0x761912379cf0>), (11.17, <rdkit.Chem.rdchem.Mol object at 0x7619123652e0>), (10.97, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4eb0>), (11.79, <rdkit.Chem.rdchem.Mol object at 0x761912392740>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x7619123566d0>), (11.4, <rdkit.Chem.rdchem.Mol object at 0x7619123d0510>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356cf0>)]
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[C=C1C(=O)c2c(nnn2-c2ccc(C(=O)Nc3ccc4ncc(C)cc4c3)c(F)c2)C(C)=CN1C,-10.46]
[CNC(=O)c1ccc(-c2ccc(=O)n(CCc3ccc4ncc(-c5cnn(CCO)c5)cc4c3)n2)cc1C(F)(F)F,-11.8]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both incorporate fluorine atoms and heterocyclic groups, which likely contribute to their binding affinity. The second molecule has a morpholine-like ring (CCO) attached to the heterocycle, but this might introduce some flexibility and potentially reduce binding strength. Replacing this morpholine ring with a more rigid, saturated cyclic amine could improve rigidity and increase favorable interactions.

Also, the linkage between the aromatic rings in the first molecule can be optimized: introducing a saturated cyclic amine in place of the reactive olefin might enhance hydrogen bonding and better fit the binding pocket.

Based on this, I propose a molecule that retains the fluorinated aromatic ring and the heterocyclic scaffold but replaces the morpholine with a piperidine ring and modifies the linker to a saturated cyclopentyl ring attached to the heterocycle.

\box{CCN1CCC(C)cc(-c2ccc(=O)n(CCc3ccc4ncc(C)cc4c3)n2)cc1F}
LLM-GENERATED: CCN1CCC(C)C=C(c2ccc(=O)n(CCc3ccc4ncc(C)cc4c3)n2)C=C1F
CCN1CCC(C)C=C(c2ccc(=O)n(CCc3ccc4ncc(C)cc4c3)n2)C=C1F

Boltz running on GPU 2
9.92
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)Nc1ccc(-c2ccc3nnc(Cc4ccc5ncccc5c4)n3n2)cc1,-10.54]
[C1=CC2=NC=C(N3CCOCC3)C=C2C=C1SC1=NN=C2C=CC(C3=CNN=C3)=CN21,-11.09]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I see that both incorporate fused heterocycles and nitrogen-rich rings, which are likely contributing to strong hydrogen bonding and π-stacking interactions in the c-MET binding pocket. The first molecule features a benzene core with a substituted pyridine ring, while the second molecule has a more rigid bicyclic system containing thiazole and pyrazole moieties.

To improve binding affinity, I would consider enhancing hydrogen bond donors/acceptors and increasing aromatic surface area for π-interactions. Additionally, incorporating polar groups or heteroatoms on the fused rings could improve interactions with polar residues in the pocket.

Based on this, I propose introducing a hydroxyl group on the aromatic ring to increase polarity and potential hydrogen bonding. Also, replacing the pyridine in the first molecule with a fused indole-like moiety could enhance π-stacking and hydrophobic contacts.

Therefore, the new molecule I propose is:

\box{O=c1ccc(-c2ccc3nnc(Cc4ccc5ncccc5c4)n3n2)cc1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 122
NON-LLM GENERATED: CNC(=O)SC1=CC=C2N=CC(N3CCOCC3)=CC2=C1
CNC(=O)Sc1ccc2ncc(N3CCOCC3)cc2c1

Boltz running on GPU 2
7.36
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN=C3C=NN(S(=O)(=O)C4=CN=C5C=CC(C6=CN(C)N=C6)=CN45)C3=C2)C=N1,-10.61]
[CN1C=C(C2=CN=C3N=NN(CC4CCCN(C5=NC=C(C6=CN(CCO)N=C6)C=N5)C4)C3=N2)C=N1,-10.76]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, both are heterocyclic structures with multiple nitrogen atoms that participate in hydrogen bonding and pi-stacking interactions within the c-MET binding pocket. The smaller molecule has an N-N linkage with two adjacent nitrogen atoms, while the larger molecule replaces one ring with a piperazine moiety, possibly increasing flexibility and solubility.

From the binding affinities (-10.61 vs. -10.76), the introduction of the piperazine ring gives a modest improvement, likely due to enhanced conformational adaptability and additional polar interactions. However, the relative rigidity and planarity of the fused heterocycles seem important for strong stacking and bioactivity.

To further improve binding, I would consider combining the beneficial features of both: maintaining the key heterocyclic cores from the smaller ligand for planarity and strong interactions, while reintroducing a flexible, basic nitrogen-containing side chain similar to the piperazine in the larger ligand to enhance solubility and additional H-bonding or ionic interactions with the receptor.

Thus, I propose a molecule that keeps the fused heterocyclic core with the N-N linkage but replaces the piperazine with a more conformationally constrained but still basic, saturated piperidine ring attached through a nitrogen atom in the aromatic ring, potentially optimizing positioning and interactions.

Final answer: \box{CN1CCN(C2=CN=C3C=NN(S(=O)(=O)C4=CN=C5C=CC(C6=CN(C)N=C6)=CN45)C3=C2)CC1}
LLM-GENERATED: CN1CCN(c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6cnn(C)c6)cn45)c3c2)CC1
CN1CCN(c2cnc3cnn(S(=O)(=O)c4cnc5ccc(-c6cnn(C)c6)cn45)c3c2)CC1

Boltz running on GPU 2
9.6
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cn1cc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1,-11.31]
[CNC(=O)c1ccc(-c2ccc3nnc(COc4ccnc5cc(OC)ccc45)n3c2)s1,-11.21]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding and hydrophobic interactions in the binding pocket. The existing molecules already have aromatic systems that interact well via π-π stacking, so retaining that scaffold is beneficial.

Molecule 1 has a trifluoromethyl group which contributes to hydrophobic contacts but might be too bulky or less optimal for polar interactions. Molecule 2 incorporates a carbonyl group and methoxy substitutions, establishing potential hydrogen bonding and improving solubility.

To further improve affinity, I would replace the trifluoromethyl with a hydroxyl group to enhance hydrogen bonding capability and add a methoxy substitution on the aromatic ring to maintain polar interactions while reducing steric hindrance. This could strengthen binding by combining hydrophobic and polar contacts in the pocket.

Based on this reasoning, I propose the molecule:

\box{COc1cc(-c2ccc3nnc(C(O)c4ccc5ncccc5c4)n3c2)cc1O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 123
NON-LLM GENERATED: COC1=CC=C2C(=C1)N=CC=C2OCC1=NN=C2C=CC(C3=CC=C(C(=O)F)S3)=CN21
COc1ccc2c(OCc3nnc4ccc(-c5ccc(C(=O)F)s5)cn34)ccnc2c1

Boltz running on GPU 2
11.09
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1CCN(c2cnc3ccc(Sc4nnc5c(F)cc(-c6cnn(C)c6)cn45)cc3c2)CC1=O,-10.7]
[CNC(=O)C1=CC=CC=C1NC1=NC(NC2=CC=C3CCN(C(C)=O)CC(C)C3=C2)=NC=C1Cl,-11.28]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrophobic interactions, hydrogen bonding, and rigidity to reduce entropy loss upon binding. Both initial molecules have heterocyclic systems that interact well with the binding pocket, but there's room to increase hydrophobic contacts and possibly introduce electron-withdrawing groups to modulate electronic properties.

The first molecule contains a methyl-substituted triazole ring and a pentagon-like heterocycle, while the second molecule has a more constrained bicyclic system with a carbonyl group that may engage in hydrogen bonding. To build on this, I would aim to replace the methyl group on the triazole with a phenyl ring to increase π-π stacking and hydrophobic interactions. Additionally, introducing a fluorine atom on the heterocyclic ring could enhance binding through both hydrophobic effects and potential halogen bonding.

Moreover, preserving the core fused heterocyclic scaffold and the oxygen-containing ring (like the morpholine or oxazine) that appears in both molecules could maintain key interactions, while modifying the substituents to optimize fit and electronic properties.

Considering these ideas, I propose the molecule 

\box{Cn1cc(-c2cc(F)c3nnc(Sc4ccc5ncc(NC6CCOCC6)cc5c4)n3c2)cn1}.
LLM-GENERATED: Cn1cc(-c2cc(F)c3nnc(Sc4ccc5ncc(NC6CCOCC6)cc5c4)n3c2)cn1
Cn1cc(-c2cc(F)c3nnc(Sc4ccc5ncc(NC6CCOCC6)cc5c4)n3c2)cn1

Boltz running on GPU 2
11.08
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COCC(C)Nc1n[nH]c2nccc(Oc3ccc(NC(=O)c4cn(C(C)C)c(=O)n(-c5ccc(F)cc5)c4=O)cc3F)c12,-10.69]
[CO/N=C(\C)C1=NN2C(CC3=C(F)C=C4N=CC=CC4=C3F)=CN=C2C=C1,-10.95]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, aromatic stacking, and polar interactions, especially at the key binding pocket. The existing molecules already have strong aromatic systems and fluorine substitutions contributing to affinity and selectivity. To further stabilize the ligand, introducing additional hydrogen bond donors or acceptors in a constrained ring structure could boost interaction specificity. Incorporating a small, rigid ring with amide functionality might also improve binding by restricting conformational flexibility and allowing better fit within the pocket.

Taking this into account, I propose adding a cyclobutane amide ring fused to the pyrimidine core to increase rigidity and introduce an additional hydrogen bonding group.

\box{CC(=O)N1CC(C)=CCc2ccc(NC(=O)c3cn(C(C)C)c(=O)n(-c4ccc(F)cc4)c3=O)cc21}
LLM-GENERATED: CC(=O)N1CC(C)=CCc2ccc(NC(=O)c3cn(C(C)C)c(=O)n(-c4ccc(F)cc4)c3=O)cc21
CC(=O)N1CC(C)=CCc2ccc(NC(=O)c3cn(C(C)C)c(=O)n(-c4ccc(F)cc4)c3=O)cc21

Boltz running on GPU 2
9.09
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COc1ccc2c(OCc3nnc4ncc(-c5ccccc5)nn34)ccnc2c1,-10.4]
[CCn1cc(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(N[C@@H](C)COC)c34)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O,-10.63]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, hydrophobic contacts, and possibly introduce groups that can better fit the binding pocket or interact with polar residues. The first molecule has a phenyl ring attached to a nitrogen heterocycle, while the second molecule contains more polar groups such as amide functionalities and fluorine substituents, contributing to better hydrogen bonding and possibly improved selectivity.

Comparing the two, the second molecule’s amide groups and fluorine atoms likely increase binding affinity through enhanced polar interactions and improved fit. To combine the beneficial features, introducing a methoxy group could provide additional hydrogen bonding or dipole interactions, and switching the phenyl ring to a pyridine might improve stacking or receptor interactions due to the nitrogen’s electronegativity.

Therefore, a promising modification would be to replace the terminal phenyl on the heterocycle with a pyridine ring substituted with a methoxy group, keeping the rest of the scaffold similar to the more binding-effective molecule.

\box{CCn1cc(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(N[C@@H](C)COC)c34)c(F)c2)c(=O)n(-c2cccnc2)c1=O}
LLM-GENERATED: CCn1cc(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(NC(C)COC)c34)c(F)c2)c(=O)n(-c2cccnc2)c1=O
CCn1cc(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(NC(C)COC)c34)c(F)c2)c(=O)n(-c2cccnc2)c1=O

Boltz running on GPU 2
8.94
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Oc1ccc(-c2cc(F)c3nnc(Sc4ccc5ncc(NF)cc5c4)n3c2)cc1,-11.17]
[CCCn1cc(-c2cnc3nnn(C(C)c4ccc5ncccc5c4)c3n2)cn1,-10.57]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: From the given binding affinities, the first molecule has a higher affinity (-11.17) with a phenyl-pyridine moiety and a methoxy group, while the second molecule (-10.57) contains a saturated ring and a triazole-containing aromatic system. Comparing the two, the higher affinity of the first molecule suggests that aromaticity and possible π-stacking in the binding pocket favor pyridine-phenyl motifs. The saturated ring in the second molecule may provide better hydrophobic interactions, but overall, maintaining aromaticity and hydrogen bonding potential seems beneficial.

To combine the advantages, I would introduce an aromatic ring in place of the saturated ring to enhance π-interactions and add a hydroxyl group on the phenyl ring to increase hydrogen bonding without losing the triazole scaffold and pyridine systems, which seem important for binding.

Therefore, the new molecule I propose is:

\box{O=c1cc(-c2ccc(O)cc2)cn2c(OCc3ccc4nnc5nnc(NCc5c4c3)c5)cnc2=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 124
NON-LLM GENERATED: CC(C1=CC=C2N=CC=CC2=C1)N1N=NC2=NC=C(F)N=C21
CC(c1ccc2ncccc2c1)n1nnc2ncc(F)nc21

Boltz running on GPU 2
8.95
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(C1=C(F)C=C2N=CC=CC2=C1F)N1C=NC2=NC=C(C3=CN(CCO)N=C3)N=C21,-11.12]
[O=C(NC1=CC=C(OC2=CC=NC(NC(=O)N3CCC3)=C2)C(F)=C1)C1=CN(CC2CC2)C(=O)N(C2=CC=C(F)C=C2)C1=O,-11.71]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase rigidity for better fit, and introduce groups that interact well with the c-MET active site. Both starting molecules have strong aromatic and heterocyclic components, but one has flexible linkers that might reduce binding strength.

From the first molecule, I see a promising pyrazole-like core (N=CC=CC) that could be improved by replacing the methyl group with a heteroatom-capable ring to increase polarity and hydrogen bonding. The second molecule introduces an amide linkage and a piperazine ring, which improves solubility and potential interactions, but its ethyleneuracil moiety has some flexibility that might reduce binding affinity.

To build on this, I would replace the methyl on the pyrazole ring with a morpholine ring to add polarity and hydrogen bonding capability. I would also reposition the piperazine ring as a fused bicyclic system to increase rigidity and improve shape complementarity with the binding site. Additionally, I would retain the key fluorinated aromatic rings that interact well with c-MET.

\box{Nc1ccc2ncc(-c3cnc4ccn(C5CCNCC6CCOCC6C5)c(=O)c4=Oc3-c2c1)c2cncn2}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 125
NON-LLM GENERATED: CC(C1=C(F)C=CC=C1F)N1C=NC2=NC=C(C3=CN(CCO)N=C3)N=C21
CC(c1c(F)cccc1F)n1cnc2ncc(-c3cnn(CCO)c3)nc21

Boltz running on GPU 2
10.08
330/1000 | avg_top1: 12.050 | avg_top10: 11.759 | avg_top100: 11.074 | avg_sa: 3.244 | div: 0.818
{'avg_top1': 12.05, 'avg_top10': 11.758999999999999, 'avg_top100': 11.074199999999996, 'auc_top1': 3.8934499999999996, 'auc_top10': 3.7842749999999987, 'auc_top100': 3.53147830952381, 'avg_sa': 3.2442996527045875, 'diversity_top100': 0.817587697586448, 'n_oracle': 330}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)c1ccc(-c2ccc3nnc(Cc4ccc(O)cc4)n3n2)cc1Cl,-10.6]
[Cn1cc(-c2ccc3nnc(Sc4ccnc5cc(OCCCN6CCOCC6)ccc45)n3c2)cn1,-10.81]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions in the binding pocket. The first molecule has a Cl atom on the phenyl ring, which could contribute to hydrophobic contacts but might be less optimal for hydrogen bonding. The second molecule incorporates a thioether-linked morpholine moiety, which may improve solubility and enable additional polar interactions, but the binding affinity is only slightly better.

To further enhance binding, I would consider replacing the chlorine with a more polar substituent that can participate in hydrogen bonding with the protein. Also, introducing an amide-linked morpholine could improve interactions through both hydrogen bonding and increased conformational flexibility.

Based on this, I propose a molecule where the Cl atom is replaced by an OH group on the phenyl ring, and the thioether is replaced by an amide linkage to a morpholine moiety attached via a methylene linker. This could provide stronger and more specific interactions with the c-MET binding site.

\box{Cn1cc(-c2ccc3nnc(Cc4ccc(O)cc4)n3c2)cc1C(=O)NCc1ccc(OCCCN2CCOCC2)cc1}
LLM-GENERATED: Cn1cc(-c2ccc3nnc(Cc4ccc(O)cc4)n3c2)cc1C(=O)NCc1ccc(OCCCN2CCOCC2)cc1
Cn1cc(-c2ccc3nnc(Cc4ccc(O)cc4)n3c2)cc1C(=O)NCc1ccc(OCCCN2CCOCC2)cc1

Boltz running on GPU 2
10.34
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C(OC(=O)C4=CC=C(F)C=C4)C(C)(C)C)C=C3F)=C2C=C1OC,-10.46]
[CN1C=C(C2=CN=C3C=NN(S(=O)(=O)C4=CN=C5C=CC(C6=CN(C)N=C6)=CN45)C3=C2)C=N1,-10.61]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase hydrophobic interactions, and optimize the balance of electronegative groups to better fit the binding pocket. The first molecule has a terminal methoxy group and a fluorinated aromatic ring that likely contributes to affinity via hydrophobic contacts. The second molecule incorporates a sulfonyl group and multiple nitrogen heterocycles, which can form strong hydrogen bonds and improve specificity.

Comparing the two, the first molecule’s methoxy substituent at the aromatic ring could be replaced by a more polar hydroxyl group to enhance hydrogen bonding without losing hydrophobic interactions. Additionally, introducing a fluorine atom on the double bond adjacent to the sulfonyl-containing heterocycle may improve binding by increasing electronegativity and possibly forming dipole interactions.

With these considerations, I propose modifying the molecule by replacing the terminal methoxy group with a hydroxyl group and adding a fluorine substituent as described:

\box{C=CC(OC(=O)C(C)(C)C=C(F)c1ccc(O)cc1)NC(=O)C1(C(=O)Nc2ccc(C#CCO)cc2)CC2(C(=O)Nc3ccc(F)cc3)CC1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 126
NON-LLM GENERATED: CN1C=C(C2=CC=C(NC(=O)C(OC(=O)C3=CC=C(F)C=C3)C(C)(C)C)C=C2)C=N1
Cn1cc(-c2ccc(NC(=O)C(OC(=O)c3ccc(F)cc3)C(C)(C)C)cc2)cn1

Boltz running on GPU 2
7.53
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COCC(C)Nc1n[nH]c2nccc(Oc3ccc(NC(=O)c4cn(C(C)C)c(=O)n(-c5ccc(F)cc5)c4=O)cc3F)c12,-10.69]
[COc1cnc2ccc([C@H](C)c3nnc4c(F)cc(-c5cn(C)cn5)cn34)cc2c1,-11.42]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase ligand rigidity, and introduce groups that complement the protein's hydrophobic pocket. The first ligand has a key amide linkage and fluorinated aromatic rings, which contribute to binding, while the second ligand is more flexible with an additional methoxy group and an inverted stereochemistry at one carbon, possibly affecting fit.

From the inversions and flexibilities, I see potential in adding double bonding to reduce flexibility and adding an additional hydrogen bond donor or acceptor to strengthen interactions. Also, replacing the methyl on the pyrimidine ring with an ethyl group could improve hydrophobic contacts without increasing size excessively.

Therefore, I propose a molecule that incorporates these ideas: introducing a pyrimidine with an ethyl substituent, a planar heterocyclic core, and an amide-linked fluorophenyl ring to maintain hydrophobic and hydrogen bonding interactions, along with a small alkyl group on the heterocycle to improve binding and rigidity.

\box{CCn1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc3[nH]nc(NC(C)C)c23)c(F)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 127
NON-LLM GENERATED: COCC(C)NC1=NNC2=C1C(OC1=CC=C(NC(=O)C3=CN(C(C)C)C(=O)N(F)C3=O)C=C1F)=CC=N2
COCC(C)Nc1n[nH]c2nccc(Oc3ccc(NC(=O)c4cn(C(C)C)c(=O)n(F)c4=O)cc3F)c12

Boltz running on GPU 2
8.52
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(NCC1CCCCN1)c1ccc(-c2cc(F)c3ncc(Cc4ccc5ncccc5c4)n3c2)cc1F,-10.9]
[C=C1C(=O)c2c(nnn2-c2ccc(C(=O)Nc3ccc4ncc(C)cc4c3)c(F)c2)C(C)=CN1C,-10.46]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding and aromatic stacking within the binding pocket. The existing molecules already have strong aromatic systems and fluorine substitutions that contribute to affinity, but there is potential to increase polarity and introduce additional hydrogen bond donors or acceptors to better interact with residues in the pocket.

Notably, the first molecule has a piperidine ring that may provide a good scaffold, but replacing it with a more polar heterocycle could improve interactions. The second molecule incorporates methyl groups on the heterocycle, which could improve hydrophobic contacts, but adding a polar amide functionality might increase binding through additional hydrogen bonding.

Based on this, I would design a molecule that keeps the fluorinated aromatic core and replaces the piperidine with a pyrrolidine ring bearing an amide group. This amide can act as a hydrogen bond donor/acceptor and improve affinity without sacrificing hydrophobic contacts.

Therefore, my proposed molecule is:  
\box{CC1CCN(C(=O)c2ccc(-c3cc(F)c4ncc(Cc5ccc6ncccc6c5)n4c3)cc2)CC1}
LLM-GENERATED: CC1CCN(C(=O)c2ccc(-c3cc(F)c4ncc(Cc5ccc6ncccc6c5)n4c3)cc2)CC1
CC1CCN(C(=O)c2ccc(-c3cc(F)c4ncc(Cc5ccc6ncccc6c5)n4c3)cc2)CC1

Boltz running on GPU 2
9.87
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN=C3C=NN(S(=O)(=O)C4=CN=C5C=CC(C6=CN(C)N=C6)=CN45)C3=C2)C=N1,-10.61]
[N#CC1=CC(C2=CN3C(CC4=CC=C5N=CC=CC5=C4)=CN=C3C(F)=C2)=CC=C1,-11.07]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a core similar fused azole ring system, but their substituents on the phenyl rings differ. The first ligand contains an N-methyl group on the phenyl ring, while the second ligand has a fluorine atom. The binding affinity of the second ligand (-11.07) is better than the first (-10.61), suggesting that the fluorine substitution may improve interactions, likely due to enhanced dipole interactions or better fit in the binding pocket.

To further improve binding, I would consider combining the beneficial features of both ligands: maintaining the N-methyl group for possible hydrophobic contacts and adding the fluorine atom to enhance polarity and complementarity. Additionally, the linker structure in the second ligand introduces more flexibility and aromatic interactions, so incorporating this aspect could strengthen binding.

Based on this reasoning, I propose a molecule that integrates an N-methyl phenyl ring with a fluorinated aromatic moiety and a flexible bridge to stabilize interactions within the c-MET pocket.

\box{Cn1cc(-c2cc(C(=O)N3CC4=CCn[-c5ccc(F)cc5C(=O)N4C=C3]c4ccccc4)nc2)cn1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 128
NON-LLM GENERATED: CCC1=CC=C2N=CC=CC2=C1
CCc1ccc2ncccc2c1

Boltz running on GPU 2
6.43
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COCCOc1cnc2ccn([C@H](C)c3nnc4c(F)cc(-c5cc(C)no5)cn34)c(=O)c2c1,-11.18]
[FC1=CC=C(C2=NN3C(=NN=C3C(F)(F)C3=CC=C4N=CC=CC4=C3)N=C2)C=C1,-10.61]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions such as increasing hydrogen bonding, improving aromatic stacking, and optimizing substituents that fit well into the binding pocket. The first molecule has a methyl-substituted oxazole ring that could be modified for better hydrophobic contacts or aromatic interactions. The second molecule’s difluoromethylated ring provides favorable electrostatics, but replacing one trifluoromethyl group with a methyl might reduce steric hindrance while maintaining hydrophobicity and electronic effects.

Based on this, I would introduce a methyl substitution on the oxazole ring to enhance hydrophobic contacts like the first molecule, and replace the trifluoromethyl with a methyl on the fused ring system to optimize size and electronic effects compared to the second molecule.

\box{COCCOc1cnc2ccn([C@H](C)c3nnc4c(C)cc(-c5cc(C)no5)cn34)c(=O)c2c1}
LLM-GENERATED: COCCOc1cnc2ccn(C(C)c3nnc4c(C)cc(-c5cc(C)no5)cn34)c(=O)c2c1
COCCOc1cnc2ccn(C(C)c3nnc4c(C)cc(-c5cc(C)no5)cn34)c(=O)c2c1

Boltz running on GPU 2
10.79
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=NN3C(=NN=C3C(F)(F)C3=CC=C4N=CC=CC4=C3)C=C2)C=N1,-10.42]
[COC1=CC2=C(OC3=CC=C(NC(=O)NN=CC4=CC=C(F)C=C4F)C=C3F)C=CN=C2C=C1OCCCN1CCC(C)CC1,-10.99]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two existing molecules, I see that both incorporate fluorinated aromatic rings and nitrogen-containing heterocycles, which likely contribute to their binding affinity through hydrophobic and hydrogen bonding interactions. However, their binding affinities are moderate, so there's room for improvement.

Molecule 1 uses a diazine core with difluoromethyl-substituted aromatic rings and a flexible linker to a pyridine ring. Molecule 2 replaces the diazine with an ether linkage and adds a flexible chain with a piperidine moiety, maintaining fluorinated aromatics and an amide-containing heterocycle.

To enhance binding, I would consider improving rigidity by reducing flexible linkers while preserving key interaction points. Incorporating a fused heterocyclic system with carbonyl groups could improve hydrogen bonding and shape complementarity. Also, introducing a cyclic amine substituent on the aromatic ring might boost affinity by better filling the binding pocket.

Based on this, I propose a molecule that has a pyridine-dione fused heterocycle with a fluorinated phenyl substituent and a cyclic amine on the aromatic ring to restrict flexibility and add favorable interactions.

\box{CC1=CC(=O)Nc2ccc(-c3cn[nH]c3)cc2C(C)=Oc1C1CCCC1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 129
NON-LLM GENERATED: CN1C=C(C2=NN3C(=NN=C3C(F)(F)NN=CC3=CC=C(F)C=C3F)C=C2)C=N1
Cn1cc(-c2ccc3nnc(C(F)(F)NN=Cc4ccc(F)cc4F)n3n2)cn1

Boltz running on GPU 2
9.45
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(C1=CC=C2N=CC(C3=CN(C)N=C3)=CC2=C1)N1N=NC2=NC=C(C3=CC=NC=C3)N=C21,-10.95]
[NC1=NNC2=CC=CC(C3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3)=C21,-10.5]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both share a similar core structure with extended aromatic rings and nitrogen atoms contributing to hydrogen bonding and π-stacking interactions. However, there are subtle differences in their substituents: the first ligand has a methyl group on the pyrimidine ring, while the second ligand has a fluorophenyl substituent.

To improve binding affinity, I would consider enhancing hydrophobic interactions and electronic effects without disrupting key hydrogen bonds. The fluorophenyl substituent in the second ligand likely adds favorable hydrophobic contacts and possibly dipole interactions, so incorporating a similar aromatic moiety with heteroatoms could further strengthen binding.

I decide to replace the methyl group on the pyrimidine ring of the first ligand with a heteroaromatic ring containing a nitrogen atom to increase hydrogen bonding potential and π-stacking contributions, while maintaining the overall scaffold. This change could enhance both specificity and affinity.

\box{NC1=NNC2=CC=CC(C3=CC=C(NC(=O)C4(C(=O)NC5=CCNCC5)CC4)C=C3)=C21}
LLM-GENERATED: Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)NC5=CCNCC5)CC4)cc3)c12
Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)NC5=CCNCC5)CC4)cc3)c12

Boltz running on GPU 2
8.46
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)C1=CC=C(C2=CN3C(=NN=C3COC3=CC=NC4=CC(OCC(=O)N5CC5)=CC=C43)C=C2)C(F)=C1,-11.06]
[CN1C=C(C2=CN=C3N=NN(CC4CCCN(C5=NC=C(C6=CN(CCO)N=C6)C=N5)C4)C3=N2)C=N1,-10.76]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a core similar to the pyrazole-pyrimidine system, essential for binding to the tyrosine kinase domain of c-MET. However, there are subtle differences in their side chains that could affect binding affinity.

The first molecule has a terminal aromatic ring with a methoxy substituent and a thiazolidine-one ring linked via a methylene linker, while the second molecule replaces the thiazolidine with a piperazine moiety. The binding affinity of the first molecule (-11.06) is slightly better than the second (-10.76), suggesting that the thiazolidine might provide favorable interactions, possibly hydrogen bonding or dipole interactions.

To enhance binding further, I would preserve the core scaffold but try to combine the beneficial features of both molecules: maintain the piperazine-like ring for flexibility and introduce a heteroaromatic ring in place of the terminal aromatic ring to increase hydrogen bonding and π-stacking. Additionally, a hydroxyl group on the terminal aromatic ring could form strong polar contacts.

Thus, I propose introducing a pyridinyl substituent with an hydroxyl on the terminal aromatic ring attached to the piperazine. This modification might improve both affinity and specificity.

The resulting molecule is:

\box{Cn1cc(-c2cc(OCC(=O)N3CCN(c4nnc5=CC(=O)N(Cc6ccc(O)cc6)CC5)CC3)c2)cn1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 130
NON-LLM GENERATED: O=C(COC1=CC=C2C(CC3CCCN(C4=NC=C(C5=CN(CCO)N=C5)C=N4)C3)=CC=NC2=C1)N1CC1
O=C(COc1ccc2c(CC3CCCN(c4ncc(-c5cnn(CCO)c5)cn4)C3)ccnc2c1)N1CC1

Boltz running on GPU 2
8.34
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4=C(I)C=CN(C5=CC=C(F)C=C5)C4=O)C=C3F)=C2C=C1OC,-11.4]
[COC1=CN=C2C=CC([C@H](C)C3=NN=C4C=CC(C5=CC=CC=C5)=NN43)=CC2=C1,-10.63]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, π-π stacking, and hydrophobic contacts. The first molecule has decent affinity but could benefit from adding polar groups to increase hydrogen bonding. The second molecule's fluorinated phenyl and fused nitrogen-containing rings engage well with the protein, but extending conjugation and introducing additional H-bond donors/acceptors might strengthen binding.

Based on this, I would aim to preserve the fused nitrogen system and fluorinated aromatic rings but add a terminal alkyne to increase binding rigidity and potential π-interactions. Also, introducing a methoxy-substituted phenyl ring could provide additional H-bond acceptor capacity and improve solubility.

Therefore, the new molecule I propose incorporates these features: a fused nitrogen heterocycle with an alkyne substituent and a methoxyphenyl group attached through a nitrogen in the ring. This design maintains key interactions from the previous ligand while adding these promising elements.

\box{C#Cc1cccc(-c2c1NC(=O)C3=C(N[C@H](C)C4=NN=C5C=CC(C6=CC=CC=C6)C(=O)C4=O)C(=O)N2Cc1ccc(OC)cc1)c1ccccc1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 131
NON-LLM GENERATED: CC(C1=CC2C(I)=CN=C2C=C1)C1=NN=C2C=CC(C3=CC=CC=C3)=NN21
CC(C1=CC2C(I)=CN=C2C=C1)c1nnc2ccc(-c3ccccc3)nn12

Boltz running on GPU 2
9.13
340/1000 | avg_top1: 12.050 | avg_top10: 11.759 | avg_top100: 11.076 | avg_sa: 3.247 | div: 0.819
{'avg_top1': 12.05, 'avg_top10': 11.758999999999999, 'avg_top100': 11.076399999999996, 'auc_top1': 4.0139499999999995, 'auc_top10': 3.901864999999999, 'auc_top100': 3.64223130952381, 'avg_sa': 3.2466926376911176, 'diversity_top100': 0.8188929184833853, 'n_oracle': 340}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[C1=CC2=NC=C(N3CCOCC3)C=C2C=C1SC1=NN=C2C=CC(C3=CNN=C3)=CN21,-11.09]
[C[C@@H](C1=CC2=CC=CN=C2C=C1F)N1C=NC2=NC=C(C3=CC=C(C(N)=O)C(F)=C3)N=C21,-10.9]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, pi-stacking, and hydrophobic contacts. The first ligand has promising aromatic and heterocyclic rings that interact well with the protein, but it could benefit from stronger hydrogen bond donors or acceptors. The second ligand includes a fluorine atom and an amide group improving polarity and potential hydrogen bonding, but the phenol group may have some steric hindrance or reduced interaction.

Comparing the two, the first ligand’s imine functionality (N=N) could be replaced or enhanced by a hydrazone (N/N=) which can participate in additional hydrogen bonding and possibly improve binding. Introducing a hydroxy-substituted phenyl ring might increase hydrogen bond interactions, and maintaining the fused heterocycles and methyl-substituted ring preserves key aromatic stacking and hydrophobic contacts.

Therefore, I would propose a molecule that replaces the imine with a hydrazone linkage, adds a hydroxy group on the terminal phenyl, and retains the rest of the scaffold for preserved interactions.

\box{CC1=NN=C(C=C2C=C(N3CCOCC3)C(C3=CC3)C12)C1=CC(c1ccc(O)cc1)N1C=NC2=NC=C(C3=CC=C(C(N)=O)C(F)=C3)N=C21}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 132
NON-LLM GENERATED: NC(=O)C1=CC=C(C2=CCOCC2)C=C1F
NC(=O)c1ccc(C2=CCOCC2)cc1F

Boltz running on GPU 2
7.27
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)C1=CC=CC=C1NC1=NC(NC2=CC=C3CCN(C(C)=O)CC(C)C3=C2)=NC=C1Cl,-11.28]
[O=C(NC1=CC(OC2=C(F)C=C(NC(=O)C3(C(=O)NC4=CC=C(F)C=C4)CC3)C(F)=C2)=CC=N1)C1CC1,-10.49]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrophobic interactions, create additional hydrogen bonds, and optimize substituents on the aromatic rings to better complement the c-MET binding pocket. Notably, molecule 1 has a methyl group on the pyrimidine ring that could be substituted with a bulkier, more hydrophobic moiety to increase van der Waals contacts. Molecule 2 incorporates fluorines and an ether linkage, which contribute to affinity but might benefit from an increased number of hydrophobic cycles and possible chlorine substitutions to strengthen nonpolar interactions.

Based on this, I would design a ligand that keeps the core heterocyclic scaffold but replaces the methyl group on the pyrimidine with a branched alkyl chain containing a chlorine atom to enhance hydrophobic contacts. Additionally, I would switch the fluorines on the other aromatic ring for chlorines to potentially improve binding.

Therefore, the new molecule I propose is:

\box{CNC(=O)c1CC(=O)n(-c2ccc(Cl)c(Cl)c2Cl)nc1C1=CC=CC=C1NC1=NC(NC=C1)C(C)=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 133
NON-LLM GENERATED: CNC(=O)C(=O)NC1=NC=CC(OC2=C(F)C=C(NC(=O)C3(C(=O)NC4=CC=C(F)C=C4)CC3)C(F)=C2)=C1
CNC(=O)C(=O)Nc1cc(Oc2cc(F)c(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)ccn1

Boltz running on GPU 2
9.68
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(N=O)C1=NN2C(=NN=C2CC2=C(F)C=C3N=CC=CC3=C2F)C=C1,-11.79]
[CC(=O)NN=C(C)C1=CN=C2N=NN(CC3=CC4=CC=CN=C4C=C3F)C2=N1,-11.07]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a similar core structure with fused aromatic systems and fluorine substituents, which likely contribute to their binding affinity through hydrophobic and electronic effects. The key differences lie in the positioning and connectivity of the nitrogen and oxygen atoms, which can affect hydrogen bonding and overall fit within the binding pocket.

Molecule 1 has a carbonyl group (C=O) linked to a diazene moiety, while Molecule 2 replaces the carbonyl with an oxime (C=N—O) and modifies the ring system slightly. The improvement in binding affinity from -11.79 to -11.07 suggests that changing the functional group and ring geometry can enhance interactions with c-MET.

To further improve binding, I would consider combining elements from both molecules to optimize hydrogen bonding potential and maintain aromatic stacking. Introducing a hydrazone linkage (NNC(=O)N) from Molecule 1 alongside the fused aromatic system with fluorine substituents from both seems beneficial. This preserves key features of each molecule and might enhance affinity through complementary interactions.

Based on this reasoning, I propose the following molecule:

\box{CC(NNC(=O)N)C1=NN2C(=NN=C2CC2=C(F)C=C3N=CC=CC3=C2F)C=C1}
LLM-GENERATED: CC(NNC(N)=O)c1ccc2nnc(Cc3c(F)cc4ncccc4c3F)n2n1
CC(NNC(N)=O)c1ccc2nnc(Cc3c(F)cc4ncccc4c3F)n2n1

Boltz running on GPU 2
10.85
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN=C3N=NN(CC4CCCN(C5=NC=C(C6=CN(CCO)N=C6)C=N5)C4)C3=N2)C=N1,-10.76]
[COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)NC5=CCC(F)C=C5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,-11.36]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase rigidity for better fit, and introduce groups that interact well with the c-MET binding pocket. The first ligand has a fused triazole core and a flexible side chain, while the second ligand uses a carbonyl-linked amide scaffold with fluorinated phenyl rings and a morpholine moiety—both contributing to affinity through hydrogen bonding and hydrophobic contacts.

Comparing the two, the second ligand’s amide and fluorinated aromatic rings seem beneficial for affinity, but its flexibility from the morpholine and alkoxy linker might limit optimal binding pose. The first ligand’s rigid triazole framework could provide less entropy loss upon binding, possibly improving binding affinity.

To combine the advantages, I would introduce a heterocyclic amide-like scaffold that maintains rigidity but offers additional hydrogen bond donors and acceptors. Replacing the alkoxy linker with an amide-linked pyridine or pyrimidine ring can enhance interactions with c-MET’s binding pocket through the nitrogen atoms, while maintaining aromaticity and planarity for stacking.

Also, adding a fluorine-substituted phenyl ring on this heterocyclic amide could give favorable hydrophobic and electronic effects without drastically increasing flexibility.

Therefore, my proposed molecule incorporates these features into a bicyclic amide linked to a pyridine ring substituted with a para-fluorophenyl group and preserves the fused triazole moiety for optimal interaction.

\box{CN1CCN(C(=O)c2ccc(-c3nnn(C[C6CCCN(C4=NC(N)=O)CC4)c3n2)c(F)c2ccccc2)cc2ccnc2c1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 134
NON-LLM GENERATED: CN1C=C(OC2=CC=C(NC(=O)C3(C(=O)NC4=CCC(F)C=C4)CC3)C=C2F)N1
Cn1cc(Oc2ccc(NC(=O)C3(C(=O)NC4=CCC(F)C=C4)CC3)cc2F)[nH]1

Boltz running on GPU 2
8.94
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)c1ccc(-c2ccc3nnc(Cc4ccc(O)cc4)n3n2)cc1Cl,-10.6]
[COCC(C)NC1=NNC2=NC=CC(OC3=CC=C(NC(=O)C4=CN(C(C)C)C(=O)N(C5=CC=C(F)C=C5)C4=O)C=C3F)=C21,-10.69]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, hydrophobic contacts, and possibly metal coordination. The first molecule has a chlorophenyl group that could contribute to hydrophobic interactions, while the second molecule includes fluorinated aromatic rings and an oxime-type linkage, providing potential for favorable dipole and electronic effects.

To strengthen the ligand, I would consider replacing the chlorine with fluorine to increase electronegativity and improving hydrogen bond donor/acceptor compatibility. Also, expanding the aromatic system with additional fused rings or heterocycles can enhance π-π stacking and hydrophobic surface area. Introducing polar substituents like hydroxyl groups could form additional hydrogen bonds with the protein.

Combining these ideas, I would design a ligand that incorporates a fluorinated aromatic core, a heterocyclic system with an oxime linkage, and a hydroxy-substituted bicyclic moiety to maximize these interactions.

\box{CNC(=O)c1ccc(-c2ccc3nnc(Cc4ccc(O)cc4)n3n2)cc1F}
LLM-GENERATED: CNC(=O)c1ccc(-c2ccc3nnc(Cc4ccc(O)cc4)n3n2)cc1F
CNC(=O)c1ccc(-c2ccc3nnc(Cc4ccc(O)cc4)n3n2)cc1F

Boltz running on GPU 2
9.96
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)C1=CC=C(C2=CN3C(=NN=C3COC3=CC=NC4=CC(OCC(=O)N5CC5)=CC=C43)C=C2)C(F)=C1,-11.06]
[C=C1C(=O)c2c(nnn2-c2ccc(C(=O)Nc3ccc4ncc(C)cc4c3)c(F)c2)C(C)=CN1C,-10.46]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both involve fused heterocycles and amide functionalities, suggesting key interactions in the binding site involve hydrogen bonding and π-π stacking. The first molecule has a methoxy substituent and a differully substituted pyridine ring, while the second molecule has a fluorophenyl group and a methyl group on the heterocyclic core.

To improve binding affinity, I would consider enhancing hydrogen bond donors/acceptors and increasing rigidity to reduce entropic penalties. Also, introducing a more electron-withdrawing group like fluorine can strengthen interactions with polar residues.

Combining these ideas, I propose replacing the methoxy group with a carbonyl to introduce an additional hydrogen bond acceptor, and substituting the methyl group on the fused heterocycle with a para-fluorophenyl ring to increase hydrophobic and halogen bonding potential. This yields the molecule:

\box{C/C(=C\C(=O)Nc1ccc(-c2ccc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1)c1ccnn(-c2ccc(F)cc2)c1=O}
LLM-GENERATED: CC(=CC(=O)Nc1ccc(-c2ccc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1)c1ccnn(-c2ccc(F)cc2)c1=O
CC(=CC(=O)Nc1ccc(-c2ccc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1)c1ccnn(-c2ccc(F)cc2)c1=O

Boltz running on GPU 2
9.86
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[C=C1C(=O)c2c(nnn2-c2ccc(C(=O)Nc3ccc4ncc(C)cc4c3)c(F)c2)C(C)=CN1C,-10.46]
[CC(=NNC(N)=O)C1=NN2C(=NN=C2[C@@H](C)C2=CC=C3N=CC=CC3=C2)C=C1,-11.42]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, aromatic stacking, and polarity in key regions of the ligand. The first molecule has a strong aromatic core but may be limited by overly rigid or overly simple substituents. The second molecule introduces a different rationalization of the oxime ether functionality and an additional nitrogen heterocycle, which improves hydrogen bonding but still lacks optimal interaction points for the c-MET binding pocket.

From comparing these two, I see an opportunity to design a molecule that incorporates dual oxime ether linkages for enhanced hydrogen bonding and stability, combined with a more planar heteroaromatic system that can engage in π-π interactions. Adding fluorine substituents often improves binding by modulating electronic properties and increasing lipophilicity without overly increasing size.

Therefore, I propose a ligand that contains two oxime ether groups linked through an imine, paired with a fused heterocyclic system that includes fluorinated aromatic rings and an amino-substituted pyridine to maximize these interactions.

\box{C/C(=N\OCC/N=C/C1=C(N)C(C)=CC(C)=C1)c1ccc2nc(Nc3ccc(F)c(F)c3)nccc2c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 135
NON-LLM GENERATED: CC(C1=CC=C2N=CC=CC2=C1)C1=NN=C2C=CC(F)=NN21
CC(c1ccc2ncccc2c1)c1nnc2ccc(F)nn12

Boltz running on GPU 2
8.76
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(C1=C(F)C=C2N=CC=CC2=C1F)N1C=NC2=NC=C(C3=CN(CCO)N=C3)N=C21,-11.12]
[COCC(C)NC1=NNC2=NC=CC(OC3=CC=C(NC(=O)C4=CN(C(C)C)C(=O)N(C5=CC=C(F)C=C5)C4=O)C=C3F)=C21,-10.69]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two existing molecules, I notice that both share a core bicyclic heteroaromatic system and incorporate substituents bearing aromatic rings with fluorine atoms, which likely contribute to binding through hydrophobic and halogen interactions. The first ligand has an acetyl-amino group and a morpholine-like ring, while the second includes an ether linkage and an N-substituted phenyl ring.

To improve binding affinity, I would consider enhancing hydrogen bonding capacity and increasing rigidity to reduce entropy loss upon binding. Also, shifting from an acetyl-amino to a more robust amide functionality could strengthen interactions with the protein backbone. Additionally, replacing the morpholine or ether-linked substituent with a more hydrophobic, branched alkyl group might better fill the hydrophobic pocket.

Combining these ideas, I propose introducing a secondary amine in place of the acetyl-amino group and substituting the morpholine or ether substituent with a branched alkyl group to increase hydrophobic contacts. Also, changing the amide oxygen to a sulfur atom could improve binding through stronger hydrogen bonding or dipole interactions.

Based on this rationale, the new molecule I suggest is:

\box{CC(C1=CC(=O)N1C=NC2=NC=C(C3=CC(C)CC3)N=C2)N1C=NC2=NC=C(C3=CC=C(NC(=O)C4=CCN(C)CC4)C3=O)C=C2}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 136
NON-LLM GENERATED: OCCN1C=C(C2=NC3=C(N=CC3)N=C2)C=N1
OCCn1cc(-c2cnc3c(n2)CC=N3)cn1

Boltz running on GPU 2
7.31
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C(OC(=O)C4=CC=C(F)C=C4)C(C)(C)C)C=C3F)=C2C=C1OC,-10.46]
[COc1cc(-c2ccc3ncccc3c2)ccc1C(=NNC(N)=O)c1ccc2ncc(C(O)c3c(F)cc4ncccc4c3F)n2n1,-11.31]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase hydrophobic interactions, and optimize the positioning of the ligand within the binding pocket. The first molecule has a fused heterocyclic core with fluorines and methoxy groups, while the second molecule features an amidine-linked moiety and a tri-heterocyclic structure with fluorines and methoxy substitutions.

Comparing the two, the second molecule's amidine group could contribute to stronger hydrogen bonding and possibly better electrostatic interactions. The fused ring system in the first molecule might provide a good shape complementarity, but adding polar groups could improve affinity. Introducing an amide next to the amidine could enhance hydrogen bonding networks and stabilize binding.

Therefore, I would design a molecule that combines the benefits of both: maintaining the fused heterocyclic core with fluorines for hydrophobic and electronic effects, while introducing an amide linked to the amidine to increase polar contacts. Additionally, preserving the methoxy groups ensures solubility and appropriate positioning.

The resulting molecule I propose is:

\box{COc1cc(-c2ccc3ncccc3c2)ccc1C(=NNC(NC(=O)C(F)C(C)C)C1=CC2=NC=CC(C)C2C2C1OC)cc1c(F)cccc1F}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 137
NON-LLM GENERATED: COC1=CC(C2=CC=C3N=CC=CC3=C2)=CC=C1C(=NNC(N)=O)C1=NN2C(C3=CC=C(F)C=C3)=CN=C2C=C1
COc1cc(-c2ccc3ncccc3c2)ccc1C(=NNC(N)=O)c1ccc2ncc(-c3ccc(F)cc3)n2n1

Boltz running on GPU 2
10.28
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CCCN1C=C(C2=CN=C3N=NN(C(C)C4=CC=C5N=CC=CC5=C4)C3=N2)C=N1,-10.57]
[NC(=O)NN=CC1=CN=C2N=NN(CC3=CC=C4N=CC=CC4=C3)C2=N1,-11.05]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, both share a similar core structure with amidine and pyrazole groups that contribute to strong hydrogen bonding and π-stacking interactions in the c-MET binding pocket. The main difference lies in the alkylation on the amidine moiety—molecule 1 has a simple alkyl group, while molecule 2 introduces a bicyclic aromatic system that likely enhances hydrophobic and π-interactions.

To improve binding affinity further, increasing hydrophobic contacts and rigidity in the structure could stabilize the ligand-protein complex. Therefore, I would modify the amidine substituent on the first aromatic ring to incorporate a bicyclic aromatic system with a methyl-substituted nitrogen to expand hydrophobic interactions and potentially engage additional pockets in the receptor.

\box{CCCN1C=C(C2=CN=C3N=NN(C(C)C4=CC(C5=CC=C6CC=CC6=C5)CC4)C3=N2)C=N1}
LLM-GENERATED: CCCn1cc(-c2cnc3nnn(C(C)C4=CC(c5ccc6c(c5)C=CC6)CC4)c3n2)cn1
CCCn1cc(-c2cnc3nnn(C(C)C4=CC(c5ccc6c(c5)C=CC6)CC4)c3n2)cn1

Boltz running on GPU 2
8.83
350/1000 | avg_top1: 12.050 | avg_top10: 11.759 | avg_top100: 11.079 | avg_sa: 3.257 | div: 0.817
{'avg_top1': 12.05, 'avg_top10': 11.758999999999999, 'avg_top100': 11.079099999999997, 'auc_top1': 4.13445, 'auc_top10': 4.019454999999999, 'auc_top100': 3.75300880952381, 'avg_sa': 3.2565445140125977, 'diversity_top100': 0.8171830570538149, 'n_oracle': 350}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cc1csc(-c2ccc3nnc(Cc4ccc5ncccc5c4)n3n2)c1,-11.2]
[COC1=CC2=C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CCC(F)C=C5)CC4)C=C3F)C=CN=C2C=C1OCCCN1CCOCC1,-11.36]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, π-π stacking, and electrostatic contacts. The first ligand has a fused heterocyclic core that interacts well, but adding polar groups or halogens can increase binding. The second ligand incorporates fluorines and an amide, which improve affinity, but its bulkier, more hydrophilic side chains might limit fit or flexibility.

To strike a balance, I would focus on introducing a methoxy group to increase polarity and potential hydrogen bonding without adding excessive bulk. Also, replacing the fused phenyl-pyridine portion with a pyridine-pyridine linkage could enhance planarity and stacking interactions. Adding a chlorine substituent on the distal aromatic ring can provide favorable halogen bonding and hydrophobic contacts.

Based on these considerations, I propose this molecule:

\box{COc1ccn(-c2ccc3nnc(Cc4ccc5ncccc5c4)n3n2)c1}
LLM-GENERATED: COc1ccn(-c2ccc3nnc(Cc4ccc5ncccc5c4)n3n2)c1
COc1ccn(-c2ccc3nnc(Cc4ccc5ncccc5c4)n3n2)c1

Boltz running on GPU 2
10.91
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[N#CC1=CC(C2=CN3C(CC4=CC=C5N=CC=CC5=C4)=CN=C3C(F)=C2)=CC=C1,-11.07]
[CNC(=O)C1=CC=C(C2=CN3C(=NN=C3COC3=CC=NC4=CC(OCC(=O)N5CC5)=CC=C43)C=C2)C(F)=C1,-11.06]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrophobic interactions and possibly introduce halogen bonding or stronger hydrogen bonding. The existing molecules already have aromatic rings and heterocycles that interact well with the protein, but one is missing a halogen substituent to increase binding complementarity, while the other could benefit from adding a polar group to form additional hydrogen bonds.

Based on this, I would aim to keep the core fused heterocyclic system and retain the methylene linker to the pyridine ring, but introduce a chlorine substituent on the terminal aromatic ring to enhance hydrophobic contacts and possibly engage in halogen bonding. Additionally, I would replace the flexible oxygen-containing side chain with a more rigid amide group to increase binding stability through stronger hydrogen bonding.

\box{N#CC1=CC(C2=CN3C(CC4=CC=C5N=CC=CC5=C4)=NN3C2)=CC(C(=O)Nc1ccc(Cl)cc1)c1ccccc1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 138
NON-LLM GENERATED: CNC(=O)C1=CC=C(C2=CN3C(CC4=CC=C5N=CC=CC5=C4)=CN=C3C(F)=C2)CC1
CNC(=O)C1=CC=C(c2cc(F)c3ncc(Cc4ccc5ncccc5c4)n3c2)CC1

Boltz running on GPU 2
10.56
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(C1=C(F)C=C2N=CC(C3=CN(C)N=C3)=CC2=C1F)N1N=NC2=NC=C(C3=CN(CCO)N=C3)N=C21,-11.72]
[CNC(=O)C1=CC=CC=C1NC1=NC(NC2=CC=C3CCN(C(C)=O)CC(C)C3=C2)=NC=C1Cl,-11.28]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a core pyrimidine structure with substituents attached to the nitrogen atoms. Molecule 1 has flexible alkyl chains and fluorinated aromatic rings, while molecule 2 contains a chloro substituent and a piperidine-like ring. The binding affinities suggest that fluorinated aromatic rings might contribute favorably, but the chlorine substituent in molecule 2 may also have beneficial interactions.

To improve binding, I want to combine the favorable features: retain the fluorinated aromatic system and introduce a heteroatom in the side chain to enhance polarity and potential hydrogen bonding. Adding a sulfonyl group can serve as a strong polar anchor and improve solubility. Also, extending the alkyl chain on the piperidine ring could improve hydrophobic interactions without losing flexibility.

Therefore, I decide to generate the molecule with a sulfonyl-substituted alkyl chain attached to the nitrogen in place of the oxygen, and a branched alkyl on the piperidine ring to enhance hydrophobic contacts.

\box{CNS(=O)(=O)CCn1cc(-c2ccc(F)c(F)c2)nc1Nc1ccc(NC(=O)CCN2CCC(C)CC2)cc1Cl}
LLM-GENERATED: CNS(=O)(=O)CCn1cc(-c2ccc(F)c(F)c2)nc1Nc1ccc(NC(=O)CCN2CCC(C)CC2)cc1Cl
CNS(=O)(=O)CCn1cc(-c2ccc(F)c(F)c2)nc1Nc1ccc(NC(=O)CCN2CCC(C)CC2)cc1Cl

Boltz running on GPU 2
8.65
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cn1cc(-c2ccc3ncc(S(=O)(=O)n4ncc5ncc(-c6cnn(-c7ccncc7)c6)cc54)n3c2)cn1,-10.97]
[O=C(NC1=CC(C(F)(F)C2=NN=C3N=CC(C4=CC=C(F)C=C4)=NN32)=CC=N1)C1CC1,-10.38]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase planarity for better stacking interactions, and introduce fluorine atoms to strengthen hydrophobic contacts and possibly improve ligand fit. The first molecule has a favorable heterocyclic core and sulfonamide group facilitating hydrogen bonding, while the second molecule uses an imine linkage and fluorinated rings for optimized interactions.

Combining these ideas, I would maintain the sulfonamide and linked heterocycles to preserve hydrogen bonding, but introduce a fluorinated aromatic ring to enhance hydrophobic interactions. Additionally, embedding an nitrogen-rich heterocycle, such as a pyrazole or pyrimidine, could improve stacking and electronic complementarity.

Therefore, a suitable modification would be to replace the terminal group with a fluorinated phenyl ring connected to the sulfonamide, and a fused heterocyclic system featuring nitrogen atoms that can engage in additional hydrogen bonds or dipole interactions.

\box{Cn1cc(-c2ccc3ncc(S(=O)(=O)n4ncc5ncc(-c6ccc(-c7cnn(C)c7)cc6F)c54)n3c2)cn1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 139
NON-LLM GENERATED: FC1=CN(C2=CC=NC=C2)N1
Fc1cn(-c2ccncc2)[nH]1

Boltz running on GPU 2
5.56
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(C1=C(F)C=C2N=CC=CC2=C1F)N1C=NC2=NC=C(C3=CN(CCO)N=C3)N=C21,-11.12]
[CC1=C2C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)=NC=NN2C=C1OCC(O)CN1CCC(O)CC1,-10.89]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two existing molecules, I notice that both incorporate fluorinated aromatic rings and nitrogen-containing heterocycles, which are known to interact well with the c-MET binding site. The first ligand has a methoxy-substituted phenyl ring and a saturated ring with a methyl group, while the second ligand adds polar functional groups such as hydroxyls and an aliphatic chain to improve solubility and potential hydrogen bonding.

To improve binding affinity, I want to combine the beneficial features of both molecules: maintaining the fluorinated aromatic system for hydrophobic and electronic effects and introducing a flexible, polar moiety to enhance interactions and solubility. Specifically, I aim to preserve the core heterocyclic scaffold with fluorinated rings, add a flexible alkyl chain to the nitrogen-containing saturated ring to increase conformational adaptability, and introduce an amide linkage to provide additional hydrogen bonding capacity.

Therefore, I propose the following molecule, which integrates these modifications:

\box{CNC(=O)c1cc(-c2ccc(F)cc2)ccc1N1CCN(CCCCN2CCN(C)CC2)C(=O)N2CC(=O)NCC2}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 140
NON-LLM GENERATED: OCCN1C=C(C2=CN=C3N=CN(CN4CCC(O)CC4)C3=N2)C=N1
OCCn1cc(-c2cnc3ncn(CN4CCC(O)CC4)c3n2)cn1

Boltz running on GPU 2
8.01
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C1C=CC(N2C=CC3=CC=C(F)C=C32)=NN1CCOC1=CC=NC2=CC(OCCCN3CCOCC3)=CC=C21,-11.57]
[COCC(C)NC1=NNC2=NC=CC(OC3=CC=C(NC(=O)C4=CN(C(C)C)C(=O)N(C5=CC=C(F)C=C5)C4=O)C=C3F)=C21,-10.69]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a key pharmacophore: a heterocyclic core linked to aromatic rings and fluorine substituents that likely engage in favorable interactions within the c-MET binding pocket. The first molecule has a small alkyl group on the oxazole ring and a flexible chain extending from the other oxazole, while the second molecule contains an amide linkage and an N-methylated heterocycle.

To improve binding affinity, I would consider enhancing hydrophobic interactions and rigidifying parts of the molecule to reduce entropy loss upon binding. Also, maintaining or enhancing hydrogen bonding capacity and positioning fluorine atoms to optimize electronic effects and metabolic stability should be beneficial.

With this in mind, I propose introducing a bulkier, branched alkyl substituent on the oxazole ring to increase hydrophobic contacts, and a cyclic amine in place of the flexible chain to improve rigidity and introduce potential additional polar interactions.

Therefore, the new molecule I suggest is:

\box{CC(C)(C)C(=NN1C=CC2=CC=C(F)C=C32)C(=O)N(C(=O)C3=CC(N4CCN5CCOCC5)CC3F)CC1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 141
NON-LLM GENERATED: COCC(C)NC1=NNC2=C1C(OC1=CC=C(NC(=O)C3=CCOCC3)C=C1F)=CC=N2
COCC(C)Nc1n[nH]c2nccc(Oc3ccc(NC(=O)C4=CCOCC4)cc3F)c12

Boltz running on GPU 2
8.55
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(N=O)C1=NN2C(=NN=C2CC2=C(F)C=C3N=CC=CC3=C2F)C=C1,-11.79]
[CC1=C2C(OC3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3F)=NC=NN2C=C1OCC(O)CN1CCC(O)CC1,-10.89]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both incorporate fluorinated aromatic rings and nitrogen-containing heterocycles, which are known to interact well with the c-MET binding site. The first ligand has a more rigid bicyclic system with fluorines optimizing hydrophobic and electronic effects, while the second ligand introduces ether linkers and hydroxyl groups for additional polarity and flexibility.

To improve binding affinity, I would consider combining the beneficial features of both molecules: maintaining the fluorinated aromatic rings for hydrophobic and electronic complementarity, and introducing a flexible nitrogen-containing side chain to enhance interactions and solubility. Additionally, incorporating an amide linkage could provide more hydrogen bonding capability.

With this in mind, I propose a molecule that has a fluorinated aromatic ring linked via an amide to a flexible piperidine-like side chain, combined with a nitrogen-containing heterocycle bearing an ether and a hydroxyl group for further enhanced interactions.

\box{CC1=C(C(=O)NCCCN2CCC(C)CC2)C(=NNC(=O)C2(C(=O)NC3=CC=C(F)C=C3)CC2)=NN1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 142
NON-LLM GENERATED: CC1=C2C(OC3=CC=C(NC(=O)N=O)C=C3F)=NC=NN2C=C1OCC(O)CN1CCC(O)CC1
Cc1c(OCC(O)CN2CCC(O)CC2)cn2ncnc(Oc3ccc(NC(=O)N=O)cc3F)c12

Boltz running on GPU 2
9.1
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[N#CC1=CC(C2=CN3C(CC4=CC=C5N=CC=CC5=C4)=CN=C3C(F)=C2)=CC=C1,-11.07]
[CC(C1=C(F)C=C2N=CC=CC2=C1F)N1C=NC2=NC=C(C3=CN(CCO)N=C3)N=C21,-11.12]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions in the ligand by increasing hydrogen bonding, improving fit into the binding pocket, and increasing favorable van der Waals contacts. The existing molecules already have key heterocycles and aromatic rings that interact with c-MET, but one has fluorines that may contribute to binding via halogen bonding or dipole interactions.

Molecule 1 uses a pyrazole-like motif and a saturated ring system, while Molecule 2 employs an isoxazole fused to an aromatic system with a flexible chain. Comparing the two, I see potential in increasing hydrogen bonding capacity and adding groups that can engage in additional polar contacts without compromising the planarity and aromaticity that supports binding.

Specifically, introducing an amide group could add strong hydrogen bonding. Also, replacing the fluorinated aromatic system with a simpler phenyl ring might improve overall hydrophobic interactions and better complement the binding pocket shape. Incorporating a flexible, polar substituent like a hydroxyethyl group could further enhance binding through additional hydrogen bonding and solvation effects.

Combining these ideas, I propose a ligand that keeps the key heterocyclic core but adds an amide functionality linked to a hydrazine moiety, replacing the fluorinated aromatic with a phenyl ring, and including a hydroxyethyl substituent to increase interactions.

The resulting molecule is:  
\box{CC1=C(C(=O)NNC(=O)C(CO)CC)C(C(=O)Nc2ccccc2)C(=C1F)C}
LLM-GENERATED: CCC(CO)C(=O)NNC(=O)C1=C(C)C(F)=C(C)C1C(=O)Nc1ccccc1
CCC(CO)C(=O)NNC(=O)C1=C(C)C(F)=C(C)C1C(=O)Nc1ccccc1

Boltz running on GPU 2
7.77
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)C1=CC=C(C2=CN3C(=NN=C3COC3=CC=NC4=CC(OC)=CC=C43)C=C2)S1,-11.21]
[CN1C=C(C2=CN=C3C=NN(S(=O)(=O)C4=CN=C5C=CC(C6=CN(C)N=C6)=CN45)C3=C2)C=N1,-10.61]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both involve fused heterocycles and hydrazone linkages, which are common features contributing to binding affinity in this area. However, there are subtle differences in their structural environments that might explain their affinity difference.

The first molecule (binding affinity -11.21) contains a thiocarbonyl group (C=S) which is not typically found in many known bioactive molecules, but it can form strong interactions through sulfur's polarizability. The second molecule (binding affinity -10.61) replaces the thiocarbonyl with a urea-like group (-NN=C-) and introduces a sulfonyl group (S(=O)(=O)), possibly enhancing polarity and hydrogen bonding capacity.

Comparing the two, the sulfonyl group in the second molecule adds polarity and H-bonding potential but may also increase molecular weight and flexibility, possibly reducing binding affinity. The first molecule's thiocarbonyl contributes to rigidity and hydrophobic interactions.

To combine the benefits, I would propose a molecule that retains the thiocarbonyl functionality to maintain favorable hydrophobic and polarizability interactions, while introducing an alkoxy substitution on the fused heterocycle to improve solubility and possibly enhance interactions through hydrogen bonding or dipole interactions.

Therefore, I chose to generate the molecule:

\box{COC(=NN=C1C=NN(C2=CC3NCCOC(C4=CC=NC5=CC(OC)=CC=C45)CC3C2)C1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 143
NON-LLM GENERATED: COC1=CC=C2C(=C1)N=CC=C2OC
COc1ccc2c(OC)ccnc2c1

Boltz running on GPU 2
7.16
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(NC1=CC(C(F)(F)C2=NN=C3N=CC(C4=CC=C(F)C=C4)=NN32)=CC=N1)C1CC1,-10.38]
[CC(C1=C(F)C=C2N=CC=CC2=C1F)N1C=NC2=NC=C(C3=CN(C)N=C3)N=C21,-10.95]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions in the ligand by increasing hydrogen bonding, improving aromatic stacking, and optimizing substituents to better fit the c-MET binding pocket. The first molecule has a strong aromatic system but may be too rigid; the second molecule has a better balance of flexibility and polar interactions but could benefit from additional hydrogen bond donors/acceptors.

Based on this, I would aim to introduce an ether linkage to increase polarity and potential hydrogen bonding without disrupting the aromatic system. Also, adding a methylated nitrogen heterocycle could improve solubility and electronic complementarity. Retaining the trifluoromethyl group is valuable for hydrophobic contacts.

With these considerations, I propose the molecule:  
\box{COc1cc(-c2ccc(F)c(N)c2)ccc2c(C(=O)NCC1=CC(N)=NN1-C(C)(C)F)c(=O)n2}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 144
NON-LLM GENERATED: O=C(NC1=CC=CC=N1)C1CC1
O=C(Nc1ccccn1)C1CC1

Boltz running on GPU 2
4.79
360/1000 | avg_top1: 12.050 | avg_top10: 11.759 | avg_top100: 11.082 | avg_sa: 3.242 | div: 0.817
{'avg_top1': 12.05, 'avg_top10': 11.758999999999999, 'avg_top100': 11.082299999999996, 'auc_top1': 4.25495, 'auc_top10': 4.137044999999999, 'auc_top100': 3.86381580952381, 'avg_sa': 3.241949920003779, 'diversity_top100': 0.8170464613207713, 'n_oracle': 360}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CO/N=C(\C)C1=NN2C(CC3=C(F)C=C4N=CC=CC4=C3F)=CN=C2C=C1,-10.95]
[CC(N=O)C1=NN2C(=NN=C2CC2=C(F)C=C3N=CC=CC3=C2F)C=C1,-11.79]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a similar core scaffold with aromatic rings and fluorine substituents, which likely contribute to their binding affinity through hydrophobic and electronic interactions. The differential binding affinities (-10.95 vs. -11.79) suggest that introducing polar groups capable of forming hydrogen bonds could improve binding, especially near the heterocyclic core.

Molecule 1 has a [CO/N=C] moiety, while molecule 2 has a [CC(N=O)] portion. The nitroso group (N=O) in molecule 2 likely enhances hydrogen bonding, improving affinity. To further improve interactions, adding a flexible, polar substituent with H-bond donor and acceptor capabilities could increase binding. Incorporating a morpholine ring could introduce such interactions via its oxygen and nitrogen atoms.

Additionally, I see potential in replacing the methyl group on the pyrazole ring with an aromatic substituent to boost π-stacking or hydrophobic contacts in the binding pocket.

Combining these insights, I propose adding a morpholine substituent linked through a double bond to the pyrazole core, while maintaining the fluorinated aromatic system and the key heterocycles for stacking and electronic effects.

Final molecule: \box{COc1cc(-c2cnc3ccc4cc(N=C5CCN6CCOCC6C5=O)ccc4=CC3c2)ccc1}
LLM-GENERATED: COc1cccc(C2=CC3C=c4ccc(N=C5CCN6CCOCC6C5=O)cc4=CC=C3N=C2)c1
COc1cccc(C2=CC3C=c4ccc(N=C5CCN6CCOCC6C5=O)cc4=CC=C3N=C2)c1

Boltz running on GPU 2
9.03
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COCCOc1cnc2ccn([C@H](C)c3nnc4c(F)cc(-c5cc(C)no5)cn34)c(=O)c2c1,-11.18]
[COC1=CN=C2C=CC([C@H](C)C3=NN=C4C(F)=CC(C5=CN(C)C=N5)=CN43)=CC2=C1,-11.42]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for enhancing hydrogen bonding, increasing polarity in favorable regions, and optimizing hydrophobic interactions. The existing molecules already have good heterocyclic frameworks and methyl substitutions that enhance hydrophobic contacts, but adding more hydrogen bond donors or acceptors might strengthen interactions with the protein.

Notably, replacing the methylated oxazole in the better ligand with a methylated pyrazole could provide an additional hydrogen bond acceptor, potentially improving affinity. Also, introducing a small polar chain such as a hydroxyethyl group on the core carbon may enhance water-mediated interactions without drastically increasing size.

Therefore, I propose a molecule that replaces the methyloxazole with a methylpyrazole and adds a hydroxyethyl substituent on the chiral center. This should facilitate better binding.

\box{CC(OCC)n1cc(-c2cc(C)nn2)c(=O)c2c1cnn([C@@H](C)c3cc4ncnc(NC)c4c3)c2=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 145
NON-LLM GENERATED: CC1=NOC(C2=CN(C)C=N2)C=C1
CC1=NOC(c2cn(C)cn2)C=C1

Boltz running on GPU 2
5.51
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN=C3N=NN(CC4CCCN(C5=NC=C(C6=CN(CCO)N=C6)C=N5)C4)C3=N2)C=N1,-10.76]
[CN1CCC(NC2=CN=C3C=CC(SC4=NN=C5C(F)=CC(C6=CN(C)N=C6)=CN45)=CC3=C2)CC1,-11.09]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both share similar fused heterocyclic cores and nitrogen-rich moieties that likely contribute to strong hydrogen bonding and π-stacking interactions in the c-MET binding site. However, there are subtle differences in their ring systems and substituents that could affect binding affinity.

The first molecule has a pyrazole-based core with an attached pyridine ring and a piperazine-containing side chain, while the second molecule replaces the piperazine with a simpler cyclic amine and introduces a thiazole-fused heterocycle with a methyl group. The improvement in the binding affinity from -10.76 to -11.09 suggests that modifying the heterocyclic framework and side chains can enhance interactions.

To build on this, I would focus on combining elements that provide improved hydrogen bonding capacity and hydrophobic contacts. Incorporating a hydroxyl group on the nitrogen-containing ring could enable additional hydrogen bonds, while adding a phenyl substituent on the heterocycle might increase π-π stacking and hydrophobic interactions with c-MET's binding pocket.

Taking these considerations and aiming for a balance between flexibility and rigidity, I propose taking the core from the first molecule and replacing the side chain with a cyclic amine containing a hydroxyl group, as well as adding a phenyl substituent on the fused heterocycle to enhance binding.

The resulting molecule is:

\box{CN1CCC(NC2=NN=C3CC4CCN(C)[nH]c4ccccc3C2)CC1}
LLM-GENERATED: CN1CCC(NC2=NN=C3CC4CCN(C)NC4=CC=CC=C3C2)CC1
CN1CCC(NC2=NN=C3CC4CCN(C)NC4=CC=CC=C3C2)CC1

Boltz running on GPU 2
8.07
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CC=C3C(=C2)N=CC=C3OCCN2C(=O)OC3=CC(C4=CN(C)N=C4)=CC=C32)C=N1,-10.47]
[CN1C=C(C2=CC=C3C(=C2)N=CC=C3OCCN2C(=O)OC3=CC(C4=CN(C)N=C4)=CC=C32)C=N1,-10.47]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Given the repeated molecule and its binding affinity of -10.47, it appears that the current ligand features a fused bicyclic heteroaromatic system and a linker region containing methoxy and morpholine-like moieties. The binding affinity remains the same for the same molecule, suggesting that there is room for improvement by optimizing interactions, possibly by enhancing hydrogen bonding or hydrophobic contacts, and increasing molecular complementarity to the binding pocket.

Reviewing the scaffold, I notice that modifying the linker region and replacing the morpholine ring with a simpler but more flexible amine-containing group could potentially improve fit and interaction. Additionally, introducing an extra methyl substitution on the aromatic ring may increase hydrophobic interactions without adding too much bulk.

Based on this, I propose a new molecule that retains the core fused bicyclic system but replaces the morpholine-linked segment with a more flexible alkyl amine chain and adds a methyl substituent on the aromatic ring to potentially boost affinity.

\box{CN1C=C(C2=CC=C3C(=C2)N=CC=C3OCCCN3CCC(C)CC3)C(=N)C(C)=CC1C}
LLM-GENERATED: CC1=CC(C)N(C)C=C(c2ccc3c(OCCCN4CCC(C)CC4)ccnc3c2)C1=N
CC1=CC(C)N(C)C=C(c2ccc3c(OCCCN4CCC(C)CC4)ccnc3c2)C1=N

Boltz running on GPU 2
8.16
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(NCC1CCCCN1)c1ccc(-c2cc(F)c3ncc(Cc4ccc5ncccc5c4)n3c2)cc1F,-10.9]
[CC(=NNC(N)=O)C1=NN2C(=NON2C(C)c2ccc3ncccc3c2)C=C1,-10.85]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to increase hydrogen bonding and polar interactions, as well as optimize hydrophobic contacts. The existing molecules already have aromatic systems that interact well with the binding pocket, so preserving that scaffold is important.

Molecule 1 uses an oxime-based moiety, which provides hydrogen bonding potential, but the hydrazide portion could be modified to enhance stability and binding. Molecule 2 employs a hydrazine linkage with an oxime, also promoting hydrogen bonding, but the constrained oxazole ring might limit flexibility and thus binding optimization.

To improve affinity, I would introduce a sulfonamide group, which is a strong hydrogen bond donor and acceptor, and also add a phenyl substituent to increase hydrophobic interactions and fill the pocket better. Additionally, preserving the fused heterocyclic system from the second molecule seems beneficial for π-π stacking and overall fit.

Based on this, I propose the molecule: 

\box{CS(=O)(=O)Nc1ccc(-c2cc(F)c3ncc(Cc4ccc5ncccc5c4)n3c2)cc1}
LLM-GENERATED: CS(=O)(=O)Nc1ccc(-c2cc(F)c3ncc(Cc4ccc5ncccc5c4)n3c2)cc1
CS(=O)(=O)Nc1ccc(-c2cc(F)c3ncc(Cc4ccc5ncccc5c4)n3c2)cc1

Boltz running on GPU 2
10.04
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[N#CC1=CC(C2=CN3C(CC4=CC=C5N=CC=CC5=C4)=CN=C3C(F)=C2)=CC=C1,-11.07]
[CC(=NNC(N)=O)C1=NN2C(=NON2C(C)c2ccc3ncccc3c2)C=C1,-10.85]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, hydrophobic contacts, and possibly introduce groups that can better fit the binding pocket or interact with key residues in the c-MET active site.

The first molecule has a pyridine-like ring and a linked pyrrole, with fluorine providing polarity and potential hydrogen bonding, while the second molecule contains more nitrogen-rich heterocycles and an hydrazide moiety for additional hydrogen bonding. Comparing the two, introducing a pyridine ring with an amino substituent could enhance hydrogen bonding and hydrophilicity, while maintaining the core fused heterocyclic system for aromatic stacking and shape complementarity.

Therefore, I would propose a molecule that incorporates an amino-substituted pyridine ring fused to a pyrrole, with the rest of the structure retaining the fused heterocyclic system and fluorine substitution for polarity. This should improve binding affinity through a combination of hydrogen bonding, hydrophobic contacts, and favorable shape.

\box{C#CC1=CC(C2=CN3C(CC4=CC=C5N=CC=CC5=C4)=CN=C3C(F)=C2)=CC(-c1cccnc(N)c1)C=C1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 146
NON-LLM GENERATED: CC(=NNC(N)=O)C1=CC=CC1C#N
CC(=NNC(N)=O)C1=CC=CC1C#N

Boltz running on GPU 2
7.33
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)C1=CC=CC=C1NC1=NC(NC2=CC=C3CCN(C(C)=O)CC(C)C3=C2)=NC=C1Cl,-11.28]
[N#CC1=CC(C2=CN=C3N=NN(CC4CN(C5=NC=C(C6=CCNCC6)C=N5)CCO4)C3=N2)=CC=C1Cl,-11.01]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity in the right regions, and maintain or enhance aromatic interactions. The existing molecules already have strong aromatic systems and heterocyclic cores, so preserving that scaffold is important.

From the two given molecules, I notice that one has a morpholine ring (NC1CCOCC1) and the other has a N-methylated version of that ring. The -O- linkage in the morpholine could contribute to favorable hydrogen bonding, and maintaining this feature might increase binding. Also, the substitution on the phenyl ring needs to balance hydrophobic and polar interactions; adding a methoxy group could improve affinity by providing an additional H-bond acceptor or modulating electronic properties.

Therefore, comparing the two, I would suggest reintroducing the morpholine ring and combining it with a methoxy substitution on the aromatic ring to potentially enhance binding affinity.

\box{CNC(=O)c1cccc(-c2ccc3ncc(NC4CCOCC4)nc3n2)c1}
LLM-GENERATED: CNC(=O)c1cccc(-c2ccc3ncc(NC4CCOCC4)nc3n2)c1
CNC(=O)c1cccc(-c2ccc3ncc(NC4CCOCC4)nc3n2)c1

Boltz running on GPU 2
8.18
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4=C(I)C=CN(C5=CC=C(F)C=C5)C4=O)C=C3F)=C2C=C1OC,-11.4]
[CCn1cc(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(N[C@@H](C)COC)c34)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O,-10.63]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase hydrophobic interactions, and optimize the positioning of electron-withdrawing groups to stabilize the ligand in the binding pocket. The first molecule has promising fluorine substitutions and aromatic rings but could benefit from additional polar functionality to engage in stronger hydrogen bonds. The second molecule already forms hydrogen bonds via the pyrimidine ring and amide linkages, but replacing certain parts with a more rigid, heterocyclic system that can better complement the protein surface might improve affinity.

Considering these points, I would introduce a fused heterocyclic system with carbonyl groups to form additional hydrogen bond acceptors, and include a flexible but constrained substituent such as a morpholine ring to enhance solubility and interactions without losing hydrophobic contacts.

\box{CCn1cc(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(NCC5CCOCC5)c34)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O}
LLM-GENERATED: CCn1cc(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(NCC5CCOCC5)c34)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O
CCn1cc(C(=O)Nc2ccc(Oc3ccnc4[nH]nc(NCC5CCOCC5)c34)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O

Boltz running on GPU 2
10.49
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(c1ccc2ncc(-c3cnn(C)c3)cc2c1)N1N=NC2=NC(=S)C(C3=CCNCC3)C2=N1,-11.26]
[COCC(C)NC1=NNC2=NC=CC(OC3=CC=C(NC(=O)C4=CN(C(C)C)C(=O)N(C5=CC=C(F)C=C5)C4=O)C=C3F)=C21,-10.69]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both incorporate nitrogen-rich heterocycles and flexible linkers to fit into the binding pocket of c-MET. The first ligand uses a pyridine-pyrazole framework combined with a thiadiazoline moiety, while the second ligand employs an oxyazolate linked to a substituted heterocycle with fluorinated phenyl rings.

To improve binding affinity, I would consider enhancing hydrophobic interactions and hydrogen bonding capabilities without sacrificing flexibility. The second ligand's fluorinated phenyl rings likely contribute to hydrophobic contacts, so maintaining one of these rings might be beneficial. However, the bulkier substituents and multiple carbonyl groups in the amide region could be limiting flexibility and cause desolvation penalties.

The first ligand's smaller, less rigid structure and presence of a methylated heterocycle suggest a possible balance between entropic and enthalpic contributions. To build on this, I would replace the thiadiazoline with a diazolinone moiety to introduce an additional hydrogen bond acceptor, potentially increasing interactions with the protein while keeping the molecule compact and hydrophobic groups intact.

Therefore, the new designed molecule incorporates the diazolinone core combined with the methylated pyrazole from the first ligand and retains the fluorinated phenyl ring to preserve hydrophobic contacts.

\box{COc1ccc2ncc(-c3cnn(C)c3)cc2c1N1N=C2NNC(C3=CCNCC3)C2=O1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 147
NON-LLM GENERATED: COCC(C)NC1=NNC2=C1C(OC1=CC=C(NC(=O)C3=CCNCC3)C=C1F)=CC=N2
COCC(C)Nc1n[nH]c2nccc(Oc3ccc(NC(=O)C4=CCNCC4)cc3F)c12

Boltz running on GPU 2
8.65
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(C1=CC=C2N=CC(C3=CN(C)N=C3)=CC2=C1)N1N=NC2=NC=C(C3=CC=NC=C3)N=C21,-10.95]
[CNC(=O)C1=CC=C(C2=CN3C(=NN=C3COC3=CC=NC4=CC(OCC(=O)N5CC5)=CC=C43)C=C2)C(F)=C1,-11.06]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase planarity for better π-stacking, and introduce electronegative groups to strengthen dipole interactions. The existing molecules already share similar core heterocycles and methyl substitutions, but one incorporates an amide and ethylene linker with a fluorine atom, which could contribute to affinity via polar interactions and improved fit.

To build on this, I would focus on maintaining the key heterocyclic frameworks but optimize the linker and substituents to enhance binding further. Introducing a fluorine on the phenyl ring could improve dipole interactions and metabolic stability. Also, replacing the morpholine or piperazine moieties with a more planar pyridine-like nitrogen could enhance stacking and hydrogen bonding capabilities.

Combining these ideas, I propose a molecule that maintains the core heterocycles with a fluorinated phenyl ring and a pyridine nitrogen in the linker to potentially improve affinity.

\box{Cn1cc(-c2cc(C(=O)N3CCN(c4ccc(F)cc4)CC3=O)ccc2=CC2CN=C1)ccc1ncc(-c2ccccc2)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 148
NON-LLM GENERATED: CNC(=O)C=CC1=CN=C2N=NN(C(C)C3=CC=C4N=CC(C5=CN(C)N=C5)=CC4=C3)C2=N1
CNC(=O)C=Cc1cnc2nnn(C(C)c3ccc4ncc(-c5cnn(C)c5)cc4c3)c2n1

Boltz running on GPU 2
10.98
370/1000 | avg_top1: 12.050 | avg_top10: 11.759 | avg_top100: 11.086 | avg_sa: 3.242 | div: 0.817
{'avg_top1': 12.05, 'avg_top10': 11.758999999999999, 'avg_top100': 11.086099999999997, 'auc_top1': 4.37545, 'auc_top10': 4.2546349999999995, 'auc_top100': 3.9746578095238103, 'avg_sa': 3.2424552678604557, 'diversity_top100': 0.8173273764894203, 'n_oracle': 370}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C1C=CC(N2C=CC3=CC=C(F)C=C32)=NN1CCOC1=CC=NC2=CC(OCCCN3CCOCC3)=CC=C21,-11.57]
[CCC(C1=CC=C2N=CC=CC2=C1F)N1C=NC2=NC=C(C3=CC=C(C(N)=O)C(F)=C3)N=C21,-10.71]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have strong aromatic interactions and fluorine substituents contributing to binding, but their core structures and linker lengths vary. The first molecule has a oxalamide-based core with an ethoxy-ethylene linker, while the second uses a triazole-like pyrazole-pyridine scaffold with an amide side chain.

To improve affinity, I would consider extending the linker region to increase flexibility and optimize reach within the binding pocket, while adding potential H-bond donors/acceptors to enhance interactions. Also, incorporating an additional aromatic ring could strengthen π-π stacking.

Therefore, I propose introducing a propyl linker replacing the ethyl/ethyl oxalamide scaffold, adding a pyridine ring in place of the pyrazole, and retaining the fluorinated phenyl for key interactions.

The new molecule I generate is: \box{CCN1CC(=O)NCC(Cc2ccc(F)cc2)C1=CC1=CC(N2CCN(CCCOCC)CC2)=CC(C)=C1C}
LLM-GENERATED: CCOCCCN1CCN(c2cc(C)c(C)c(C=C3C(Cc4ccc(F)cc4)CNC(=O)CN3CC)c2)CC1
CCOCCCN1CCN(c2cc(C)c(C)c(C=C3C(Cc4ccc(F)cc4)CNC(=O)CN3CC)c2)CC1

Boltz running on GPU 2
9.4
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(NC1=CC=C(OC2=CC=NC(NC(=O)N3CCC3)=C2)C(F)=C1)C1=CN(CC2CC2)C(=O)N(C2=CC=C(F)C=C2)C1=O,-11.71]
[CNC(=O)C1=CC=C(C2=CN3C(=NN=C3COC3=CC=NC4=CC(OCC(=O)N5CC5)=CC=C43)C=C2)C(F)=C1,-11.06]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase rigidity to reduce entropy loss, and introduce groups that interact well with the c-MET binding pocket. The first molecule has a key amide linkage that can be optimized, and the second molecule shows potential in the heterocyclic core but may benefit from additional polar functionalities to increase interactions.

Focusing on improving the first molecule, replacing the N-methylmorpholine ring with a more hydrogen-bonding capable amide-linked piperazine could increase affinity through additional H-bonds and better conformational rigidity. Adding a para-fluorophenyl substituent on the piperazine nitrogen may enhance hydrophobic interactions and binding pocket fit.

\box{CNC(=O)C1=CC=C(C(=O)N2CCC(N[C(=O]NC(=O)Cc3ccc(F)cc3)N2)CC2)C(F)=C1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 149
NON-LLM GENERATED: CC(=O)NC1=CC=C(OC2=CC=NC(NC(=O)N3CCC3)=C2)C(F)=C1
CC(=O)Nc1ccc(Oc2ccnc(NC(=O)N3CCC3)c2)c(F)c1

Boltz running on GPU 2
7.11
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=NN3C(=NN=C3C(F)(F)C3=CC=C4N=CC=CC4=C3)C=C2)C=N1,-10.42]
[CNC(=O)C1=CC=C(C2=CN3C(=NN=C3COC3=CC=NC4=CC(OC)=CC=C43)C=C2)S1,-11.21]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two existing molecules, I see that both incorporate fused heterocycles and trifluoromethyl groups for strong hydrophobic and electronic effects, which likely enhance binding affinity. The first molecule uses a trifluoromethyl-substituted ring with a fluorine atom positioned on a pyrrole ring, while the second molecule incorporates an ether-linked aromatic system with fluorines on the phenyl rings.

To improve binding, I would consider maintaining the trifluoromethyl group to preserve lipophilicity and electronic effects, but increase the connectivity of fluorines on the aromatic moiety to enhance interactions and possibly improve metabolic stability. Introducing a fluorine at a different position on the fused heterocycle could also optimize binding geometry and pi-stacking.

Based on this, I propose a molecule where the trifluoromethyl group remains but the fluorine is now on a pyrrole ring with an additional fluorine on the fused phenyl ring, increasing fluorine substitution while preserving core heterocycles.

The new molecule is: \box{CN1CC=C(C2=NN3C(=NN=C3C(F)(F)C3=CC4=CC(F)ccc43)C=C2)C1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 150
NON-LLM GENERATED: CNC(F)(C1=CC=C2N=CC=CC2=C1)C1=NN=C2C=CC(C3=CN(C)N=C3)=NN21
CNC(F)(c1ccc2ncccc2c1)c1nnc2ccc(-c3cnn(C)c3)nn12

Boltz running on GPU 2
9.43
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CCC(C1=CC=C2N=CC=CC2=C1F)N1C=NC2=NC=C(C3=CC=C(C(N)=O)C(F)=C3)N=C21,-10.71]
[CNC(=O)c1ccc(-c2ccc3nnc(Cc4ccc(O)cc4)n3n2)cc1Cl,-10.6]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: From the given binding affinities, both molecules have close interactions with the c-MET receptor, but there is room for improvement. The first molecule contains a fused ring system with aromatic and heterocyclic moieties that likely contribute to strong π-π stacking and hydrogen bonding. The second molecule includes a chlorinated phenyl ring and an amide group, suggesting key interactions but slightly lower affinity.

To boost binding, I would focus on enhancing hydrogen bond donors/acceptors and increasing planarity to improve stacking, while maintaining or improving hydrophobic interactions. Introducing a methoxy group could improve solubility and offer additional H-bond acceptor capacity. Also, shifting the substituents to optimize positioning within the binding pocket is key.

Based on these considerations, I propose the molecule:

\box{COc1cc(-c2ccc3nnc(Cc4ccc(O)cc4)n3n2)ccc1N=Cc1ccc(=O)n(-c2ccc3nccn3c2)c1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 151
NON-LLM GENERATED: OC1=CC=C(CC2=NN=CC2)C=C1
Oc1ccc(CC2=NN=CC2)cc1

Boltz running on GPU 2
6.69
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN=C3C=NN(S(=O)(=O)C4=CN=C5C=CC(C6=CN(C)N=C6)=CN45)C3=C2)C=N1,-10.61]
[CCC(C1=CC=C2N=CC=CC2=C1F)N1C=NC2=NC=C(C3=CC=C(C(N)=O)C(F)=C3)N=C21,-10.71]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have strong aromatic and heterocyclic features that contribute to their binding affinity. The first molecule contains multiple nitrogen atoms and sulfonyl groups, which likely engage in hydrogen bonding and polar interactions within the binding pocket. The second molecule has a similar theme with pyridine and pyrrole rings, but substituted with carbonyl and fluorine groups that seem to modulate electronic properties and hydrophobic contacts.

To improve binding, I would aim to enhance hydrogen bonding capacity while maintaining or increasing aromatic stacking and hydrophobic interactions. Introducing electron-donating groups like methoxy could improve affinity via polar interactions and electronic effects. Also, incorporating fused heterocycles with multiple nitrogen atoms may better complement the binding site topology and engage additional contacts.

Based on this, I propose a new molecule that integrates a methoxy-substituted pyridine ring fused to a pyrrole system with an amide-linked heterocycle bearing methyl and N-methyl groups to optimize hydrophobic and hydrogen bonding interactions.

\box{COc1ccn(-c2ccc3ncc(NC(=O)c4cn(C)cn(-c5ccc6c(c5)CN=C6C)c4=O)cc3c2)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 152
NON-LLM GENERATED: CCC(C1=CC=C2N=CC=CC2=C1F)S(=O)(=O)C1=CN=C2C=CC(C3=CN(C)N=C3)=CN12
CCC(c1ccc2ncccc2c1F)S(=O)(=O)c1cnc2ccc(-c3cnn(C)c3)cn12

Boltz running on GPU 2
10.58
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)C1=CC=C(C2=CN3C(=NN=C3COC3=CC=NC4=CC(OCC(=O)N5CC5)=CC=C43)C=C2)C(F)=C1,-11.06]
[CC(N=O)C1=NN2C(=NN=C2CC2=C(F)C=C3N=CC=CC3=C2F)C=C1,-11.79]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity in favorable regions, and maintain or enhance aromatic interactions. The first molecule has a terminal amide group that could be improved by replacing it with a more rigid and hydrogen bond-donating group like a heterocyclic amine. The second molecule has fluorinated aromatic rings that contribute to hydrophobic and electronic effects, which are beneficial, but the nitrogen-oxygen heterocycle might be optimized further.

Given these observations, I would focus on replacing the amide group with an ethylamine-substituted pyrazole ring to provide additional hydrogen bonding and stability. Also, modifying the oxygen-containing heterocycle to a more nitrogen-rich pyrazole could enhance polar interactions and possibly metal coordination. This leads me to propose:

\box{CCN1CC(=NNC(C)=O)CC(C)=CC2=CN3C(=NN=C3COC4=CC=NC5=CC(NCCN(C)N=CC1)CC45)C=C2}
LLM-GENERATED: CCN1CC=NN(C)CCNC2C=C3N=CC=C(OCc4nnc5ccc(cn45)C=C(C)CC(=NNC(C)=O)C1)C3C2
CCN1CC=NN(C)CCNC2C=C3N=CC=C(OCc4nnc5ccc(cn45)C=C(C)CC(=NNC(C)=O)C1)C3C2

Boltz running on GPU 2
9.44
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)C1=CC=CC=C1NC1=NC(NC2=CC=C3CCN(C(C)=O)CC(C)C3=C2)=NC=C1Cl,-11.28]
[CC(=O)NN=C(C)C1=CN=C2N=NN(CC3=CC4=CC=CN=C4C=C3F)C2=N1,-11.07]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase ligand flexibility in key areas, and introduce groups that can better interact with the c-MET binding pocket. Notably, the first molecule has a pyrazole ring system with a bulky isopropyl substituent, while the second molecule uses an oxime-based linkage with a fluorinated fused aromatic system.

To build on this, I might replace the bulky isopropyl group with a more flexible, polar substituent that can form additional hydrogen bonds. Also, incorporating a pyridine ring instead of the pyrazole could improve binding through better π-stacking or hydrogen bonding with the protein. Adding a keto group in the side chain could increase polarity and interaction potential.

Combining these ideas, I propose a molecule that retains the core fused heterocycle scaffold but replaces the pyrazole with a pyridine and introduces a hydroxyalkyl substituent to improve solubility and hydrogen bonding.

\box{O=C(Cc1ccc2nccn2c1)c1c[nH]c(-c2ccc3ncccc3n2)c1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 153
NON-LLM GENERATED: CC(=O)NN=C(C)C
CC(=O)NN=C(C)C

Boltz running on GPU 2
4.88
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN3C(SC4=CC=C5N=CC6=C(OCC(=O)N6C)C5=C4)=NN=C3C(F)=C2)C=N1,-10.8]
[CN1C=C(C2=CN=C3N=NN(CC4CCCN(C5=NC=C(C6=CN(CCO)N=C6)C=N5)C4)C3=N2)C=N1,-10.76]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a core bicyclic nitrogen-rich scaffold with aromatic rings and heterocycles, which interacts well with the binding site. However, there may be room to improve hydrophobic interactions and flexibility by introducing electron-donating groups or linkers that enhance van der Waals contacts without sacrificing binding geometry.

Molecule 1 has a fluorine substituent on one aromatic ring, which likely contributes to affinity through halogen bonding or dipole interactions. Molecule 2 uses a flexible nitrogen-containing side chain with a morpholine-like ring, which may improve solubility and binding by forming additional hydrogen bonds.

To build on these features, I would consider adding a methoxy group (–OCH3) on the aromatic ring to increase electron density and enhance hydrophobic interactions. Also, extending the side chain with a short alkyl linker (like a methylene) before the nitrogen heterocycle could improve fit and binding by allowing better contouring to the pocket. Retaining the fluorine substituent seems beneficial, so I would keep that in place.

Based on this reasoning, I propose the following molecule:

\box{COc1cccc(-c2nn3c(C=C(C)c4ncc(-c5ccc(F)cc5)cc4=NN3C2)c(=O)n1-c2ccccc2)c1cc1c2ccccc2c1C}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 154
NON-LLM GENERATED: CN1C=C(C2=CN3C(=NN=C3C3=CN(CCO)N=C3)C(F)=C2)C=N1
Cn1cc(-c2cc(F)c3nnc(-c4cnn(CCO)c4)n3c2)cn1

Boltz running on GPU 2
8.32
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(=NNC(N)=O)c1cnc2nnn(Cc3cc4cccnc4cc3F)c2n1,-11.67]
[Cn1cc(-c2ccc3nnc(Sc4ccnc5cc(OCCCN6CCOCC6)ccc45)n3c2)cn1,-10.81]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding and hydrophobic interactions, particularly in the region interacting with the protein's active site. The first molecule offers a good starting point with the amidine-like moiety (NNC(N)=O), but introducing polar groups that can form additional hydrogen bonds may increase affinity. The second molecule incorporates piperazine-based side chains for solubility and potential interactions, but the ether linkage (OCC...) might be replaced by a more rigid or aromatic scaffold to improve binding specificity.

Given these considerations, I would focus on incorporating an amide group to boost hydrogen bonding capacity and add an aromatic heterocycle to enhance π-stacking or hydrophobic contacts. Also, introducing a chlorine substituent can improve binding through halogen bonding or enhanced lipophilicity.

Based on this, I propose the following molecule:

\box{CC(=NNC(N)=O)c1cnc2nnn(Cc3ccc4ncccc4c3F)c2n1}
LLM-GENERATED: CC(=NNC(N)=O)c1cnc2nnn(Cc3ccc4ncccc4c3F)c2n1
CC(=NNC(N)=O)c1cnc2nnn(Cc3ccc4ncccc4c3F)c2n1

Boltz running on GPU 2
11.41
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)C1=CC=C(C2=CN3C(=NN=C3COC3=CC=NC4=CC(OC)=CC=C43)C=C2)S1,-11.21]
[C[C@@H](C1=CC2=CC=CN=C2C=C1F)N1C=NC2=NC=C(C3=CC=C(C(N)=O)C(F)=C3)N=C21,-10.9]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase aromatic stacking, and optimize substituents on the heterocycles to better complement the c-MET binding pocket. The first molecule features a thiophene ring with methyl and oxygen-containing substituents, while the second molecule includes fluorine substitutions and an amide group contributing to polarity and potential hydrogen bonding.

Comparing the two, the first molecule has a more planar, aromatic framework that might support stronger π-π interactions, while the second molecule’s fluorines and amide could improve specificity and hydrogen bonding. To combine these benefits, introducing an ether linkage to connect an aromatic heterocycle with oxygen-containing substituents might increase flexibility and interaction possibilities. Also, maintaining the ketone or amide functionality to provide hydrogen bonding remains important.

Therefore, a promising approach is to design a molecule containing a fused heterocycle with an ether-linked phenyl ring, maintaining the aromatic core and adding an amide group on a substituted pyridine ring to engage in additional hydrogen bonding and stacking interactions.

The molecule I propose is:  
\box{Cn1cc(-c2cc3nccc(Oc4ccc5ncccc5c4)c3n2)cn1C(=O)Nc1ccc(C(=O)Nc2ccccc2)cc1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 155
NON-LLM GENERATED: COC1=CC=C2C(=C1)N=CC=C2OCC1=NN=C2C=C(C3=CC=C(C(N)=O)C(F)=C3)CN21
COc1ccc2c(OCc3nnc4n3CC(c3ccc(C(N)=O)c(F)c3)=C4)ccnc2c1

Boltz running on GPU 2
10.96
380/1000 | avg_top1: 12.050 | avg_top10: 11.759 | avg_top100: 11.098 | avg_sa: 3.244 | div: 0.816
{'avg_top1': 12.05, 'avg_top10': 11.758999999999999, 'avg_top100': 11.097700000000001, 'auc_top1': 4.49595, 'auc_top10': 4.372224999999999, 'auc_top100': 4.08557680952381, 'avg_sa': 3.244180052800861, 'diversity_top100': 0.8159935085370011, 'n_oracle': 380}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(C1=CC=C2N=CC(C3=CN(C)N=C3)=CC2=C1)N1N=NC2=NC(=S)C(C3=CCNCC3)C2=N1,-11.26]
[CCC(C1=CC=C2N=CC=CC2=C1F)N1C=NC2=NC=C(C3=CC=C(C(N)=O)C(F)=C3)N=C21,-10.71]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both leverage fused aromatic systems and heterocyclic groups to engage in key interactions within the c-MET binding pocket. The first molecule employs a pyrazole-pyrimidine core with an appended piperazine moiety, while the second uses a pyridine-pyrazole framework combined with a phenyl ring bearing an amide group.

To improve binding affinity, I would consider enhancing hydrogen bonding capacity and hydrophobic contacts simultaneously. Extending the linker region with a flexible alkyl chain could allow better reach into the pocket. Additionally, introducing a cyclic amine instead of a linear one might improve binding rigidity and complementarity. Keeping the heterocyclic core intact is important, but adding a methyl group on the nitrogen could optimize electronic properties and increase lipophilicity modestly.

Based on these considerations, I propose a molecule that maintains the pyrazole-pyrimidine core, adds a butyl chain as a flexible linker, and replaces the piperazine with a cyclic amine fused to a methylated nitrogen on the heterocycle.

\box{CCC(C1=CC=C2N=CC=CC2=C1)N1N=C(C2CCCC2)C(c3cn(-c4ccccc4)nc3N)N1}
LLM-GENERATED: CCC(c1ccc2ncccc2c1)N1N=C(C2CCCC2)C(c2cn(-c3ccccc3)nc2N)N1
CCC(c1ccc2ncccc2c1)N1N=C(C2CCCC2)C(c2cn(-c3ccccc3)nc2N)N1

Boltz running on GPU 2
10.15
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4=C(I)C=CN(C5=CC=C(F)C=C5)C4=O)C=C3F)=C2C=C1OC,-11.4]
[CC(C1=CC=C2N=CC(C3=CN(C)N=C3)=CC2=C1)N1N=NC2=NC=C(C3=CC=NC=C3)N=C21,-10.95]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both share some key features: fused heterocycles and fluorinated aromatic rings, which likely contribute to their binding affinity through hydrophobic and electronic interactions. However, their binding affinities are close but not optimal, suggesting subtle improvements could enhance interaction with the c-MET receptor.

Molecule 1 has a methoxy-substituted aromatic ring with a carbonyl group, while Molecule 2 has a methylated heterocycle and fluorinated aromatic rings. Comparing the two, I think introducing an alkyl chain linking the fused heterocycles could improve hydrophobic contacts and better fill the binding pocket. Additionally, maintaining the fluorine substituents seems beneficial for binding, so incorporating those into the new design is wise.

Therefore, I propose a molecule that combines elements from both: an alkyl linker connecting a substituted fused heterocycle with fluorinated aromatic rings to enhance hydrophobic interactions and electronic complementarity.

\box{CCCC1=CC=C(C(=O)N2CC3=CC(N)=CC(C3=O)C2=CC1OCc1ccc(F)c(F)c1)C(c2ccnn2)c1ccccc1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 156
NON-LLM GENERATED: COC1=CC2=NC=C(C3=CC=NC=C3)C2C=C1OC
COC1=CC2=NC=C(c3ccncc3)C2C=C1OC

Boltz running on GPU 2
7.35
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)C1=CC=C(C2=CN3C(=NN=C3COC3=CC=NC4=CC(OCC(=O)N5CC5)=CC=C43)C=C2)C(F)=C1,-11.06]
[CCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1,-10.92]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions such as increasing hydrogen bonding, improving aromatic stacking, and introducing polar groups to better fit the binding pocket. Molecule one has a ketone and amide moiety that may contribute to binding, while molecule two has a fused heterocyclic system with nitrogen atoms that can act as hydrogen bond acceptors or donors.

Comparing the two, I see potential in increasing polarity and flexibility to improve interactions, especially by adding ether linkers or hydroxyl groups that may increase hydrogen bonding without disrupting aromatic systems. Also, maintaining the fused heterocyclic core from molecule two is promising for preserving key interactions.

Therefore, I propose a new molecule that incorporates an ether-linked hydroxy substituent on a phenyl ring, combined with the fused heterocyclic system and an amide-linked cyclopentane to boost binding affinity. This design balances polarity, flexibility, and aromaticity.

\box{COc1ccc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cc1OC(C(=O)C1CCCC1)c1ccc2ncccc2c1}
LLM-GENERATED: COc1ccc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cc1OC(C(=O)C1CCCC1)c1ccc2ncccc2c1
COc1ccc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cc1OC(C(=O)C1CCCC1)c1ccc2ncccc2c1

Boltz running on GPU 2
10.92
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CN=C2C=CC([C@H](C)C3=NN=C4C(F)=CC(C5=CN(C)C=N5)=CN43)=CC2=C1,-11.42]
[CO/N=C(\C)C1=NN2C(CC3=C(F)C=C4N=CC=CC4=C3F)=CN=C2C=C1,-10.95]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, π-π stacking, and electrostatic contacts. The existing molecules already have aromatic rings and heterocycles that contribute to these interactions, but there's room to increase polarity and hydrogen bond donors/acceptors in key positions.

Comparing the two, the higher-affinity molecule has a methylated nitrogen which may provide subtle electronic effects, but the overall scaffold is more reduced in polar groups. The lower-affinity molecule has a methoxy group that could contribute to improved solubility and potential hydrogen bonding but may be less planar or have steric clashes.

To propose a stronger ligand, I would incorporate an amide functionality to introduce both hydrogen bonding capability and rigidity, while maintaining the aromatic system and fluorine substituents that may engage in favorable interactions with the c-MET binding pocket. The amide linked to an ethoxy-containing side chain could provide improved binding through additional polar contacts and possibly better shape complementarity.

Therefore, based on these considerations, I choose the molecule:

\box{CCOC(=O)Nc1ccc2ncccc(-c3ccc4c(c3)NCCN4=C[C@H](C)C(=NN=C4C(C)=O)[C@@H](C)C2=O)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 157
NON-LLM GENERATED: CON=C(C)C1=NN2C(CC3=NN=C4C(F)=CC(C5=CN(C)C=N5)=CN34)=CN=C2C=C1
CON=C(C)c1ccc2ncc(Cc3nnc4c(F)cc(-c5cn(C)cn5)cn34)n2n1

Boltz running on GPU 2
9.69
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COCCOC1=CN=C2C=CN([C@H](C)C3=NN=C4C(F)=CC(C5=CC(C)=NO5)=CN43)C(=O)C2=C1,-11.18]
[Cc1csc(-c2ccc3nnc(Cc4ccc5ncccc5c4)n3n2)c1,-11.2]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for enhancing interactions with the active site of c-MET, particularly hydrogen bonding, hydrophobic contacts, and possibly reducing flexibility to increase binding entropy. The existing molecules have similar heterocyclic cores and methyl substitutions that contribute to hydrophobic interactions, but there is potential to introduce additional hydrogen bond donors or acceptors to strengthen enzyme-ligand interactions.

Comparing the two, incorporating a carbonyl group adjacent to the fused heterocycles could offer a new hydrogen bonding opportunity and potentially improve polarity without compromising hydrophobic contacts. Maintaining the chiral center and the methyl-substituted oxazole ring preserves key interactions.

Based on this, I propose introducing a carbonyl group between the fused rings and the methylated oxazole to enhance binding affinity while preserving the core scaffold and stereochemistry.

\box{CC[C@@H](C)[nH]c1ncnc(O=Cc2ccc3nnc4C[C@H](C)C(=O)NN34)c1n1}-
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 158
NON-LLM GENERATED: COCCOC1=CN=CCC1
COCCOC1=CN=CCC1

Boltz running on GPU 2
5.56
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CN=C2C=CC([C@H](C)C3=NN=C4C(F)=CC(C5=CN(C)C=N5)=CN43)=CC2=C1,-11.42]
[NC(=O)NN=CC1=CN=C2N=NN(CC3=CC=C4N=CC=CC4=C3)C2=N1,-11.05]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity, and optimize interactions with the binding pocket. The first molecule has moderate affinity, but adding polar groups like amides or hydroxyls could improve interactions with nearby residues. The second molecule already incorporates nitrogen-rich heterocycles for strong hydrogen bonding, but adding an additional polar group such as a hydroxamic acid (NNC(=O)O) might increase chelation and solubility, potentially boosting affinity.

Based on this reasoning, I would combine the scaffold of the first molecule with a hydroxamic acid group to leverage both hydrogen bonding potential and maintain a favorable core structure. This leads me to propose this new molecule:

\box{COC1=NN=C2C(C3=CC=C4N=CC=CC4=C3)C(C(=O)NNC(=O)O)C(=C2C1)C}
LLM-GENERATED: COC1=NN=C2C(=C(C)C(C(=O)NNC(=O)O)C2c2ccc3ncccc3c2)C1
COC1=NN=C2C(=C(C)C(C(=O)NNC(=O)O)C2c2ccc3ncccc3c2)C1

Boltz running on GPU 2
8.05
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CCN1CCC(N2C=C(C3=CN=C4C=CC5=CC=C(NS(=O)(=O)N(C)C)C=C5C(=O)C4=C3)C=N2)CC1,-11.1]
[OCCN1C=C(C2=CN=C3N=NN(CC4=CC=C5N=CC=CC5=C4)C3=N2)C=N1,-10.74]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both share a fused heterocyclic core and an imine functionality that likely contributes to binding through hydrogen bonding and π-stacking. However, there are key differences in their side chains and substituents:

1. The first molecule contains a piperazine ring linked through an imine, while the second has an oxyalkyl chain with a hydrazone moiety. The piperazine ring may provide more conformational rigidity and interactions, but the hydrazone could optimize hydrogen bonding and flexibility.

2. The second molecule's sulfonamide substituent (in the hydrazone side chain) may enhance binding affinity through polar interactions and solubility, which is not explicitly seen in the first molecule.

3. The aromatic portions of both molecules could improve binding by incorporating electron-donating groups to increase π-stacking or hydrogen bonding capacity.

Considering these points, a promising strategy would be to combine the benefits of rigidity and hydrogen bonding by introducing a sulfonamide group on the piperazine-based ligand to improve polar interactions, and add an electron-donating methoxy group on the aromatic ring to enhance π-stacking and solubility. This could potentially increase binding affinity by improving both enthalpic and entropic contributions.

Therefore, I propose the molecule:

\box{COC(=O)N1CCN(C(=O)Nc2ccc(-c3ccc4c(c3)NCCN(C)c4=O)cc2)CC1}.
LLM-GENERATED: COC(=O)N1CCN(C(=O)Nc2ccc(-c3ccc4c(c3)NCCN(C)C4=O)cc2)CC1
COC(=O)N1CCN(C(=O)Nc2ccc(-c3ccc4c(c3)NCCN(C)C4=O)cc2)CC1

Boltz running on GPU 2
8.03
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)C1=CC=C(C2=CN3C(=NN=C3COC3=CC=NC4=CC(OC)=CC=C43)C=C2)S1,-11.21]
[CCN1CCC(N2C=C(C3=CN=C4C=CC5=CC=C(NS(=O)(=O)N(C)C)C=C5C(=O)C4=C3)C=N2)CC1,-11.1]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity for c-MET, I would look for ways to enhance hydrogen bonding, increase polarity in favorable regions, and maintain or enhance aromatic interactions. The first molecule has a favorable aromatic system but may be too hydrophobic. The second molecule includes polar groups (like amides) that improve binding but has a different core scaffold.

To bridge this, I would focus on incorporating a heterocyclic system that offers multiple hydrogen bond donors/acceptors and maintain aromatic substituents that engage in π-π stacking. Introducing an amide group adjacent to a nitrogen heterocycle could improve affinity via hydrogen bonding and polarity. Also, adding a methoxy group on an aromatic ring may enhance interactions without adding too much bulk.

Based on this, I propose the molecule:

\box{COc1cccc(-c2cnc(NC(=O)c3ccc4ncccc4c3)c2)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 159
NON-LLM GENERATED: CNC(=O)C1=CC=C(C2=CN3C(=NN=C3CS(=O)(=O)N(C)C)C=C2)S1
CNC(=O)c1ccc(-c2ccc3nnc(CS(=O)(=O)N(C)C)n3c2)s1

Boltz running on GPU 2
7.5
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)C1=CC=C(C2=CN3C(=NN=C3COC3=CC=NC4=CC(OCC(=O)N5CC5)=CC=C43)C=C2)C(F)=C1,-11.06]
[CC(=NNC(N)=O)c1cnc2nnn(Cc3cc4cccnc4cc3F)c2n1,-11.67]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity in favorable regions, and maintain or enhance aromatic interactions. The first ligand has a ketone and amide functionality that contribute to affinity, but may be limited in hydrogen bond donors/acceptors. The second ligand includes nitrogen-rich heterocycles and fluorine substituents, which can improve electronic properties and binding specificity.

To build on this, introducing an ester linkage with an amide group could increase hydrogen bonding capacity and add flexibility without sacrificing affinity. Also, incorporating a fused heterocycle with carbonyl groups might enhance binding through additional hydrogen bonds and dipole interactions. Retaining the fluorine substituent can maintain favorable electronic effects.

Therefore, I propose a molecule that combines these features:

\box{COC(=O)N1CC(=O)N(C(=O)c2ccc(-c3nnn(Cc4ccc5ncccc5c4)n3)cc2)CC1}.
LLM-GENERATED: COC(=O)N1CCN(C(=O)c2ccc(-c3nnn(Cc4ccc5ncccc5c4)n3)cc2)C(=O)C1
COC(=O)N1CCN(C(=O)c2ccc(-c3nnn(Cc4ccc5ncccc5c4)n3)cc2)C(=O)C1

Boltz running on GPU 2
8.77
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(C1=CC=C2N=CC(C3=CN(C)N=C3)=CC2=C1)N1N=NC2=NC(=S)C(C3=CCNCC3)C2=N1,-11.26]
[CC(C1=C(F)C=C2N=CC=CC2=C1F)N1C=NC2=NC=C(C3=CN(CCO)N=C3)N=C21,-11.12]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a similar core scaffold with variations in substituents and ring compositions. Both incorporate the pyrazole-pyrimidine core known to interact well with the c-MET binding site, but one uses a thiazole ring and the other a pyridine. The difference in heterocycles could affect binding affinity, and substituents like fluorines and alkyl groups contribute to hydrophobic and electronic effects.

To improve binding, I would consider maintaining the pyrazole-pyrimidine core and pyridine ring system due to their compatibility, but also optimize hydrophobic interactions by replacing the morpholine or piperazine moieties with more hydrophobic cyclic amines such as piperidine or piperazine with alkyl substituents to enhance van der Waals contacts.

Thus, a promising modification would be to keep the pyridine-pyrazole pyrimidine core and replace the N-methylpiperazine or morpholine with a piperidine ring substituted with a methyl group to balance polarity and hydrophobicity, aiming for improved fit and affinity.

\box{CC(C1=CC=C2N=CC(C3=CNCC3)CC2=C1)N1NC=C(C2=CC3NCCN(C)CC3=NC2)N1}
LLM-GENERATED: CC(c1ccc2c(c1)CC(C1=CNCC1)C=N2)N1NC=C(C2=CC3NCCN(C)CC3=NC2)N1
CC(c1ccc2c(c1)CC(C1=CNCC1)C=N2)N1NC=C(C2=CC3NCCN(C)CC3=NC2)N1

Boltz running on GPU 2
10.29
390/1000 | avg_top1: 12.050 | avg_top10: 11.759 | avg_top100: 11.101 | avg_sa: 3.252 | div: 0.816
{'avg_top1': 12.05, 'avg_top10': 11.758999999999999, 'avg_top100': 11.100800000000003, 'auc_top1': 4.6164499999999995, 'auc_top10': 4.489814999999999, 'auc_top100': 4.19656930952381, 'avg_sa': 3.251901390551674, 'diversity_top100': 0.8157306072145087, 'n_oracle': 390}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN=C3N=NN(CC4CCCN(C5=NC=C(C6=CN(CCO)N=C6)C=N5)C4)C3=N2)C=N1,-10.76]
[CCCNS(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C5CCN(CC)CC5)c4)cc3c(=O)c2c1,-10.77]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase rigidity to reduce entropy loss upon binding, and introduce groups that interact well with the c-MET active site. Both initial molecules have oxazole or oxadiazole rings and a flexible side chains, but one could propose a more constrained, fused heterocycle to improve binding geometry.

Comparing the two, the first molecule has a semipolar scaffold with extensive methylene linkers, while the second introduces an acyl hydrazide moiety and a pyridine-like fused ring system, which may contribute to better π-stacking or hydrogen bonding. However, the second molecule's binding affinity is only slightly better, suggesting room for optimization in rigidity and polar interactions.

To build on this, I would aim for a scaffold that maintains key heterocycles but adds a rigid bicyclic or fused structure to reduce conformational flexibility and enhance binding. Introducing an amide or lactam group could improve hydrogen bonding while avoiding excessive bulk. Retaining the oxadiazole and pyridine-like elements could preserve key aromatic and polar contacts.

Based on this reasoning, I propose the molecule:

\box{CC1CN(C2CCN(C3=NC=N(C4=CCNC(=O)C5(c6ccnc(NC(=O)C5)cc6)C4=O)C3=O)CC2)CC1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 160
NON-LLM GENERATED: CCN1C=C(C2=CN(C)N=C2)N1
CCn1cc(-c2cnn(C)c2)[nH]1

Boltz running on GPU 2
5.81
[(12.05, <rdkit.Chem.rdchem.Mol object at 0x761912363820>), (11.87, <rdkit.Chem.rdchem.Mol object at 0x761aa402a660>), (11.86, <rdkit.Chem.rdchem.Mol object at 0x761912392b30>), (11.8, <rdkit.Chem.rdchem.Mol object at 0x7619123636d0>), (11.8, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9c190>), (11.79, <rdkit.Chem.rdchem.Mol object at 0x761912392740>), (11.72, <rdkit.Chem.rdchem.Mol object at 0x761912392660>), (11.71, <rdkit.Chem.rdchem.Mol object at 0x761912365430>), (11.67, <rdkit.Chem.rdchem.Mol object at 0x761912392f20>), (11.57, <rdkit.Chem.rdchem.Mol object at 0x7619123790b0>), (11.55, <rdkit.Chem.rdchem.Mol object at 0x761912363200>), (11.52, <rdkit.Chem.rdchem.Mol object at 0x761912392ac0>), (11.52, <rdkit.Chem.rdchem.Mol object at 0x761912363430>), (11.5, <rdkit.Chem.rdchem.Mol object at 0x761912365dd0>), (11.44, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabeb0>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912392eb0>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x7619123566d0>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912365580>), (11.41, <rdkit.Chem.rdchem.Mol object at 0x761aa3dbd350>), (11.4, <rdkit.Chem.rdchem.Mol object at 0x7619123d0510>), (11.39, <rdkit.Chem.rdchem.Mol object at 0x761912392f90>), (11.39, <rdkit.Chem.rdchem.Mol object at 0x761912365b30>), (11.36, <rdkit.Chem.rdchem.Mol object at 0x7619123653c0>), (11.32, <rdkit.Chem.rdchem.Mol object at 0x761912379cf0>), (11.31, <rdkit.Chem.rdchem.Mol object at 0x7619123923c0>), (11.31, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99580>), (11.3, <rdkit.Chem.rdchem.Mol object at 0x7619123637b0>), (11.3, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4ac0>), (11.28, <rdkit.Chem.rdchem.Mol object at 0x761912365890>), (11.26, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00120>), (11.22, <rdkit.Chem.rdchem.Mol object at 0x761912392a50>), (11.21, <rdkit.Chem.rdchem.Mol object at 0x761912363040>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912392350>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912392510>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912379eb0>), (11.18, <rdkit.Chem.rdchem.Mol object at 0x761912356820>), (11.18, <rdkit.Chem.rdchem.Mol object at 0x7619123656d0>), (11.17, <rdkit.Chem.rdchem.Mol object at 0x7619123d0970>), (11.17, <rdkit.Chem.rdchem.Mol object at 0x7619123652e0>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912356900>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912365ac0>), (11.1, <rdkit.Chem.rdchem.Mol object at 0x761912392e40>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356b30>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356cf0>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912365c10>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912365200>), (11.08, <rdkit.Chem.rdchem.Mol object at 0x761912392820>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x7619123927b0>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x761912365740>), (11.06, <rdkit.Chem.rdchem.Mol object at 0x761aa402af90>), (11.06, <rdkit.Chem.rdchem.Mol object at 0x761912365a50>), (11.05, <rdkit.Chem.rdchem.Mol object at 0x761912392970>), (11.03, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00890>), (11.01, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabf20>), (10.99, <rdkit.Chem.rdchem.Mol object at 0x761912365350>), (10.98, <rdkit.Chem.rdchem.Mol object at 0x761aa3dbd3c0>), (10.97, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4eb0>), (10.96, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99c80>), (10.96, <rdkit.Chem.rdchem.Mol object at 0x761aa3dbdb30>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912392ba0>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356eb0>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356f90>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912365820>), (10.94, <rdkit.Chem.rdchem.Mol object at 0x761912392890>), (10.94, <rdkit.Chem.rdchem.Mol object at 0x761912392900>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761912365d60>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00660>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9cb30>), (10.92, <rdkit.Chem.rdchem.Mol object at 0x761912363190>), (10.92, <rdkit.Chem.rdchem.Mol object at 0x761aa402a740>), (10.92, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabc80>), (10.91, <rdkit.Chem.rdchem.Mol object at 0x761912356890>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912379dd0>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365190>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365eb0>), (10.89, <rdkit.Chem.rdchem.Mol object at 0x761912365f90>), (10.85, <rdkit.Chem.rdchem.Mol object at 0x7619123654a0>), (10.85, <rdkit.Chem.rdchem.Mol object at 0x7619123569e0>), (10.81, <rdkit.Chem.rdchem.Mol object at 0x761912379f90>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912392120>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x7619123d09e0>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761912379e40>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761aa402ac80>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99dd0>), (10.79, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99430>), (10.79, <rdkit.Chem.rdchem.Mol object at 0x761912363270>), (10.78, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00190>), (10.77, <rdkit.Chem.rdchem.Mol object at 0x761aa3d996d0>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365900>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365ba0>), (10.75, <rdkit.Chem.rdchem.Mol object at 0x761aa402ab30>), (10.74, <rdkit.Chem.rdchem.Mol object at 0x761912392c10>), (10.72, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4d60>), (10.72, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4820>), (10.71, <rdkit.Chem.rdchem.Mol object at 0x761912365510>), (10.7, <rdkit.Chem.rdchem.Mol object at 0x761aa3d995f0>), (10.69, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4dd0>), (10.67, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabcf0>), (10.65, <rdkit.Chem.rdchem.Mol object at 0x761912365e40>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123650b0>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123634a0>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x761912392c80>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x7619123922e0>), (10.6, <rdkit.Chem.rdchem.Mol object at 0x761912356970>), (10.6, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00c10>), (10.59, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9c5f0>), (10.58, <rdkit.Chem.rdchem.Mol object at 0x7619123657b0>), (10.58, <rdkit.Chem.rdchem.Mol object at 0x761aa3dbd0b0>), (10.57, <rdkit.Chem.rdchem.Mol object at 0x761aa3d990b0>), (10.56, <rdkit.Chem.rdchem.Mol object at 0x761912365cf0>), (10.56, <rdkit.Chem.rdchem.Mol object at 0x761aa3dab660>), (10.56, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9ce40>), (10.54, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99f20>), (10.54, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4a50>), (10.52, <rdkit.Chem.rdchem.Mol object at 0x761912392270>), (10.51, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00e40>), (10.5, <rdkit.Chem.rdchem.Mol object at 0x761912356d60>), (10.5, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4cf0>), (10.5, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99eb0>), (10.49, <rdkit.Chem.rdchem.Mol object at 0x761912363660>)]
[0.009112220205679564, 0.008976104053230708, 0.008968542044761328, 0.008923169993945042, 0.008923169993945042, 0.008915607985475662, 0.008862673926189996, 0.008855111917720615, 0.008824863883843091, 0.008749243799149284, 0.008734119782210522, 0.008711433756802379, 0.008711433756802379, 0.008696309739863616, 0.00865093768904733, 0.00863581367210857, 0.00863581367210857, 0.00863581367210857, 0.008628251663639189, 0.008620689655169808, 0.008613127646700428, 0.008613127646700428, 0.008590441621292284, 0.008560193587414762, 0.008552631578945381, 0.008552631578945381, 0.008545069570476, 0.008545069570476, 0.008529945553537237, 0.008514821536598476, 0.008484573502720952, 0.008477011494251572, 0.00846944948578219, 0.00846944948578219, 0.00846944948578219, 0.008454325468843428, 0.008454325468843428, 0.008446763460374047, 0.008446763460374047, 0.008408953418027143, 0.008408953418027143, 0.008393829401088381, 0.008386267392619001, 0.008386267392619001, 0.008386267392619001, 0.008386267392619001, 0.00837870538414962, 0.00837114337568024, 0.00837114337568024, 0.008363581367210859, 0.008363581367210859, 0.008356019358741478, 0.008340895341802716, 0.008325771324863954, 0.008310647307925193, 0.008303085299455813, 0.008295523290986432, 0.00828796128251705, 0.00828796128251705, 0.008280399274047669, 0.008280399274047669, 0.008280399274047669, 0.008280399274047669, 0.008272837265578288, 0.008272837265578288, 0.008265275257108908, 0.008265275257108908, 0.008265275257108908, 0.008257713248639525, 0.008257713248639525, 0.008257713248639525, 0.008250151240170145, 0.008242589231700764, 0.008242589231700764, 0.008242589231700764, 0.008235027223231384, 0.00820477918935386, 0.00820477918935386, 0.008174531155476337, 0.008166969147006957, 0.008166969147006957, 0.008166969147006957, 0.008166969147006957, 0.008166969147006957, 0.008159407138537574, 0.008159407138537574, 0.008151845130068194, 0.008144283121598813, 0.008136721113129432, 0.008136721113129432, 0.008129159104660052, 0.008121597096190671, 0.00810647307925191, 0.00810647307925191, 0.00809891107078253, 0.008091349062313147, 0.008083787053843767, 0.008068663036905005, 0.008053539019966242, 0.008038415003027481, 0.008038415003027481, 0.008023290986088718, 0.008023290986088718, 0.008015728977619338, 0.008015728977619338, 0.008008166969149957, 0.008000604960680576, 0.008000604960680576, 0.007993042952211196, 0.007985480943741815, 0.007985480943741815, 0.007985480943741815, 0.007970356926803052, 0.007970356926803052, 0.007955232909864291, 0.00794767090139491, 0.00794010889292553, 0.00794010889292553, 0.00794010889292553, 0.00793254688445615]
[(10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365eb0>), (11.08, <rdkit.Chem.rdchem.Mol object at 0x761912392820>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x761912392c80>), (10.74, <rdkit.Chem.rdchem.Mol object at 0x761912392c10>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x7619123566d0>), (10.92, <rdkit.Chem.rdchem.Mol object at 0x761aa402a740>), (10.79, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99430>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356eb0>), (11.52, <rdkit.Chem.rdchem.Mol object at 0x761912363430>), (10.96, <rdkit.Chem.rdchem.Mol object at 0x761aa3dbdb30>), (11.06, <rdkit.Chem.rdchem.Mol object at 0x761912365a50>), (11.17, <rdkit.Chem.rdchem.Mol object at 0x7619123d0970>), (10.92, <rdkit.Chem.rdchem.Mol object at 0x761912363190>), (11.17, <rdkit.Chem.rdchem.Mol object at 0x7619123d0970>), (11.3, <rdkit.Chem.rdchem.Mol object at 0x7619123637b0>), (10.77, <rdkit.Chem.rdchem.Mol object at 0x761aa3d996d0>), (11.31, <rdkit.Chem.rdchem.Mol object at 0x7619123923c0>), (10.7, <rdkit.Chem.rdchem.Mol object at 0x761aa3d995f0>), (10.5, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4cf0>), (11.05, <rdkit.Chem.rdchem.Mol object at 0x761912392970>), (10.69, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4dd0>), (11.4, <rdkit.Chem.rdchem.Mol object at 0x7619123d0510>), (10.71, <rdkit.Chem.rdchem.Mol object at 0x761912365510>), (10.51, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00e40>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356eb0>), (11.26, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00120>), (11.41, <rdkit.Chem.rdchem.Mol object at 0x761aa3dbd350>), (10.56, <rdkit.Chem.rdchem.Mol object at 0x761912365cf0>), (11.17, <rdkit.Chem.rdchem.Mol object at 0x7619123d0970>), (10.96, <rdkit.Chem.rdchem.Mol object at 0x761aa3dbdb30>), (11.06, <rdkit.Chem.rdchem.Mol object at 0x761912365a50>), (11.06, <rdkit.Chem.rdchem.Mol object at 0x761912365a50>), (10.75, <rdkit.Chem.rdchem.Mol object at 0x761aa402ab30>), (10.56, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9ce40>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365eb0>), (10.52, <rdkit.Chem.rdchem.Mol object at 0x761912392270>), (11.39, <rdkit.Chem.rdchem.Mol object at 0x761912365b30>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00660>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x7619123d09e0>), (10.79, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99430>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365ba0>), (11.17, <rdkit.Chem.rdchem.Mol object at 0x7619123652e0>), (10.59, <rdkit.Chem.rdchem.Mol object at 0x761aa3d9c5f0>), (11.44, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabeb0>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912392350>), (10.99, <rdkit.Chem.rdchem.Mol object at 0x761912365350>), (10.92, <rdkit.Chem.rdchem.Mol object at 0x761aa402a740>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912392510>), (10.57, <rdkit.Chem.rdchem.Mol object at 0x761aa3d990b0>), (11.03, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00890>), (11.52, <rdkit.Chem.rdchem.Mol object at 0x761912392ac0>), (10.67, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabcf0>), (10.51, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00e40>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912365ac0>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761912365d60>), (10.92, <rdkit.Chem.rdchem.Mol object at 0x761912363190>), (10.7, <rdkit.Chem.rdchem.Mol object at 0x761aa3d995f0>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912365580>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123634a0>), (10.79, <rdkit.Chem.rdchem.Mol object at 0x761912363270>), (11.8, <rdkit.Chem.rdchem.Mol object at 0x7619123636d0>), (10.93, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00660>), (11.8, <rdkit.Chem.rdchem.Mol object at 0x7619123636d0>), (10.96, <rdkit.Chem.rdchem.Mol object at 0x761aa3dbdb30>), (10.92, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabc80>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365eb0>), (10.56, <rdkit.Chem.rdchem.Mol object at 0x761aa3dab660>), (11.2, <rdkit.Chem.rdchem.Mol object at 0x761912379eb0>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123634a0>), (11.03, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00890>), (10.81, <rdkit.Chem.rdchem.Mol object at 0x761912379f90>), (10.7, <rdkit.Chem.rdchem.Mol object at 0x761aa3d995f0>), (10.79, <rdkit.Chem.rdchem.Mol object at 0x761912363270>), (10.71, <rdkit.Chem.rdchem.Mol object at 0x761912365510>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365eb0>), (10.7, <rdkit.Chem.rdchem.Mol object at 0x761aa3d995f0>), (10.57, <rdkit.Chem.rdchem.Mol object at 0x761aa3d990b0>), (10.58, <rdkit.Chem.rdchem.Mol object at 0x761aa3dbd0b0>), (11.17, <rdkit.Chem.rdchem.Mol object at 0x7619123d0970>), (10.5, <rdkit.Chem.rdchem.Mol object at 0x761912356d60>), (11.72, <rdkit.Chem.rdchem.Mol object at 0x761912392660>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912379dd0>), (10.96, <rdkit.Chem.rdchem.Mol object at 0x761aa3d99c80>), (11.3, <rdkit.Chem.rdchem.Mol object at 0x7619123637b0>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912365820>), (11.71, <rdkit.Chem.rdchem.Mol object at 0x761912365430>), (10.94, <rdkit.Chem.rdchem.Mol object at 0x761912392900>), (10.61, <rdkit.Chem.rdchem.Mol object at 0x761912392c80>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912392eb0>), (11.17, <rdkit.Chem.rdchem.Mol object at 0x7619123d0970>), (10.9, <rdkit.Chem.rdchem.Mol object at 0x761912365eb0>), (11.1, <rdkit.Chem.rdchem.Mol object at 0x761912392e40>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x761912365740>), (11.12, <rdkit.Chem.rdchem.Mol object at 0x761912356900>), (10.97, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4eb0>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356cf0>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x7619123566d0>), (11.36, <rdkit.Chem.rdchem.Mol object at 0x7619123653c0>), (11.67, <rdkit.Chem.rdchem.Mol object at 0x761912392f20>), (10.99, <rdkit.Chem.rdchem.Mol object at 0x761912365350>), (10.63, <rdkit.Chem.rdchem.Mol object at 0x7619123634a0>), (11.55, <rdkit.Chem.rdchem.Mol object at 0x761912363200>), (10.85, <rdkit.Chem.rdchem.Mol object at 0x7619123569e0>), (11.07, <rdkit.Chem.rdchem.Mol object at 0x761912365740>), (10.6, <rdkit.Chem.rdchem.Mol object at 0x761912356970>), (11.09, <rdkit.Chem.rdchem.Mol object at 0x761912356b30>), (10.8, <rdkit.Chem.rdchem.Mol object at 0x761aa402ac80>), (11.08, <rdkit.Chem.rdchem.Mol object at 0x761912392820>), (10.94, <rdkit.Chem.rdchem.Mol object at 0x761912392890>), (10.74, <rdkit.Chem.rdchem.Mol object at 0x761912392c10>), (10.51, <rdkit.Chem.rdchem.Mol object at 0x761aa3e00e40>), (11.42, <rdkit.Chem.rdchem.Mol object at 0x761912392eb0>), (10.95, <rdkit.Chem.rdchem.Mol object at 0x761912356f90>), (11.44, <rdkit.Chem.rdchem.Mol object at 0x761aa3dabeb0>), (11.8, <rdkit.Chem.rdchem.Mol object at 0x7619123636d0>), (10.76, <rdkit.Chem.rdchem.Mol object at 0x761912365900>), (10.5, <rdkit.Chem.rdchem.Mol object at 0x761aa3db4cf0>), (10.92, <rdkit.Chem.rdchem.Mol object at 0x761aa402a740>), (11.67, <rdkit.Chem.rdchem.Mol object at 0x761912392f20>), (11.72, <rdkit.Chem.rdchem.Mol object at 0x761912392660>)]
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CC2=C(OC3=CC=C(NC(=O)NN=CC4=CC=C(F)C=C4F)C=C3F)C=CN=C2C=C1OCCCN1CCC(C)CC1,-10.99]
[FC(F)(C1=CC=C2N=CC=CC2=C1)C1=NN=C2N=CC(C=CC3=CC=NC=C3)=NN21,-10.75]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like increasing hydrogen bonding, improving aromatic stacking, and introducing groups that can better fill hydrophobic pockets or interact with polar residues in the binding site.

The first molecule has a methoxy-substituted phenyl ring and a difluorophenyl-propanedazine moiety, with a flexible chain linking to a piperidine ring. The second molecule has a fluorinated aromatic system with an imidazolidine-like core and a substituted triazole ring, showing strong aromatic and heterocyclic interactions.

Comparing the two, I see potential in combining the flexible linker and heterocyclic systems to create multiple hydrogen bonds and improve shape complementarity. The first molecule’s linker could be modified to incorporate an amide nitrogen that can participate in hydrogen bonding, and the second molecule’s trifluoromethyl group could be rearranged to a difluorophenyl substituent to maintain hydrophobic interactions while allowing more precise positioning in the pocket.

Therefore, I propose introducing an amide nitrogen into the linker, shifting the difluorophenyl group onto a more central position, and retaining the fused heterocycles and flexible chain to maximize binding contacts.

\box{CNC(=O)/C=C1\CN=C(Nc2ccc(-c3cn[nH]c3)cc2F)c1C(=O)N1CCN(CCCOCC=C2CCOCC2)CC1}
LLM-GENERATED: CNC(=O)C=C1CN=C(Nc2ccc(-c3cn[nH]c3)cc2F)C1C(=O)N1CCN(CCCOCC=C2CCOCC2)CC1
CNC(=O)C=C1CN=C(Nc2ccc(-c3cn[nH]c3)cc2F)C1C(=O)N1CCN(CCCOCC=C2CCOCC2)CC1

Boltz running on GPU 2
10.08
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COCCOc1cnc2ccn(C(C)c3nnc4c(C)cc(-c5cc(C)no5)cn34)c(=O)c2c1,-10.79]
[CNC(=O)C1=CC=C(c2cc(F)c3ncc(Cc4ccc5ncccc5c4)n3c2)CC1,-10.56]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions in the ligand by increasing hydrogen bonding, improving complementarity to the binding pocket, and optimizing substituents to better engage with key residues in the c-MET active site.

From the given molecules, the first contains a methyl-substituted oxazole ring and a carbonyl group contributing to affinity, while the second features a fluorine substitution and a bicyclic heteroaromatic system with potential for additional hydrogen bonding. Comparing the two, the second molecule's fluorine may enhance binding through polar interactions, and the bicyclic system could better fit the pocket and engage in π-stacking or hydrophobic contacts.

To build on this, I would combine elements that provide good hydrogen bonding (like the carbonyl group) with a heteroaromatic moiety that can maintain or increase hydrophobic and stacking interactions. Introducing a pyridine ring with a methyl substituent on the nitrogen could improve both solubility and interaction with the protein, while retaining the fluorine to preserve polar contacts.

Based on this reasoning, I propose the molecule:

\box{CCOc1cnc2ccn(C(C)c3nnc4c(C)cc(-c5ccc6ncccc6c5)cn34)c(=O)c2c1}
LLM-GENERATED: CCOc1cnc2ccn(C(C)c3nnc4c(C)cc(-c5ccc6ncccc6c5)cn34)c(=O)c2c1
CCOc1cnc2ccn(C(C)c3nnc4c(C)cc(-c5ccc6ncccc6c5)cn34)c(=O)c2c1

Boltz running on GPU 2
10.68
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[NC1=NC=NC2=C1C(C1=CC(F)=C(NC(=O)C3=CN(CC4CCOCC4)C=C(C4=CC=C(F)C=C4)C3=O)C=C1F)=CN2,-11.42]
[CN1C=C(C2=CN3C(=NN=C3SC3=CC=C4N=CC(NC(=O)C(F)(F)F)=CC4=C3)C=C2)C=N1,-10.51]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to increase hydrogen bonding and hydrophobic interactions while optimizing the rigidity of the molecule to fit snugly in the binding pocket. Both initial molecules have fluorines that contribute to affinity, but one may benefit from additional polar groups to enhance interactions with residues in the binding site.

Molecule 1 has a methyl substituent on the pyridine ring, while Molecule 2 has a thiophene moiety that could provide favorable π-stacking or hydrophobic contacts. However, Molecule 2’s binding affinity is slightly lower, suggesting that maintaining or modifying the cyclic amine portion might improve stability.

To balance hydrophobicity and hydrogen bonding, I would consider replacing the pyridine methyl with a cyclic amine that introduces hydrogen bond donors or acceptors in a constrained geometry, aiming to enhance interactions with the active site residues without increasing flexibility too much.

Therefore, I propose introducing a piperazine ring substituted with a methyl group on the nitrogen, which can offer additional hydrogen bonding potential and modulate the electronic environment. This replaces the original methyl on the pyridine ring while retaining the rest of the molecule.

The resulting molecule is:  
\box{NC1=NC=NC2=C1C(C1=CC(F)=C(NC(=O)C3=CN(C[C(@HydrogenBond)]C4=CC=C(F)C=C4)C(C4=CC=C(N5CCN(C)CC5)C(C5=CC=C(F)C=C5)C4=O)C3=O)C=C1F}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 161
NON-LLM GENERATED: CN1C=C(C2=CN(CC3CCOCC3)C=C(C3=CC=C(F)C=C3)C2=O)C=N1
Cn1cc(-c2cn(CC3CCOCC3)cc(-c3ccc(F)cc3)c2=O)cn1

Boltz running on GPU 2
7.98
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[OCCN1C=C(C2=CN=C3N=NN(CC4=CC=C5N=CC=CC5=C4)C3=N2)C=N1,-10.74]
[C/C(=N\OCCCO)C1=NN2C(=NN=C2CC2=C(F)C=C3N=CC=CC3=C2F)C=C1,-11.55]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a key heterocyclic core with aromatic rings and nitrogen atoms contributing to potential hydrogen bonding and pi-stacking interactions within the c-MET binding pocket. However, there are subtle differences that could improve binding affinity:

1. The first molecule has a flexiblle chain (OCCN) connecting to the core, possibly enabling better conformational adaptability but may lack favorable polar interactions.
2. The second molecule introduces fluorine atoms on the aromatic rings, which can enhance binding via improved hydrophobic contacts and possibly better fit due to electronic effects.
3. The overall shape and electron distribution in the second molecule’s core seem more optimized for aromatic stacking and hydrogen bonding.

To improve on these, I would aim to combine the beneficial features: maintain the core heterocyclic system with fused aromatic rings for planarity and strong pi interactions, introduce fluorine atoms to enhance hydrophobic and electronic effects, and introduce a terminal polar group that can form additional hydrogen bonds, such as a hydroxyl (-OH), to increase specificity and affinity.

Therefore, my proposed molecule incorporates a hydroxyl substituent on an aromatic ring to boost polarity and a fluorinated heterocyclic core to maintain hydrophobic and electronic benefits, leading me to choose:

\box{CC(O)c1c(N[N=P(N)N]c2ccc3ncccc3c2)nc2[nH]cc(-c3ccc(O)cc3)c12}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 162
NON-LLM GENERATED: OCCN1C=C(C2=NN3C(=NN=C3CC3=C(F)C=C4N=CC=CC4=C3F)C=C2)C=N1
OCCn1cc(-c2ccc3nnc(Cc4c(F)cc5ncccc5c4F)n3n2)cn1

Boltz running on GPU 2
11.18
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[[C-]#[N+]C1=C2COCCN2C2=C(C(=O)OC2)C1C1=CC=C2NN=C(C)C2=C1,-10.9]
[CC(=NNC(N)=O)C1=NN2C(=NN=C2[C@@H](C)C2=CC=C3N=CC=CC3=C2)C=C1,-11.42]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity in favorable regions of the ligand, and strengthen aromatic interactions since c-MET contains aromatic residues in its binding pocket. The first molecule lacks hydrogen bond donors/acceptors on the ring system, while the second molecule has more functional groups (urea and hydrazine) that can participate in H-bonding, but its binding affinity is only slightly better.

To improve further, I would introduce a nitrogen-containing aromatic ring (a pyridine or pyrrole) to provide additional H-bond acceptor sites and potentially enhance π-π stacking with the protein. I would also add a heteroatom in the fused ring system to increase polarity and hydrogen bonding capacity. Replacing one aromatic ring with a nitrogen-containing aromatic ring can increase binding affinity through additional polar interactions.

Therefore, the new molecule I propose incorporates a pyridine ring fused to the dopamine-like system and retains the urea moiety to maintain hydrogen bonding. This design should improve binding affinity by combining the beneficial features of the two previous ligands.

\box{CC(=NNC(N)=O)C1=NN2C(=NN=C2[C@H](C)C2=CC3CNCC(=O)CC3=NC2=C1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 163
NON-LLM GENERATED: [C-]#[N+]C1=C2COCCN2NN=C1C1=CC=C2NN=C(C)C2=C1
[C-]#[N+]C1=C2COCCN2NN=C1c1ccc2[nH]nc(C)c2c1

Boltz running on GPU 2
8.09
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CCC(c1ccc2ncccc2c1F)S(=O)(=O)c1cnc2ccc(-c3cnn(C)c3)cn12,-10.58]
[CNC(=O)NC1=CC=C(C2=NN3C(CC4=CC(Cl)=C5N=CC=CC5=C4)=CN=C3N=C2)C=C1F,-11.03]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the given molecules, I see that both feature a heterocyclic core and halogen substitutions, which often enhance binding through halogen bonding or hydrophobic interactions. The first ligand uses a fused ring system with fluorine and sulfonyl groups, while the second incorporates a more flexible aliphatic linker and multiple nitrogen-containing heterocycles.

To improve binding affinity, I would consider increasing the number of halogen atoms to enhance halogen bonding and hydrophobic contacts, especially chlorine which is larger and more polarizable than fluorine. Also, maintaining the sulfonyl group may be beneficial for polar interactions, but incorporating it near additional aromatic rings could improve π-stacking and van der Waals interactions.

Based on this, I propose combining the key elements: keeping the sulfonyl group linked to an aromatic ring, adding an extra chlorine substituent to increase halogen bonding, and incorporating a fused heterocyclic system with an ethyl-substituted pyrazole to enhance both hydrophobicity and hydrogen bonding.

\box{CC(C(=O)Nc1ccc(-c2ccc3ncccc3c2)cc1Cl)C(=O)Nc1ccc2ccc(NS3CCN(C4=CC(Cl)=C5N=CC=CC5=C4)CC3)cc2c1}
LLM-GENERATED: CC(C(=O)Nc1ccc2ccc(N[SH]3CCN(c4cc(Cl)c5ncccc5c4)CC3)cc2c1)C(=O)Nc1ccc(-c2ccc3ncccc3c2)cc1Cl
CC(C(=O)Nc1ccc2ccc(N[SH]3CCN(c4cc(Cl)c5ncccc5c4)CC3)cc2c1)C(=O)Nc1ccc(-c2ccc3ncccc3c2)cc1Cl

Boltz running on GPU 2
9.61
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1CCN(c2cnc3ccc(Sc4nnc5c(F)cc(-c6cnn(C)c6)cn45)cc3c2)CC1=O,-10.7]
[CN1C=C(C2=CN3C(=NN=C3SC3=CC=C4N=CC(NC(=O)C(F)(F)F)=CC4=C3)C=C2)C=N1,-10.51]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both incorporate fused heterocycles and fluorinated groups for enhanced binding, likely targeting key pockets and improving affinity through hydrophobic and electronic interactions. The first molecule has a trifluoromethyl-like motif adjacent to the heterocyclic core, while the second molecule features a trifluoromethyl group attached to a nitrogen heterocycle.

To improve binding further, I would consider maintaining the central pyrazole-pyridine fused system from the first molecule, which seems to provide a favorable scaffold for interaction. I would also preserve the difluoro substituents to enhance lipophilicity and potential halogen bonding, as fluorines often improve metabolic stability and binding strength.

To combine the advantages, I will introduce a pyridine ring directly attached to the central heterocycle to increase hydrogen bonding and aromatic stacking opportunities, while keeping the difluoroacetamide substituent to engage polar residues and improve overall affinity.

The resulting molecule is:  
\box{O=C(C(F)F)Nc1ccc2nnc(Sc3ccc4ncc(-c5cccnc5)cc4c3F)c2c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 164
NON-LLM GENERATED: CN1C=C(F)C=N1
Cn1cc(F)cn1

Boltz running on GPU 2
5.62
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=NN3C(=NN=C3C(F)(F)C3=CC=C4N=CC=CC4=C3)N=C2)C=N1,-11.31]
[O=C(NC1=CC=C(OC2=CC=NC(NC(=O)C3CC3)=C2)C=C1)C1=NC2=CC=CC=C2N(C2=CC=C(F)C=C2)C1=O,-10.76]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have strong aromatic and heterocyclic groups that contribute to binding, but there are subtle differences in their substructures. The first molecule contains a fluorinated cycloalkyl group and linked pyrazole rings, while the second molecule has ether linkages and amide functionalities connected to fused aromatic systems.

To improve binding affinity, I would consider increasing hydrogen bonding potential and enhancing hydrophobic interactions without adding too much steric hindrance. The fluorines in the first molecule contribute to lipophilicity and metabolic stability, but the fused ring may be rigidifying the structure. In the second molecule, the amide and ether groups provide hydrogen bonding, but the fused bicyclic aromatic system could offer better π-π stacking.

Therefore, a potential strategy is to combine the beneficial features of both molecules: keep the pyrazole core with fluorinated groups for lipophilicity, but replace the fused ring with a more flexible, planar bicyclic aromatic system to enhance stacking interactions and hydrogen bonding capability via an amide group. Additionally, introducing an oxygen heteroatom into the bicyclic system could also improve solubility and binding.

Based on this reasoning, I propose the following molecule:

\box{Cn1cc(-c2ccc3ncc(NC(=O)c4cc5cccnc5c(=O)n(-c5ccc(F)cc5)c4=O)nc3c2)cn1}
LLM-GENERATED: Cn1cc(-c2ccc3ncc(NC(=O)c4cc5cccnc5c(=O)n(-c5ccc(F)cc5)c4=O)nc3c2)cn1
Cn1cc(-c2ccc3ncc(NC(=O)c4cc5cccnc5c(=O)n(-c5ccc(F)cc5)c4=O)nc3c2)cn1

Boltz running on GPU 2
8.96
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)NC1=CC=C(C2=NN3C(CC4=CC(Cl)=C5N=CC=CC5=C4)=CN=C3N=C2)C=C1F,-11.03]
[COCCOc1cnc2ccn(C(C)c3nnc4c(C)cc(-c5cc(C)no5)cn34)c(=O)c2c1,-10.79]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, aromatic stacking, and hydrophobic interactions simultaneously. The first ligand has a fluorinated aromatic ring that likely contributes to hydrophobic contacts, while the second ligand incorporates heterocycles and oxygen-containing groups, possibly improving solubility and polar interactions.

Comparing the two, the second ligand’s oxygen-rich scaffold (COCCO) seems effective but may limit hydrophobic interactions. The first ligand’s fluorine likely aids binding through enhanced van der Waals interactions and possibly better fit in a hydrophobic pocket.

To combine the benefits, I would introduce a flexible alkyl chain to increase solubility and introduce hydrophobic groups near the aromatic system while retaining key heterocycles for hydrogen bonding. Adding a methyl group on the aromatic ring may enhance π-π stacking and hydrophobic contacts without compromising binding geometry.

Thus, a promising approach is to generate a molecule with a propyl chain linked to a substituted pyrazole-containing heterocycle, combining elements from both previous structures for improved affinity.

Final molecule: \box{CCCNC(=O)c1cccc2c1C=C(N=C2Nc1ccc(C)cc1Cl)c1ccnn(-c2ccccc2)c1-c2ccccc2)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 165
NON-LLM GENERATED: ClC1=C2N=CC=CC2=NN=C1
Clc1cnnc2cccnc12

Boltz running on GPU 2
5.22
400/1000 | avg_top1: 12.050 | avg_top10: 11.759 | avg_top100: 11.107 | avg_sa: 3.251 | div: 0.814
{'avg_top1': 12.05, 'avg_top10': 11.758999999999999, 'avg_top100': 11.106800000000005, 'auc_top1': 4.73695, 'auc_top10': 4.607405, 'auc_top100': 4.307607309523811, 'avg_sa': 3.2507297747182884, 'diversity_top100': 0.8140096785350043, 'n_oracle': 400}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[[C-]#[N+]C1=C2COCCN2C2=C(C(=O)OC2)C1C1=CC=C2NN=C(C)C2=C1,-10.9]
[COCC(C)NC1=NNC2=NC=CC(OC3=CC=C(NC(=O)C4=CN(C(C)C)C(=O)N(C5=CC=C(F)C=C5)C4=O)C=C3F)=C21,-10.69]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, hydrophobic contacts, and possibly introduce groups that can better fit the binding pocket or interact with nearby residues. 

From the given molecules, I notice that maintaining the core fused heterocyclic systems and positioning certain substituents are important for binding, as seen from the similar binding affinities. However, there's room to optimize substituents to increase hydrophobic interactions or improve fit.

Molecule 1 has a methyl group on the pyrazole ring which might provide hydrophobic contacts but molecule 2 replaces this with a fluorophenyl group, likely to enhance π-stacking or dipole interactions. Introducing a fluorine atom can improve binding via polar interactions and metabolic stability.

To further improve affinity, I would consider combining the beneficial features: retain the methyl group on the pyrazole for hydrophobic contact and introduce the fluorophenyl substituent to increase stacking and dipole interactions on the other key heterocycle. This way, we can maximize both hydrophobic and polar interactions without losing the core scaffold.

Therefore, I propose the molecule with methyl-substituted pyrazole and fluorophenyl on the amide-bearing heterocycle:

\box{CNC(=O)c1cc(-c2ccc(F)cc2)ccc1N1CC=C(c2ncccc2C(C)=C2CC(=O)N(C(=O)C(C)C)C2=O)c1C}
LLM-GENERATED: CNC(=O)c1cc(-c2ccc(F)cc2)ccc1N1CC=C(c2ncccc2C(C)=C2CC(=O)N(C(=O)C(C)C)C2=O)C1C
CNC(=O)c1cc(-c2ccc(F)cc2)ccc1N1CC=C(c2ncccc2C(C)=C2CC(=O)N(C(=O)C(C)C)C2=O)C1C

Boltz running on GPU 2
9.53
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[NC(=O)NN=CC1=CN=C2N=NN(CC3=CC=C4N=CC=CC4=C3)C2=N1,-11.05]
[COC1=CN=C2C=CC([C@H](C)C3=NN=C4C(F)=CC(C5=CN(C)C=N5)=CN43)=CC2=C1,-11.42]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase planarity for better π-stacking, and introduce fluorine atoms to strengthen hydrophobic interactions and metabolic stability. The first molecule has strong hydrogen bonding groups (NN=N and carbonyl), but the second molecule’s ring system and fluorine substitution may provide favorable interactions in the pocket.

Comparing the two, the second molecule’s fluorine atom on the heterocyclic ring could be a promising feature to retain for hydrophobic contacts. However, the overall scaffold in the second molecule is bulkier and more flexible, which might reduce binding affinity by causing entropic penalties.

Therefore, I would simplify the molecule by reducing the morpholine-like ring and replacing it with a more planar pyridine-type structure, maintaining the fluorine substitution to preserve hydrophobic interactions while improving π-stacking potential via greater planarity and reducing flexibility.

Thus, the new proposed molecule incorporates a pyridine ring with a fluorine-substituted fused heterocycle to balance rigidity, hydrogen bonding, and hydrophobic contacts.

\box{Cn1cc(-c2ccc3ncc(NC4=CC(=O)NN=C4C(F)=CC4)cc3c2)cn1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 166
NON-LLM GENERATED: CC(C(N)=O)C1=NN=C2C(F)=CC(C3=CN(C)C=N3)=CN21
CC(C(N)=O)c1nnc2c(F)cc(-c3cn(C)cn3)cn12

Boltz running on GPU 2
7.08
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CCC(C1=CC=C2N=CC=CC2=C1F)N1C=NC2=NC=C(C3=CC=C(C(N)=O)C(F)=C3)N=C21,-10.71]
[CN1C=C(C2=CN3C(SC4=CC5=CC(N6CCN(C)C(=O)C6)=CN=C5C=C4)=NN=C3C(F)=C2)C=N1,-10.7]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have similar binding affinities with slight structural differences. Molecule 1 has a fluorinated aromatic ring and an amide group on a phenyl ring, while Molecule 2 incorporates a piperazine-linked aromatic system with a para-fluoro substitution. The intensity of the hydrogen bonding and hydrophobic interactions seems key to improving binding.

To enhance affinity, increasing hydrogen bond donors/acceptors and adding small electron-withdrawing groups to improve interaction with the metal's coordination geometry could be beneficial. Introducing a trifluoromethyl group on the aromatic ring might boost hydrophobic contacts and dipole interactions without drastically changing size.

Therefore, I decided to modify the phenyl ring by replacing the amide group with a trifluoromethyl substituent to increase hydrophobicity and possibly improve binding through favorable dipole interactions while keeping the rest of the core intact to maintain key interactions.

\box{CN1C=C(C2=CN3C(SC4=CC5=CC(N6CCN(C)C(=O)C6)=CN=C5C=C4)N=CC3C2)C(=O)e1C(F)(F)F}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 167
NON-LLM GENERATED: CN1C=C(C2=CN3C(SC4=CC5=CC(N6CC=C(C(N)=O)C(=O)C6)=CN=C5C=C4)=NN=C3C(F)=C2)C=N1
Cn1cc(-c2cc(F)c3nnc(Sc4ccc5ncc(N6CC=C(C(N)=O)C(=O)C6)cc5c4)n3c2)cn1

Boltz running on GPU 2
11.26
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COCCOC1=CN=C2C=CC([C@H](C)N3N=NC4=C3C(=O)N(C3=CC=CS3)C=C4)=CC2=C1,-10.93]
[CCC(c1ccc2ncccc2c1F)S(=O)(=O)c1cnc2ccc(-c3cnn(C)c3)cn12,-10.58]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, pi-stacking, and electrostatic bonding. The first molecule has a thiazolidinone ring with a methyl substituent, which may contribute to hydrophobic contacts but might limit flexibility. The second molecule includes a fluorinated aromatic system and an imine-linked heterocycle, providing potential for both electronic effects and hydrogen bonding.

Comparing the two, the heterocyclic portion in the second molecule could be improved by introducing a more hydrogen bond donor-acceptor rich scaffold to engage with the active site residues. Additionally, incorporating a small, flexible, basic amine-containing side chain might enhance solubility and form new polar contacts.

Therefore, I would design a molecule that replaces the thiazolidinone with a related heterocycle bearing a substituted pyrimidinone ring, and attaches a piperazine moiety to improve interactions and solubility.

\box{CC(c1cc2ncccc2c1F)C(=O)N1CCN(c2ccc(-c3cnc(N[C@H]4CCNC5=CC(=O)N(C6=CC=CS6)C=C45)nc3)nc2)C1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 168
NON-LLM GENERATED: CCC(C1=CC=C2N=CC(OCCOC)=CC2=C1)C1=CC=C2N=CC=CC2=C1F
CCC(c1ccc2ncc(OCCOC)cc2c1)c1ccc2ncccc2c1F

Boltz running on GPU 2
10.05
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[O=C(NC1=CC=C(OC2=CC=NC(NC(=O)N3CCC3)=C2)C(F)=C1)C1=CN(CC2CC2)C(=O)N(C2=CC=C(F)C=C2)C1=O,-11.71]
[Cc1cnc2ccc(Sc3nnc4c(F)cc(-c5ccc(O)cc5)cn34)cc2c1,-11.06]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, aromatic stacking, and polarity in key regions of the ligand. The first molecule has useful amide linkages and aromatic rings for interaction, but it could benefit from added hydrogen bond donors or acceptors to increase interactions with the protein. The second molecule includes sulfur and heterocycles, showing potential for aromatic stacking and polar contacts, but may be limited by flexibility or solubility.

Focusing on the first molecule, introducing a hydroxyl group on the aromatic ring could provide additional hydrogen bonding to stabilize the ligand-protein complex. Also, modifying the central aromatic system to include a pyrrole or imidazole moiety might enhance binding through increased polarity and protonation capabilities. Substituting the ethoxy group with a hydroxyethyl side chain could improve solubility and interaction profiles.

Combining these ideas, I propose the following molecule:

\box{O=C(Nc1ccc(O)c(-c2ccc3nnc(Sc4nnc5c(F)cc(-c6ccc(O)cc6)cn45)cc3c2)c1)CCO}
LLM-GENERATED: O=C(CCO)Nc1ccc(O)c(-c2ccc3nnc(Sc4nnc5c(F)cc(-c6ccc(O)cc6)cn45)cc3c2)c1
O=C(CCO)Nc1ccc(O)c(-c2ccc3nnc(Sc4nnc5c(F)cc(-c6ccc(O)cc6)cn45)cc3c2)c1

Boltz running on GPU 2
9.46
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN3C(SC4=CC5=CC(N6CCN(C)C(=O)C6)=CN=C5C=C4)=NN=C3C(F)=C2)C=N1,-10.7]
[CC(=NNC(N)=O)C1=NN2C(=NN=C2[C@@H](C)C2=CC=C3N=CC=CC3=C2)C=C1,-11.42]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity in the right regions, and introduce groups that can better interact with the hydrophobic pocket or 100s of active site residues in c-MET. The first molecule has a fluorine substitution, which often improves metabolic stability and binding. The second molecule includes a piperazine moiety that may improve solubility and offer interaction points, but its binding affinity is slightly lower.

To propose a new molecule, I would combine features from both: maintain the fluorine substitution for favorable interactions, and increase hydrogen bonding capacity by introducing an amide group linked to an ethyl chain terminating in a hydroxyl-containing moiety (like a piperazine or morpholine). This change could enhance polar contacts without compromising hydrophobic interactions.

Based on this reasoning, the new molecule I propose is:  
\box{CC(=NNC(N)=O)C1=NN2C(=NN=C2[C@H](C)C2=CC=C3N(CCOCCOCC3)=CC3=NC(N)=CC3C(F)=C2)C=C1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 169
NON-LLM GENERATED: CN=C(C)C1=NN2C(=NN=C2C(C)C2=CC=C3N=CC=CC3=C2)C=C1
CN=C(C)c1ccc2nnc(C(C)c3ccc4ncccc4c3)n2n1

Boltz running on GPU 2
10.43
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=NN3C(=NN=C3C(F)(F)C3=CC=C4N=CC=CC4=C3)N=C2)C=N1,-11.31]
[CNC(=O)NC1=CC=C(C2=NN3C(CC4=CC(Cl)=C5N=CC=CC5=C4)=CN=C3N=C2)C=C1F,-11.03]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both involve fused azole rings and fluorinated aromatic groups, suggesting key interactions in the c-MET binding pocket favor electron-withdrawing substituents and rigid heterocycles. The second molecule includes a carbonyl group and a fluorine on the aromatic ring, which might improve binding affinity through hydrogen bonding or dipole interactions. To build on this, introducing an electron-donating group like a methoxy substituent could enhance π-stacking or hydrogen bonding capacity while maintaining overall planarity. Also, simplifying the side chain to reduce flexibility while preserving key heterocycles might increase binding entropy.

Based on this reasoning, I propose a molecule that replaces the carbonyl with a methoxy group and simplifies the substituent on the fused ring, retaining the fluorine for electronic effects.

\box{COc1cccc(-c2ccc3ncc(OCc4=CC=C5N=CC=CC5=C4)ncc3n2)c1F}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 170
NON-LLM GENERATED: CNC(=O)NC1=CC=C(C2=NN3C(=NN=C4N=CC(C5=CN(C)N=C5)=NN43)N=C2)C=C1F
CNC(=O)Nc1ccc(C2=NN3C(=NN=C4N=CC(c5cnn(C)c5)=NN43)N=C2)cc1F

Boltz running on GPU 2
9.29
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)C1=CC=C(C2=NN3C(=NN=C3CC3=CC=C(O)C=C3)C=C2)C=C1Cl,-10.6]
[COC1=CN=C2C=CC([C@H](C)C3=NN=C4C(F)=CC(C5=CN(C)C=N5)=CN43)=CC2=C1,-11.42]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, π-π stacking, and electrostatic contacts. The first molecule has a chlorophenyl ring and a triazole-like moiety, while the second molecule incorporates fluorine substitution and a more flexible heterocyclic framework.

Comparing the two, the second molecule’s fluorinated ring and multiple nitrogen-containing heterocycles could contribute to stronger hydrogen bonding and dipole interactions. However, its bulkier, more flexible structure might also increase entropic penalties upon binding.

To balance rigidity and interaction potential, I would consider simplifying the scaffold while retaining key heterocycles for strong hydrogen bonding and aromatic stacking. Introducing a pyridine ring can provide an additional hydrogen bond acceptor site and a potential target for polar interactions. Substituting the fluorophenyl with a chlorophenyl may maintain hydrophobic interactions while modifying electronic properties.

Therefore, a molecule featuring a pyridine fused to a triazole with a chlorophenyl substituent and a methylated pyrazole group could optimize binding affinity by balancing polarity, rigidity, and interaction patterns.

\box{CNC(=O)c1cccc(-c2ccc3nnc([C@@H](C)C4=NN=C5C=C[C@H]4C=C5)c3n2)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 171
NON-LLM GENERATED: COC1=CN=C2C=CC(C(C)C3=NN=C4C(F)=CC(C5=CN(C)C=N5)=CN43)=CC2=C1
COc1cnc2ccc(C(C)c3nnc4c(F)cc(-c5cn(C)cn5)cn34)cc2c1

Boltz running on GPU 2
11.47
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[NC1=NNC2=CC=CC(C3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3)=C21,-10.5]
[CN1C=C(C2=CN=C3C=CC4=CC=C(N)C=C4C(=O)C3=C2)C=N1,-10.8]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two existing molecules, I notice that both share a fused bicyclic heteroaromatic core with electron-donating groups. The stronger binding affinity of -10.8 kCal/mol belongs to a molecule with a methylated nitrogen and increased rigidity, suggesting that subtle electronic and steric modifications can improve interaction with the c-MET binding site.

To enhance binding, I would aim to increase hydrophobic interactions and possibly introduce halogen bonding or improved π-stacking with the protein. The existing methyl group on the pyridine ring could be replaced by a chlorine atom, which is slightly larger and more electron-withdrawing, potentially improving affinity through halogen bonding and hydrophobic contacts. Additionally, maintaining the fused bicyclic core but optimizing hydrogen bonding around the amide moiety might increase specificity and binding strength.

Based on this rationale, I propose the molecule:  
\box{CN1CC=C(c2cc3nccc(Oc4cccc5cnc(NC(=O)C6(C(=O)NC7=CC=C(F)C=C7)CC6)cc45)c3c2)CL1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 172
NON-LLM GENERATED: NC1=NNC2=CC=CC(C3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3)=C21
Already in buffer
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC1=NC([C@H](C)NC(=O)C2=CC=C(C3=NN4C(CC5=CC=C6N=CC=CC6=C5)=CN=C4N=C3)C=C2Cl)=NO1,-10.52]
[C/C(=N\OCCCO)C1=NN2C(=NN=C2CC2=C(F)C=C3N=CC=CC3=C2F)C=C1,-11.55]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both feature fused heterocyclic systems with nitrogen-rich rings, which likely contribute to strong hydrogen bonding and π-stacking interactions in the c-MET binding pocket. The first molecule includes a chlorinated phenyl ring and an N-N linked bicyclic system, while the second molecule replaces part of the bicyclic system with fluorinated phenyl rings and an oxime-based side chain.

To improve binding affinity, I would consider enhancing hydrogen bonding capacity and optimizing hydrophobic interactions. The introduction of ethylene glycol or hydroxyl-containing side chains could increase solubility and form additional hydrogen bonds. Also, maintaining or expanding the fused heterocyclic core with nitrogen atoms may strengthen polar interactions.

Combining these ideas, I propose adding a hydroxyalkyl substituent (like an ethylene glycol moiety) on the oxime-containing ring to increase hydrogen bonding opportunities, while preserving the chiral center and key heterocycles from the first ligand for shape complementarity.

Therefore, the new molecule I suggest is:

\box{CC(C)(O)CO/N=C(\C[C@@H](C)N=C1C(=NN2C(CC3=CC=C4N=CC=CC4=C3)=CC2=O)C(C(=O)N[C@H](C)N=C1)=O)N/C=C1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 173
NON-LLM GENERATED: CC1=NC2C=CC=NC2=NO1
CC1=NC2C=CC=NC2=NO1

Boltz running on GPU 2
6.02
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN3C(=NN=C3SC3=CC=C4N=CC(NC(=O)C(F)(F)F)=CC4=C3)C=C2)C=N1,-10.51]
[CCCNS(=O)(=O)NC1=CC=C2C=CC3=NC=C(C4=CN(C5CCN(CC)CC5)N=C4)C=C3C(=O)C2=C1,-10.77]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, π-π stacking, and electrostatic contacts. The first molecule has a strong heterocyclic core and methyl substitutions that contribute to affinity, but it might benefit from the introduction of polar groups to increase binding interactions. The second molecule includes an acetamide group and fluorine atoms for polarity and potential hydrogen bonding, along with a piperazine moiety for solubility and interaction versatility.

Comparing the two, the first molecule’s methyl groups on the pyrazole ring could be replaced with an amide linked to a polar side chain to increase hydrogen bonding capacity. Incorporating a fluorinated aromatic ring might enhance π-π stacking and dipole interactions. Also, switching the piperazine from the second molecule to the first molecule’s core could improve fit and interaction pattern.

Therefore, I propose a molecule that retains the heterocyclic core with an amide-linked fluorophenyl group and preserves the piperazine substituent, aiming to combine favorable features from both originals.

\box{CCN1CCN(C(=O)c2ccc(F)cc2)CC1=CC1C(=NN=C2C(=O)C(C(=O)NC3CCNCC3)SC2=CC=C2)C=C1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 174
NON-LLM GENERATED: CCCC1=CN(C)N=C1
CCCc1cnn(C)c1

Boltz running on GPU 2
5.16
410/1000 | avg_top1: 12.050 | avg_top10: 11.759 | avg_top100: 11.121 | avg_sa: 3.256 | div: 0.812
{'avg_top1': 12.05, 'avg_top10': 11.758999999999999, 'avg_top100': 11.1209, 'auc_top1': 4.85745, 'auc_top10': 4.724995, 'auc_top100': 4.418745809523811, 'avg_sa': 3.256117355273986, 'diversity_top100': 0.8123746607028084, 'n_oracle': 410}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[N#CC1=CC(C2=CN3C(CC4=CC=C5N=CC=CC5=C4)=CN=C3C(F)=C2)=CC=C1,-11.07]
[[C-]#[N+]C1=C2COCCN2C2=C(C(=O)OC2)C1C1=CC=C2NN=C(C)C2=C1,-10.9]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, pi-stacking, and electrostatic contacts. The first molecule has a pyridine ring involved in key interactions, while the second molecule introduces an oxygen atom in the fused ring system, potentially increasing polarity and hydrogen bond capacity. Combining these features could yield a stronger ligand.

Specifically, maintaining the pyridine nitrogen for key contacts and adding a carbonyl group to introduce additional hydrogen bonding acceptance and rigidity might enhance affinity. Also, expanding the fused aromatic system could improve pi-stacking interactions.

Therefore, I propose the following molecule:

\box{O=C1CC=C(Nc2ccc3nccn3c2=CC(C)=C1)N=C1CC=C(C)N=CC1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 175
NON-LLM GENERATED: [C-]#[N+]C1=C2COCCN2C2=C(C(=O)OC2)C1CC1=CN=C2C(F)=CC(C3=CC=CC(C#N)=C3)=CN12
[C-]#[N+]C1=C2COCCN2C2=C(C(=O)OC2)C1Cc1cnc2c(F)cc(-c3cccc(C#N)c3)cn12

Boltz running on GPU 2
10.16
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COCC(C)NC1=NNC2=NC=CC(OC3=CC=C(NC(=O)C4=CN(C(C)C)C(=O)N(C5=CC=C(F)C=C5)C4=O)C=C3F)=C21,-10.69]
[COC1=CN=C2C=CC([C@H](C)C3=NN=C4C=CC(C5=CC=CC=C5)=NN43)=CC2=C1,-10.63]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, π-π stacking, and hydrophobic contacts. The existing molecules already use aromatic rings and heterocycles to engage the protein, so expanding this scaffold to add more aromaticity and potential hydrogen bond donors/acceptors could strengthen binding.

Specifically, the molecule I generate next will incorporate a fused bicyclic system with an extra phenyl ring to increase π interactions and introduce a slight electron-donating pyrrole-like NH that can form additional H-bonds, while maintaining the fluorinated phenyl and amide motifs seen before. This design aims to improve affinity by increasing favorable contacts without excessive steric hindrance.

\box{C[C@H](C)C1=NN=C2C=CC([C@@H](C)C3=NN=C4NCC(-c5ccc6ccccc6c5)C4=O)CC2=CN1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 176
NON-LLM GENERATED: CC(C)C1=NN=C2C=CC(C3=CC=CC=C3)=NN21
CC(C)c1nnc2ccc(-c3ccccc3)nn12

Boltz running on GPU 2
6.31
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CCCN1C=C(C2=CN=C3N=NN(C(C)C4=CC=C5N=CC=CC5=C4)C3=N2)C=N1,-10.57]
[CCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1,-10.92]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both contain fused aromatic systems and heterocycles, which contribute to π-π stacking and hydrogen bonding interactions within the binding pocket. However, there are subtle differences in their ring connections and substituents that might affect binding affinity.

The first molecule has a fused pyrazole-pyrimidine system with an alkyl chain linking to a benzimidazole-like moiety, while the second molecule has a pyridine ring connected to a fused heteroaromatic system including pyrazole and pyrrole rings. The second molecule’s structure offers more aromatic surfaces for stacking but may lack the rigid chain and conformational geometry found in the first molecule.

To propose an improved molecule, I want to combine the benefits of both: maintaining the planar heterocyclic cores for strong stacking and adding a flexible yet polar linker that can form additional hydrogen bonds or dipole interactions. Introducing a pyrazole as a central heterocycle connected to both aromatic regions could optimize binding through added hydrogen bonding and improved electronic complementarity.

Therefore, I choose to generate the molecule:

\box{CN1CC=C(Cc2ccc3ncccc3c2)N/N=C1/C=C1CCN(C)N=C2NCC(-c3cnc4nnn(Cc5ccc6ncccc6c5)c4n3)C2=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 177
NON-LLM GENERATED: CCCN1C=C(CN2N=NC3=NC=C(C4=CN(CCC)N=C4)N=C32)C=N1
CCCn1cc(Cn2nnc3ncc(-c4cnn(CCC)c4)nc32)cn1

Boltz running on GPU 2
9.02
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[COC1=CN=C2C=CC([C@H](C)C3=NN=C4C(F)=CC(C5=CN(C)C=N5)=CN43)=CC2=C1,-11.42]
[NC(=O)NN=CC1=CN=C2N=NN(CC3=CC=C4N=CC=CC4=C3)C2=N1,-11.05]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, increase polarity, and optimize hydrophobic interactions. The first molecule has a methyl substitution on the pyrazole ring which might be suboptimal for interactions, while the second molecule incorporates multiple nitrogen atoms and carbonyl groups that facilitate hydrogen bonding, resulting in better affinity.

To bridge the gap, I would consider introducing polar functional groups like an amide near the central pyrazole core to boost hydrogen bonding capabilities. Additionally, adding a methoxy substituent could improve solubility and possibly engage in favorable dipole interactions. Retaining the fused aromatic system from the first molecule ensures maintenance of hydrophobic and π-stacking interactions.

Based on this reasoning, I propose the molecule:

\box{COc1cc(-c2ccc3ncc(NC(=O)NN=C2)ccc3c1)cn1c(=O)ncc(-c2ccc3nccn3c2)c1=O}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 178
NON-LLM GENERATED: COC1=CC2=CC(C(C)C3=NN=C4C(F)=CCCN43)=CC=C2N=C1
COc1cnc2ccc(C(C)c3nnc4n3CCC=C4F)cc2c1

Boltz running on GPU 2
9.37
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[[C-]#[N+]C1=C2COCCN2C2=C(C(=O)OC2)C1C1=CC=C2NN=C(C)C2=C1,-10.9]
[[C-]#[N+]c1ccc2ccc3ncc(-c4cnn(C5CCN(CC)CC5)c4)cc3c(=O)c2c1,-10.5]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, π-π stacking, and electrostatic contacts. The first molecule has a heterocyclic core with carbonyl groups that could participate in hydrogen bonding, while the second molecule introduces an aromatic system and a methylated nitrogen that might contribute to hydrophobic and electronic effects.

Comparing the two, the first molecule’s carbonyl oxygen might make a good hydrogen bond acceptor, but it's less aromatic and less planar than the bicyclic system in the second molecule. The second molecule’s aromatic rings and methylated nitrogen could increase π-π stacking and hydrophobic interactions, but the methylation on the nitrogen might reduce hydrogen bonding potential.

To combine the benefits, I would design a molecule that retains the heterocyclic core with the carbonyl group for hydrogen bonding, while introducing a phenyl substituent to enhance π-π interactions and add an aromatic ring that can engage in additional stacking or hydrophobic contacts. Attaching a piperazine moiety could maintain the hydrogen bonding capacity seen in the first molecule and introduce conformational flexibility.

Therefore, the new molecule I propose integrates these features to potentially improve binding affinity:

\box{Cn1cc(-c2ccc3ccc4ncc(-c5cnn(C6CCNCC6)c5)cc4c(=O)c3c2)cn1}
LLM-GENERATED: Cn1cc(-c2ccc3ccc4ncc(-c5cnn(C6CCNCC6)c5)cc4c(=O)c3c2)cn1
Cn1cc(-c2ccc3ccc4ncc(-c5cnn(C6CCNCC6)c5)cc4c(=O)c3c2)cn1

Boltz running on GPU 2
10.93
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[NC1=NNC2=CC=CC(C3=CC=C(NC(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)C=C3)=C21,-10.5]
[COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2N(C)S(C)(=O)=O)=N1,-10.95]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both involve fused heterocycles and aromatic rings to engage the c-MET binding pocket. The first ligand includes a pyrazole-pyrimidine core with a flexible alkyl chain linking to a phenyl ring, while the second ligand has a methylated piperazine moiety connected to a substituted triazole-pyrimidine core.

To improve binding affinity, I would consider enhancing hydrogen bonding and aromatic stacking interactions. The second ligand's methyl group on the piperazine ring could be replaced by a heteroaromatic ring that can participate in additional hydrogen bonding or π-π interactions with the protein. Also, maintaining the thioether moiety is beneficial for solubility and possibly favorable dipole interactions.

Therefore, I propose replacing the methyl substituent on the piperazine with a pyridine ring to increase potential interactions while keeping the thioether group intact. This leads me to generate the molecule:

\box{COC1=CC(N2CCC(N3CCN(c4ccncc4)CC3)CC2)=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC2N(C)S(C)(=O)=O)=N1}
LLM-GENERATED: COc1cc(N2CCC(N3CCN(c4ccncc4)CC3)CC2)ccc1Nc1ncc(Cl)c(NC2=CC=CC2N(C)S(C)(=O)=O)n1
COc1cc(N2CCC(N3CCN(c4ccncc4)CC3)CC2)ccc1Nc1ncc(Cl)c(NC2=CC=CC2N(C)S(C)(=O)=O)n1

Boltz running on GPU 2
9.3
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[Cc1cnc2ccc(Sc3nnc4c(F)cc(-c5ccc(O)cc5)cn34)cc2c1,-11.06]
[CN1C=C(C2=CN3C(SC4=CC5=CC(N6CCN(C)C(=O)C6)=CN=C5C=C4)=NN=C3C(F)=C2)C=N1,-10.7]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would consider enhancing hydrogen bonding and hydrophobic interactions while optimizing the rigidity of the molecule to better fit the binding pocket. The first ligand has a phenol group that likely forms beneficial hydrogen bonds, but the methoxy substituent may be bulky and reduce hydrophobic contacts. The second ligand incorporates a flexible piperazine moiety, but this flexibility might reduce binding specificity.

To balance these forces, I would simplify the hydroxy substituent to a methoxy group to reduce steric hindrance while maintaining potential hydrogen bonding. Also, replacing the piperazine with a more constrained cyclic amine like piperidine could improve binding by reducing entropy loss upon binding.

Based on this reasoning, I propose the molecule:

\box{COc1ccc(-c2ccc3nnc(C4=CC5=CC(N6CCCC6)CC5=NN3C2)C4)cc1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 179
NON-LLM GENERATED: CN1C=C(C2=CN3C(SC4=CC5=CC(N6CCN(O)C(=O)C6)=CN=C5C=C4)=NN=C3C(F)=C2)C=N1
Cn1cc(-c2cc(F)c3nnc(Sc4ccc5ncc(N6CCN(O)C(=O)C6)cc5c4)n3c2)cn1

Boltz running on GPU 2
10.98
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(C1=C(F)C=C2N=CC=CC2=C1F)N1C=NC2=NC=C(C3=CN(CCO)N=C3)N=C21,-11.12]
[CC1=CSC(C2=NN3C(=NN=C3CC3=CC=C4N=CC=CC4=C3)C=C2)=C1,-11.2]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, pi-stacking, and hydrophobic contacts. The existing molecules already have aromatic systems that likely contribute to pi-stacking with the protein, so preserving that is important. 

Molecule 1 has fluorine atoms that may assist with hydrophobic and electronic effects, while Molecule 2 incorporates sulfur and multiple heterocycles to stabilize the binding through diverse interactions. To build on this, introducing additional aromatic rings or heteroatoms could increase binding possibilities. Also, adding polar groups like hydroxyl may improve hydrogen bonding without compromising hydrophobic contacts.

Considering these points, I would design a molecule that maintains the core heterocyclic system for strong stacking and adds a phenol group to enhance hydrogen bonding. Additionally, incorporating a methoxy-substituted phenyl ring could offer both electron-donating effects and extra interaction points.

Therefore, my proposed molecule is:

\box{COc1ccc(-c2ccc3ncc(N=Cc4cc(-c5ccc6ncccc6c5)ccc4=O)cc3=nc2)cc1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 180
NON-LLM GENERATED: CC1=CSC(CN2C=C(C3=CN=C4N=CN(C(C)C5=C(F)C=C6N=CC=CC6=C5F)C4=N3)C=N2)=C1
Cc1csc(Cn2cc(-c3cnc4ncn(C(C)c5c(F)cc6ncccc6c5F)c4n3)cn2)c1

Boltz running on GPU 2
11.21
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CN1C=C(C2=CN3C(=NN=C3SC3=CC=C4N=CC(NC(=O)C(F)(F)F)=CC4=C3)C=C2)C=N1,-10.51]
[Cn1cc(-c2cc(F)c3nnc(Sc4ccc5ncc(NC6CCOCC6)cc5c4)n3c2)cn1,-11.08]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, pi-stacking, and hydrophobic contacts. The first ligand has strong aromatic and heterocyclic features that contribute to binding, but its trifluoromethyl group could be rigid and limit conformational flexibility. The second ligand incorporates a morpholine ring for polarity and solubility, which is beneficial, but its binding affinity is only slightly higher.

To strike a balance between rigidity and flexibility, I would replace the trifluoromethyl group with a less bulky but still electron-withdrawing substituent that can maintain strong interactions while allowing the ligand to adapt better in the pocket. Introducing a chloro substituent on the aromatic ring could enhance hydrophobic contacts and sometimes form additional halogen bonds, improving affinity.

Therefore, I propose the following molecule, which replaces the trifluoromethyl group with a chlorine atom and keeps the key heterocycles and morpholine moiety that seem important for activity:

\box{Cn1cc(-c2cc(Cl)c3nnc(Sc4ccc5ncc(NC6CCOCC6)cc5c4)n3c2)cn1}
LLM-GENERATED: Cn1cc(-c2cc(Cl)c3nnc(Sc4ccc5ncc(NC6CCOCC6)cc5c4)n3c2)cn1
Cn1cc(-c2cc(Cl)c3nnc(Sc4ccc5ncc(NC6CCOCC6)cc5c4)n3c2)cn1

Boltz running on GPU 2
10.78
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(c1ccc2ncccc2c1)n1nnc2ncc(-c3cnn(C4CCN(C(N)=O)CC4)c3)nc21,-10.56]
[CC(CO)OC1=CC=CC(NCC(O)COC2=CC=NC3=CC(C4=CN(C)N=C4)=CC=C32)=C1,-10.67]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions such as increasing hydrogen bonding capacity and improving fit into the binding pocket. The first molecule has a urea-containing side chain that provides hydrogen bonding but may be too flexible or poorly oriented. The second molecule incorporates more aromatic rings and ether linkers, which improve rigidity and stacking potential, but its ether groups might add bulk or reduce hydrophobic contacts.

By combining the benefits, I would design a molecule with an amide-containing piperazine ring to maintain hydrogen bonding and rigidity, linked via a hydrophobic alkyl chain to a fused aromatic heterocycle that includes nitrogen atoms for strong polar interactions. This structure should optimize both hydrophobic and polar contacts while balancing size and flexibility.

\box{CCN1CCN(C(N)=O)CC1CCc1ccc2ncccc2c1-n1nnc2ncc(-c3cnn(C4CCCCC4)c3)nc22}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 181
NON-LLM GENERATED: CC(CO)OC1=CC(N)=CC=C1
CC(CO)Oc1cccc(N)c1

Boltz running on GPU 2
4.75
420/1000 | avg_top1: 12.050 | avg_top10: 11.759 | avg_top100: 11.132 | avg_sa: 3.250 | div: 0.812
{'avg_top1': 12.05, 'avg_top10': 11.758999999999999, 'avg_top100': 11.132100000000003, 'auc_top1': 4.97795, 'auc_top10': 4.842585, 'auc_top100': 4.530010809523811, 'avg_sa': 3.250062669330855, 'diversity_top100': 0.8119464579283904, 'n_oracle': 420}
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CC(C1=C(F)C=C2N=CC=CC2=C1F)N1C=NC2=NC=C(C3=CN(C)N=C3)N=C21,-10.95]
[COCCOC1=CN=C2C=CN(C(C)C3=NN=C4C(C)=CC(C5=CC(C)=NO5)=CN43)C(=O)C2=C1,-10.79]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: Analyzing the two given molecules, I notice that both have a core aromatic system with nitrogen atoms contributing to hydrogen bonding and pi-stacking interactions. Molecule 1 has fluorinated phenyl rings which likely enhance hydrophobic and electronic effects, while molecule 2 incorporates oxygen-containing heterocycles and an ethoxy substituent, possibly improving solubility and binding versatility.

To improve binding affinity, I would consider combining the beneficial features from both molecules: maintaining the fluorinated aromatic system for hydrophobic and electronic effects, and introducing additional heterocyclic motifs that can form stronger or more diverse interactions. Incorporating an isoxazole ring could provide hydrogen bonding acceptors/donors and rigidity, while a methylated amine substituent might enhance sensitivity and specificity.

Based on this reasoning, I propose the following molecule:

\box{COc1cc(-c2cc(C(=O)Nc3ccc4ncccc4c3C)c2NC(=O)C2(C(=O)N3CC(=O)N(C)C3)CC2)c1}
LLM-GENERATED: COC1=CC(C2=CC(C(=O)Nc3ccc4ncccc4c3C)=C2NC(=O)C2(C(=O)N3CC(=O)N(C)C3)CC2)=C1
COC1=CC(C2=CC(C(=O)Nc3ccc4ncccc4c3C)=C2NC(=O)C2(C(=O)N3CC(=O)N(C)C3)CC2)=C1

Boltz running on GPU 2
9.44
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[N#CC1=CC(C2=CN3C(CC4=CC=C5N=CC=CC5=C4)=CN=C3C(F)=C2)=CC=C1,-11.07]
[[C-]#[N+]C1=C2COCCN2C2=C(C(=O)OC2)C1C1=CC=C2NN=C(C)C2=C1,-10.9]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance interactions like hydrogen bonding, pi-stacking, and electrostatic bonding. The first molecule has a strong aromatic system that likely contributes to stacking, while the second molecule introduces oxygen atoms for polarity and potential H-bonds. Combining these features could yield a stronger ligand.

Specifically, adding a polar group such as a hydroxyl attached to an aromatic ring can improve hydrogen bonding without disrupting the planar stacking. Also, maintaining the triazole or related fused rings that interact well with the c-MET binding site would preserve key interactions.

Combing a hydroxy-substituted phenyl ring with the existing fused heterocycles and methyl-substituted aromatic systems from the first ligand seems promising. This addition should enhance affinity by adding H-bond donor/acceptor groups while retaining aromatic stacking.

\box{CC1=CC(C2=CN3C(CC4=CC=C5N=CC=CC5=C4)=CN=C3C2)=CC(-c1ccc(O)cc1)C1=CC=C2NN=C(C)C2=C1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 182
NON-LLM GENERATED: CC1=CC=C2N=CC=CC2=C1
Cc1ccc2ncccc2c1

Boltz running on GPU 2
5.22
Prompt: We will collaborate on generating a ligand for c-MET with high binding affinity. I will give you the output from docking software after each of your attempts. Assume that there are always more improvements to be made to the current ligand.
Provided are two existing molecules and their binding affinities to c-MET:
[CNC(=O)C1=CC=C(C2=NN(CCC3=CC=C4N=CC(C5=CN(CCO)N=C5)=CC4=C3)C(=O)C=C2)C=C1C(F)(F)F,-11.8]
[COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4=C(I)C=CN(C5=CC=C(F)C=C5)C4=O)C=C3F)=C2C=C1OC,-11.4]
First describe what you have learned from the above information. Then propose a new molecule that binds better to c-MET. You can either make crossovers and mutations based on the two given molecules or just propose a new molecule based on your knowledge of the protein target. Ensure that your generation is unique from the two input molecules. Follow this exact format for your final answer, character by character: \box{MOLECULE}, where MOLECULE is your proposed ligand in SMILES format.
Response: To improve binding affinity, I would look for ways to enhance hydrogen bonding, aromatic stacking, and polar interactions, especially in the region interacting with the tyrosine 1234 motif in c-MET. The trifluoromethyl group in the first molecule contributes to hydrophobic interactions but might be balanced with more polar functionalities. The second molecule includes methoxy groups that could improve solubility and hydrogen bonding, but increasing rigidity and planarity might stabilize binding.

Based on this, introducing a hydroxyl group to add hydrogen bonding capacity and incorporating a fused bicyclic aromatic system could enhance π-π stacking and shape complementarity. Also, placing an amide linkage to link a substituted pyridine ring may optimize interactions with the active site while maintaining lipophilicity.

Therefore, I propose the molecule:

\box{CCOc1cc(=O)n(-c2ccc(Oc3ccnc4cc(OC(=O)Nc5ccc6c(c5)cccc6C)c(=O)cc34)c(F)c2)c(=O)n1-c1ccc(=O)n2cc(OCCO2)c1}
LLM-GENERATED: None
Traceback (most recent call last):
  File "/home/ubuntu/MOLLEO/single_objective/main/molleo/custom_llm.py", line 112, in edit
    assert proposed_smiles != None
AssertionError
AssertionError 
NUM LLM ERRORS: 183
NON-LLM GENERATED: CNC(=O)C1=CC=C(OC2=CC=NC3=CC(OC)=C(OC)C=C32)C1F
CNC(=O)C1=CC=C(Oc2ccnc3cc(OC)c(OC)cc23)C1F

Boltz running on GPU 2
